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Abstract 
 
Background: People with depression should be actively involved in deciding what 
treatment they are prescribed. In order to facilitate informed decision-making, 
healthcare professionals need to be aware of, and respond to the decision-making 
issues patients find important. Whilst a number of factors have been related to 
particular treatment decisions in depression, little is known about how these factors 
relate to each other and how influential people think they are in relation to 
treatment decision-making.  
Aim: To better understand what factors influence treatment decisions made by 
depressed people.  
Method: Using concept mapping, an established mixed methods design, I collected 
and compared the views of patients (n=28), their family and friends (n=14) and 
healthcare workers (n=22). The method involves three data collection tasks.   
1. Brainstorming – within the group or in individual sessions, participants 
brainstorm about the factors that influence treatment decisions made by 
depressed people. The factors are recorded as individual ‘statements’, and 
pooled at the end of the phase in order to be reviewed and reduced to below 
98. All participants are invited again to take part in the following tasks. 
2. Clustering – participants individually put together into groups the statements 
that they consider to be related based on their own criteria. 
3. Prioritising – participants individually rank their perceived relative importance 
of each statement with regards to its effect on patients’ treatment decisions. 
Results: The three stakeholder groups differed significantly in their opinions about 
which factors they considered to be most influential l of patients’ treatment 
decisions. These factors included patients’ insight, emotional states (i.e. how I feel 
right now), external views about depression (stigma) and doctors’ advice. I also 
identified five subgroups of patients with depression who differed significantly in 
their views about how they make treatment decisions.  
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Conclusion: To facilitate more considered decisions about depression treatment, 
mental health professionals need to better understand how treatment choices are 
made. Health professionals should be more vigilant to the differences of individual 
patients. 
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 Chapter 1 Introduction to thesis 
 
1.1 Introduction  
Depression is a mood disorder with a profound impact on wellbeing of the patients 
and their close family and friends. Depression affects up to one in ten people in 
their lifetime (Waraich et al., 2004) and it is the leading cause of burden of disease 
(Ferrari et al., 2013b). At the same time, depression is treatable and with 
appropriate intervention most people could fully recover and lead healthy lives 
(Dawson et al., 2004). Treatment of depression, including less severe forms of the 
illness is important, since even mildly depressed mood can significantly impact on a 
person’s wellbeing (Klein et al., 2006). But research shows that only a limited 
proportion of depressed people seek help for their symptoms (Alonso et al., 2000). 
Moreover, receiving appropriate treatment is not very common (Kessler et al., 
2003) and most patients discontinue their treatment too early and without prior 
consultation with their physician (Olfson et al., 2006).  
 
In recent years, patients’ active engagement in treatment decisions has received 
considerable attention. The practice guidelines recommend that professionals 
should involve patients in the treatment decision-making (NICE, 2009), whilst 
research shows that many professionals perceive considerable barriers to doing so 
(Legare et al., 2008). But regardless of the professionals’ views, many patients also 
make their own decisions about what treatment they would prefer, which health 
professional they visit, whether they follow the tasks involved in psychological 
therapies or whether they take the medication as prescribed. Patients have become 
more autonomous in their healthcare choices and in order to provide adequate 
help, mental health professionals should understand how depressed people make 
decisions about treatment. I therefore aimed to explore the factors affecting 
patients’ treatment decisions about depression treatment. Rather than viewing 
depressed people as detached individuals making solely independent decisions, I 
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sought to understand their treatment choices within the context of their family and 
friends and healthcare professionals.  
 
1.2 Study aims and objectives 
This study was designed to help develop understanding about how people with 
depression decide about their treatment for the illness.  
 
1 To explore what factors influence treatment decisions made by people with 
depression from the perspectives of the patients, their family and friends, 
and healthcare workers who have professional contact with people with 
depression. 
2 To gain insight into how these three groups understand the relative 
importance of the factors identified, and compare and contrast their views 
about patients’ depression treatment choices. 
3 To explore the possibility of identifying different types (categories) of 
patients, family and friends and professionals, based on their opinions about 
the factors affecting patients’ treatment choices. 
 
To achieve these aims I worked with people with depression; partners, family 
members or close friends helping these patients (family and friends) and healthcare 
workers currently or recently involved in the treatment of people with depression. 
This study provides an in-depth analysis of the aspects people with depression 
consider when making a decision about treatment for depression and the 
perspectives of family and friends and healthcare workers about this issue. The 
overall objective was to obtain a better understanding about how depressed 
patients consider and select the different treatment options. In this study I did not 
distinguish between the individual types of decisions, e.g. help-seeking or 
adherence. Instead, I worked with an assumption that all types of treatment 
decisions are influenced by the same set of factors. This was based on the similarity 
of the factors previously identified as important in the individual types of treatment 
choices, such as health professionals, access to treatment or stigma. Moreover, 
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since people often make irrational rather than fully informed decisions, the factors 
that are important for a person in a given period of time might affect their choices 
regardless of type. 
 
1.3 Contribution of the thesis 
The need to understand how patients with depression make treatment decisions 
has been articulated in previous research. In this thesis, I explored the factors that 
influence treatment decisions made by depressed people. Specifically, I focused on 
the views of patients, their family and friends and healthcare workers about the 
relative importance and relationships between the individual factors. Whilst a 
number of factors have previously been identified as impacting on patients’ 
treatment choices, this study is the first to systematically involve three stakeholder 
groups in order to explore their perspectives about the topic. 
 
This study provides a novel observation about the relationships between the 
individual factors participants identified. This is also the first study to show the 
relative importance of the individual factors from the participants’ views. Using 
concept mapping method enabled the collection of invaluable information about 
how the stakeholders perceive patients’ treatment choices. The views of the 
individual groups about the factors’ influence can therefore be compared and 
contrasted. Such comparisons show to what extent the groups agree about how 
decisions are made about depression treatment. Based on this information, future 
interventions can be developed to address the identified issues, and help 
professionals to facilitate effectively patients’ involvement in the decisions. 
 
1.4 Structure of the thesis 
In Chapter 2 I describe depression, its epidemiology and recommended treatment. 
Research shows that despite availability, adequate treatment is not provided to 
most depressed patients. In Chapter 3 I provide an overview about decision-making 
and the potential effects of depression on the related cognitive processes. I then 
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review the literature about the factors influencing patients’ treatment choices. In 
Chapters 4 and 5, I explain and justify the methodology, procedure and data 
analysis used in this study. Descriptive results are shown in Chapter 6, the individual 
factors affecting choices are presented in Chapter 7 and the perceived relative 
importance of these factors, as viewed by the three stakeholder groups is shown in 
Chapter 8. I present the differences between types of participants in Chapter 9. The 
study findings are discussed in detail in Chapter 10, and conclusions and future 
recommendations are provided in Chapter 11.  
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 Chapter 2 Depression and treatment 
 
2.1 Introduction 
In order to review the literature about depression and treatment decisions made by 
depressed patients, I searched the main medical and psychological databases, 
including Medline, Psychinfo and Cinahl. In the searches I combined the term 
depression with relevant keywords, including adherence, help seeking, treatment 
preference, treatment choice, patient choice, patient preference, decision, belief 
and attitude. I included peer reviewed research articles written in English, published 
from year 2000 onwards as the original criteria but included a few key earlier 
papers. In the process of the review, these papers were signposted in other 
publications. I specifically looked at systematic, scoping and other comprehensive 
reviews of the relevant literature and reports of primary research using qualitative, 
quantitative and mixed methods with participants aged 18 years or older. I also 
included relevant practice guidelines as appropriate. 
 
2.2 Depression 
Whilst everyone can feel down and sad in response to various life stressors, 
depressive episode can be diagnosed when such emotions impact significantly on 
everyday life and are experienced over a prolonged period of time. 
 
2.3  Severity of depression 
Depression can be diagnosed as a single episode, recurrent or chronic illness. Based 
on the assumed aetiology, it has been described as endogenous, when there is no 
apparent environmental trigger for the illness, or reactive, when patients can 
identify stressful life events prior to developing an episode. It is typically described 
as mild, moderate or severe, depending on the number and severity of symptoms. 
Some authors have suggested that it might be better understood on a continuum 
from normal mood to severe depression, rather than as three distinct types. For 
Page 23 of 386 
 
example, Cuijpers et al (2004) in a Dutch population-based interview study with 
7,076 respondents described depression within 5 categories based on the number 
of symptoms and functional disability. They found that even mild depression had an 
impact on patients’ functionality.  
 
Additionally, even sub-threshold depression often has a strong impact on people’s 
health and wellbeing. In a World Health Organisation Survey based on a sample of 
252,503 members of general population from 68 countries, Ayuso-Mateos et al 
(2010) reported that impact of depression on health status is similar in patients with 
any severity. Similarly, Nuevo et al (2010) found in a general health survey with 551 
participants, that quality of life appears to decrease significantly after becoming 
depressed regardless of diagnostic severity. Sub-threshold depression has also been 
associated with an increased probability of developing a depressive episode and 
suicide attempts, based on an epidemiological community study (N=10,526) (Judd 
et al., 1997). A chronic type of sub-threshold or mild depression is dysthymia, 
characterised by at least four symptoms present on most days for duration of at 
least two years (APA, 2010).  
  
2.4  Symptoms  
Depression affects people on emotional, cognitive and somatic levels. Key 
symptoms include depressed mood, loss of pleasure in most activities and fatigue. 
Based on the widely used diagnostic manuals, the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-V) (APA, 2013) and the International Classification of 
Diseases (ICD-10) (WHO, 2010), at least one or two of these symptoms need to be 
present for a diagnosis respectively. In addition, four out of ten symptoms are 
required by the DSM-V or at least five out of nine depressive symptoms according 
to the ICD-10. The symptoms should be present almost every day, most of the day 
for at least two weeks (APA, 2013, WHO, 2010). These additional symptoms include 
appetite/weight disturbances, too much or too little sleep, notably slower activity 
(for example, speech), fatigue, tiredness or loss of energy, thoughts of excessive 
guilt, desperation, worthlessness, lower concentration and attention, and thoughts 
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of self-harm, death or suicide (APA, 2013, WHO, 2010). People with depression also 
often report medically unexplained physical pain. Overall, the particular set of 
symptoms varies considerably among different people and in different times during 
the illness (Judd et al., 1997). In a selective review, Patten et al (2008) suggested 
that even people with a diagnosable syndrome might not require intensive 
treatment and that patients should be treated in a more individual manner.  
 
2.5 Impact  
Depression has a substantial impact on life and wellbeing of patients and their 
social environment. Based on a systematic review and meta-analysis of 
epidemiological data, Ferrari et al (2013b) found that depression is a leading cause 
of years lived with disability (YLD). In another review of epidemiological studies, 
Moller et al (2003) found that nearly 70% of suicides in England were related to 
depression. Additionally, they reported that between 60% and 70% of patients with 
acute depression considered suicide and 10-15% attempted a suicide. In a pan-
European cross-sectional study, the lifetime risk of suicide attempt in depressed 
people was around 28% (Bernal et al., 2007). The authors also reported that almost 
8% of the population have experienced suicidal thoughts (Bernal et al., 2007). In 
England in 2000, depression resulted in a loss of almost 110 million working days 
and a loss of 2,615 lives (Thomas, 2003). The author reported that the total 
estimated cost of depression in people over the age of 15 years in England was 
more than £9 billion, while the cost of direct treatment was £370 million. 
 
2.6 Epidemiology  
Depression is a common mental illness and affects approximately 350 million 
people around the world (WHO, 2012). Despite the general consensus that the 
illness is common, the reported prevalence of depression varies considerably across 
continents and individual countries. In a review of epidemiological studies, Waraich 
et al (2004) found that depression is approximately three times more common in 
Europe, and seven times less common in Asia than the rest of the world.  
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Authors of the Adult Psychiatric Morbidity Survey in England (n=7,403) reported 
that at any one time, approximately 2.3 percent of the general population in 
England aged over 16 meet the diagnostic criteria for depression (Deverill and King, 
2009). Studying specifically the UK primary care population (n=47,170), Martin-
Merino et al (2010) found that the prevalence of depression in this sample was 
more than 11%. They reported findings of a cohort study using data from a primary 
care research database (THIN) with nearly 50,000 primary care patients and 
matched controls (Martin-Merino et al., 2010).  
 
Reports of the 12-month and lifetime prevalence of depression vary across studies, 
as well. In a US-based general population survey conducted using face-to-face 
interviews (n=9,090), 12-month prevalence of depression was 6.6 percent (Kessler 
et al., 2003). On the other hand, Waraich et al (2004) systematically reviewed 23 
studies conducted in different countries and found that depression globally affected 
just over 4 percent (range of 0.6 to 15.4 per 100) and dysthymia affected 2 percent 
(range of 0.8 to 3.3 per 100) of the general population in the previous year. In terms 
of lifetime prevalence, Waraich et al (2004) found that nearly 7 percent (range 
between 0.9 and 29 per 100) of the general population have depression and almost 
4 percent (range of 0.9 to 14 per 100) have dysthymia. On the other hand, Kessler 
et al (2003) reported the lifetime prevalence of depression to be over 16 percent. 
Kessler et al (2003) also found that of people with 12-month depression, 10% had a 
diagnosis of mild, 39% had moderate, 38% had severe and 13% had very severe 
depression. 
 
Whilst the authors of these studies aimed to calculate the prevalence of depression 
within the general or primary care populations, the reported data should be 
compared carefully due to differences in inclusion criteria, study populations and 
assessment methods. For example, while Martin-Merino et al (2010) included 
primary care patients aged 10-79 years, Deverill and King (2009) included members 
of the general population older than 16 years, with no upper age limit. Additionally, 
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Waraich et al (2004) included people aged over 16, but Kessler et al (2003) only 
interviewed people aged over 18 years, although the studies were generally focused 
on the adult population. Another issue is the diagnostic manual used to determine a 
diagnosis, as some authors used the DSM-III and ICD-10 criteria, but in more recent 
studies, the DSM-IV was used. Additionally, some authors have criticised the varying 
definitions of the term ‘prevalence’ and the resulting differences in the prevalence 
periods reported (Waraich et al., 2004). All of these variations make it more difficult 
to compare the results across studies. 
 
2.7  Course of depression 
As required by diagnostic manuals, a depressive episode typically lasts for at least 
two weeks, but can vary considerably among individuals. Findings from general 
population surveys in the US and Netherlands (n=7,076) suggest that an average 
episode lasts between 3 and 8 months (Kessler et al., 2003; Spijker, 2002). Spijker 
(2002) also reported that approximately half of all patients reached remission of 
symptoms after three months. About 30 percent of patients do not recover within 
six months, 25 percent are depressed after one year and almost 20 percent of 
patients still meet diagnostic criteria after two years (Spijker, 2002). Based on the 
findings of a systematic review, Holzel et al (2011) suggested that chronicity of 
depression was associated with its onset at age below 21-25, a longer duration of 
episodes and a family history of affective disorders.  
 
2.7.1 Demographic characteristics 
In a large US-based household survey (n=14,710), the average age of depression 
onset was found to be 24 years for 12-month prevalence and 26 years in case of 
lifetime depression (Gonzalez et al., 2010). The results of another US household 
survey (n=9,282) showed that half of all people with depression have their first 
episode before the age of 14 and 75% before age 24 (Kessler et al., 2005). 
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In a large European general population survey (n=1,884), Angst et al (2002) found 
that depression appears to affect men and women in different ways in terms of 
symptoms and disability based on a number of symptoms. Other population-based 
studies showed that depression is more common in women than men with a risk 
ratio of almost 1.5 (Ferrari et al., 2013b). Whilst this might be caused by women’s 
higher susceptibility to depression, Doherty and Kartalova-O’Doherty (2010) 
suggested that this might be because women are also more likely to disclose the 
symptoms and seek help. Conversely, men are more likely to die by suicide 
accounting for up to 75 percent (ONS, 2012). This might suggest that men might 
address emotional difficulties in different ways. In the European survey, depression 
with more than five symptoms was most common in people aged 45-54 (8.9% in 
men and 16.6% in women) (Angst et al., 2002). Mild depression (up to four 
symptoms) was most common in young men aged 16-24 (6.6%), in women aged 65-
74 (7.9%) and in young women (7.3%) (Angst et al., 2002).  
 
2.8 Risk factors 
The cause of depression is often unknown, but multiple factors contribute to the 
development of an episode. Meng and D’Arcy (2014) reported that modifiable risk 
factors such as chronic illness, smoking and low income might explain 
approximately 40% of depression cases. Their findings were based on a 16-year 
cohort study in a sample of 15,254 participants in the Canadian general population. 
Other risk factors include previous episodes of depression, family history and 
genetic factors, adverse life events and individual characteristics such as 
personality. 
 
2.8.1 Previous episodes 
Depression is highly recurrent. Results of a 15 year follow-up study (n=485) showed 
that female gender, the duration of a depressive episode and quantity of previous 
episodes increased the risk of recurrence (Mueller et al., 1999). Approximately one 
in five patients treated with antidepressants relapse within one year after diagnosis, 
compared to more than double in those treated with placebo, according to meta-
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analysis of 11 studies (Williams et al., 2009). In a follow up of 37 depressed patients 
over 23 years, Yiend et al (2009) suggested that almost two in three patients 
experience at least one further episode within 23 years after diagnosis. The authors 
reported that most people had at least two additional episodes that were often 
chronic. In a systematic review of epidemiological studies, Hardeveld et al (2010) 
reported that, in a specialised mental health setting, 60% of patients have another 
depressive episode within 5 years and 85% have another episode after 15 years. 
 
2.8.2 Comorbidity   
Depression has been associated with a number of comorbid illnesses. Mergl et al 
(2007) reported findings of a cross-sectional primary care-based study (n=394) and 
suggested that a combination of depression and anxiety or somatoform disorders 
were the most common, affecting more than 6 times more patients than depression 
alone. In a longitudinal study of 8,387 people aged between 51 and 61 years, Polsky 
et al (2005) found that, within two years of diagnosis, depression affected 
approximately 13% of people with cancer and chronic lung disease, 9% of patients 
with stroke and 5% of people with heart disease, diabetes and arthritis. Over an 
eight-year study period, patients with chronic lung disease and heart disease were 
at the highest risk of depression (Polsky et al., 2005). Findings of a meta-analysis 
showed that the risk of depression was doubled for people with diabetes compared 
to people without diabetes (OR=2.0; 95%; CI 1.8-2.2) (Anderson et al., 2001). 
Reviewing the literature, Robinson (1998) found that between 20 and 40 percent of 
post-stroke patients develop depression. Additionally, approximately half of 
patients after myocardial infarction (MI) become depressed, based on the findings 
of a prospective study with 288 patients (Lane et al., 2002).  
 
2.8.3 Personality 
Personality characteristics, mainly neurotic and distressed traits, have been 
associated with increased risk of becoming depressed. In a large pan-European 
study across 21 countries, Kupper et al (2013) found that a combination of 
increased negative affectivity and social inhibition to express emotions (Type D 
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personality) was significantly related to a depressive episode. Additional personality 
traits, such as increased trait neuroticism and low conscientiousness were related 
to depression in a recent prospective community-based study with 500 older adults 
(Weiss et al., 2009). 
 
2.8.4 Stress, adverse life events and genetic predisposition 
Adverse and stressful life events such as loss of job, divorce, bereavement have 
been identified as a risk factor for developing a depressive episode. Farmer and 
McGuffin (2003), in a study with 108 depressed patients and 105 controls, found 
that having experienced a severe humiliating or loss-related life events was linked 
to developing depression, but encountering a large number of non-severe events 
was not. Zubenko et al (2001) in a diagnostic study involving 81 depressed people 
and their nuclear families suggested that genetic predisposition is linked to 
depression with onset before age 25. In a 9-year longitudinal study with twins, 
Kendler et al (2001) linked these effects with genetic predisposition, suggesting that 
people with an increased genetic risk for depression reported fewer stressful life 
events prior to having an episode.  
 
2.9 Diagnosis 
Most people with depression are diagnosed and treated in primary care. Screening 
using a two-question test (Whooley et al., 1997) can detect the illness in 86% of 
depressed people. To determine the diagnosis and severity, further testing is 
needed since its specificity was found to be 78% in a New Zealand validation study 
with 2,642 primary care patients (Arroll et al., 2010). In primary care, the Patient 
Health Questionnaire is commonly used (Kroenke et al., 2001). It contains nine 
questions about individual symptoms based on the diagnostic criteria in DSM IV, 
and patients are asked to rank how frequently they experienced the symptoms over 
past 2 weeks. The questionnaire has been tested in a number of studies. In an US-
based study with primary care and obstetrics-gyneacology patients (n=6,000), 
Kroenke et al (2001) reported both the sensitivity and specificity of PHQ-9 to be 
88% (Kroenke et al., 2001). Arroll et al (2010) tested the questionnaire against a 
Page 30 of 386 
 
structured interview (CIDI) and found the sensitivity and specificity to be 74% and 
91% respectively.  
 
A full diagnosis of mental illnesses can be determined by a clinical fully structured 
interview (Composite International Diagnostic Interview) (WHO, 1990). It is based 
on the mental illness diagnostic criteria of ICD-10 and DSM-IV (Kessler and Ustun, 
2004). 
 
2.10 Treatment  
The majority of people with depression are seen in primary care where optimised 
treatment should achieve remission in about 50-67% of patients, based on a meta-
analysis of 13 randomised controlled trials (n=3,202 patients) (Dawson et al., 2004). 
In the UK, treatment of depression in primary care should be based on the clinical 
guidelines published by the National Institute of Health and Clinical Excellence 
(NICE, 2009). Other influential guidelines include those published by the British 
Association for Psychopharmacology (Anderson et al., 2008) and the American 
Psychiatric Association (APA, 2010). The guidelines comment on the recognition and 
diagnosis of depression, recommendations about the clinician’s approach to 
patients and strategies of treatment selection.  
 
All three guidelines recommend that professionals should involve patients in 
treatment decision-making (NICE, 2009, APA, 2010, Anderson et al., 2008). The NICE 
guidelines also advise that professionals should encourage patients to play an active 
role during prescription of treatment for depression. Health professionals should 
also sensitively explore and address patients’ concerns about the illness and 
treatment (NICE, 2009). The factors that should be considered when making a 
choice include patients’ preferences and experiences, evidence of treatment 
effectiveness, side effects and its availability.  
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The NICE guidelines recommend a stepped care approach to patients with 
depressive symptoms.  In this approach patients with any depressive symptoms are 
offered an appropriate intervention that is minimally intrusive. If the desired effects 
are not achieved, a more intense treatment should be recommended. The other 
two guidelines also recommend different treatments for people with various 
symptoms, but do not specifically mention the stepped care model. 
 
For sub-threshold depression, the NICE guidelines recommend watchful waiting, 
lifestyle changes and guided self-help programmes. For mild to moderate 
depression all three guidelines recommend psychological therapies such as 
cognitive behavioural therapy (CBT) and interpersonal psychotherapy (IPT) 
(Anderson et al., 2008, APA, 2010, NICE, 2009). Only one of the manuals endorsed 
counselling (NICE, 2009). The NICE and BAP guidelines also suggest regular exercise 
or self-help therapies. The APA and BAP guidelines recommend medication for 
people with mild and moderate depression, but the NICE guidelines do not 
recommend medication for mild depression due to lack of evidence of efficacy. In a 
meta-analysis of antidepressant trials, Kirsch et al (2008) found that the effect of 
the medication was greater in more severe depression. The clinical guidelines 
consistently advise prescription of mediation to people with persistent dysthymia, 
moderate and severe depression (Anderson et al., 2008, APA, 2010, NICE, 2009). 
 
2.10.1 Antidepressant medication 
Antidepressants are prescribed for depression based on evidence that they increase 
the levels of available neurotransmitters such as noradrenaline, dopamine and 
serotonin in the brain areas including the prefrontal cortex, hippocampus, amygdala 
and thalamus (Willner et al., 2013). Whilst Andrews et al (2011) in a literature 
review suggested that the evidence that low levels of these neurotransmitters 
cause depression is inconclusive, Dawson et al (2004) in a meta-analysis of 13 
studies (n=3,202 patients), found that antidepressants can effectively reduce 
symptoms in 50-67% of patients, compared to 32% remission in placebo conditions. 
In a secondary analysis of an earlier longitudinal study with 225 patients starting to 
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take antidepressants, 45% of people reached remission within two years from start 
of treatment (Simon, 2000). There are four main types of antidepressant 
medication, including Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic 
antidepressants (TCAs), Mono Amine Oxidase Inhibitors (MAOIs) and third-
generation antidepressants. The drugs differ in the effects and side-effects.  
 
All guidelines recommend that treatment with antidepressants should continue 
beyond patients’ remission, but they differ in the suggested duration. The APA 
guidelines suggest a continuation phase of between four and nine months, whilst 
the NICE recommend at least 6 months and the BAP a duration of 6 to 9 months 
after full remission. If the risk of relapse is considered to be high, guidelines 
recommend at least 1 to 2 years (Anderson et al., 2008) or at least 2 years (NICE, 
2009) of maintenance treatment. 
 
Results of a primary care cohort study showed that antidepressants are prescribed 
to approximately 90% of patients with depression (Martin-Merino et al., 2010). 
Despite their frequent use and the evidence of effectiveness in reducing depressive 
symptoms (Dawson et al., 2004), antidepressant medication is commonly perceived 
in a negative light. For example, in a Danish postal survey involving 500 hospital 
patients with depression or bipolar disorder, Kessing et al (2005) found that 
between 40 and 80 percent of respondents had negative views about the effect of 
antidepressants. Jorm et al (1997), in a large Australian survey, compared the 
perceptions of 2,031 members of the public and 2,454 health professionals about 
the helpfulness of mental health treatment. The authors found that professionals 
had more positive views about medication, while members of the public more often 
thought that people with mental illness should take dietary supplements and read 
self-help books. On the other hand, reporting findings of an Australian national 
survey (n=1,796 adults), Reavley and Jorm (2012) found that almost 64 percent of 
the general population viewed the medication as helpful, whilst almost 20 percent 
thought it was harmful. One of the most common worries about antidepressants is 
that they are addictive, even though these medications do not cause addiction. For 
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example, Stone et al (2004) reported results of interviews with 89 neurology 
outpatients, suggesting that almost three in four people thought that 
antidepressants were addictive and almost half of the sample considered them to 
be harmful. 
 
2.10.1.1 SSRIs 
SSRIs are generally recommended as the first line treatment when medication is 
indicated. They are the most frequently prescribed treatment for depression, and 
include citalopram, fluoxetine, paroxetine and sertraline among others. Their main 
effect is to block the reuptake of serotonin, with the intent to stimulate the neural 
pathways to improve mood and increase activity, but some of the drugs also affect 
reuptake of noradrenaline and dopamine (NICE, 2009). Their first effect can be felt 
almost immediately (Symonds and Anderson, 2012), although part of it is thought to 
be a result of placebo effect, which is a positive effect patients might perceive and 
attribute it to their therapy or treatment. In a meta-analysis of 96 antidepressant 
drug trials, Rief et al (2009) found that as much as 68% of the medication effect was 
accounted for by placebo. Some researchers suggested that due to the high placebo 
effect and limited ‘true’ effect of the medication, antidepressants should not be 
prescribed as widely as they are (Kirsch et al., 2008). Others, on the other hand, 
have argued that antidepressants are effective and even if they have a clinical but 
non-significant impact, the drugs should be made available to all patients, including 
people with milder depressive symptoms (Hegerl et al., 2012). 
 
Contrary to popular belief, SSRIs are not addictive, but due to a short half-life many 
types need to be discontinued gradually, in order to prevent withdrawal symptoms 
(NICE, 2009). Side effects of SSRIs are generally less severe than the older TCAs and 
MAOIs, yet are persistent and common in around two in three patients, as shown in 
a Dutch study with naturalistic primary care setting (n=927 patients) (Bet et al., 
2013). Most often the side effects include headache, nausea, diarrhoea, sexual 
difficulties, sweating and weight gain (Bet et al., 2013).  
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2.10.1.2 TCAs and MAOIs 
Tricyclic antidepressants (such as amitriptyline and imipramine) and monoamine 
oxidase inhibitors (MAOIs), for example moclobemide, were among the first 
medications for depression, developed in the 1950s (Kuhn, 1958). Their main effect 
is to block reuptake of monoamines and increase availability of noradrenaline and 
serotonin. The TCAs and MAOIs are toxic in overdose and have severe side effects 
including blurred vision, constipation, sedation, hypotension and cardiac toxicity 
(NICE, 2009). Anderson (2000) conducted a meta-analysis of data about the efficacy 
and tolerability of TCAs and SSRIs from 102 trials (n=10,706 patients) and 95 trials 
(n=10,553 patients), respectively. He reported that SSRIs were slightly better 
tolerated, but less effective than TCAs in hospitalised patients (Anderson, 2000).  
 
Monoamine oxidase inhibitors (MAOIs) and TCAs have mostly been replaced by the 
SSRIs and they are now suggested only for patients who do not respond to newer 
antidepressants (APA, 2010, NICE, 2009). 
 
2.10.2 Psychological therapies 
Psychological therapies recommended for depression are based on the principles of 
cognitive behavioural therapy (CBT), structured to help patients develop skills 
enabling them to identify and challenge their irrational thoughts. The therapy is 
based on cognitive theories suggesting that people’s automatic negative and 
dysfunctional thoughts influence emotions and behaviours, which are acting as an 
underlying risk factor for developing depression (Beck, 1967, Ellis, 1987). Beck 
(1967) referred to a cognitive triad, suggesting that a person’s dysfunctional or 
irrational thoughts about themselves trigger negative thoughts about their 
experiences and subsequently about the future. The two models describe 
depressed people’s thoughts as automatic, emphasising the negative and self-
criticising attitudes, over-generalisation of negative events, excessive 
personalisation and self-blaming, ignoring or dismissing positive aspects and 
minimising positive aspects of situations (Beck, 1967, Ellis, 1987). The aim of the 
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psychological therapies is to replace the negative thinking with a more effective 
approach to self and to external situations.  
 
NICE divides the therapies recommended for depression into two categories, which 
are low- or high-intensity (NICE, 2009). Low-intensity treatments are recommended 
for people with sub-threshold and mild depression and are based on principles of 
cognitive behavioural therapy (CBT). They are offered as a set of six to eight 
sessions of self-help and guided self-help (with brief contact with a health 
professional), such as computerised CBT, over a period of 9 to 12 weeks. Low-
intensity therapies have been found beneficial for people with mild to moderate 
depression. For example, Matcham et al (2014) systematically reviewed self-help 
interventions for psychological distress in people with physical comorbidities. In a 
meta-analysis of 25 studies and 421 patients, they suggested that the interventions 
had a significant positive effect on patients’ depressive symptoms. 
 
High intensity therapies are recommended for people with persistent mild or 
moderate to severe depression (NICE, 2009). They include individual or group CBT 
and interpersonal therapy (IPT), which should be provided for up to 16 to 20 
sessions over three to four months. Studies show that cognitive therapies can be 
effective for depression and prevent relapse. For example, Hollon et al (2005) found 
that cognitive therapy had a preventive effect on patients even after withdrawal of 
therapy, which was comparable to the effect of medication maintenance treatment. 
The authors reported findings of a randomised controlled trial with a 12 month 
naturalistic follow up with 104 patients with moderate to severe depression (Hollon 
et al., 2005). Despite the effectiveness of cognitive therapies, some authors 
questioned the causal effect of automatic negative thoughts on depression. For 
instance, reporting results of a 12-week group cognitive behaviour therapy 
programme with 168 depressed people, Oei et al (2006) suggested that treatment 
might affect patients’ depressive symptoms prior to helping them reduce the 
negative thoughts. For mild to moderate depression, the NICE guidelines also 
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suggest psychodynamic psychotherapy or counselling provided for up to 20 sessions 
within three to four months. 
 
2.10.3 Mindfulness-based therapy 
Mindfulness is a meditation technique originating in Buddhist philosophy (Kabat-
Zinn, 1990). To prevent and treat depressive symptoms, Segal developed 
mindfulness-based cognitive therapy (MBCT), in which people focus on their 
present state of mind with the aim of observing their emotions and thoughts and of 
interrupting the negative thinking modes as soon as they occur (Segal et al., 2002). 
It was developed as an 8-week individual or group-based therapy. During its course, 
patients also learn to identify the triggers of their negative thoughts and 
approaches to address them. The therapy is based on a theory that after 
experiencing a depressive episode, people are emotionally more vulnerable and 
sensitive to stress. Adopting a conscious awareness of thoughts could therefore 
help prevent further relapses (Segal et al., 2002).  
 
Research shows that the mindfulness based therapies can effectively reduce 
depressive symptoms. For example, Britton et al (2012) reported findings of an 8-
week randomised controlled trial with 52 people with depression in partial 
remission. They compared the effects of the MBCT and a waiting list condition, 
suggesting that participants in the experimental group had improved emotional 
reactivity to stress, whilst the control group showed anticipatory anxiety (Britton et 
al., 2012). In a larger trial with 60 people in remission from depression, Bondolfi et 
al (2010) compared the protective effect of MBCT and treatment as usual over a 
period of 14 months. The authors found that mindfulness therapy prolonged the 
time before relapse by almost 200%, although rates of relapse were similar in both 
groups (Bondolfi et al., 2010). Their findings were supported by the findings of a 
similar RCT by Van Aalderen et al (2012), who suggested that adopting MBCT 
effectively reduced the patients’ depressive symptoms through reducing rumination 
and anxiety. 
 
Page 37 of 386 
 
2.10.4 Other treatment 
General lifestyle changes including healthy diet and regular exercise can effectively 
reduce depressive symptoms and can be recommended for patients in addition to 
their usual care (NICE, 2009). Findings of a recent Cochrane systematic review 
showed that exercise can be as effective as cognitive therapy in alleviating 
symptoms of depression, but that more research is needed to determine the most 
suitable type (such as aerobic, anaerobic) and the exact therapeutic effect (Mead et 
al., 2009). The treatment guidelines also comment on alternative medicines, such as 
light therapy, nutritional and herbal supplements (for example St. John’s Wort) and 
generally do not recommend them as treatment for depression (APA, 2010, NICE, 
2009, Anderson et al., 2008). Light therapy is an exception, as it has been suggested 
as a potential choice for Seasonal Affective Disorder (APA, 2010, NICE, 2009, 
Anderson et al., 2008). 
 
2.10.4.1 Electroconvulsive therapy (ECT) 
ECT involves inducing an epileptic-like seizure through an electrical current applied 
to a patient’s brain. The therapy is provided under general anaesthesia. The therapy 
can have serious side effects, such as short-term or partial memory loss (amnesia), 
and it is generally recommended as a last resort treatment or treatment of choice in 
patients who do not respond to other treatments or are in a risk-of-life situation 
(APA, 2010, NICE, 2009, Anderson et al., 2008). 
 
2.11 Conclusion 
Depression is a distressing and potentially serious illness that has a profound impact 
on a person’s mental state and day-to-day functioning and treatment is 
recommended for all types of depression. An important aspect of treatment of 
depression is the ability and opportunity for patients to actively contribute to the 
treatment decision-making.  
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 Chapter 3 Patients’ treatment decision-
making 
 
3.1 Treatment decisions 
Despite the availability of effective treatment in primary care, depression is often 
under-treated. This is largely caused by patients’ and professionals’ need to make 
decisions about treatment. Before selecting an appropriate treatment option, 
depressed people need to seek medical help and disclose their symptoms to their 
doctor in order to access the formal treatment options, and physicians need to 
recognise the symptoms and provide an appropriate diagnosis.  
 
The factors associated with the suboptimal treatment of depressed people are 
related to health professionals as well as patients. For example, in a systematic 
review and meta-analysis, Cepoiu et al (2007) found that non-psychiatric primary 
care physicians often fail to recognise the illness. Goldman et al (1999), in another 
literature review, suggested that only half of all patients with depressive symptoms 
are given a diagnosis. Other issues are more associated with the patients, for 
example deciding to seek professional help and adherence to prescribed treatment 
regimen. 
 
Even when people consult their doctor and receive a diagnosis, prescription of 
adequate treatment is not guaranteed. Reporting findings of a large European study 
with 21,425 participants, Alonso et al (2004) found that 21 percent of people with 
mood disorders were not receiving any treatment at the time of the study. Results 
of large household surveys with around 10,000 respondents showed that between 
14 and 52 percent of people with depression or other neurotic disorders were 
receiving treatment (Bebbington et al., 2000, Kessler et al., 2003). Despite this, 
adequate treatment as recommended by practice guidelines was prescribed to only 
half of those people (Kessler et al., 2003). 
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3.2 Treatment decision-making framework 
According to the practice guidelines, depressed patients should be given an 
opportunity to take an active part in treatment choices and professionals should 
facilitate shared decision-making (NICE, 2009). Shared decision-making (SDM) is one 
of three main models of approaching patients, the others including paternalistic 
model and patients’ informed decisions (Charles et al., 1997). Rather than three 
unrelated models, the authors described the approaches as a continuum of the 
involvement the doctor and patient have in decisions, and communication between 
them. 
 
In the paternalistic approach, the clinician is viewed as the dominant figure and 
consultations are focused on collecting information about symptoms and giving 
advice about the best treatment, or persuading the patient to consent to the advice 
(Charles et al., 1997). In the model of patients making informed decisions, one of 
the parties is also expected to have a dominant role in the decision-making process, 
although it is the patient in this model. When patients are expected to, or they 
prefer to make their own informed choices, health professionals have limited 
involvement in the process, assuming that the patient is fully autonomous. The 
main problem with these two models is their emphasis on sole dominance of one of 
the involved parties, rather than a constructive conversation between them 
(McCabe et al., 2013). Within another approach, the preferred concept of shared 
decision-making, the professional and patient are both involved in the process of 
making treatment choices (Charles et al., 1997).  
 
According to the basic principles of SDM, the patient and at least one health 
professional should play an active role in the decision-making process (Charles et 
al., 1999). To do this, they are expected to share information (such as symptoms, 
diagnosis and treatment options) with each other. The aim is to determine a 
treatment schedule on which both doctor and patient agree. As part of respecting 
the patients’ views, physicians should facilitate discussions about treatment choice, 
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initiation, but also its discontinuation or change if patients wish (McCabe et al., 
2013).  
 
3.2.1 Impact of patients’ involvement 
Many patients want to have an opportunity to influence their treatment choices, 
but the reported numbers vary considerably. For example, Patel and Bakken (2010) 
surveyed 60 people who were seeking medical care for depression and reported 
that 98% of the sample wanted to be involved in the decisions. In another 
questionnaire survey with 94 depressed patients, Stacey et al (2008) found that half 
of the participants wanted to make the decisions alone, 40 percent wanted to share 
the decision and 10 percent wished to rely completely on the advice of physician or 
a relative. Moreover, Chewning et al (2012) found in a systematic review that up to 
71 percent of patients with a range of conditions wanted to be involved in their 
treatment choices. On the other hand, in a narrative review of the factors affecting 
preference for engagement, Say et al (2006) found that patients’ favoured levels of 
involvement can vary across different conditions. The differences might be 
explained by variations in how patients interpret the concept of active engagement 
(Entwistle, 2009). Other influential factors include demographic characteristics, 
experience with the illness, health status and experiences with their health 
professionals (Say et al., 2006). 
 
Treatment for depression is considered as ‘preference-sensitive’, since several 
options are recommended as adequate and effective (O'Connor et al., 2007). The 
importance of patients’ choice about treatment has been widely recognised, and 
patients’ active involvement in the treatment decision-making is also advocated by 
the practice guidelines (APA, 2010, NICE, 2009, Anderson et al., 2008). The relatively 
recent focus on patients as consumers’ rights and professionals’ respect for 
patients’ autonomy have been cited as factors contributing to the emphasis placed 
on involving patients in treatment decisions (Entwistle, 2009).  
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Patients’ active engagement in the decision-making process often has many positive 
effects on satisfaction, adherence and even treatment outcomes. For example, in a 
3-year follow-up study with 205 patients, Hack et al (2006) suggested that being 
involved in decisions about breast cancer treatment had positive effects on the 
patients’ wellbeing and quality of life. The authors found that, regardless of 
patients’ preference for active engagement in the decisions, those who reported 
having contributed to the choices also reported better social and physical 
functioning. Similar findings were reported in relation to depression. For example, 
in a follow-up study with 30 GPs and 207 patients, Loh et al (2007a) found that 
patients’ engagement in treatment choices has been related to improved 
satisfaction and adherence, although not treatment outcomes directly. The benefits 
were further supported in a cluster RCT of a shared decision-making intervention 
with 23 GPs and 405 patients (Loh et al., 2007b). Symptom improvement was 
reported to result from patients’ active engagement in treatment decisions and 
consequent receipt of adequate treatment in a prospective cohort study (Clever et 
al., 2006).   
 
3.2.2 Patients’ involvement in treatment decisions 
Despite the practice guideline recommendations and the positive influence of 
patients’ involvement in treatment choices, professionals often fail to facilitate 
shared decision-making. The health professionals’ lack of cooperation was 
demonstrated in a secondary analysis of 287 recordings of doctor-patient 
consultations (Young et al., 2008). The authors found that most physicians did not 
support patients in contributing to their treatment choices. One of the reasons 
might be that doctors lack the skills that would enable them to facilitate shared 
decision-making in consultations, such as communication and understanding of the 
SDM principles. This can be questioned based on a trial followed by focus groups 
with 20 GPs (Edwards et al., 2005). The authors found that even after receiving 
specific training to deliver SDM in practice, clinicians often reported barriers to 
engaging patients in shared decision-making about their care and can be reticent 
about patients’ involvement. 
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Reporting findings of a systematic review, Legare et al (2008) proposed that 
professionals’ barriers include time constraints and thinking that the approach is 
not suitable for particular patients or illnesses. This suggests that doctors might 
often decide whether they involve patients in treatment decisions based on their 
subjective judgements of patients’ preference and ability or based on their own 
desire for including patients in the decision-making process (Legare et al., 2008). 
Whilst professionals might perceive patients’ involvement as an additional 
complication during consultations, some research shows that adoption of SDM 
principles need not increase the time of patient visit (Loh et al., 2007b). Similarly, in 
an observational study where 20 psychiatrists were recorded during a total of 72 
consultations, McCabe et al (2013) found that patients’ involvement was not 
related to the length of consultations. Instead, it was influenced by professionals’ 
individual characteristics, patients’ symptoms and the length of time spent 
discussing the particular choices. 
 
Regardless of the professionals’ consultation style or an opportunity to engage in 
shared decision-making, people with depression make their own treatment choices. 
Patients often have preferences for specific treatment options such as alternative 
therapies that lack evidence, decisions about whether or not to seek medical advice 
for depression, and whether or not to adhere to medical advice. Conceptualising 
how depressed people make treatment choices is therefore important. Facilitation 
of patients’ active involvement in treatment decision-making can be easier and 
more straightforward when professionals empathise with patients and have an 
understanding of the factors that influence their choices. 
 
3.3 Decision-making principles 
Decision-making is a set of complex cognitive processes, some of which take place 
below people’s conscious awareness. Our choices are therefore often influenced by 
factors about which we are not cognizant, including mental shortcuts, i.e. heuristics 
and biases, and emotions. In order to explain and predict decision-making, 
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researchers have proposed a number of theories. For example, the central 
assumption of the economic models of decision-making is that choices result from 
conscious processes. When making choices, people are assumed to systematically 
evaluate the costs and benefits of an anticipated outcome, while also considering 
their likelihood (Oliveira, 2007). Such models have, however, been criticised for 
over-emphasis on rational choices, which rarely reflect the way people make 
decisions in real life. Another type of decision-making model assumes that the 
rational aspect is intertwined with an intuition- or emotion-based process (Reyna, 
2008).  
 
Evidence from economic and cognitive psychology research suggests that a number 
of factors are involved in decision-making, including individual differences, cognitive 
abilities, past experiences and cognitive biases (Juliusson et al., 2003). Some 
decisions appear to be made with the aim of avoiding physically or mentally 
demanding tasks in the future, for example, attempting to avoid future regret (Kool 
et al., 2010). Also relevant in cognitive psychology are heuristics, i.e. cognitive 
shortcuts people use to aid in making choices. Heuristics and biases are cognitive 
shortcuts in which people save effort due to ignoring part of information 
(Gigerenzer and Gaissmaier, 2011). 
 
Another important, but not very well-understood, aspect of decision-making is 
emotion. Paulus and Yu (2012) suggested that emotions can explain changes in 
people’s perceptions of the situation and consequently the decisions made. 
Research shows that depressed people might engage in different decision-making 
strategies compared to healthy people. For example, van Randenborgh et al (2010) 
asked 40 depressed inpatients and 45 healthy people to fill in questionnaires about 
depression, decision-making processes and decision conflict. They suggested that 
depressed people experience more decisional conflict due to their symptoms, 
including low self-efficacy and rumination. In addition, reporting findings of the 
Iowa gambling task (IGT) experiment with 19 depressed and 20 healthy participants, 
Cella et al (2010) suggested that depressed people are less responsive to reward 
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and punishment. The IGT (Bechara et al., 1994) is a card game involving five blocks 
of 20 trials during which participants make decisions about drawing cards from one 
of the four decks for monetary gain. The task involves learning from previous losses 
and wins, and Cella et al (2010) found that depressed people performed worse on 
the task. Consequently, people with depression were thought to show less flexibility 
in making decisions. 
 
3.4 Health related decision theories 
In order to understand and predict health-related behaviours, several psychological 
models have been developed and tested. For example, models such as Theory of 
Planned Behaviour (Ajzen, 1991), Health Belief Model (HBM) (Rosenstock et al., 
1988) and the Self-regulation Model (Leventhal et al., 1992) have been applied in 
attempts to explain and predict behaviours such as adherence to treatment. The 
models share several common aspects, including acknowledging the importance of 
patients’ individual beliefs, attitudes, intention to engage in the predicted 
behaviour and self-efficacy, but their assumed roles vary (Conner and Norman, 
2008). For example, the Self-regulation Model assumes that people form 
representations about their illness (i.e. identity, consequences, causes, time-line 
and control) and use them as clues in development of preferences for treatment 
options. 
 
The Self-regulation Model (Leventhal et al., 1992) has been used in a systematic 
review of literature to explain people’s preferences for various treatments for 
depression and anxiety (Prins et al., 2008). For instance, people who think that 
antidepressants are addictive tend to prefer counselling in a cross-sectional survey 
with 895 primary care patients (Churchill et al., 2000a). In an Australian postal 
survey (n=3,109 adults) with a 6-month follow-up of 422 depressed people, Jorm et 
al (2000) reported that individuals’ beliefs about particular treatments were 
associated with the actual use of those treatments. A number of beliefs were linked 
to particular preferences, but it is not clear what roles the beliefs and attitudes play 
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in decision-making, what other factors are important in the process and how the 
factors interact.  
 
3.5 Patients’ treatment decisions 
Treatment decisions people commonly face are complex and many are made by 
patients outside of consultations with health professionals, even though their 
impact is large.  
 
3.5.1 Help-seeking 
Despite the debilitating effects of depression, most depressed people do not seek 
medical help. Based on the findings of a large UK based household survey of 
psychiatric morbidity with a sample of 10,000 respondents, Bebbington et al (2000) 
reported that only a third of people with neurotic disorders, such as mixed 
depression and anxiety, sought medical help for their problem. European 
population-based studies show help-seeking rates between 13% and 36% in people 
with mood disorders (Alonso et al., 2004, Roness et al., 2005). On the other hand, 
based on a US-based general population survey with over 8,000 respondents, 
Kessler et al (1998) suggested that most depressed people will eventually seek help, 
although with average delays lasting between 6 and 14 years. Similarly, in a 
representative sample of 3,516 psychiatric patients across 11 European countries, 
the average delay was 8 years (Christiana et al., 2000).  
 
In a retrospective questionnaire study with 273 people with depressive or anxiety 
conditions, delay in help-seeking was associated with more severe symptoms at the 
start of treatment and poorer treatment outcomes (Thompson et al., 2008). Despite 
the benefits of receiving treatment, delays in seeking medical help are common. 
Bell et al (2011) found in a Californian telephone survey with 1,054 adults that 43 
percent of depressed people appear to have at least one reason why they would 
not disclose their symptoms to their physician. The reasons were often related to 
beliefs about the illness and patients’ expectations of professionals (Bell et al., 
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2011). Other factors commonly associated with seeking help for depression include 
perceived need for care, recognition of depression, personal beliefs and attitudes, 
personal stigma, past experience and views about health professionals. 
 
3.5.2 Treatment preferences 
Developing a preference for a particular treatment option is another type of 
decisions people often make, although treatment preferences can also influence 
other treatment decisions. For example, a mismatch between a received and 
preferred treatment can negatively impact on patients’ adherence (Raue et al., 
2009). Studies show that most depressed people have a specific preference for 
depression treatment. A systematic review showed that approximately 51%-66% of 
people with depression would choose psychological therapies over medication if 
given the choice (van Schaik et al., 2004). Results of a more recent cross-sectional 
survey of 88 depressed people showed that antidepressant medication might be 
becoming more preferred, since psychotherapy was favoured by 41 percent, while 
medication by 31 percent of people (Houle et al., 2013). A general trend towards a 
preference for psychotherapy was not confirmed in a US study of 1,439 patients 
who were given the choice of second-step treatment (Wisniewski et al., 2007). Only 
three percent of the patients accepted switching to CBT alone and 26 percent were 
willing to switch to a combined treatment of antidepressants with CBT. However, as 
the authors pointed out, the relatively low number of CBT-accepting patients might 
have been caused by recruiting only participants who had already been treated with 
antidepressants, as an unsatisfactory first step treatment (Wisniewski et al., 2007). 
Despite people’s preferences, antidepressants are in practice prescribed to about 
90% of primary care patients with depression (Martin-Merino et al., 2010). Many 
patients feel uncomfortable if a treatment they do not want is given to them, as 
shown in qualitative study with 60 depressed participants (Nolan and Badger, 
2005). 
 
The authors of a literature review about the effects of patients’ treatment 
preferences on health outcomes suggested there is little difference in symptom 
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change between patients receiving their preferred or random treatment (Winter 
and Barber, 2013). For example, some researchers have used partially randomised 
preference trials to compare effectiveness of either choosing or being randomised 
to a psychological therapy or medication. In a trial in which 220 patients received 
their preferred treatment and 103 were randomly assigned to treatment, Bedi 
(2000) found no difference between the groups at 8 weeks follow up, although 
those receiving preferred counselling had better outcomes than those randomised 
to counselling at 12 months (Chilvers et al., 2001). In another trial with 60 patients, 
Raue et al (2009) found that adherence to treatment was related to the strength of 
patients’ preference, rather than the type of treatment favoured. The findings of a 
systematic review of the impact of patients’ preferences showed that receiving 
their preferred treatment may have had a greater impact on the professional 
patient relationship and treatment adherence, rather than on treatment outcomes 
(Gelhorn et al., 2011). 
 
3.5.3 Adherence  
Another problem related to patients’ acceptance and receipt of prescribed 
treatment is adherence. Patient adherence to treatment has been described as an 
active involvement in the treatment or health behaviours agreed together with a 
health professional (Meichenbaum and Turk, 1987). A systematic review of 
adherence to depression treatment showed that patients’ adherence to treatment 
varies between 30 percent and 97 percent (Pampallona et al., 2002). Non-
adherence rates in both unipolar and bipolar depression ranged between 10 
percent and 40 percent in a review (Lingam and Scott, 2002). Reporting the findings 
of analysis of a household survey data, Olfson et al (2006) found that within a 
sample of 829 depressed patients, 42 percent discontinued the treatment within 
the first month and less than one in three continued the treatment at 3 months. 
 
Adherence is commonly studied as a health behaviour that patients do and 
researchers apply theoretical models of behaviour change in order to understand or 
address it (Gray et al., 2010). Additionally, it can also be explored in terms of a 
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treatment-related decision or set of decisions that patients make on a regular basis. 
Pompili et al (2013) reviewed the literature about predictors of medication 
adherence in mood disorders. They identified a number of various factors, many of 
which were similar to those found influencing other treatment decisions such as 
patients’ beliefs and attitudes to illness and treatment, therapeutic alliance, 
symptom severity and poor insight. Additional factors include comorbidity with 
personality or substance disorders and side effects of medication (Pompili et al., 
2013).  
 
3.5.4 Are all types of treatment decisions affected by the same 
factors? 
Previous studies showed that many influential factors are shared across different 
types of treatment decisions. Based on the factors’ similarity and the close relations 
of the individual types of decisions, I decided to work with an assumption that all 
types of treatment choices could be considered as a result of interplay of the same 
set of factors. This assumption was also supported by research in cognitive 
psychology suggesting that depression causes more decisional conflict 
(Randenborgh et al., 2010). Consequently, people might find it more 
straightforward to make a decision if they follow a simple and familiar pattern. In 
the following sections, I explore the factors identified in previous research as 
important for depressed people’s treatment choices. 
 
3.6 What factors influence treatment choices made by people 
with depression? 
3.6.1 Demographic and individual characteristics 
The evidence about the influence of demographic and socio-economic 
characteristics on patients’ treatment choices is inconclusive. Epidemiological 
studies with 1,400 respondents in the UK (Meltzer et al., 2003) and more than 
90,000 respondents in Norway (Roness et al., 2005) showed no effects of 
demographic or socio-economic characteristics on people’s reluctance to seek 
Page 49 of 386 
 
treatment for mood disorders. Another UK-based telephone household survey of 
382 people with mental problems showed that more women than men consulted 
health professionals for symptoms of mental distress (Doherty and Kartalova-
O'Doherty, 2010). Being female and under 65 were also related to more positive 
attitudes to help-seeking in a pan-European epidemiological study with 8,796 
participants (ten Have et al., 2010). Similarly, Segal et al (2005) found in a cross-
sectional survey of 175 depressed patients, that older people had more negative 
views about depression and perceived it as a weakness. The authors, however, 
found no effect of age on willingness to seek treatment.  
 
In relation to treatment preferences, a survey with 104 depressed people showed 
that people vary in their values when selecting treatment (Thacher et al., 2005). 
Using a latent-class analysis, the authors identified three groups of patients holding 
different preferences and attitudes towards treatment for depression, based on 
how sensitive they were to either side effects of treatment, its costs or to its 
effectiveness. Male and younger patients showed higher sensitiveness towards 
treatment costs and side effects (Thacher et al., 2005). Supporting these findings, 
Prins et al (2008) in a literature review reported that people were more likely to 
prefer counselling over antidepressants if they were female, had better knowledge 
about this therapy, had previous experience with counselling but not medication, 
and those who had paid sick leave. Although talking therapies are more commonly 
preferred by women (Prins et al., 2008), almost one in four men also prefer 
psychotherapy and more than two in three men would choose a combination of 
talking therapy and medication. This was shown in a trial testing collaborative care, 
involving `500 people with depression or dysthymia (Lin et al., 2005). 
 
Using self-administered questionnaires in addition to a telephone survey with 1,187 
depressed people in the US, higher income and more knowledge about 
antidepressants were associated with preference of active treatment for depression 
over ‘watchful waiting’ style (Dwight-Johnson et al., 2000). Preference for 
psychological therapy was more common in participants of African-American origin 
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(p<0.04) and those with more knowledge about counselling (p<0.01). On the other 
hand, the authors of a UK-based cross-sectional survey (n=8,978) found that, 
although gender, previous experience with counselling and believing in the 
addiction of antidepressants were related to counselling preference, age was not a 
significant predictor of outcomes (Churchill et al., 2000). Furthermore, in a US 
National Comorbidity Survey with 1,792 respondents with a common mental health 
problem, the authors found no effects of demographic characteristics such as age, 
gender or marital status on help-seeking in people with a perceived need for 
treatment (Mojtabai et al., 2002). 
 
3.6.2 Symptom severity 
Severity of depression has been associated with patients’ perception of need for 
help and receipt of treatment. For example, reporting data of the British National 
Survey of Psychiatric Morbidity with over 10,000 respondents, Bebbington et al 
(2003) found that symptom severity was one of the largest determinants of 
receiving treatment for depression. Severity of symptoms has also been related to 
delayed care-seeking. Reporting findings of the same survey, Meltzer et al (2003) 
reported that people with more severe depression were also more likely to have 
avoided help-seeking in the past. A follow-up questionnaire study involving 110 
depressed people from 18 community pharmacies showed that that together with 
beliefs about illness, severity of patients’ depression was strongly related to failing 
to initiate treatment (van Geffen et al., 2010). Having moderate-to-severe 
depressive symptoms was also related to the perception of more barriers to seeking 
professional care for the condition according to a Californian telephone survey (Bell 
et al., 2011). On the other hand, reporting findings of a qualitative study with 20 
depressed participants, Farmer et al (2012) suggested that with increasing severity 
of depression people would be more likely to seek professional help as a result of 
decreased ability to function. In relation to treatment preferences, in a US-based 
study (n=1,187) using questionnaires and interviews, Dwight-Johnson et al (2000) 
found that severity of depression was related to specific preferences only in 
patients who were already receiving treatment. Severity of depression was not 
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found to be a strong predictor of adherence to antidepressant medication in a 
systematic review of literature by Pompili et al (2013).  
 
3.6.3 Perceived need for care 
Patients’ perception of a need for care has been cited as one of the most important 
factors affecting help-seeking for mental distress in population-based studies. 
Andrews described unmet need as having a disorder, but not being seen by a 
professional (Andrews, 2000). The patient’s perception of need is therefore their 
subjective view about requiring attention from a mental health professional, and is 
commonly measured by a validated scale (Meadows et al., 2000). Research shows 
that a large proportion of people with a diagnosable mental illness do not seek help 
because they do not think they need it.  
 
Population-based surveys showed that people often postpone consulting health 
professionals for mental problems due to a lack of perceived need for care and not 
recognising having symptoms of a mental illness. In a systematic review about the 
perceived need for care of patients with depression and/or anxiety, Prins et al 
(2008) reported that between 49% and 84% of patients with depression or anxiety 
had experienced an unmet need for care. Also, Thompson et al (2008) found that if 
people with depression or anxiety did not recognise their symptoms within one year 
of onset, they were twenty times more likely to delay help-seeking. Nevertheless, 
the perception of need alone does not predict seeking treatment. 
 
3.6.4 Problem recognition and insight 
The perceived need for help is closely related to patients’ recognition of symptoms 
and their association with an illness, which have been identified as important in 
population-based surveys in a Dutch interview study (n=743) (Verhaak et al., 2009)  
and a British survey (n=1,400)  (Meltzer et al., 2003). Recognition of experiencing 
depressive (or other) symptoms is related to having insight into one’s condition. 
Insight into illness was originally formulated in relation to psychosis and was 
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described in three dimensions, including recognising symptoms, awareness that the 
symptoms are part of an illness, and accepting treatment (David, 1990). This factor 
was also associated with decisions made by depressed people. 
 
Lack of insight and not recognising depressive symptoms as a problem has been 
related to delayed care-seeking and general lack of involvement in treatment 
decisions (Thompson et al., 2008). Similar findings were reported by Ng et al (2008) 
in a Singaporean interview study (n=2,801) and in a German qualitative study with 
40 depressed people (Simon et al., 2007). Results of a large German lay public 
survey (n=5,015) showed participants vignettes of a person with either depression 
or schizophrenia and asked them to suggest the best way of dealing with their 
problem (Riedel-Heller et al., 2005). The authors found that participants judged an 
action as appropriate based on their understanding that a vignette character had an 
illness. Illness recognition and decision about its management were also found to be 
related in a pilot study using interviews and questionnaires assessing depression, 
coping strategies and other health behaviours in 41 depressed patients (Brown et 
al., 2001).  
 
Another concept that has been explored as a factor affecting people’s decision to 
seek help for emotional problems, is patients’ insight. For example, Epstein et al 
(2010) conducted interviews with 116 people with experience of depression and 
found that knowing, naming and explaining depression were three main stages 
which depressed people were thought to go through during the process of seeking 
help. Participants in this study thought that the process was influenced by their 
personality, their understanding of a relationship between their experience and the 
symptoms of depression, and their perceived stigma. In a similar attempt to explain 
how depressed people make sense of their condition and make an actual decision 
to seek professional care, Farmer et al (2012) interviewed 20 participants. The 
researchers developed a theoretical framework suggesting that with depressive 
symptoms people first experience a sense of an identity crisis and therefore rarely 
seek help immediately after becoming depressed. As a solution, they proposed that 
Page 53 of 386 
 
people need to accept the threat they feel and deal with the change in perception 
of their own self (Farmer et al., 2012). This process might be helped by factors such 
as support from family and friends. Alternatively, the increasing burden and distress 
due to depressive symptoms might lead the individual to seek medical care.  
 
3.6.5 Past experience 
People’s own and indirect experiences have been found related to patients’ 
treatment decisions. For example, people who had previously sought help for 
depressive symptoms were more likely to consult a professional again, according to 
a study interviewing 25 currently depressed people (Schomerus et al., 2009a). 
Moreover, preference for treatment has been related to the type of treatment 
patients had previously received, although the evidence is inconclusive about 
whether people want the same type of treatment or specifically different (Churchill 
et al., 2000). Previous experience with treatment is also related to adherence in a 
systematic review of factors affecting it (Pompili et al., 2013). 
 
People’s decisions about depression treatment can also be influenced by 
experience that is not directly personal, but lived by close family or friends, i.e. 
vicarious experience. Findings of a telephone follow-up of a national survey with 
1,054 respondents in California, showed that depressed people who had a vicarious 
experience with depression had more positive attitudes to medication, irrespective 
of other factors (Berkowitz et al., 2012).  
 
3.6.6 Beliefs and attitudes 
A number of beliefs and attitudes have been associated with particular treatment 
decisions. Vogel et al (2005) found in a cross-sectional questionnaire study with 354 
university students that psychological factors and attitudes explained more than 
60% of the variance of intention to seek medical help. The authors suggested that 
use of health-professional services was related to people’s expectations about 
treatment outcomes.  
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Patients’ beliefs about treatment have also been found important in explaining 
preferences for treatment. For example, people who think that antidepressants are 
addictive appear to prefer counselling (Churchill et al., 2000). An Australian postal 
survey with over 3,000 respondents showed that if individuals believe a particular 
treatment can help them, they are more likely to use it (Jorm et al., 2000). Similarly, 
a systematic review of patients’ preferences and factors affecting them showed that 
many people thought that antidepressants are addictive and that counselling or 
other psychological therapies would address the root of depression (van Schaik et 
al., 2004).  
 
A review of studies about treatment preferences has shown that a large number of 
beliefs, such as perceived consequences of  the illness, and beliefs about the 
importance of treatment and its side effects, have an effect on patients’ preference 
for therapy (Prins et al., 2008). Side effects, especially those of a sexual nature, 
dizziness, emotion and memory related were also reported to be the most 
important factor affecting adherence to antidepressants in a systematic review 
(Pompili et al., 2013). Similarly, authors of a cross-sectional study with 225 people 
with depression found that believing that the antidepressants work was related to 
better adherence. While worries about side effects were common, they did not 
impact on adherence (Wouters et al., 2014). Common side effects were, on the 
other hand, rated as the most important factor affecting selection of 
antidepressants in a survey with 127 depressed patients and 110 physicians 
(Gardner et al., 2007).  
 
People’s beliefs about the need for treatment and their worries about their 
medication have been used to develop the Necessity-Concerns Framework in order 
to explain and predict adherence (Horne et al., 1999). In a meta-analysis of 94 
studies using the framework across a range of different long-term conditions, Horne 
et al (2013a) found that people’s beliefs and concerns could effectively predict both 
observed and self-reported adherence.  
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3.6.7 Stigma and relying on self 
Stigmatising views are a specific type of belief that some people hold about 
depression and depressed people. Stigma is frequently associated with patients’ 
treatment decisions and nearly 80 percent of depressed people encounter 
discriminatory or stigmatising attitudes in everyday life, as shown in a cross-
sectional survey with 1,082 people in 35 countries worldwide (Lasalvia et al., 2013). 
Link and Phelan (2001) conceptualised stigma as a process involving four steps, 
including labelling, stereotyping, separating and emotional reaction. Whilst the 
word ‘stigma’ is used commonly as a general term for negative attitudes, it 
describes different types of negative views about a person, which are a patients’ 
personal stigma and the stigma perceived or anticipated in society and/or close 
social circles (Corrigan et al., 2005). In addition, Lasalvia et al (2013) suggested that 
anticipated and experienced stigma should be considered separately, since people 
who expect negative views in their social environment might not also come across 
such views. This distinction is important because the personal and perceived types 
of stigmatising views can have different effects on people, even though they are 
related to the same concept. Self-stigmatising attitudes about depression were 
found to be related to stigmatising views in the society and to decreased willingness 
to seek help in a large European general population survey (n=29,248) (Mojtabai, 
2010). The author also emphasised that the influence of the specific beliefs and 
attitudes can differ and while thinking that mentally ill people are dangerous might 
support help-seeking, blaming and shaming mental illness appeared to decrease the 
willingness to seek care.  
 
In a systematic review about stigma and its impact on health behaviours, Livingston 
and Boyd (2010) found that internalised stigmatising views were related to poor 
adherence and to having more depressive symptoms. The importance of personal 
stigma was also demonstrated by Coppens et al (2013). In a cross-sectional 
questionnaire survey of the general population in four European countries 
(n=4,011), they reported that people with stigmatising attitudes were less likely to 
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be open about their emotional problems and thought that professional treatment 
was less valuable than people without stigmatising views (Coppens et al., 2013).  
 
In relation to the impact of external stigma, the evidence is contradictory. For 
example, Griffiths et al (2011) in a national household survey (n=2,000) used 
vignettes showing depressed or suicidal people to elicit the respondents’ views. 
They found that embarrassment about being depressed and other self-stigmatising 
views, but not perceived stigma, were found associated with thinking that dealing 
with depression alone would be most helpful (Griffiths et al., 2011). While 
perceived stigma was reported as a barrier to help-seeking in a population-based 
study (Meltzer et al., 2003), the findings of a systematic review of help-seeking 
interventions showed no impact of strategies aiming to reduce stigma in society 
(Gulliver et al., 2012). On the other hand, results of a 3-month follow-up interview 
study with 134 depressed adults showed that lower perceived stigma was 
associated with a better self-reported adherence to antidepressants (Sirey et al., 
2001). However, a systematic review of factors related to adherence in mood 
disorders showed no significant influence of stigma (Pompili et al., 2013). 
 
3.6.8 Health professionals 
Important factors affecting help-seeking and symptoms disclosure to physicians 
include patients’ perspectives about their doctors and their interpersonal 
relationships. For example, a qualitative US-based study with 116 depressed people 
showed that many appear to be confused about the appropriateness of consulting 
primary care practitioners for depression and their competence in dealing with 
patients with emotional difficulties (Kravitz et al., 2011). Using focus groups, the 
authors found that participants often had doubts about the physicians’ competence 
or the appropriateness of primary care for treatment of depression. Similarly, in a 
telephone survey with 1,054 respondents in California, Bell et al (2011) found that 
people are often unsure whether a primary care practitioner would see patients 
with depression. Others said that they delayed seeking help due to axiety about 
being referred to a psychiatrist (Bell et al., 2011). The authors also reported that 
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almost 1 in 4 people feared that doctors would prescribe antidepressants. Such 
reports suggest that people have specific views about health professionals, which 
may be based on anecdotal evidence rather than on physicians’ real behaviour. 
Patients’ perceptions about the professionals’ ability to help with depression was 
also found related to attitudes to help-seeking in a study in six European countries 
(n=8,796) (ten Have et al., 2010). The findings of this study showed that almost one 
in three people thought that professional help for mental conditions was not more 
effective than receiving no help. 
 
On the other hand, population surveys and other large studies showed that GPs are 
often viewed as the primary source of help for depression. For example, in an 
Australian population survey (n=1,312) using vignettes of depressed people, Barney 
et al (2006) found that around two in three people would most likely consult a GP 
for depression, although most people also viewed GPs as most stigmatising (18%) 
and patronising (20%). On the other hand, the authors of a German population 
survey with 5,015 respondents found that most members of the general public 
would recommend help from mental health professionals, once they recognised the 
symptoms of depression (Riedel-Heller et al., 2005).  
 
Despite people’s concerns about health professionals’ attitudes and 
appropriateness for consulting depressive symptoms, professionals are generally 
perceived as an important factor affecting patients’ decisions. For example, Cooper 
et al (2000) asked depressed people (n=76) to rank the importance of 126 factors 
related to their depression treatment and found that professionals and their 
opinions were among the most valued aspects. While related to treatment 
perceptions, the authors did not directly focus on the importance or perceived 
influence of the factors on patients’ decision-making. Health professionals’ 
communication style and the therapeutic alliance were identified to be among the 
most important predictors of adherence in a systematic review (Pompili et al., 
2013). 
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3.7 The value of self-reports 
Self-reports about decisions or past events are often used in research and whilst 
they are useful for understanding people’s perceptions, people’s memory is not 
always a reliable source of information. For example, cognitive research shows that 
we remember emotionally charged situations (Sakaki et al., 2014). Research also 
shows that we automatically think that we make rational decisions and when asked 
to explain past choices that were in fact a result of chance or external factors, we 
tend to provide justifications that fit our current thinking about the decision 
(Andrade and Ariely, 2009). It therefore appears that what people say might not 
always reflect past events due to cognitive and memory biases that often slip our 
awareness, such as individual perceptions of experiences. In addition, for various 
reasons, people might try to consciously avoid bringing up certain memories or 
ideas. This is, for instance, commonly observed in people who fail to disclose to 
their doctor symptoms or observations they find embarrassing or distressing, such 
as mental health problems (Farmer et al., 2012).  
 
People’s self-reports are a crucial part of clinical practice when patients consult 
their clinician about their symptoms. Some clinicians perceive self-reports as an 
issue in the treatment of people with mental conditions (Whitebird et al., 2013). 
The authors interviewed 81 clinicians about the barriers to improving depression 
care and reported that one of the barriers to improving depression treatment is 
professionals’ concerns about patients’ self-reports being the only way of assessing 
their depressive symptoms and treatment outcomes.  
 
Despite the potential problems such as patients over-estimating their desired 
behaviour and under-reporting the unwanted actions, self-reports are a widely used 
technique for eliciting information about patients’ beliefs and attitudes towards 
treatment. Self-reports are a valuable way of exploring people’s perceptions and 
opinions. Garfield et al (2011) reviewed the literature about self-report measures 
used to determine patients’ adherence, suggesting that they are an accurate 
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method. This was confirmed in a meta-analysis of the impact of beliefs about 
medication on patients’ adherence (Horne et al., 2013a). 
 
3.8 Summary of the literature 
Overall, a body of research has been conducted aiming to explain the decisions 
people with depression make about their treatment. Whilst a number of factors 
have been found to be associated with individual choices, it is not yet clear how 
people make particular decisions about how to deal with their depressive 
symptoms. Researchers have linked certain personal characteristics to particular 
treatment preferences or decisions. For example, women appear to be more likely 
to prefer psychological therapies (Prins et al., 2008) and younger men appear to be 
concerned about side effects (Thacher et al., 2005). Despite their clear influence, 
the demographic and socioeconomic characteristics alone cannot explain fully the 
decisions patients make about their treatment for depression. There is evidence, 
although contradictory, about the impact of symptom severity on decisions about 
dealing with depression (Bebbington et al., 2003), but people’s personal beliefs and 
attitudes also play an important role. Evidence supports the predictive validity of 
patients’ beliefs about the necessity and concerns in explaining adherence to 
medication (Horne et al., 2013b). Beliefs and attitudes can, however, predict 
adherence to a limited extent (Horne et al., 2013a). Instead, the authors suggested 
that people’s beliefs and attitudes should be viewed within the context of other 
factors, such as experience and health professionals, in order to help facilitate 
shared decision-making. In relation to help-seeking decisions, research shows that 
recognition of symptoms and awareness of the need for treatment are important 
(Farmer et al., 2012, Epstein et al., 2010). Instead, rather than developing in a 
vacuum, patients’ awareness of their symptoms and the decision to consult a health 
professional are a result of the influences of various factors. There is also conflicting 
evidence about the effects of personal and perceived stigma on the different 
decisions people make about treatment. In addition, little is known about how 
depressed patients perceive the process of making treatment decisions. Although a 
number of factors have been associated with specific choices, there is a paucity of 
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literature about how patients’ views relate to these factors and how people say 
they make decisions. 
 
Understanding how people say they make decisions about treatment for depression 
is important in order to facilitate shared decision-making about treatment and 
support patients in making choices in collaboration with their physicians (Gray, 
2014). Shared and collaborative decision-making is based on effective 
communication and understanding of the involved parties. Giving patients an 
opportunity to say how they make decisions will therefore help professionals better 
facilitate the shared decisions and tailor the consultations and treatment to better 
meet patients’ individual needs. 
 
In this study I aim to explore the depressed patients’ views about how they make 
treatment decisions. In order to understand their perspectives within the wider 
context, I also aimed to explore and compare the views of people’s family and 
friends and healthcare workers. 
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 Chapter 4 Methodology 
 
4.1 Study design 
I adopted a pragmatic approach to research and used a mixed methods design. The 
purpose of the study is exploratory, that is, to better understand how people with 
depression make treatment decisions, and how patients, their family and friends 
and healthcare workers perceive this process. For this reason I involved these 
stakeholder groups in the research processes, which allows the study to be 
described as participatory. The qualitative part of the study was conducted in 
accordance with the COREQ framework for qualitative research (Tong et al., 2007).  
 
4.2 Approach to the study 
According to Cresswell (2013) research has three components that relate and 
interact with each other. They are philosophical worldview (for example, post-
positivist, constructivist, pragmatic), research design (such as quantitative, 
qualitative or mixed), and research methods (such as questions, data collection, 
data analysis). The design and methods used in a study impact on the way results 
are produced and interpreted. Selecting the appropriate approach is therefore an 
important part of the research planning (Muncey, 2009).  
 
4.2.1 Pragmatism  
Pragmatism is focused on searching for information which is relevant to a particular 
situation and can be used as a tool to inform action (Cornish and Gillespie, 2009). 
This approach allows a shift of the focus from search for ‘the truth’ to attempts to 
understand an issue from a particular perspective, relevant to a particular situation. 
Cornish and Gillespie (2009) argued that health and other researchers usually do 
not attempt to uncover the one ‘Truth’ about the world, but aim to provide answers 
to specific questions. The proposed purpose of such research is therefore to 
generate knowledge that would serve a specific use, for example, developing 
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suggestions for appropriate solutions (Cresswell, 2013). Consequently, different 
research methods are deemed to have their place and use, according to the type of 
information that is required and the types of questions that are posed. For example, 
when determining the effects of an intervention, using randomised controlled trials 
might be most appropriate, but if seeking to understand patients’ opinions about 
their new treatment, methods such as interviews are likely to be useful.  
 
4.2.2 Positivism and quantitative methods 
The positivist approach to research is based on a view that truth is independent of 
human perception and observation (Proctor, 1998). It is focused on the measurable 
facts and discredits subjective explanations of observations as it is held that 
research should be quantitative and researcher should be objective. As a result, 
within this approach all data is supposed to be quantitative, aiming to reveal the 
underlying causal relationships between the individual variables (Cresswell, 2013). 
This would then allow the findings to be interpreted independently from 
researcher’s own beliefs and opinions (Crossan, 2003). 
 
Quantitative methods have been used extensively in cognitive research. The designs 
can be broadly described as experimental and non-experimental. Non-experimental 
designs include surveys using questionnaires to detect causal relationships between 
particular variables (Cresswell, 2013). Decision-making is often studied using 
experiments with arranged situations, in which people are expected to make 
choices. In some experiments, participants may be unaware of the true aim of the 
research. This is due to cognitive and memory biases which commonly influence our 
behaviour (Tversky and Kahneman, 1974) and the way we justify our actions 
(Chance et al., 2011). For example, participants in different study groups are faced 
with the same choice under different study conditions (for example, varying 
numbers and types of pens or jams to choose from). Participants’ decisions are 
recorded and the factors that supposedly influence them are discussed (Shah and 
Wolford, 2007, Iyengar and Lepper, 2000).  
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In relation to healthcare decisions, researchers have used vignettes and theoretical 
scenarios to connect people’s hypothetical preferences of treatment types to 
certain beliefs (Griffiths et al., 2011). Such methods can be used to test different 
conditions and their effects on people’s decisions, and provide important 
information about the studied populations’ preferences (Griffiths et al., 2011, Bedi, 
2000). Purely quantitative designs can, however, rarely provide in-depth 
explanations of human behaviour and reasoning. A special type of quantitative 
methods is a discrete choice experiment in which participants are asked to select 
their preferred option (such as the treatment they would want to receive) and 
define attributes of conditions under which they would be willing to take the 
selected option (Mangham et al., 2009). The method is designed to determine the 
participants’ decisions in situations that resemble the real world, but similarly to 
validated questionnaires, the variables and attributes of the offered options need to 
be established in advance (Mangham et al., 2009). This suggests that using a 
discrete choice experiment or other quantitative methods alone might not be 
appropriate if the research aim is to identify the different factors affecting the 
patients’ decision-making. Although quantitative methods can be used, such 
approaches often require a list of existing factors which can be studied in terms of 
their relationships, causal effects, perceived importance and the like. They are, 
therefore, not considered to be sufficient to fully explore the topic and generate 
novel concepts. 
 
4.2.3 Constructivism and qualitative methods 
The meticulous and objective positivist approach is countered by constructivism, a 
philosophical paradigm which emphasises people’s subjective interpretations of 
their reality, i.e. recognition of the complexity and multiplicity of ‘truths’ (Cresswell, 
2013). Strong constructivism approaches problems in a more relative way. It is best 
adopted using qualitative research methods, such as interviews and participant 
observations. Emphasis is placed on obtaining an in-depth understanding of 
perceptions of a small number of participants, rather than an attempt to produce 
generalisable and universally applicable conclusions (Malterud, 2001, Cornish and 
Gillespie, 2009). Consequently, it is difficult to provide accurate measures of 
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participants’ beliefs, which could then be compared or applied to other groups of 
population.  
 
Qualitative designs include, for example, phenomenological research, ethnography, 
or grounded theory and the methods often used are, such as interviews, 
observations and focus groups (Cresswell, 2013). Such methods can be useful tools 
when investigating the participants’ experiences and aiming to understand their 
reasoning for particular preferences. They may be especially helpful if researchers 
use open and eliciting questions that enable participants to access memories 
related to preferences. For example, utilising interviews, Farmer et al (2012) 
provided detailed self-reported accounts about how people make a decision to seek 
help for depression. Based on their findings the research team developed a 
conceptual framework describing the decisions preceding help-seeking and 
identified aspects of this process, which needed further study. Focus groups can 
also be useful in exploring participants’ views and identifying aspects relevant for a 
particular population (Cooper-Patrick et al., 1997). Using appropriate qualitative 
methods would enable an in-depth exploration of individual factors related to 
patient decision-making, and participants’ perceptions about them. Conversely, 
such methods alone would not allow to fully achieve the aims of this study, i.e. to 
provide comparisons of the perspectives of people with depression, their families 
and health professionals.  
 
4.2.4 Pragmatic approach to this study: a mixed methods design 
Considering the aims of the study, using either qualitative or quantitative methods 
as a single approach would be insufficient, although both methods have their 
advantages. For example, qualitative methods such as phenomenological interviews 
or focus groups allow researchers to explore the participants’ perspectives in depth, 
and identify novel viewpoints and concepts (Farmer et al., 2012). One of the 
limitations of such methods is an increased risk of researcher’s subjectivity in data 
collection and analysis. Additionally, they offer limited empirical generalisability of 
the findings to the wider population, often because of generally smaller sample 
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sizes (Cresswell, 2013). Quantitative methods, such as surveys and experiments, 
which often involve larger samples, enable greater generalisability and are less 
susceptible to researcher subjectivity. Although such methods could be used to 
collect data about perceived importance rankings of various decision factors and 
their effects on other factors, they would not allow in depth exploration of 
participants’ views about what concepts should be considered as factors affecting 
treatment choices.  
 
A mixed methods design allows researchers to harness the strengths of the 
individual methods (Crossan, 2003, Malterud, 2001). They are combined in two 
main ways, i.e. concurrently and sequentially within the research process timeline 
(Cresswell, 2013). Further interpretation of the findings is informed by the priority 
assigned to each method in the process of analysis, the phase at which the data are 
integrated, and the presence or absence of theoretical perspective (Cresswell, 
2013). Triangulation is one of the most common mixed methods, in which the 
individual findings from the qualitative and quantitative methods are interpreted 
either together to enhance the completeness of the data or to confirm the results. 
Consequently, they provide a more complete picture of the investigated 
phenomenon. Methods combined sequentially are utilised in a particular order, and 
can be explanatory, exploratory and transformative (Cresswell, 2013) depending on 
the specific objectives of using mixed methods design. Using such design in this 
study will allow a detailed exploration of the participants’ perspectives about the 
factors affecting patients’ treatment choices, and subsequent collection of 
quantitative data about the factors’ importance and interrelationships. This design 
will allow possible identification of novel decision factors, and collect information 
about the participants’ understanding of their effects. 
 
4.2.5 Mixed methods explored 
Mixed methods studies previously used to explore participants’ opinions and 
perceptions about development of problem-solving strategies and conceptual 
frameworks include Delphi study (Okoli and Pawlowski, 2004, von der Gracht, 
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2012), nominal group technique (Gallagher et al., 1993), cultural domain analysis 
(Collins and Dressler, 2008) and concept mapping (Armstrong and Steffen, 2009, 
Kikkert et al., 2006). They all have been adopted with the aim to bring together 
different groups of experts (stakeholder groups) and exploring their views in order 
to aid decision-making. All four methods were designed to use open questions and 
encourage participants’ brainstorming in the first phase of data collection, as a 
means of identifying factors relevant to the given problem or question. The 
individual methods also differ in a number of aspects related to their purposes, 
further data collection and analysis.  
 
4.2.5.1 Delphi study and a Nominal group technique 
A Delphi method was developed by Dalkey and Helmer (1963) and has been widely 
used as a group consensus technique (Hsu and Sandford, 2007). Its ultimate goal is 
to find a solution to a query or a problem. Reaching an agreement of all groups 
involved with the final decision is therefore important (von der Gracht, 2012). A 
Nominal group technique (NGT) shares the aim of a Delphi method, i.e. to reach a 
group consensus about a problem (Gallagher et al., 1993). On the other hand, unlike 
Delphi, it is traditionally conducted in a group session where participants meet each 
other in person. As part of a brainstorming process to generate ideas, NGT involves 
six steps in which participants mostly work alone, although they are present in a 
group setting (Rohrbaugh, 1981).  
 
The Delphi method is also designed to explore the views of the participating 
experts, but only to the extent which would allow identification of a solution they 
all agree with. The stakeholders are first presented with a list of factors or items 
relevant to the given problem (Minkman et al., 2009), and are given an opportunity 
to add issues they might feel are missing (Linstone and Turoff, 2002). In several 
subsequent steps the participants are then asked to select the items that they 
consider to be the most relevant to the query investigated (von der Gracht, 2012). 
Researchers after each round select the most frequently favoured items and send 
them to participants in the next step, omitting the remaining items. The whole 
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procedure takes place remotely via post or electronically in order to avoid 
stakeholders’ interaction and group discussion (Linstone and Turoff, 2002). 
 
Both NGT and Delphi methods have been used as brainstorming strategies and as 
simple decision-making tools (Aspinal et al., 2006, Minkman et al., 2009). Their main 
benefit lies in an ability to effectively prevent problems with group dynamics, for 
example, dominant or reserved individuals, which is achieved by not involving any 
group discussions in the brainstorming process (Gallagher et al., 1993, Rietzschel et 
al., 2006). Consequently, these methods do not allow benefiting from the 
participants’ free association of ideas resulting from their exposure to others’ 
suggestions and opinions. In addition, due to their emphasis on seeking the groups’ 
mutual agreement in identification of a single solution or recommendation to a 
problem, the methods lack an opportunity to distinguish and compare the 
perspectives of different subgroups within the study sample. They cannot provide 
sufficiently detailed information about the different groups’ perceived importance 
of the concepts, the perceived relationships between the generated ideas or other 
underlying features (Minkman et al., 2009). As methods on their own, Delphi and 
CDA are therefore considered insufficient for research intending to explore the 
views of different groups, and then compare and contrast their opinions, which is 
one of the aims in the present study.  
 
4.2.5.2 Cultural domain analysis and concept mapping 
Cultural domain analysis (CDA) and concept mapping (CM) differ from the Delphi 
and the Nominal group technique in their more complex analyses and the emphasis 
placed on the underlying relationships between the concepts. Both CDA and CM 
involve participants in brainstorming and in expressing their views about the 
concepts’ relationships (for instance, by ranking their closeness. This data is 
analysed using similar multivariate techniques (Kane and Trochim, 2007, Borgatti, 
1994). The differences between the methods reside in their focus. Unlike concept 
mapping, CDA aims to involve participants who already share a viewpoint about the 
concepts’ relationships and underlying structure, i.e. have similar perspectives due 
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to having a ‘culturally correct view’ (Borgatti, 1994). This allows CDA to investigate 
in greater depth how the domains mentioned by most participants relate to each 
other. On the other hand, Cultural domain analysis is limited in the types of 
participants who can be involved in the research, and it is not suited for 
comparisons of stakeholder groups whose opinions are likely to vary (Borgatti, 
1994). 
 
Concept mapping is a widely used method for bringing together and comparing the 
views of different stakeholder groups, for example, patients, carers and 
professionals in a study about adherence to medication in schizophrenia (Kikkert et 
al., 2006). In CM all groups express their opinions about the concepts’ relationships 
and an overall result for the whole group of participants is generated. Similarly to 
CDA, Concept mapping aims to reveal the underlying structure of the concepts 
generated, but it also looks at the items’ importance as perceived by participants, in 
order to understand how the different groups’ views contrast.  
 
Concept mapping allows an in-depth exploration of the groups’ views, and it 
provides a unique combination of data collection and analysis methods. Unlike the 
other techniques, it allows comparison of different groups’ perceptions about 
concepts’ importance and the underlying relationships characterising them. As a 
result, I select concept mapping as the most appropriate research method for this 
study. 
 
4.3 Concept mapping  
Concept mapping is a commonly used method, which has been applied in more 
than 80 individual studies over the past ten years (Rosas and Kane, 2012). It was 
described by Trochim (1989) in an attempt to aid organisation of a large number of 
ideas into a structured ‘map’ which can be used to inform decision-making or 
planning processes. It can also be described as ‘structured conceptualisation’ 
(Trochim and Kane, 2005), and it is an established method developed to help create 
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a structured representation of views held by participant groups (Rosas and Kane, 
2012).  
 
The purpose of concept mapping is to explore a variety of ideas about a focus 
question, and collect participants’ perspectives about the relations and the 
importance of the generated ideas (statements). This is done using qualitative and 
quantitative phases systematically and in an exact sequence, and concept mapping 
can therefore be described as a sequential exploratory method. Each of the phases 
has its exact place in the procedure and the results of one part are used as data in 
the other (Rosas and Kane, 2012). First, participants brainstorm about the focus 
question, to generate ideas related to it. Only after all the stakeholders have 
completed this phase, can the second part of the research take place, when 
participants evaluate the ideas in terms of relations to each other, and their 
importance. The information collected in this phase is quantitative, since by 
completing the two tasks, participants are in fact assigning numerical values to each 
factor (i.e. importance rankings on a Likert-scale, and data reflecting which 
statements were put together into groups). Use of these tasks limits room for 
possible subjective interpretation of data by the researcher, in contrast to other 
more qualitative methods, and enables statistical comparison of the stakeholder 
groups’ relative importance ratings to take place (Kikkert et al., 2006). 
 
In addition to comparing the participants’ perceptions of importance, concept 
mapping allows for an exploration of participants’ perceptions about how the 
generated statements relate to each other. Analysis of this information reveals the 
structure of the topic represented by the individual statements. A graphical 
representation of this structure is produced, called a concept map, which 
demonstrates the proximity of the ideas. As a result, the individual concepts are not 
only listed, but it is possible to explore their relationships with each other as 
perceived by participants, which has been a highly valued feature of the method 
(Burke et al., 2005, Kikkert et al., 2006). 
 
Page 70 of 386 
 
4.3.1 Concept mapping: an illustrative example of its 
application 
Concept mapping is an effective method producing findings with many potential 
applications, including in developing conceptual frameworks about the studied 
phenomenon, and in clinical practice. In the following section I will explain a study 
conducted by Kikkert et al (2006) using concept mapping in a related area (i.e. 
patient treatment decision-making in mental illness). The findings of this study were 
used to develop adherence therapy (AT), which is an intervention to improve 
adherence to medication in schizophrenia patients (Gray et al., 2010). This section is 
provided as an illustrative example of how findings from a concept mapping project 
can be utilised to develop an effective intervention that directly targets the issues 
identified in the study process. This demonstrates that concept mapping is a 
powerful research tool and its results can be successfully applied in clinical practice. 
 
Kikkert et al (2006) used concept mapping to explore the views of patients with 
schizophrenia, their carers and health professionals about the factors affecting 
adherence to antipsychotic medication. In the study, they involved 91 participants 
from four different European countries, and held 12 brainstorming sessions during 
which the participants generated 769 statements about the factors affecting 
patients’ adherence. Participants prioritised and clustered together a final set of 82 
statements – factors affecting adherence, according to their own views. The authors 
identified six main factors that affect patients’ adherence, i.e. efficacy of 
medication, side-effects self-management, clinician characteristics, medication side-
effects, subjective experiences of medication and illness, and beliefs and attitudes 
about medication (Kikkert et al., 2006, Gray et al., 2010). The six factors were 
viewed differently by the participant groups, suggesting that professionals did not 
fully understand their patients’ priorities. The professionals thought that patients 
did not take medication due to the side effects, whilst patients and carers said that 
it was more important to have effective medication and to be able to manage side 
effects.  
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Gray et al (2010) recognised the importance of a patient-centred approach and 
empowerment in the treatment of people with mental illness. They developed an 
adherence therapy based on three aspects, directly linked to the six factors, i.e. 
professionals’ skills, therapy cornerstones, and adherence therapy assessment and 
exercises. This intervention is intended to run for up to an hour for 8 sessions. To 
deliver the therapy a trained professional uses a set of skills to enable patients to 
make informed and shared decisions about their treatment, and to help them learn 
about how to deal with treatment difficulties. This is to be achieved by a 
professional using active and reflective listening and working collaboratively with 
the patient. The aims of the individual sessions are to be set by both, the 
professional and patient to maintain patient engagement about medication choice, 
whilst managing and developing a patient-professional relationship. The ultimate 
goal of the therapy is for patients to develop a set of skills which can help them deal 
with possible future problems and their future decisions about medication (Gray et 
al., 2010). The effects of AT have been tested in nine trials focusing on a variety of 
conditions, showing significant results in six of the studies. For example, AT has 
been shown to significantly improve self-reported medication adherence and 
quality of life in Parkinson’s Disease (Daley et al., 2014) and medication adherence 
in hypertension (Alhalaiqa et al., 2012). AT trials also showed a significant 
improvement in psychopathology of patients with schizophrenia (Schulz et al., 2013; 
Maneesakorn et al., 2007; von Bormann e al., 2014). Brown et al. (2013) explored 
the effects of AT training in the management of early psychosis and found 
significant reduction of relapse rates. These promising trials demonstrate that the 
findings of a concept mapping study can be used to inform the development of an 
effective intervention. 
 
Using findings of a concept mapping study to develop a therapy targeting patient 
treatment decision-making represents an important milestone for the method, and 
for exploratory and participatory research. It emphasises the importance of 
conducting research in which patients and their carers are encouraged to be active 
in informing the research topic and providing their own perspectives about 
treatment choices. In this research I aim to understand how people with depression 
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make treatment decisions, and concept mapping is considered to be a resourceful 
tool that can facilitate studying this topic in depth by incorporating the different 
stakeholder groups’ perspectives.  
 
4.3.2 Concept mapping: a participatory method 
Participatory research can be broadly characterised as an active involvement of the 
study participants or their representatives in the process of planning and 
conducting research, and in interpreting the findings (Cornwall and Jewkes, 1995). It 
is based on the view that people who take part in research about a particular illness, 
for example, patients with a condition, or carers and clinicians treating the patients, 
are and should be considered the experts in their area. Their perspectives and 
experiences can therefore add a valuable angle to the issues under investigation 
(Entwistle and Watt, 2006). By exploring the participants’ personal experiences, 
researchers can develop strategies that maximise relevance of the research and 
utilisation of findings (Kikkert et al., 2006, Gray et al., 2010). 
 
Entwistle (2006) suggested that the conduct of participatory research might be 
rising in response to issues such as increased public awareness of and resentment 
over unethical research practices (Goodare and Smith, 1995). Patients’ active 
engagement in research conduct appears to be related to their involvement in 
treatment decision-making (Entwistle and Watt, 2006) and is in line with a person-
centred approach to healthcare (NICE, 2009). 
 
The level and type of public involvement in research vary considerably across 
studies. The term participatory research is often used to describe various levels of 
involvement, which can include participants’ brief brainstorming and feedback 
about research, an involvement of health service users in a study planning phase, 
but also continuous consulting of the study conduct with the stakeholders (Cornwall 
and Jewkes, 1995). Concept mapping offers opportunities for stakeholders’ 
involvement in each step of the study process, which are, developing the research 
question for the qualitative study phase, generating responses to the question, and 
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interpreting the findings (Kane and Trochim, 2007, Burke et al., 2005). The objective 
for using concept mapping is often to develop or inform planning or decision-
making about a particular problem, and the stakeholders’ perspectives can help 
identify the most appropriate solutions. For example, Kikkert et al (2006) involved 
patients with the condition as well as their carers and health professionals in the 
formulation of the study focus and in the interpretation of the generated concepts. 
They were then able to recognise all three groups’ perspectives (Kikkert et al., 2006) 
and utilised them in the development of a person-centred adherence therapy (Gray 
et al., 2010). 
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 Chapter 5 Methods  
 
5.1 Introduction 
In order to achieve the study aims, I used concept mapping and in this chapter I 
describe in detail the method procedure of the study. 
 
5.2 Concept mapping procedure: an overview 
There are six accepted phases in concept mapping: preparation, generating the 
ideas, clustering and prioritising tasks, data analysis, interpreting the results and 
implementation of findings (Severens, 1995b, Kane and Trochim, 2007).  
 
5.2.1 Phase 1: Preparation 
I organised to meet with my academic supervisors, a health professional and a 
relative of a person with depression, in order to develop the focus question for the 
study. The participant (stakeholder) groups were selected to allow exploration of 
the views of the people most involved in the process of decision-making concerning 
treatment for depression. Ethics and governance approvals, recruitment, planning 
of data collection and obtaining consent from participants also took place in this 
this stage, in order to prepare for the subsequent phases of the study.  
 
5.2.1.1 Choice of a specialised software 
In concept mapping, a specialised software package is used to analyse data in step 
4, and it can aid data collection in steps 2 and 3 (Severens, 1995b, Kane and 
Trochim, 2007). The choice of the software is done early in the preparation stage, 
since its selection influences some of the decisions made in the planning phase of 
the project, such as data collection modes and maximum number of statements 
that can be used in the prioritising and clustering tasks. Two main software 
packages are currently used within concept mapping. These are: Ariadne (Severens, 
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1995a) and Concept Systems, Inc., and both are widely used in peer-reviewed 
concept mapping research (Kikkert et al., 2006, Windsor, 2013, Rosas and Kane, 
2012). The most important differences between the packages lay in their price and 
in several specific features in data analysis. The cost of Concept Systems software is 
$1,000 for a single graduate student project, whilst Ariadne was provided for free 
by the software developer.  
 
Both packages perform established multivariate data analyses, which are done in 
two consecutive steps, i.e. multidimensional analysis and a cluster analysis (Kane 
and Trochim, 2007, Severens, 2012). The specific types of these analyses in the two 
packages are pre-determined, but the data can be exported to other statistical 
software that allows performing several types of cluster analysis, such as SPSS for 
Windows. I planned to use SPSS in addition to Ariadne, because the results of the 
cluster analysis are used as the main study findings and a choice of its type can 
directly influence the factors’ formation.  
 
In addition to the main analyses, Concept Systems software allows evaluating 
reliability of the statements’ representation on the concept map, reliability of the 
cluster analysis, and of the importance rankings of the statements (Rosas and Kane, 
2012). Whilst these are not possible to determine in Ariadne, the software has 
previously been used in large studies (Kikkert et al., 2006, Armstrong and Steffen, 
2009) whose findings were effectively utilised further (Gray et al., 2010). In 
addition, SPSS can be used to perform a reliable cluster analysis and statistical 
analysis to compare importance rankings of the groups. I decided to use Ariadne in 
combination with SPSS because this option allows an opportunity to make informed 
selections of the analyses to perform.  
 
5.2.1.2 Mode of study 
In concept mapping data can be collected either during face-to-face meetings and 
group sessions with participants, or remotely via post, email or a specialised 
website (i.e. provided by Concept Systems, Inc.). Most authors tend to use a 
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combination of these methods to allow participants more flexibility and reduce the 
burden (Rosas and Kane, 2012). Using the web-based method is linked to larger 
sample sizes, but lower rates of completed clustering and prioritising tasks than the 
face-to-face method (Rosas and Kane, 2012). The authors reported that the task-
completion rates were the lowest in studies using a combination of the methods, 
but they also had the lowest attrition rates, compared to the single-mode methods. 
To reflect these findings, I used face-to-face mode as the main data collection 
method. Participants were able to submit their responses by telephone, email or 
post if they were not otherwise able to take part in the study. 
  
5.2.1.3 Selection of participants 
The goal of this research project is to enhance understanding about how people 
with depression make treatment decisions, by exploring the views of those who are 
involved in, and affected by this process. The stakeholder groups were purposively 
selected to include people with depression, their family and friends, and healthcare 
professionals who work with people with depression in either primary or secondary 
care.  
 
5.2.1.4 Number of participants 
Average number of participants in concept mapping studies varies depending on 
their mode; it is 62 in studies with face-to-face data collection mode, and 122 
participants in studies combining the modes (Rosas and Kane, 2012). The authors 
reported that the internal reliability of study results increases with a growing 
sample size, and they recommended that the clustering task should be completed 
by a minimum of 20-30 participants. Larger numbers of participants in prioritising 
task were also linked to better reliability of the scale, but no specific 
recommendation was suggested. The mean number of respondents in this task was 
82 for studies using any of the modes (Rosas and Kane, 2012). In order to allow a 
strong statistical comparison of the groups’ views, and to allow for possible loss of 
participants due to follow up throughout the concept mapping process (3% of 
participants in Kikkert et al, 2006; task completion rates between 50-
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and Kane, 2012), I intended to recruit 30 members of each stakeholder group, i.e. 
approximately 90 altogether.  
 
5.2.1.5 Development of focus question 
The focus question within concept mapping studies is an open-ended question 
presented to participants during brainstorming sessions. It is a subject which they 
are encouraged to openly discuss in order to think of all possible issues that are 
relevant for them. The focus question for this study was developed during 
numerous discussions with my supervisors and people affected by depression but 
not directly involved in this study. We intended for the aim of this study to be the 
main topic discussed during brainstorming sessions, and therefore articulated the 
following questions. 
 
People with depression answered the following focus question: ‘My most recent 
choice of treatment for depression was influenced by…?’  
Family and friends and healthcare workers were asked: ‘Treatment choices made by 
people with depression are influenced by…?’ 
 
The focus questions were formulated to reflect an assumption made in this study, 
i.e. that all treatment choices are influenced by the same set of factors. This was a 
decision made by all members of our research group after numerous discussions. 
The purpose of this exploratory and rather broad question was to allow participants 
to explore all potentially relevant factors affecting their real-life treatment 
decisions. Asking about their most recent decisions gave participants an opportunity 
to consider a decision that was most recent and relevant for them.  
 
5.2.1.6 Ethics and Governance approvals 
Prior to recruitment of participants and conduct of any study procedures, the study 
was reviewed and approved by a local NHS Ethics Committee and the Governance 
committees of the NHS Trusts involved in the study. The ethics and governance 
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approval letters are shown in Appendices 1-4 and the study protocol is in Appendix 
7. Appendices 5 and 6 show my Good Clinical Practice certificates. I applied for two 
substantial amendments to the protocol, which are detailed in section 5.5. A full 
description and the ethics and governance approval letters for the first amendment 
are provided in Appendices 8-10 and Appendix 14. The description of amendment 2 
is in Appendix 11 and the ethics and governance approval letters are in Appendices 
12-14.  
 
5.2.2 Phase 2: Generating the ideas 
The aim of this phase is to generate as many statements as possible in response to 
the focus question. Statements can be generated using several different methods. 
The most commonly used is brainstorming led by a trained facilitator within group 
or individual sessions during personal meetings or remotely, for example by 
telephone or email (Kikkert et al., 2006, Kane and Trochim, 2007). Other options of 
generating ideas can include a Delphi technique (Minkman et al., 2009), and 
Nominal group technique (Rohrbaugh, 1981), although these methods can also be 
used as data collection methods on their own (Linstone and Turoff, 2002, 
Rohrbaugh, 1981).  
 
The remote methods of generating ideas, such as submitting statements via email, 
or the structured methods Delphi and Nominal group techniques, have an 
advantage of reducing the participant and researcher burden and allowing larger 
numbers of participants to take part in the process (Kane and Trochim, 2007, Rosas 
and Kane, 2012). Such methods may also allow identification of sensitive concepts, 
which the stakeholders might not be willing to discuss within groups, but also more 
duplicate statements are likely to be produced (Kane and Trochim, 2007). On the 
other hand, when using techniques that limit participants’ communication with 
each other, the free association of ideas and concepts is not enabled. Consequently, 
some ideas, which are less apparent to a person, might not be generated (Kane and 
Trochim, 2007). Group brainstorming sessions can provide an environment where 
stakeholders freely discuss the factors that had influenced their treatment choices, 
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but the situation depends on the group dynamics and skills of the facilitator to allow 
participants to think freely about a given topic. Unlike in the other techniques, 
when running face-to-face brainstorming sessions, the facilitator can directly 
communicate with the stakeholders, ask about specific issues, or use active listening 
to help participants focus on the research question. For this reason I decided to 
facilitate generating the ideas within face-to-face brainstorming sessions where 
practically possible. In order to counter the disadvantages of this approach, I 
decided to give participants an opportunity to take part in brainstorming within 
other settings as well, including individual and remote modes.   
 
5.2.2.1 Brainstorming sessions 
During brainstorming group sessions a trained facilitator and assistant lead the 
group discussions and worked with participants to maintain a non-judgemental and 
comfortable atmosphere. This was to aid participants to relax, and to use free 
association to think about the relevant ideas. The generated ideas were noted down 
as statements, which needed to be clear, understandable and singular. An example 
of a statement generated in response to the focus question could be ‘severity of 
depression’. 
 
5.2.2.2 Refining the statements 
Once all brainstorming sessions have been held, all the statements that have been 
generated are pooled together and reviewed. The purpose of this exercise was to 
discard any duplicate responses and reduce the total number of statements in the 
final set to below 98, a maximum number of statements that the software Ariadne 
can use in the analyses (Severens, 1995b) 
 
5.2.3 Phase 3: Prioritising and clustering tasks  
Participants from the brainstorming phase completed the prioritising and clustering 
tasks either individually during group sessions or in their own homes. This phase is 
separate from the brainstorming phase. It is, therefore, possible for additional 
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members of the three stakeholder groups to take part in the structuring phase even 
if they had not been involved in brainstorming. Whilst it is not intended to initiate a 
new recruitment process in this stage, any members of the three stakeholder 
groups who are interested in taking part in the study, and meet the inclusion 
criteria are allowed to join in. 
 
5.2.3.1 Clustering 
When undertaking the clustering exercise, the task for participants is to put the 
statements that seem to go together into groups, using criteria that they think are 
most appropriate and relevant. The criteria are therefore based on individual 
interpretation and are not pre-determined by the researcher. Data collected in this 
task therefore represents the participants’ perceptions of how related the individual 
statements are to each other, or how ‘close to each other’ they are. 
 
5.2.3.2 Prioritising 
When prioritising, participants were asked to place the statements into five equal 
piles, based on their perceived importance (i.e. using a Likert-type scale from 1 - the 
least to 5 - the most important).  
In both tasks, participants were instructed to use all statements and not to create 
any 'miscellaneous' clusters or piles. 
 
5.2.4 Phase 4: Data analysis 
Data from the two tasks is analysed using a specialised concept mapping software 
called Ariadne (Severens, 1995a).  
 
5.2.4.1 A concept map 
Information about participants’ perceptions of the relations between statements is 
analysed using multivariate statistical techniques (Kane and Trochim, 2007). A 
procedure called principal component analysis (Severens, 2012) is used to identify 
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five main dimensions (axes) in the data, and to assign each statement a value for 
each dimension. The first two axes are used to generate a graph labelled a concept 
map, and the statements’ values are used as their coordinates on the concept map. 
 
5.2.4.2 Cluster analysis 
Data from the PCA procedure is further analysed using a cluster analysis. This 
technique groups the statements that are related to each other based on the 
distances between them (as identified within the PCA). The clusters are also 
indicated on the concept map, to aid visual understanding of the underlying 
relationships between them. 
 
5.2.4.3 Prioritising 
Data from the prioritising stage is then used to calculate mean relative importance 
rankings for each statement and cluster. The perceptions of the stakeholder groups 
are contrasted against each other, in order to better understand the groups’ views 
about what is important in terms of the depression treatment choices that patients 
make. 
 
5.2.4.4 Subgroups of stakeholder groups 
Using the data produced in the PCA analysis, it is possible to explore the 
identification of subgroups of the original stakeholder groups. Such subgroups 
would be characterised by their participants’ common preferences for particular 
clusters.  
 
5.2.5 Phase 5: Interpreting the results 
5.2.5.1 A concept map 
The concept map produced using this process is a graphical illustration of the 
relationships among statements. The more often that any two statements were put 
into the same group during the clustering task, the closer they are placed on the 
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final concept map. The same is true for the final clusters. The closer they are 
located to each other, the more related are the concepts they represent. 
Interpretation of the concept map, therefore, entails understanding the underlying 
relationships between the individual clusters. It is useful to distinguish between the 
clusters which are positioned close to each other, since their concepts might be 
related, and the clusters positioned apart. The combination of a PCA procedure 
followed by a cluster analysis helps to identify and differentiate between the 
individual factors that influence patients’ treatment choices. 
 
5.2.5.2 Differences between groups and subgroups 
The average importance ratings calculated for clusters allow for comparisons of the 
stakeholder groups’ views, as well as the differences between any subgroups which 
may have been identified. Due to the relatively small number of participants, 
between- and within-group comparisons need to be interpreted carefully. 
 
5.2.6 Phase 6: Implementation of findings 
The implementation of findings from the study involves their dissemination to 
healthcare professionals dealing with people with depression, and to members of 
the general public who could benefit from understanding the differences between 
the views of patients, family and friends, and professionals. Researchers have 
previously used concept mapping, for example, to develop conceptual frameworks 
of issues related to occupational health (de Vries et al., 2012), to understand the 
views about adherence to treatment in schizophrenia (Kikkert et al., 2006) and to 
develop an assessment instrument (Armstrong and Steffen, 2009, Ahmad et al., 
2012). The findings of this study could be used to inform clinical practice about 
factors affecting patient treatment decision-making, and to develop strategies to 
support patients in making considered and well-informed choices. Identification of 
different ‘types’ of patients or health professionals might also be important for 
clinical practice. It could be beneficial for health professionals to be aware of the 
potential patient types according to their decision-making needs and preferences. 
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Similarly, it might prove beneficial for professionals to better understand their own 
perspectives, in order to help to support patients in their decisions. 
 
5.3 Participants 
This study was planned with the aim to improve understanding about how people 
with depression make their treatment decisions. I therefore recruited members of 
three groups of people who are involved in the process of patients’ treatment 
choices: people with depression, their family and friends, and healthcare workers. 
Each of these groups plays their role when a person is deciding whether to seek 
help for depression or which professional to visit. The aim was to recruit 
approximately 30 members of each stakeholder group to allow for possible attrition 
within the phases of data collection, and to ensure a sufficient sample size for 
reliable data analyses. 
5.3.1 Sampling strategy 
Participants were selected and recruited purposively for pragmatic reasons, that is 
to maximise the sample size and specifically target recruitment methods to access 
various difficult to access groups of participants. These included, for example, 
people with depression who had sought medical help and were or had been 
receiving treatment, people who thought had depression but had decided not to 
seek help, and family and friends of such people with depression.   
 
5.3.2  Inclusion criteria 
In developing the sample frame for the study, it was decided in general terms that 
participants should be over 18 (no upper age limit) to enable providing a fully 
informed consent. They also needed to be able to verbalise their thoughts in 
English, in order to take part in discussions with other participants and researcher 
about the focus question. There was no funding available for commissioning 
translation services. Each stakeholder group was recruited and involved in data 
collection separately, but people with depression and family and friends were 
accessed using the same methods, in order to maximise intake of participants in the 
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study. Members of these groups were able to join in the study, regardless of 
whether a person close to them was taking part, since limiting recruitment to 
people who were directly associated with each other would not have added a 
tangible benefit to the study findings. 
 
During typical brainstorming sessions, stakeholders were expected to talk about the 
factors affecting depression treatment decisions made by themselves or someone 
close to them. The inclusion criteria were therefore set to ensure that we involved 
the people who are able and competent to provide perspectives relevant to the 
focus question. 
 
5.3.2.1 People with depression were required to: 
a) Confirm by self-report that they had been recommended or receiving 
treatment for unipolar depression of any severity, currently or within past 
12 months. Treatment is considered to include any activity recommended 
with the intent to help relieve depressive symptoms, for example, taking 
antidepressant medication, talking therapies, alternative therapies, self-help 
activities. It was not possible to include people who report having bipolar 
disorder due to different treatment options that are recommended for such 
conditions.  
b) Be aged over 18 years, and for participants to be adults with the capacity to 
consent. I intended to include 10 people aged over 65 to ensure 
representation of the elderly population in the study.  
c) Provide written informed consent prior to taking part. 
 
5.3.2.2 Family and friends were required to: 
a) Be close to a person with unipolar depression as their family member or a 
friend, in order to be able to describe their views of the factors affecting the 
person’s treatment choices.  
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b) Be aged 18 or above, to ensure participants are adults with the capacity to 
consent  
c) Provide written informed consent to participation. 
 
5.3.2.3 Healthcare workers 
I aimed to include a multidisciplinary group of healthcare workers, in order to 
collect a variety of views about different treatment choices people with depression 
make. For this reason, I wished to recruit General Practitioners (GPs), psychiatrists, 
nurses, mental health nurses, psychological therapists, psychologists, occupational 
therapists, alternative medicine (AM) practitioners or other healthcare workers. We 
considered but rejected including case managers, psychoanalysts, family therapists 
and other healthcare workers to participate. This was decided based on the 
practical difficulties of accessing and inviting them.  
To take part, healthcare workers were required to: 
a) Be working or had worked with people with unipolar depression currently 
(at time of study) or within past 12 months. This is to ensure healthcare 
professionals have a recent experience with helping patients make 
depression treatment choices. 
b) To provide written informed consent to take part in the study. 
 
AM practitioners were expected to demonstrate a low interest in taking part in the 
study. I believe that this is an important population to access because there is a 
public perception that treatment such as herbal therapies, homeopathy or light 
therapy, although not evidence-based, may be effective against depression. To help 
me access the relevant therapists, in addition to the above, I set the following 
inclusion criteria for AM practitioners: 
c) Practice a therapy for which there is at least anecdotal evidence for 
effectiveness in depression. 
d) Practice in the Norwich area.  
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5.3.3 Information collected about participants 
Before taking part in the study, all participants were asked to provide their 
informed consent to involvement in the study, and complete a short questionnaire 
to provide basic information for descriptive purposes. The questionnaires used for 
this purpose are in Appendices 32 and 33. In addition to name and preferred 
contact details, I asked participants to answer questions about the following 
domains: 
 
5.3.3.1 People with depression 
a) Demographic information: gender, age, ethnicity, marital status, level of 
education and employment status 
b) The most recent treatment prescribed and received for depression 
c) Year of first depressive episode 
d) Relationship with the family and friend (if a person close to them was taking 
part) 
 
5.3.3.2 Family and friends 
a) Demographic information: gender, age, ethnicity, marital status, level of 
education and employment status 
b) Relationship with the person with depression who was close to them 
(regardless of whether taking part) 
c) Whether they were receiving treatment for depression and any details 
d) Whether a person with depression who was close to them was taking part in 
the study 
 
5.3.3.3 Healthcare workers 
a) Type of profession 
b) Length of time spent helping people with depression  
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5.4 Study procedures 
5.4.1 Recruitment of participants 
In order to access the stakeholder groups required for this research, I combined 
purposive and convenience sampling and applied multiple recruitment  strategies. I 
made attempts to specifically involve participant samples which would be 
representative of the target populations and would involve participants with a 
variety of opinions and clinical backgrounds. Participants recruited in each 
stakeholder groups were therefore expected to reflect the wide spectrum of 
treatment decisions people make and the treatment options people use.  
 
People with depression and family and friends did not have to be related or 
recruited together, but I anticipated that asking the potential participants to invite a 
member of the other group (for example, a partner or a friend), might help me 
reach the target numbers of participants (30 in each group). The strategies I used to 
invite these two groups will, therefore, be described for patients and family and 
friends together. All invitation letters and adverts used for recruitment are shown in 
Appendices 15-23. Prior to commencing recruitment, all strategies and materials 
were reviewed and approved by the relevant NHS research ethics and governance 
committees. 
 
5.4.1.1 People with depression and their family and friends 
People with depression were recruited using several recognised strategies, 
including the assistance of a familiar health professional, adverts published in the 
local media, the assistance of the local charities specialised in helping people with 
mental illness, and snowballing. The use of different strategies was thought to 
maximise the effectiveness of the recruitment process and to allow the inclusion of 
depressed people and their family or friends from various clinical backgrounds. This 
was thought to reflect the trends in the population, such as the proportion of 
depressed people seeking medical help, or those seeking psychological, alternative 
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or no treatment. Additionally, the use of a number of different recruitment 
strategies was expected to minimise the risk of selection bias.  
 
Recruiting patients with the assistance of their health professionals who identify the 
potentially eligible patients is a common technique, used in a number of studies 
(Kikkert et al., 2006; Carder et al., 2003). However, the health professionals might 
also unconsciously introduce the risk of bias by selecting the patients with less 
severe illness, or those adhering to the professionals’ own opinions. Inviting 
depressed people and their family and friends through the local media (i.e. 
newspapers and magazines) and posters (i.e. flyers) distributed to GP practice 
waiting rooms, was expected to make the study known and accessible to the 
population within the county. On one hand, a limitation of these methods is their 
reliance on the aspiring participants to initiate contact with the researcher, which 
might be a barrier to some people. On the other hand, their benefit lies in the 
potential to reach out to the wider audience who read the particular newspapers or 
visit the GP practice, without the decision made by the health professionals about 
who can see the information. Flyers and media articles are recruitment methods 
commonly used in qualitative health research and in postgraduate research 
(Namageyo-Funa et al., 2014), and I considered them to be potentially useful in this 
study, as well.  
 
Snowball sampling is another type of recruitment method, commonly used in 
qualitative research. It involves an informal sharing of the information about the 
research study by individuals (for example, current participants) to their family or 
friends, who can then tell other people, and so forth (Vogt, 1999). This type of 
sampling can enable researchers to access specific or difficult to reach populations 
(Sadler et al., 2010), but it is also associated with selection bias (Groger et al., 1999). 
In order to address these risks, I used snowballing  as a complementary recruitment 
method, rather than as a main strategy. 
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a) Press release in the local newspaper: Following an NHS research ethics and 
governance approvals, a press release (Appendix 15) was published on the 
University’s website and sent to the local newspapers in November 2011. 
The articles provided brief information about the study and what would be 
expected from prospective participants. The article primarily targeted 
people with depression, but it was noted that family and friends were also 
needed in the study. My email and phone details were listed, and readers 
were encouraged to get in touch if they were interested in having more 
information or in taking part in the study. Having proved to be a successful 
recruitment strategy, I published a second press release (Appendix 16) in 
April 2012, focusing mainly on family and friends. Snapshots of the media 
articles published in the newspapers and magazines are shown in 
Appendices 17-19. 
b) An article in the Mind charity newsletter: In June 2012, I published a brief 
article in a local mental health charity’s newsletter (Mind), describing the 
study and inviting people with depression and their family and friends to 
take part (Appendix 20).  
c) Snowballing technique: people who had agreed to take part in the study 
were asked to tell their relatives, friends or colleagues about the project, 
and to provide the researcher’s contact details to anyone that might be 
interested in potential participation.  
d) Advertising in GP surgeries: In the waiting rooms of 5 Norwich General 
Practitioner surgeries I distributed posters that provided brief information 
about this study and invited patients and their family and friends to join in 
the research (Appendices 21 and 22). This was discussed and approved by 
the GP practice managers at their discretion, in addition to the approval 
granted by the NHS Research Ethics Committee for this to happen.  
e) Contact via healthcare workers: as agreed with team leaders in a local NHS 
Trust, I asked healthcare workers in the Trust to briefly explain my research 
project to their clients who were meeting the inclusion criteria. Healthcare 
workers also made the information sheets about the study available for 
people with depression with whom they were in touch.  
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f) Contact via the Age UK charity: I contacted this charity with the aim to 
specifically invite a group of older people with depression. Facilitator of the 
support groups held in the Norwich branch of the charity Age UK distributed 
the information sheets about the study to the clients meeting the inclusion 
criteria, and organised for those interested in further information to meet 
with me, and discuss the research process.  
 
5.4.1.2 Healthcare workers  
a) Team leaders in the NHS Trusts: I presented the study to workers in 6 team 
meetings in the local NHS Trust. Their team leaders supported the study and 
handed out study information sheets and my contact details. This strategy 
was used to recruit the majority of healthcare workers. The team leaders 
were also asked to approach GPs with an interest in mental health and send 
them information sheets to invite them to take part in the study.  
b) Alternative medicine practitioners: In order to identify the relevant AM 
practitioners in this study, I first listed the alternative therapies with 
anecdotal evidence for depression. I searched the Yellow Pages and Google, 
in order to create a directory of practitioners offering such therapies in 
Norwich. I purposively selected ten practitioners from this list, in order to 
include as many different therapies as possible, and sent them an invitation 
letter (Appendix 23). This was repeated, with the aim to include at least one 
AM practitioner in the study. 
c) Snowballing techniques: Healthcare workers who knew about this study 
were encouraged to tell their colleagues about the study, and invite them to 
contact the researcher if interested in the project. 
d) GP practice managers: I contacted practice managers and research 
managers of several medical practices in the Norfolk area to invite GPs and 
nurses to take part in the study. The managers who agreed to help with 
recruitment of healthcare workers distributed information sheets about the 
study to the potential participants, and suggested they could contact me for 
further details about the research. 
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All of the recruitment posters, adverts and information sheets listed my study email 
and phone details and potential participants were encouraged to use them to 
contact me for more information about the study. All people who contacted me and 
expressed interest in more information about the study were sent information 
sheets with reply slips and stamped-addressed return envelopes, together with a 
sheet containing useful information about depression (Appendices 24-26). Those 
who identified themselves as people with depression or family and friends were 
sent an information pack for both of these groups, with a suggestion that they could 
also invite a person close to them to join in the study, if they wished so. In order to 
prevent over-recruitment of people with depression or family and friends, a ‘Refusal 
letter’ was developed (Appendix 35), but it was never used. 
 
5.4.2 Participants’ consent 
Prior to taking part, potential participants were required to provide written 
informed consent, usually during a personal meeting with me, which was scheduled 
mainly for the purpose of obtaining consent. Healthcare workers were assumed to 
have a professional capacity and it was not necessary to meet them personally for 
consent. They could send their reply slips and signed consent forms by post or 
before the first data collection session that they took part in. This was a way of 
reducing the burden on participating healthcare workers, and it might have 
positively affected how the workers responded to study invitations. All consent 
forms are shown in Appendices 29-31 and the questionnaire, participants were 
asked to fill in are in Appendices 32 and 33. 
 
5.4.2.1 Consenting meetings 
In order to obtain informed consent, meetings were held with people with 
depression and family and friends who contacted me and were interested in taking 
part, before their first data collection session. The meetings were scheduled to take 
approximately 30 to 60 minutes and their purpose was to provide an opportunity to 
discuss the study in detail and to explain the ethical issues related to the study. 
People who agreed to take part then signed the consent form and filled in a short 
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questionnaire about personal and clinical information. Some participants, if 
assumed full capacity to decide about taking part in research, were not required to 
provide written consent during face-to-face meetings. This decision was based on 
the participants’ individual situations. All people were given an opportunity to 
discuss the study and any queries they might have had regarding the research in a 
personal meeting, via telephone or email. Reasons for any distance-based 
communication were practical and financial barriers to personal meetings, since 
some people who wished to take part in the study were either based outside of 
Norfolk, or were unable to meet due to their other commitments. Since they met 
the study inclusion criteria, I considered it unethical to deny them participation 
solely on the basis of practical barriers, such as location. Consent was re-confirmed 
verbally with participants prior to the start of all data collection meetings, 
regardless of the mode. 
 
5.4.3 Data collection 
5.4.3.1 All meetings 
Data collection in concept mapping consists of two main stages. First, all 
participants join in brainstorming sessions to generate statements in response to 
the focus question. In the second phase of data collection participants are invited to 
perform two tasks: prioritising and clustering of the statements, decisions being 
made according to their own opinions.  
 
5.4.3.1.1 Conduct of the meetings 
All sessions were held separately for each stakeholder group to prevent interaction 
between the different groups, and I facilitated most of the groups with the help of 
one trained assistant who took notes. When two groups were held for practical 
reasons at the same time, another trained facilitator and assistant facilitated the 
other session. All group sessions lasted up to two hours, including a short break for 
refreshments, which I had provided.  
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5.4.3.1.2 Location of the meetings 
Most sessions for people with depression and family and friends were in groups and 
took place in rooms at the University of East Anglia. In order to meet the 
participants’ particular needs (for example practical reasons or anonymity issues), 
they were also able to take part during individual meetings or telephone 
conversations (only for the brainstorming stage). When required, I offered 
participants an opportunity to complete the brainstorming task in their own time, 
and to submit their suggested statements by email.  
 
Sessions for healthcare workers were organised individually or for the whole teams 
together, depending on the willingness of the workers to take part in the study. 
Team leaders were very cooperative and supported this research wherever 
possible. For example, they allowed the study sessions to take place during their 
team meetings if majority of healthcare workers in their team decided to join in. 
When necessary, I held individual brainstorming discussions either in person or as a 
phone conversation. Personal sessions always took place either at healthcare 
workers’ workplace or in University rooms. Participants also had the opportunity to 
submit their responses via email if they so wished. 
 
5.4.3.2 Brainstorming 
The aim was to generate as many statements as possible, in response to the focus 
questions: ‘My most recent choice of treatment for depression was influenced 
by…?’(for people with depression) and ‘Treatment choices made by people with 
depression are influenced by…?’ (for family and friends and healthcare workers). All 
statements used in the subsequent phases of the study were generated in the 
brainstorming phase. The sessions were, therefore, audio-recorded in order to 
capture the group discussions and ensure that all the concepts discussed in the 
sessions were included in the final set of statements.  
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5.4.3.2.1 Generating the statements 
During the face-to-face brainstorming sessions the relevant focus question was 
always visible to all participants to help them remember the focus of discussions. 
During the telephone sessions and when sending the instructions via email, I 
suggested to the participants that they might note down the focus question, to help 
them brainstorm about the topic. I encouraged them to use free association of 
ideas in order to help them recall as many different factors that influenced their 
treatment choices, as possible. Participants were assured that the environment 
within sessions was non-judgemental towards any ideas presented, in order to 
respect other people and facilitate the brainstorming process. When generating the 
statements, it was emphasised that there were no right or wrong answers, since the 
statements generated reflected the factors that had influenced their own decisions 
and these were individually based. Family and friends and healthcare workers were 
also assured that their own views were of interest, and no judgement would be 
imposed on their opinions.  
 
No consensus was sought regarding the content of statements, to allow me to 
include all generated statements, which could have been applicable to all, 
regardless of whether everybody agreed on the factors’ effects. If someone at the 
session did not agree about an issue raised, they had an opportunity to generate an 
opposing statement (for example, my doctor being supportive versus the lack of my 
doctor’s support). Participants were encouraged to note any ideas on Post-it notes 
if they felt uncomfortable discussing them in the group setting. All statements 
submitted this way, by email or by post were added to the overall list of statements 
generated, and considered in the final review process. 
 
5.4.3.3 Prompts 
Based on the factors identified in previous literature (Prins et al., 2008) I created a 
list of prompts and topics relevant to decision-making about depression treatment 
(Appendix 36). These topic areas were used as prompts during brainstorming 
sessions, if not mentioned already spontaneously by participants. The prompts 
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were restricted to be used only as general topics for further group discussion if 
needed. This was decided to help participants cover a variety of factors, while not 
influencing the nature of statements they generated. 
 
5.4.3.3.1 Number of attendees 
Sessions were held for 2-8 people, or on an individual basis. Telephone meetings 
were held for one person at a time. 
 
5.4.3.3.2 Characteristics of statements 
The facilitator and the assistant at brainstorming sessions were responsible for the 
data collected and quality of the statements. In concept mapping it is important to 
generate statements which are clear, singular and understandable, in order to allow 
their use in the subsequent stages of analysis and evaluation (prioritising and 
clustering tasks). Participants could discuss these issues during the brainstorming 
sessions, to help generate statements, which made sense to all of them. 
a) Clear: Statements were required to be of sufficient clarity, in order to be 
potentially applicable to other participants, as well (for instance, they could 
not include specific names or medicine labels). It was also important not to 
generate statements that were too specific and covered too large an area of 
topics (for example, ‘my doctor’).  
b) Singular: It was important to keep statements simple, containing only one 
topic. An example of a statement that contains more than one concept is: 
‘my doctor and my family’. Such issues were discussed at the sessions, and 
the concepts separated into multiple statements. 
c) Understandable: All statements needed to contain vocabulary that would be 
easily understood by all members of the stakeholder groups. I ensured that 
they contained no highly medical or technical words, for instance ‘euthymia’ 
or ‘remission’.   
 
Page 96 of 386 
 
5.4.3.4 Reviewing the statements 
All statements from all brainstorming sessions were pooled and reviewed. The goal 
of this process was to discard all duplicates, and reduce the number of statements 
in the final set to below 98. This is the maximum number the software package 
Ariadne can process in analysis (Severens, 1995b). Another reason for keeping the 
total number of statements lower is the consideration of the possibility of 
participants’ increasing fatigue and decreasing concentration if they are given too 
many items to sort in the later phases of the study (Rosas and Kane, 2012).  
 
Refining the statements was an iterative process which involved numerous 
discussions with my academic supervisors and two participants, all of whom 
provided feedback in the process of generating the final set of statements to be 
used. At this stage some of the concepts originally generated were combined into 
broader ones, to achieve similar levels of clarity and detail in all statements in the 
final set. This was to allow participants to compare and evaluate the statements 
during the prioritising and clustering tasks. 
 
5.4.3.4.1 The process of refining the statements 
To allow me to review the statements, discard duplicated items and to combine 
those that were very similar or too concrete, all statements were printed 
individually on paper strips. I sorted them according to the main topic they 
described. The topics included, for example, healthcare professionals, beliefs about 
depression, stigma, and so forth. Then I put together the statements that covered 
the same aspects of these themes (i.e. duplicates) and all items that appeared to be 
closely related to them. For clarity and my own navigation in the set of statements, I 
gave all groups of items working labels, capturing the main idea common for each 
group. These helped me to keep structure in the process, and take note of all similar 
or identical statements. During the review process, I put aside all statements that I 
considered to be too ambiguous or not answering the focus question, and attended 
to them again at the end of the process. Then, I checked relevance of these items 
with the research team members. 
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When reviewing the statements, my goal was to produce a final set with items that 
were equally specific, to allow participants’ evaluation of them in the successive 
data collection phases without undue difficulty. In this process I combined some 
items and aimed to reduce their overall number to a manageable set (up to 
approximately 200 items). These were then presented to the other members of the 
research team and two people with depression. In the course of several group 
discussions the items’ content, level of detail and wording were reviewed, making 
sure that the original statements were well represented by the final items. Relevant 
literature on factors affecting treatment decision-making in relation to depression 
was checked to ensure no items previously identified as important were missing. In 
this iterative process a final set of statements to be used in the structuring sessions 
was generated. 
 
Statements were then allocated a number for identification and were printed on 
paper cards (10x7cm). An example of a final statement on a card, as used in the 
prioritising and clustering tasks, is shown in Figure 1.  
 
Figure 1: Example of a card used in structuring sessions 
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5.4.3.5 Structuring sessions: Clustering and prioritising tasks 
When the final set of statements was reviewed and agreed by members of the 
research team, all participants were invited to take part in the second data 
collection phase of the study. This was labelled as a structuring phase, and involved 
two individual tasks: prioritising and clustering of the statements in the final set. 
Participants could perform these tasks during group sessions organised for this 
purpose for each stakeholder group separately, or individually, within their own 
homes. The following tasks could be completed in no particular order. It was 
emphasised, that there were no right or wrong answers, and the purpose was to 
understand people’s own perspectives. In both tasks, all statements had to be used, 
and each could only be put into one group. For both tasks, I provided an answer 
sheet with pre-printed tables (Appendix 37), and asked participants to record their 
responses in the tables. 
 
5.4.3.5.1 Clustering  
When clustering, participants were asked to put together the statements that they 
thought were related, based on their own criteria. It was important to create a 
minimum of 2 and a maximum of 12 groups. Each group had to contain at least two 
statements, and a maximum of 20% of all statements in the set (due to the 
limitations automatically set by the concept mapping software Ariadne). 
 
5.4.3.5.2 Prioritising  
When prioritising, participants evaluated the perceived importance of the individual 
statements on a 5 point Likert scale (Likert, 1932), and sorted them into the 
following five piles according to the rankings: 
Pile 1: The least important 
Pile 2: Somewhat important 
Pile 3: Moderately important 
Pile 4: Very important 
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Pile 5: The most important 
 
5.5 Ethical considerations 
5.5.1 Research team 
In addition to my academic supervisors and me, the research team included several 
people with depression and health professionals who offered feedback and help 
with decisions and planning of the study.  
 
5.5.2 Study setting 
This study took place in Norwich, England. It is a main city in the region, a county 
with a population of 862,300, mostly White British or White Irish people (91%) 
(Council, 2012). According to the Community Mental Health Profile, 12.5% of adults 
in Norfolk suffered from depression in 2011/2012, which is significantly higher than 
the average for England (11.68%) (NEPHO, 2013). The report, on the other hand, 
showed that wider determinants of health which are related to mental health, such 
as unemployment (2.25% in Norfolk) and the proportion of the population living in 
the most deprived areas (9.8% in Norfolk) were significantly better in Norfolk than 
in England on average (5.94% and 19.8% respectively).  
 
Specialist mental health care in the area is provided by Norfolk and Suffolk NHS 
Foundation Trust, which is supported by 7 Clinical Commissioning Groups (CCGs) 
who offer mental health care in the community and GP practices in the area. The 
seven CCGs are as follows: Norwich, West Norfolk, North Norfolk, South Norfolk, 
Great Yarmouth and Waveney, Ipswich and East Suffolk and West Suffolk. 
 
5.5.3 Potential bias 
5.5.3.1 Sampling bias 
Due to the geographical area where this study was conducted, people with 
depression and family and friends who are members of ethnic minorities, who do 
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not speak English and those who live in rural areas were likely to be 
underrepresented in the research. This can pose limitations on the generalisability 
of findings to wider populations in other parts of the UK with more diverse 
populations and different health services provided by their local NHS Trusts. In 
addition, there was a potential for selection bias due to recruitment strategies used 
in this study, which include purposive sampling and recruitment methods that rely 
on patient-initiated contact  and self-reports. Consequently, some patients and 
their families might not have come into contact with the study-advertising 
materials.  
 
In order to minimise the risk of sampling bias, I used multiple recruitment methods, 
including information shared via healthcare workers, two charities and adverts in 
GP practices. Due to the recruitment methods to be used, healthcare workers 
recruited in the study were likely to be working in the Norfolk area, within the same 
NHS Trusts and possibly within closely collaborating teams in this area. As a 
consequence, it is possible that the healthcare workers who took part in this study 
might have been representative of the professionals working in this geographical 
area, but not of the professionals across the UK. 
 
5.5.3.2 Researcher bias 
It has been suggested that people who are communicative and have more socially 
desirable opinions might be more likely to participate in research studies, and this 
may be especially true for group discussions where individuals might feel inhibited 
to express their views due to embarrassment (Lauber et al., 2005). To help 
participants feel comfortable during the study sessions, facilitators agreed with 
participants about the ground rules to refrain from any judgement of people or 
opinions, to respect all individuals, and to offer confidential means of submitting 
ideas to the researcher. 
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5.5.4 Legal and ethical frameworks guiding this research 
This study is not a Clinical Trial of an Investigational Medicinal Product (non-CTIMP), 
and was therefore bound to be conducted in line with the following research 
standards: Research Governance Framework (DoH, 2005), Declaration of Helsinki 
(Helsinki.) and Good Clinical Practice (NIHR, 2011). Other relevant laws applicable to 
this study were The Data Protection Act 1998, Freedom of Information Act 2000 and 
Equality Act 2010.  
 
5.5.5 Good clinical practice and The Declaration of Helsinki 
I received and renewed my training in Good Clinical Practice (GCP) provided by the 
National Institute for Health Research during the course of this research, and 
conducted this study fully adhering to the principles of GCP and the Declaration of 
Helsinki (published in 1964 and last updated in 2008). Good clinical practice (GCP E6 
R1) is a set of guidelines for medical researchers, monitors and sponsors, developed 
at the National Conference of Harmonisation (ICH, 1996), to ensure planning, 
conduct, audit and reporting of high quality scientific and ethically sound research. 
The GCP standards are based on the Declaration of Helsinki, and set out that the 
researchers conducting the study need to be adequately qualified and overseen by 
a medically trained professional. The most important objective of the guideline and 
the Declaration of Helsinki is the protection of the research participants over the 
research or the society. In order to ensure the research is conducted safely and 
lawfully, the guideline further sets out the specific responsibilities of the sponsor in 
relation to ensuring the overall adherence to the guideline, and the researcher’s 
responsibilities. These include planning and fully adhering to a research protocol 
that needs to be approved by a relevant ethics committee, including research 
participants based on specifically set definitions, and recording and storing research 
data according to the relevant legislation.   
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5.5.6 Ethics and governance approvals 
The study and all procedures described here were set out in a study protocol 
(Appendix 7), which was approved by the local NHS Ethical committee (NRES) in the 
process of a Proportionate review in November 2011, with an assigned registration 
number 11/EE/0321. The Research and Development Departments in the local NHS 
Trusts involved in the study also granted governance approvals, with a reference 
number 2011MH48. In February and April 2012 I submitted two substantial 
amendments to the protocol to the NRES committee, and both were fully approved 
in the subsequent months. The main reason for the amendments was to add new 
recruitment strategies (all listed in section 8) in order to improve the chance of 
achieving the target number of participants.  
 
In the first amendment (Appendix 8) I proposed publishing a second press release 
and article in charity magazines, posters in community venues and snowballing via 
friends and relatives to recruit people with depression and their family and friends. I 
also added the use of a snowballing technique via colleagues to invite more 
healthcare workers. I submitted the second amendment to clarify wording of 
sections in the protocol relating to recruitment methods (Appendix 11).  
 
5.5.6.1 Informed consent 
In accordance with the GCP and the Declaration of Helsinki, all study participants 
were first provided a full explanation of the study aims, procedures and possible 
risks. They were asked to take at least 24 hours to think about their wish to 
participate in the study, and sign and submit a written informed consent form prior 
to taking part in the study. Verbal confirmation of informed consent was sought 
again before every data collection session. 
 
5.5.6.2 Distress, safety and withdrawal of participants 
This study was considered to pose a low risk to participants and the researchers, 
since the aim was to discuss the participants’ views about how people with 
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depression make treatment decisions. Participants were advised that they could 
submit any additional factors to the researcher in confidence via email, Post-it notes 
after the sessions or via telephone, if they did not want to discuss them within the 
group session. During all data collection sessions a group facilitator and an assistant 
were present, and for sessions with people with depression and family and friends 
there was also a professional available in case participants became upset and 
wished to talk to someone in private. Participants were informed about this option 
but it was never needed.  
 
All participants were advised that if any of the research team through discussion 
became aware of any unprofessional practice (for example, health care workers 
prescribing inadequate treatment), abuse or maltreatment of a vulnerable person, 
such information would have to be shared with the appropriate authority.  
 
In line with the Equality Act 2010 participants were treated equally, and were not 
discriminated against on the basis of age, gender, ethnicity, disability, language, 
sexual orientation or other characteristics, if in line with the inclusion criteria 
necessary to be met for this research. For example, it was only possible to include 
adults aged over 18 due to their legal right to provide informed consent. Also, we 
could only involve people with full capacity to consent to participation, and people 
who spoke English, in order to involve them in discussions about the focus question. 
 
5.5.6.3 Anonymity and confidentiality of participants’ data 
All data were collected and processed, and has been stored according to the Data 
Protection Act 1998. In this study no member of the research team had any access 
to medical history or other clinical or personal information about the participants, 
except for the information they voluntarily shared in order to fill in the basic 
information questionnaire and during the brainstorming sessions. Personal 
information, such as names, was recorded on the questionnaires and consent 
forms, whilst the consent forms also contained additional demographic 
characteristics and self-reported depressive histories of people with depression. All 
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brainstorming sessions were audio-recorded after the participants agreed to it. All 
recordings and documents with personal and confidential information was 
transported from site to the University in a locked briefcase, and stored in a locked 
cabinet in a room accessible to a group of researchers by card. All information was 
transferred to electronic password-protected documents, which have been saved 
on the University of East Anglia’s central network server within the University’s 
firewall. In accordance with the study protocol, all research data were anonymised 
within 12 months of the end of the  study. In accordance with the Freedom of 
Information Act 2000 all data stored about any of the participants has to be shared 
with them upon request. No such request was received before the data were 
anonymised. 
 
5.6 Data analysis 
5.6.1 Descriptive statistical analysis 
Demographic, clinical and professional characteristics of the participant groups 
were analysed first, to describe the study population in this project. This 
information was entered into a statistical analysis package for Windows, SPSS 
version 18 (SPSS, 2009). The characteristics measured by continuous variables (i.e. 
age, number of depressive episodes, number of years with depression, and the 
number of years of professional experience of working with people with 
depression) are described by the means, standard deviations and information about 
the minimum and maximum values reported. Categorical variables were used in the 
following demographic characteristics: gender, highest level of education, marital 
status, employment status; and in these clinical characteristics: treatment history: 
treatment prescribed, treatment participants reported to have been taking and 
reported adherence to the type of treatment prescribed. For these variables I 
provide the number of participants (N) and the proportion of the relevant 
stakeholder group (in percent). 
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5.6.1.1 Characteristics of the participants in two study phases 
Not all people who took part in the brainstorming phase also continued to take part 
in the clustering and prioritising phase of the study. To test whether the people 
participating in the two phases have different characteristics, I compared their 
demographic, clinical and professional data. Continuous variables were contrasted 
using a two sample t-test and data recorded in categorical variables were tested 
using a Chi-Square test. 
 
5.6.2 Concept mapping data analysis 
Concept mapping analysis involves the following steps: 1) data entry, 2) 
computation of a distance matrix, 3) reduction of dimensionality of the matrix 
dataset, 4) generation of a concept map, and 5) cluster analysis. 
 
5.6.3 Data entry 
Data from the clustering and prioritising tasks were entered into a specialised 
concept mapping software, designed for this purpose (Severens, 1995a) and all 
entries were double checked against the original data sheets. For each task 
separately, I entered card numbers of statements, participant by the participant 
into a table, where columns represent groups (clustering) or piles (prioritizing). Data 
from the two tasks are initially analysed separately.  
 
5.6.4 Distance matrix 
In the first step of analysis, Ariadne uses data from the clustering task to calculate a 
distance matrix, where each column and each row represents one statement from 
the set (similar to a correlation matrix). Each value in the matrix is calculated by 
dividing the number of participants, who put the two particular statements in the 
same group, by the total number of participants who had used those statements 
(Severens, 2012). The values in the matrix therefore represent the participants’ 
overall perception of how related (or distant) each statement was to every other 
statement in the set. Larger values in the distance matrix indicate that a larger 
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proportion of the sample placed the two statements in the same group, i.e. they 
thought that the two statements were related (Kane and Trochim, 2007). This 
matrix is calculated by Ariadne as an intermediate step in the data analysis 
procedure, and cannot be accessed for subsequent inspection (Severens, 2012). 
 
5.6.5 Reducing the dimensionality of data 
The distance matrix is highly multidimensional, and contains a large volume of 
information about the relations among statements, which cannot be interpreted 
purely by visual assessment of the matrix. To conceptualise the information it 
contains, its dimensionality (complexity) needs to be reduced using multivariate 
techniques (Roskos-Ewoldsen and Roskos-Ewoldsen, 2008). In concept mapping, 
this is done by performing a set of multivariate analyses, which first identify the 
main dimensions, and then separate the statements into appropriate groups 
(clusters). 
 
5.6.5.1 Multivariate analyses 
Various methods can be used to reduce dimensionality of a dataset, and in concept 
mapping these are multidimensional scaling (MDS) (Kane and Trochim, 2007), or 
principal component analysis (PCA) (Severens, 2012). A commonly known method, 
Factor analysis (FA), is also used for the purpose of reducing dimensionality of data, 
although not in concept mapping (Kane and Trochim, 2007; Severens, 2012). This 
method is often compared to PCA, but the latter is viewed as mathematically 
simpler and more stable (Pallant, 2001).  
 
5.6.5.1.1 Multidimensional scaling (MDS) and principal component analysis 
(PCA) 
Multidimensional scaling is a technique used to plot items (in this case, statements) 
on a graph, to demonstrate the distances (or dissimilarities) between the individual 
items (Jackson, 2005). While both MDS and PCA analyse a similarity matrix, MDS 
first estimates the distances among statements and then detects the characteristic 
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dimensions in the data (Jackson, 2005). PCA, on the other hand, identifies the 
dimensions (principal components) prior to calculating the statements’ coordinates 
on each dimension (Jolliffe, 2002). 
 
The results of these techniques are similar when applied to Euclidean distances 
(Williams, 2002), which is one of the standard measures of distances between items 
(statements) on a number of dimensions (Jackson, 2005, Quinn and Keough, 2002). 
Both methods have also been successfully used in combination with a cluster 
analysis (Jolliffe, 2002, Ben-Hur and Guyon, 2003) and in high quality concept 
mapping studies (Kikkert et al., 2006), despite some authors suggesting that PCA is 
less appropriate for this type of analysis (Yeung and Ruzzo, 2001). Researcher 
makes the choice of the technique to use in concept mapping when selecting a 
software package. Because of the similarity between the methods and the practical 
advantages associated with the software package Ariadne, I used PCA as part of the 
analysis for this study.  
 
5.6.5.2 Principal component analysis (PCA) 
The distance matrix generated in the first step contains information about 
statements’ relations to every other statement in the set. To characterise the 
dataset and explain its variance, PCA identifies a set of principal components, and 
assigns values for every item on each component (Jackson, 2005, Pallant, 2001, 
Quinn and Keough, 2002). The components are dimensions, or themes, that run 
through the data, each capturing a proportion of the variance within the dataset. 
The variance is largest for the first dimension and gradually decreases for every 
subsequent one. In PCA, each statement is assigned a value for each of the 
dimensions, based on the ‘average’ distances of statements to each other.  
 
The total number of components equals the number of items (i.e. statements), but 
usually only the first few are used in subsequent analyses. This decision is made by 
researchers and depends on the research aims and specific characteristics of the 
dataset in question (Jolliffe, 2002).  
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5.6.5.2.1 Eigenvalues 
Each dimension identified in the PCA is described by an eigenvalue, which indicates 
the proportion of variance explained by the dimension (Jolliffe, 2002). These values 
are used to decide the number of dimensions that will be used in the interpretation 
of findings or in further analysis, which in concept mapping is cluster analysis. 
Ariadne by default displays the first five dimensions, altogether expressing 76% of 
variance in the data. The remaining 24% of variance is not accessible for further 
analysis, due to being contained in the subsequent dimensions with a rapidly 
decreasing size and the ability to capture meaningful information about the data.  
 
5.6.5.2.2 A concept map 
A concept map is usually a 2-dimensional graph (Kane and Trochim, 2007) and its 
axes are the first two dimensions identified by PCA. It is a scattergram where 
statements are pictured as dots, according to their dimension values, used as their 
coordinates. The purpose of the concept map is to graphically demonstrate the 
relationships between statements, and to aid their visual interpretation. The 
observed distance between any two statements represents how often participants 
had placed them in the same group, i.e. how related they were perceived to be. 
Each dimension can be thought of as a continuum of a theme (or criteria) used by 
participants when grouping the statements, and can be labelled accordingly (for 
instance, practical vs. emotional aspects). Any two statements can be located 
relatively close on one dimension but far apart on another dimension. 
Consequently, they can be closely related from one perspective, whilst rather 
different from another. This indicates the multiplicity of viewpoints from which the 
statements’ relations can be considered.  
 
5.6.5.3 Cluster analysis 
The next step in the concept mapping analysis is to identify groups of statements, 
which are related to each other. This is done using cluster analysis; a method that 
separates the items in a data set into groups based on their relative distances on 
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the PCA dimensions (Jolliffe, 2002). Each cluster contains statements which are 
located close to each other, and therefore related to the same concept, but distinct 
from those in other clusters (Kane and Trochim, 2007, Rosas and Kane, 2012). They 
are portrayed on the concept map to graphically demonstrate the location of 
statements they consist of, and to illustrate the relations among the different 
clusters. 
 
5.6.5.3.1 Data input: practical issues 
The software Ariadne was used to calculate a distance matrix using raw data, which 
was inputted into the data sheets of the software package. After performing the 
first step, i.e. PCA on the distance matrix, Ariadne produces reports, including 
statements’ coordinates for five dimensions, and the relevant eigenvalues. This data 
can be further analysed in Ariadne, or it can be exported to different software, such 
as SPSS. I decided to use SPSS, since it offers more options for analysing the PCA 
output than Ariadne. For instance, it is possible to specify the number of dimensions 
to be processed, and the type of the clustering method to be performed. 
 
5.6.5.3.2 Number of dimensions to be used 
A decision has to be made about the number of dimensions to be used, and there 
are several rules to guide this choice.  
 
5.6.5.3.3  Two dimensions 
Using two dimensions is common in concept mapping studies, because it allows a 
straightforward graphical representation of the statements and non-overlapping 
clusters to appear on the concept map (Kane and Trochim, 2007). A disadvantage of 
using only the first two dimensions is the loss of information (variance) contained in 
the additional dimensions. The amount of variance in each dimension can be 
determined based on the eigenvalues that characterise each of the dimensions.  
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5.6.5.3.4 More than two dimensions 
Using additional dimensions in cluster analysis is common in other disciplines where 
large volumes of data are analysed (for example, studies on gene expression with 
1,000 dimensions in a dataset) (Ben-Hur and Guyon, 2003). The reason for utilising 
more than two dimensions is usually a desire to include the proportions of variance 
contained in the higher dimensions (Jolliffe, 2002). This way, more information 
about the relationships of the items (statements) to each other can be considered 
when generating the clusters. The selection of the number of dimensions needs to 
be balanced, since using too many dimensions negatively influences the cluster 
solutions and their stability (Jolliffe, 2002). 
 
The problem with utilising numerous dimensions is their graphical representation. A 
three dimensional graph would convey more information about the statements’ 
distances from each other (due to displaying the ‘depth’ of the graph, in addition to 
its length and width). It is, nevertheless, difficult to display four or more dimensions 
in a graph. To deal with this issue, it is possible to display several concept maps, 
with only two dimensions at a time. Using this type of approach allows for visual 
inspection of the relations between statements and clusters on the additional 
dimensions.  
 
5.6.5.3.5 How many dimensions? 
The number of dimensions selected for further analysis can vary and there are 
several rules that have been used to inform this decision. These include 1) 
evaluating the amount of variance expressed by the dimensions to include between 
70-90% of the total variance, and 2) including dimensions with eigenvalue lk of more 
than lk>1 (Jolliffe, 2002, Quinn and Keough, 2002). When using multidimensional 
scaling, for example, in Concept Systems software, a ‘stress’ value is typically 
calculated to determine how well the selected dimensions represent the original 
distance matrix (Rosas and Kane, 2012). Since this is not done in Ariadne, I decided 
the number of dimensions based on the proportion of variance explained by the 
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five dimensions reported in Ariadne, which is generally around 76%. I therefore 
used data for all five dimensions in the subsequent cluster analysis.  
 
5.6.5.4 Clustering method 
The aim of performing a cluster analysis is to identify homogenous groups of related 
items, which would be distinct from other groups (Burns and Burns, 2008). There 
are many different methods, but three main types exist: hierarchical, partitioning 
and two-step. The last one is a combination of the former two, specially used in 
analysing large data sets (more than 10,000 cases) (Norusis and Inc., 2011) and was 
not considered for this study. Depending on the method, clustering results can 
differ, since the algorithms vary considerably. Selection of a clustering method is 
therefore important and influences the final results, and depends on the size of a 
dataset as well as the objectives for using the analysis (Mooi and Sarstedt, 2011, 
Norusis and Inc., 2011). 
 
5.6.5.5 Hierarchical clustering 
Hierarchical clustering methods are used in concept mapping studies mainly 
because they are straightforward, and generally allow generation of clusters that do 
not overlap when portrayed on a graph (Kane and Trochim, 2007). This is because 
the statements are allocated into clusters according to their distances on the 
dimensions. The process is either agglomerative i.e. statement are first considered 
as individual clusters, which are merged with the closest neighbours in successive 
steps, or divisive, in which the process starts with one large cluster containing all 
statements, which is then divided into smaller groups in each step (Norusis and Inc., 
2011). Examples of the commonly used hierarchical clustering methods include 
centroid and Ward’s methods, both of which are typically used in concept mapping 
research. 
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5.6.5.5.1 Centroid method  
The centroid method is used in the Ariadne software (Severens, 2012), the program 
that was used in the first step of data analysis to identify the principal components 
in the original matrix of data. This method identifies the cluster centre as a means 
of all its statements’ distances (Norusis and Inc., 2011). Distance between any two 
clusters is considered to be the distance between their centres. After merging, a 
new centre is calculated, based on the clusters’ original centres. A disadvantage of 
this method is the decreasing distance between the clusters in progressive steps, 
meaning that the clusters merged later on appear to be closer to each other, 
although they might in fact be less related than those merged earlier (Norusis and 
Inc., 2011). For this reason I decided to select one of the other clustering methods 
available.  
 
5.6.5.5.2 Ward’s method 
Ward’s method is the only hierarchical method to determine the clusters’ distances 
based on the analysis of variance (Roskos-Ewoldsen and Roskos-Ewoldsen, 2008). It 
allocates statements into groups by calculating the sums of squared deviations from 
the cluster mean (Burns and Burns, 2008). The method is advantageous over te 
other hierarchical methods due to its more stable algorithm (Norusis and Inc., 2011) 
and is applied in concept mapping software Concept Systems (Kane and Trochim, 
2007) to generate non-overlapping clusters.  
 
5.6.5.5.3 Hierarchical clustering evaluated 
In the hierarchical clustering methods the similarity of clusters is determined by the 
distances between them, with the algorithm for calculating the distances 
dependent on the specific method (Norusis and Inc., 2011). Their generally 
accepted advantage is an opportunity to inspect the steps of the cluster-forming 
procedure using a dendrogram, a graphical tree-like representation of the process 
produced by SPSS. This aids in the decision-making about the final cluster solution 
and the number of clusters (Mooi and Sarstedt, 2011). The feature viewed as an 
advantage in the examination of the cluster solution is a disadvantage in the 
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process of generating the solutions. Due to the tree-like process of generating 
clusters in each step, the clusters that have been combined cannot be further 
divided, which negatively affects their quality and ability to reproduce the 
statements’ relationships from the original data matrix (Norusis and Inc., 2011). 
Considering this limitation, I decided that using other than hierarchical clustering 
would be ideal.  
 
5.6.5.6 k-means clustering 
K-means clustering is a partitioning method and is widely used in different 
disciplines, for instance environmental science and biology (Mooi and Sarstedt, 
2011). In contrast to hierarchical methods, this algorithm does not need to calculate 
distances between all pairs of statements and only produces one cluster solution 
specified in advance, making it more appropriate for larger datasets (Norusis and 
Inc., 2011). It divides the data space into the set number of parts, and then locates 
the individual clusters and statements that belong to them (Burns and Burns, 2008). 
This is done by evaluating the within-cluster variation and keeping it at a minimum 
(Mooi and Sarstedt, 2011); this is similar to the Ward’s method but is more effective 
(Punj and Stewart, 1983).  
 
One iteration of k-means method yields only one cluster solution, which has two 
main consequences. Firstly, the desired number of clusters to be produced needs to 
be set in advance (Norusis and Inc., 2011). This can be an advantage in terms of 
saving time if the optimal number of clusters is already known, but would also be a 
disadvantage if one wished to explore different options. To address this feature, it is 
possible to rerun the algorithm several times, in order to view more than one set of 
clusters and select the best one. Secondly, whilst in hierarchical methods 
statements’ cluster memberships do not change once items are allocated, 
rerunning k-means to produce a different number of clusters often results in the 
relocation of items (Norusis and Inc., 2011). Consequently, for example, statements’ 
memberships in clusters in a 7-group solution can be different from those in an 8-
group solution. This would depend on the optimal cluster centres identified in the 
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new cluster iteration. This also means that unlike in hierarchical methods, in a k-
means analysis, it is not possible to watch the process of clusters being combined by 
the algorithm. This is because in hierarchical algorithms, the neighbouring clusters 
are combined/ separated at some stage of the analysis, whilst in the k-means 
method each cluster is generated independently. In both types of analyses, the 
items are being grouped into clusters based on their dimension scores, i.e. their 
position in space, in relation to other statements.  
 
In addition to these differences, the k-means method picks up outliers (statements 
which are relatively distant from others) more easily than hierarchical methods, 
placing them into small clusters alone or with a few other items (Norusis and Inc., 
2011). Some authors suggested deleting the outliers and advised against having 
clusters with a small number of items (i.e. fewer than four) (Burns and Burns, 2008). 
Within concept mapping, such small clusters are accepted, since they can provide 
valuable insight into participants’ perspectives about relationships between 
statements (Kikkert et al., 2006).  
 
5.6.5.7 Number of clusters 
Deciding the final number of clusters, i.e. the final cluster solution, is an iterative 
and subjective process (Roskos-Ewoldsen and Roskos-Ewoldsen, 2008). Clusters are 
interpreted based on the items they contain, and the aim is to generate clusters 
which are as unrelated as possible (Norusis and Inc., 2011). Generally authors agree 
that no single best cluster solution exists, and different clustering outcomes should 
be compared to identify the one that seems to be most appropriate and best fits 
the research topic (Kane and Trochim, 2007). There are several techniques to aid 
this decision-making process, and the main ones are briefly explained below.  
 
5.6.5.7.1 Dendrogram 
A dendrogram is a special, tree-like type of graphical representation and is only 
produced in hierarchical clustering. It displays all original items (statements) and 
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demonstrates all steps at which the items were merged into clusters. Rescaled 
distances between clusters when combined are also annotated to help decision-
making about the number of clusters and the ‘acceptable’ distances between them 
(Norusis and Inc., 2011). 
 
5.6.5.7.2 An elbow graph of clusters’ coefficients 
An elbow graph can be generated to compare different cluster solutions produced 
by one clustering method (Sugar and James, 2003). In hierarchical methods one 
would plot the ‘agglomeration coefficients’ on this graph, which are automatically 
produced in SPSS to describe the distances (similarity) of clusters combined in each 
step (Norusis and Inc., 2011). Using a k-means these values are not produced 
because there is only one step where the required number of clusters is generated. 
Instead, SPSS calculates distances between each statement and its cluster, which 
can be used to calculate the clusters’ ability to represent the data variability, i.e. 
entropy values (Hunter, 2012). Entropy values are sums of squared distances 
between all statements and their clusters (Hunter, 1989, Hunter, 2012). 
 
The k-means analysis can be run repeatedly to produce a different number of 
clusters each time. I calculated entropy values for each cluster solution, and plotted 
them onto an elbow graph to visually inspect the differences between them. A line 
of best fit was generated to connect the plotted coefficients, and inspected to 
identify a point of change in its shape and direction (Hunter, 2012). The line 
typically shows a steep drop for the first few points (i.e. a ‘jump’), which is followed 
by one or more points on the graph placed at a similar level, making the line appear 
flat (Sugar and James, 2003). The most appropriate number of clusters is then 
represented by a point at the bottom of the ‘jump’, which is followed by the flat 
part of the line. More than one suitable number of clusters can be present within a 
dataset, and each of them is identified as a bottom of a ‘jump’. The selection of the 
most suitable option for a particular dataset is made by the researcher, and 
depends on the evaluation of the clusters and their interpretability (Kane and 
Trochim, 2007, Hunter, 2012). 
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5.6.5.8 Clustering in this study 
After careful consideration of the different clustering methods, I decided to use k-
means for its ability to identify outliers and the higher quality of clusters compared 
to hierarchical methods. To choose the final number of clusters I used the elbow 
graph plotting method, portraying the entropy values for several solutions on a 
graph. One or more points where the line on the graph sharply changes its 
direction, were investigated and evaluated within the research team, in order to 
select the most suitable cluster solution. 
 
5.6.6 Participant subgroups 
In addition to categorising of statements, it is also possible to identify subgroups or 
profiles of participants using cluster analysis (Thacher et al., 2005). The input 
variables for this analysis can be participants’ Likert-type scale (Likert, 1932) 
importance rankings for the statements (Thacher et al., 2005). It is also possible to 
use data generated through the use of the Ariadne package as Pearson’s R 
correlations between each statements’ dimension coordinates (unit normalised) 
and participants’ importance ratings of the statements (unit normalised) (Severens, 
2012). These values are calculated for all five dimensions produced in Ariadne. I 
performed a k-means method on values assigned to participants on five 
dimensions, for the reasons explained in section 5.6.5.3.5. and section 5.6.5.6.  
 
Thacher et al (2005) evaluated k-means clustering and a latent-class analysis in 
order to characterise a participant population into separate groups. The authors 
suggested that both were appropriate, but the latter was superior due to allowing 
participants to be considered in more than one category. In this study I decided to 
use k-means to allow generation of clusters that represent the original data as 
closely as possible, whilst avoiding the extra limitations posed by the hierarchical 
methods, i.e. the inability to re-categorise the items which were once placed in 
clusters. The main objective of clustering cases in this study was to explore the 
possibility of identifying different types of the stakeholder groups. In order to 
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decide the number of final clusters (i.e. stakeholder group types), I used the same 
method as in clustering of statements (i.e. entropy values for each cluster solution 
plotted on an elbow graph).  
 
5.6.7 Differences between stakeholder groups 
Once the final cluster solution was identified, the objective was to compare the 
three stakeholder groups’ perspectives about the clusters’ relative importance. 
Data from the prioritising task were used to calculate participants’ average 
importance rankings for each statement and compare the groups’ views. Using the 
‘Compute’ option in SPSS I calculated participants’ mean rankings for each cluster, 
and performed a one-way ANOVA to explore differences between the stakeholder 
groups and generate 95% Confidence Intervals. Tukey’s post-hoc test was then 
performed and calculations made to identify the groups whose responses were 
significantly different.  
 
5.6.8 Type of data 
Information about participants’ perceptions of statements’ importance was 
collected using a 5 point Likert-type scale (from 1 – the least important to 5 – the 
most important). This type of data is considered to be ordinal since we cannot 
assume that all participants viewed the five Likert points as equally distinct, and 
authors often advise using non-parametric statistical tests (Clason and Dormody, 
1994). This is because Likert-type data is not considered to meet the assumptions of 
parametric tests, such as one-way ANOVA, which are as follows: 1) the study 
samples are independent, 2) the means are normally distributed, 3) data is 
measured on an interval scale, and 4) the study groups’ variances are homogenous 
(Jamieson, 2004). Inappropriate use of statistical methods was suggested to carry a 
risk of drawing inaccurate conclusions about the samples (Clason and Dormody, 
1994). Despite this, analysing Likert-type and other ordinal data with parametric 
statistics is common and according to some authors, not even problematic.  
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Norman (2010) proposed that the question of type of scale should not be viewed 
too strictly, since the choice of the most appropriate data analysis method depends 
on more than simply labelling a scale. Parametric tests, such as one-way ANOVA, 
are more robust and powerful than their non-parametric alternatives (in this case, 
Kruskal-Wallis test) (McCrum-Gardner, 2008). The question should, therefore be 
asked: what are the consequences of violating these tests’ assumptions (Norman, 
2010). Large Monte Carlo simulations showed that not satisfying some of the 
theoretical requirements about data in fact does not always cause inaccurate 
results (Norman, 2010, Lantz, 2013). For example, normality of distribution of 
means is not an important requirement in samples of more than 5-10 participants, 
since the parametric tests are robust enough to deal with skewed data (Norman, 
2010). In addition, when items scored on a Likert scale are combined into groups 
(i.e. clusters in this study), this data can be considered as interval rather than 
ordinal and the use of parametric statistical tests is then held to be appropriate 
(Norman, 2010). 
 
5.6.9 Missing data 
Missing data in this study could occur when participants were entering the 
statement IDs to the answer sheets, in order to record their responses about the 
statements’ importance and the perceived relationships between them. It could be 
caused by random mistakes, for example forgetting to enter a number, or by 
mistake writing a different number. Participants could also generate missing data 
intentionally. For example, if they thought that a particular statement (or a group of 
statements) was not important enough to be entered into the answer sheet table, 
or if they thought that a statement was not related to any other items and should 
not belong to any cluster. The primary data could be missing in the records of 
participants’ responses for the prioritising and clustering tasks.  
 
The way missing data is dealt with depends on how an analysis is performed. Data 
from the clustering task are entered into Ariadne, to calculate a similarity matrix. 
This calculation involves dividing the number of times that any two statements had 
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been put together into one group, by the number of times the statements had been 
used in the participants’ responses. If a participant omitted one of those items, the 
denominator in this equation is the total minus 1. The missing data is therefore 
dealt with during the calculation of the matrix. 
 
There are several main strategies of treating missing data, which are: 1) excluding 
participants with any missing values from the analysis, 2) replacing the missing 
values with multiple imputation values, and 3) ignoring the missing data (Altman 
and Bland, 2007).  
 
In order to deal with the missing data when computing the clusters’ mean 
importance rankings (based on the statements’ rankings), I excluded the data of any 
participant who had omitted 25% or more of the statements in that cluster. If less 
than 25% of the data was missing, the participant’s responses were included in 
further analysis. This was a pragmatic decision to allow inclusion of participants who 
had omitted a random statement due to recording errors. Participants who 
explained in their answer sheets the reasons for omitting statements were excluded 
from the particular analysis, since their missing values could not be considered to 
be random. 
 
5.7 Conclusion to the chapter 
The aim of this research is to provide better understanding about how people with 
depression perceive their treatment decision-making, and how their views contrast 
with those of healthcare workers and family and friends. I selected concept 
mapping method as the method that could best help me accomplish the aims, and 
which could also add valuable information about the three groups’ viewpoints.  
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 Chapter 6  Descriptive results  
 
6.1 Reflection on the research process 
6.1.1 Research team 
The first part of this study was characterised by qualitative data collection and 
subsequent analysis of this data. All of the facilitators and assistants helping with 
data collection were either PhD students or established researchers within the 
Faculty. We all had experience with qualitative data collection or facilitating group 
discussions and were at the time actively involved in health and social science 
research. In addition, the groups were run in accordance with the focus group plan I 
had prepared. This involved helping participants to come back to the focus question 
if the discussion diverged from the main topic. Facilitators were able to suggest 
prompts from the list provided in order to encourage further discussion and 
generation of ideas. The sessions were therefore maintained to a structure as 
similar as possible, in order to limit personal bias.  
 
6.1.2 Relationship with participants 
I scheduled a preliminary meeting prior to focus groups with most participants, 
which took approximately one hour and involved a relaxed discussion about the 
study aims, about my personal reasons for doing the study, about their role in the 
study and any other questions they might have. This allowed me to ensure that 
their consent to take part in the study was fully informed and they understood the 
aims and objectives of the study. Additionally, I was also able to establish a 
relationship appropriate for research study. Before asking people to talk about the 
factors they had found influential of their treatment choices, I made sure they were 
able to feel safe in the study setting. I aimed to maintain a relaxed professional 
relationship where my sole role was a researcher and purpose of the focus groups 
was research rather than a self-help or a therapy group. This setting was reinforced 
by facilitators reminding groups the study aims and by audio-recording the 
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discussions, if participants agreed. In order to maintain safe and professional but 
relaxed researcher-participant relationships, I did not meet participants outside of 
the study setting during the course of data collection. I also refrained from 
discussing personal topics that fell outside of the research topic. 
 
6.1.3 Researchers’ personal views 
One of the potential biases posing risk to the scientific integration of this research 
were my personal views about depression, its treatment and decision-making, and 
the views held by other facilitators. In order to help participants feel safe and 
relaxed during study sessions, I always explained that the facilitators and 
participants would not judge anyone for their beliefs or thoughts.  
 
Depression is an illness that can affect any person regardless of their social, socio-
economic or educational status. People with this illness should be supported in 
accessing effective treatment and they should not be discriminated against, judged 
or blamed. Whilst some form of treatment is recommended for all people with 
depression irrespective of its severity (NICE, 2009), my view reflects the person-
centred philosophy of practice guidelines, that people should be supported to make 
decisions based on their personal beliefs and they should not be judged based on 
their treatment choices. To my best knowledge and ability, I facilitated focus groups 
in a tolerant and open-minded way to encourage free sharing of opinions. When 
focus groups were held by other researchers, I briefed them to ensure they held a 
similar approach, in order to minimise personal bias and risk to scientific 
integration. 
 
6.2 Recruitment methods 
6.2.1 People with depression and family and friends 
Table 1 shows the processes used to recruit people with depression and family and 
friends. A total of 104 people contacted me based on the articles published about 
the study, asking for more information about the study, and 70 of them self-
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reported having depression, 31 said they were close to a person with depression, 
and 3 did not disclose which group they would belong to. Almost three quarters of 
all people with depression who made contact did so following the publication of the 
first article describing this study on the University’s website and in the local 
newspapers in November 2011. One person was recruited via an article in the 
newsletter of the charity Mind. Approximately equal numbers of family and friends 
requested more information about the study after the publication of the two 
articles in November 2011 and April 2012.  
 
Three other recruitment methods which were used but did not bring any 
participants to the study included posters displayed in GP practices, healthcare 
workers providing information to their clients, and support groups run by the 
charity Age UK. 
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Table 1: Recruitment processes used for people with depression and family and friends. 
 Recruitment method Made contact  
 November 2011 – July 2012 Total 
N (%) 
People with depression 
N (%) 
Family and friends 
N (%) 
Undisclosed 
N (%) 
 Recruitment initiative 1 (Nov 2011) total 75 (72%) 57 (73%) 16 (52%) 2 (67%) 
 Article on the UEA website 14 (13%) 12 (17%) 2 (6%) 0 
 Article in the newspaper 42 (41%) 39 (55%) 1 (3%) 0 
 Snowballing1 19 (18%) 6 (9%) 13 (42%) 0 
 Unknown2 0 0 0 2 (67%) 
 Recruitment initiative 2 (April 2012) total 28 (27%) 13 (19%) 15 (48%) 1 (33%) 
 Article on the UEA website 7 (7%) 4 (6%) 2 (6%) 1 (33%) 
 Article in the newspaper 10 (10%) 1 (1%) 9 (29%) 0 
 Snowballing1 9 (9%) 7 (10%) 3 (10%) 0 
 Unknown2  2 (2%) 1 (1%) 1 (3%) 0 
 Article in the Norwich Mind newsletter 1 (1%) 1 (1%) 0 0 
 Total 104 (100%) 70 (100%) 31 (100%) 3 (100%) 
1 If people reported having read about the study in newspapers and told their partner about it, one of them was categorised as recruited via snowballing. 
2 Did not disclose where they had read about the study  
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6.2.2 Healthcare workers 
The recruitment methods used for healthcare workers are shown in Table 2. At least 
142 healthcare workers were given information about the study using the methods 
listed in the table. Most participants were recruited via the NHS Trust teams. Of the 
89 healthcare workers who attended the presentations, more than 1 in 3 consented 
to take part in the research. 
 
Table 2: Methods of recruiting healthcare workers  
Recruitment method Given information 
about study 
N (%) 
Requested more 
information 
N (%) 
Consented to take 
part in study 
N (%) 
Attended NHS Trust 
team presentations [N 
of teams] 
89 [6] (63%)  35 [4] (74%) 34 [4] (76%) 
Snowballing1 33 (23%) 2 11 (23%) 10 (22%) 
AM therapist 
invitations3 
20 (14%) - - 
GP practices3 2 (1%) 4 - - 
Total 142 (100%) 47 (100%) 45 (100%) 
1 Snowballing involved potential participants sharing information about the study and researcher’s 
contact details with colleagues 
2At least 33 healthcare workers were invited to take part in the study via the snowballing method 
but it is not possible to determine a total number of professionals who might have been contacted 
and never responded. 
3 Due to low numbers of AM therapists and GP practice health professionals responding to the study 
invitations, I only provide the total number of therapists who were sent the invitations. 
4Practice managers or research leads in two GP practices were contacted, inviting health 
professionals to take part in the study. The number of professionals who received information about 
this study is unknown.  
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6.3 Participant flow 
6.3.1 People with depression 
Figure 2 shows the sequence of study events, which took place for people with 
depression. One person did not meet the inclusion criteria for unipolar depression 
(reported having bipolar disorder). Twenty-eight people did not return a reply slip 
and did not provide any reason for not expressing interest in taking part in the 
study. One person decided not to take part since they did not want to talk about 
their difficult experiences with depression. One person did not attend a scheduled 
consenting meeting due to health reasons, 1 due to time constraints and 1 gave no 
reason. Having consented to take part in the study, one person did not respond to 
an invitation to a brainstorming session. A total of 36 people with depression took 
part in the first study phase. Of the 8 people who withdrew before performing the 
prioritising and clustering phase, 3 had agreed to take part but never returned their 
answer sheets with recorded data, 2 did not respond to invitations to take part, 1 
did not think they could be helpful for the project, 1 did not attend a meeting, and 1 
was not interested in further participation in the study. Twenty-eight people with 
depression took part in the prioritising and clustering phase. 
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Figure 2: Recruitment flowchart for people with depression 
Requested more information 
(n=70) 
-Not sending a reply slip – no further reason given 
(n=28), fear of talking about own depression 
(n=1); 
-Not attending a scheduled consenting meeting 
(n=3): no reason, health reason and time 
constraint. 
Took part in the brainstorming 
phase (n=36) 
Not meeting the inclusion criteria 
(n=1, bipolar disorder) 
Consented (n=37) 
Invited to take part in the 
prioritising and clustering phase 
(n=36) 
Withdrew (n=8) 
-Did not return answer sheets (n=3) 
-Did not respond to invitations to prioritising and 
clustering phase (n=2) 
-Felt they could not contribute to the study any 
more (n=1) 
-Did not attend a scheduled session (n=1)  
-Not interested in the study anymore (n=1) 
Withdrew: 
-Did not respond to invitation to a 
session (n=1) 
Performed the prioritising and 
clustering tasks (n=28) 
Did not provide contact address 
(n=1) 
Were sent information sheets 
(n=69) 
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6.3.2 Family and friends 
Figure 3 shows the sequence of study events that took place for the group of family 
and friends. Among the people who were sent the information sheets, the most 
frequent reason for not taking part was not sending a reply slip expressing their 
interest in joining in the study. One person initially scheduled a consenting meeting 
but cancelled due to time constraints. Having consented to take part, one person 
did not respond to a brainstorming session invitation. Following an invitation to 
perform the prioritising and clustering tasks, 6 people withdrew for the following 
reasons: not returning an answer sheet with data for the two tasks, not attending a 
scheduled session, time commitments, personal reasons, and loss of interest in the 
study. One person did not give any reason. One person from this group withdrew 
after completing the prioritising task, finding the instructions to the clustering task 
too difficult.  
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Withdrew: found the clustering 
task too difficult (n=1) 
Requested more information 
(n=31) 
Took part in the brainstorming 
phase (n=20) 
Did not express interest to take part 
(n=9); cancelled a meeting due to time 
constraints (n=1) 
Consented (n=21) 
Invited to take part in the 
prioritising and clustering phase 
(n=21) 
Withdrew (n=6) 
-Did not return answer sheets (n=1) 
-Did not attend a scheduled session (n=1) 
-Did not provide any reason (n=1) 
-Not interested in the study any more (n =1) 
-Time commitments at work (n=1) 
-Personal reasons (split up with his partner) (n=1) 
Did not respond to invitation to a 
brainstorming session (n=1) 
Performed the prioritising task 
(n=14) 
Performed the clustering task 
(n=13) 
Were sent information sheets 
(n=31) 
Figure 3: Recruitment flowchart for family and friends 
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6.3.3 Healthcare workers 
The numbers of healthcare workers informed about the study, withdrawing in 
different stages, and taking part are shown in Figure 4. Of the 142 workers who 
were given information about the study, 95 did not express an interest in the study 
and did not request further information. Of those who did, 5 did not respond to 
invitations to attend any of the data collection sessions. A total number of 45 
healthcare workers consented to take part in the study. Forty-two people took part 
in brainstorming, and 19 of them completed the prioritising and clustering phase. 
The remaining 23 workers did not perform the second phase of the study, mainly 
due to not responding to invitations. One person withdrew due to going on 
maternity leave, and one due to health reasons. Three healthcare workers only took 
part in the prioritising and clustering phase due to being recruited at a later stage in 
the study. Two of them withdrew after completing the first task, having found the 
instructions for the clustering task too difficult. 
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Figure 4: Recruitment flowchart for healthcare workers 
 
 
Total contacted and given information about study 
(n=142) 
Withdrew: found the 
clustering task too 
difficult (n=2) 
Took part in the brainstorming 
phase (n=42) 
Did not express an interest in the study 
(reasons unknown, n=95) 
Consented (n=45) 
Completed the prioritising and clustering 
tasks (n=1) 
Withdrew (n=23) 
-Did not respond to invitations (no 
reasons provided, n=21) 
-Went on maternity leave (n=1) 
-Health reasons (n=1) 
Did not respond to invitation to a 
session (n=5) 
Completed the prioritising and 
clustering tasks (n=19) 
Requested more information (n=47) 
Only took part in the prioritising and 
clustering phase (due to being recruited at a 
later stage, n=3) 
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6.4 Description of participants 
6.4.1 People with depression 
6.4.1.1 Demographic characteristics 
Demographic characteristics of the people with depression taking part in the two 
phases of the study are shown in Table 3, together with the characteristics of the 
general population of England and Wales collected in the national census in 2011 
(Office of National Statistics, 2011). No significant differences were identified 
between the whole group of people with depression who took part in brainstorming 
(n=36), and the part of the group who continued to participate in the clustering and 
prioritising phase (n=28). Almost two thirds of the sample were female, and almost 
all people described themselves as White British or White Irish. This is more than in 
the general population of England and Wales in 2011. Almost twice as many people 
in the study sample had achieved a University degree or higher, compared to the 
general population. There were also differences in employment status between the 
general and study populations. Just over a half of our participants were people 
currently employed, compared to almost 90% of the general population in 
economically productive age (16-74), based on the census (Office of National 
Statistics, 2011). There were also approximately twice as many unemployed 
participants and students in the study, compared to the general population.  
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Table 3: Demographic characteristics of people with depression  
 Brainstorming (n=36) Prioritising and clustering (n=28) P-value (based 
on Chi-Square, 
unless * then 
based on t-test)  
Norfolk 
population 
(Census 2011) 
Norfolk 
population 
(Census 2011) 
 N (%), unless * then Mean (SD; min-max) (%)2 (%)2  
Female 23 (64%) 18 (64%) NS1 51% 51% 
Age in years* 47 (16.5; 18-79) 46 (16; 18-79) NS - - 
White British or White Irish 34 (94%) 27 (96%) NS 92.9% 80.9% 
Highest achieved qualification      
Secondary education 16 (44%) 12 (43%) NS 46.5% 44.5% 
University Degree or higher 20 (56%) 16 (57%) NS 21.9% 27.4% 
Marital status      
Single 15 (42%) 11 (39%) NS 29.5% 34.6 
Married/co-habiting 16 (44%) 14 (50%) NS 50.2% 46.8 
Divorced/separated 5 (14%) 3 (11%) NS 10.1% 11.7 
Employment status      
Employed  19 (52%) 15 (54%) NS 61.5% 62.1% 
Not employed 5 (14%) 3 (11%) NS 13.8%2 15%2 
Student 4 (11%) 4 (14%) NS 6.9% 9.2% 
Retired 8 (22%) 6 (21%) NS 17.9% 13.7% 
1 NS – not significant 
2 Not employed include those looking after home or family, long-term sick or disabled and ‘other’ according to Census 2011 
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6.4.1.2 Clinical characteristics 
Table 4 shows the reported history of depression by participants in the study. The 
sub-sample who took part in the prioritising phase did not significantly differ from 
the whole study sample in the reported number of depressive episodes, or the 
number of years that they reported that they had lived with depression. 
 
Table 4: Clinical characteristics of people with depression: history of depressive 
episodes 
 Brainstorming 
phase  
(n=36) 
Prioritising and clustering 
phase  
(n=28) 
P-value 
 (Mean, SD, min-max)  
Number of depressive 
episodes  
5.4 (5.3; 1-25)1 5.8 (5.6; 1-25)2 NS5 
Years with depression 20 (15.3; 1-62)3 22 (15.9; 1-62)4 NS 
1 Data for 9 people was not included in calculation: 1person reported having had more than 150 
episodes, 5 people reported having had one constant episode, and 3 did not know the number of 
episodes they had experienced  
2 Data for 6 people was not included in the calculation: 1 person reported having had more than 150 
episodes, 3 reported having had one constant episode, and 2 people did not know how many 
episodes they had experienced   
3 Data for 3 people was missing – not provided. 
4 Data for 1 person was missing – not provided. 
5Not significant 
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Table 5 shows the different types of treatment participants reported to have been 
prescribed most recently, and the treatment they said they were taking at the time 
of study. Almost half of all people with depression were prescribed antidepressant 
medication alone, and almost 40% said they had been given medication in 
combination with psychological therapy. Two people had been prescribed 
psychological therapy alone.  
 
Table 5: Clinical characteristics of people with depression: treatment history 
 Were prescribed  Reported that they took  
Treatment Brainstorming 
phase 
Prioritising 
and 
clustering 
phase 
P-
value 
Brainstorming 
phase 
Prioritising 
and 
clustering 
phase  
P-
value 
 N (%)  N (%)  
Antidepressa
nt medication 
alone 
18 (50%) 12 (43%) NS6 14 (39%) 12 (43%) NS6 
Psychological 
therapy alone 
2 (6%) 2 (7%) - 0 0 - 
Combination 
of medication 
and 
psychological 
treatment 
14 (39%) 12 (43%) NS 4 (11%) 3 (11%) NS 
Combination 
of medication 
and self-
initiated 
therapy1 
N/A N/A NS 8 (22%) 6 (21%) NS 
Other 2 (6%)2 2 (7%)3 NS 10 (28%)4 7 (25%)5 NS 
Total 36 (100%) 28 (100%)  36 (100%) 28 (100%)  
1 Self-initiated treatment included psychological therapy accessed privately, self-help and 
mindfulness-based therapy or books, and complementary therapies, such as blu-light box, 
reflexology, emotional regulation therapy. 
2, 3 One person did not seek medical help and was therefore not prescribed any treatment, and one 
person was recommended mindfulness-based therapy 
4 One person was recommended and reported receiving mindfulness-based therapy, two people had 
only alternative or self-initiated psychological workshop, and 7 people (19%) reported taking no 
treatment at all 
5 One person was recommended and reported receiving mindfulness-based therapy and 6 people 
(21%) reported taking no treatment at all. 
6 Not significant  
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Table 6 shows a summary of participants’ reported adherence to the type of 
treatment they had been prescribed.  Over one third of the whole sample of people 
with depression reported that they undertook the treatment they had been 
prescribed or recommended. Approximately a third of people with depression said 
they either took no treatment or only a part of what they had been prescribed (e.g. 
was prescribed medication and CBT workshop, but only took the medication). Just 
over a quarter of the participants said they initiated psychological or alternative 
therapy on their own, in addition to their prescribed treatment (or to replace a part 
of it). There were no significant differences between the whole sample and the sub-
sample who also took part in the second phase of the study.  
 
Table 6: Clinical characteristics of people with depression: treatment history, 
reported adherence to prescribed treatment options 
 Type of treatment reported to 
have taken: 
Brainstorming phase 
N (%) 
Prioritising and 
clustering phase 
N (%) 
P-value 
 As prescribed  13 (36%) 10 (36%) NS3 
 Discontinued one or more of the 
prescribed treatment options  
12 (33%) 11 (39%) NS 
 Reported taking one or more 
self-initiated treatment options 
in addition1 
6 (17%) 4 (14%) NS 
 One or more prescribed 
treatment options replaced by a 
different type of treatment2 
4 (11%) 2 (7%) NS 
 Total 36 (100%) 28 (100%)  
1 Self-initiated treatment options participants reported to have been taking included privately 
accessed psychological therapy, as well as self-help books, emotional regulation therapy, 
mindfulness-based therapy, and alternative treatments, for example, reflexology, blu-light box,  
2 For example, when prescribed medication and CBT course, but reported taking medication and 
having private counselling, or when prescribed medication but reported having reflexology instead. 
3 Not significant 
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6.4.2 Family and friends 
Demographic characteristics of family and friends are shown in Table 7. The whole 
sample did not significantly differ across any of the variables from the sub-group 
who also took part in the prioritising and clustering phase of the study. Two thirds 
of all family and friends were female, and all said they were of either the White 
British or White Irish ethnic group. The study sample included a higher proportion 
of people holding a University degree or higher, when compared to the general 
population. More than two thirds of the sample reported that they were married or 
co-habiting, and just over a half reported being employed.  
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Table 7: Demographic characteristics of family and friends 
 Brainstorming phase  
(n=36) 
Prioritising and 
clustering phase 
(n=28) 
P-value calculated 
using Chi-Square 
unless *, then p-
value calculated 
using t-test 
Usual residents of 
Norfolk, Census 2011, 
Usual residents of 
England, Census 2011 
 N (%), unless * then Mean (SD; min-max) (%)2 (%)2 
Female 13 (65%) 10 (71%) NS1 51% 51% 
Age in years* 58 (14; 32-80) 60 (13; 41-80) NS - - 
White British or White Irish 20 (100%) 14 (100%) - 92.9% 80.9% 
Highest achieved qualification      
Secondary education 8 (40%) 6 (42%) NS 46.5% 44.5% 
University Degree or higher 9 (45%) 7 (50%) NS 21.9% 27.4% 
Marital status      
Single 2 (10%) 2 (14%) NS 29.5% 34.6 
Married/co-habiting 13 (65%) 9 (64%) NS 50.2% 46.8 
Divorced/separated 1 (5%) 0 NS 10.1% 11.7 
Widowed 3 (15%) 3 (21%) NS 7.9% 6.9% 
Employment status      
Employed  11 (55%) 8 (57%) NS 61.5% 62.1% 
Retired 8 (40%) 6 (43%) NS 17.9% 13.7% 
1 Not significant 
2 Based on usual population aged 16 and over  
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6.4.3 Healthcare workers 
Demographic characteristics of the healthcare workers taking part in the two 
phases of the study are shown in Table 8. The subgroup did not differ from the 
whole sample of healthcare workers across any of the variables. More than one fifth 
of the groups were female, all were employed, and the average age was 
approximately 40 years old. One third of the sample consisted of healthcare 
professionals such as doctors, nurses and psychologists. 
 
Table 8: Demographic and professional characteristics of healthcare workers  
  Brainstorming phase (n=42) 
N (%), unless * then Mean 
(SD; min-max) 
Prioritising and 
clustering phase (n=22) 
N (%), unless * then 
Mean (SD; min-max) 
P value 
 Female 34 (81%) 18 (82%) NS3 
 Mean age in years 
(SD; min-max) 
41 (11; 24-61) 43 (12; 24-61) NS 
 Employed  42 (100%) 22 (100%) - 
 Profession    
 Healthcare 
professionals1 
14 (33%) 7 (32%) NS 
 Unqualified staff2 27 (64%) 14 (64%) NS 
 Experience in 
years* 
9 (8.5; 1-35) 10 (9; 2-35) NS 
1Healthcare professionals included General Practitioners, psychiatric consultants, psychologists, 
occupational therapists and mental health nurses 
2 Unqualified staff included psychological therapists, wellbeing practitioners, counsellors, CBT 
practitioners and alternative medicine practitioners. 
3 Not significant  
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6.5.1 Contrasting the stakeholder groups’ demographic 
characteristics 
Demographic characteristics of people with depression, family and friends, and 
healthcare workers, are shown in Table 3, Table 7 and Table 8, respectively. All 
three groups included a higher proportion of women than in the general 
population, and this trend was the strongest in the group of healthcare workers. 
Among the participants, family and friends had the highest average age of 58. 
People with depression were on average 11 years younger, and the healthcare 
workers 17 years younger than family and friends. Data for the remaining 
demographic characteristics was only collected for people with depression and 
family and friends. Both groups were characterised by over-representation of the 
White ethnic group, and University educated people when compared with the 
general population. 
 
The two groups differed in their reported marital and employment statuses. The 
proportion of retired participants was twice as high in the group of family and 
friends as in people with depression, while the numbers of employed people were 
similar in the two groups. More people with depression than family and friends 
were therefore unemployed. Also, more people with depression were single or 
divorced than family and friends. On the other hand, more family and friends 
reported being married or co-habiting, and more of them said they had lost their 
partner, compared to the group of people with depression.  
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6.6 Description of the study phases 
6.6.1 Brainstorming sessions 
A total of 98 participants were involved in generating statements about the factors 
influencing treatment decisions made by people with depression. Table 9 shows 
that the majority of participants in all stakeholder groups took part in group 
sessions. Altogether we held 80 group sessions and 17 individual meetings (face to 
face with researcher or phone conversations) across the three groups in order to 
facilitate brainstorming about the focus question. An average number of attendees 
was 5 for groups with healthcare workers (ranged from 2-13; SD=4.5) and 4 for both 
people with depression and family and friends (range from 3-8; SD=1.7 and range 
from 3-5; SD=1, respectively).  
 
Table 9: Types of brainstorming sessions.  
 People with 
depression  
(n=36) 
Family and 
friends  
(n=20) 
Healthcare workers  
 
(n=42) 
Total 
Type of session N of attendees (% of the stakeholder group) 
Group sessions 34 (94%) 15 (75%) 31 (74%) 80 (82%) 
Individual 
conversation 
with researcher 
1 (3%) 3 (15%) 7 (17%) 11 (11%) 
Email  0 1 (5%) 0 1 (1%) 
Phone 
conversation 
1 (3%) 1 (5%) 4 (10%) 6 (6%) 
Total 36 (100%) 20 (100%) 42 (100%) 98 (100%) 
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6.6.2 Statements 
During the brainstorming phase participants generated a total of 1,400 statements 
related to the factors affecting treatment decisions that people with depression 
make. In the review process I categorised the items into 6 main groups and 
separated those that seemed too specific, too vague or not clearly understandable. 
Those items were excluded from the further review process.  
 
Table 10 shows the six main categories with the numbers of statements in the set of 
original statements and the final set. The table shows that the proportions of three 
categories were similar in the two sets (i.e. personal factors and depression, culture 
and other people, and practical issues). Two categories differed by 5 percent 
(patients’ personal characteristics and treatment related issues) and one differed by 
7 percent (healthcare professionals). 
 
The largest proportion, one third of all statements, was related to the personal 
factors of people with depression, and their own experience of depression. This 
group included ideas such as desperation to try anything that could help relieve 
depressive symptoms, feelings of responsibility and guilt for the depression, being 
ready to take treatment, desire to get to the root of the depression, understanding 
that depression affects other people as well, and various negative effects of 
depression on one’s decision-making about treatment options.  
 
The second largest group of statements was related to treatment, and included a 
quarter of all statements. They covered topics such as positive and negative past 
experiences with various treatments, awareness of different treatment options and 
having been given a choice, concerns about the effects of medications, statements 
related to specific expectations of treatment (such as, wanting an easy or fast-acting 
treatment), and weighing up the risks and benefits of the different options. The four 
remaining categories contained more homogenous statements. Culture and other 
people included a total of 15% of the concepts generated, which were related to 
positive and negative beliefs, views and attitudes of one’s family and friends and 
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the wider social circle, social isolation and other people’s experiences with 
depression. Statements associated with a person’s healthcare professional made 
another 15% of all concepts, and included their beliefs, attitudes, knowledge, and 
patients’ perceptions of the professionals, including for example relationship, 
experience and expectations from them. 
 
Table 10: Main categories of statements generated in the brainstorming phase 
Main category of statements Original statements 
N (%) 
Revised statements (final set) 
N (%) 
Personal factors and depression 441 (32%) 19 (32%) 
Treatment related issues 351 (25%) 12 (20%) 
Culture and other people 214 (15%) 8 (14%) 
Healthcare workers 217 (15%) 13 (22%) 
Practical issues, such as financial 
problems and access to treatment 
102 (7%) 3 (5%) 
Patients’ personal characteristics 24 (2%) 4 (7%) 
Vague statements not included in 
further review 
51 (4%) 0 
Total 1,400 (100%) 59 (100%) 
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6.6.3 Prioritising and clustering phase 
Table 11 shows that the majority of participants in the prioritising and clustering 
phase of the study performed the two tasks during group sessions with a researcher 
and other participants.  
 
Table 11: Types of prioritising and clustering sessions.  
 People with 
depression (n=28) 
Family and friends 
(n=14) 
Healthcare workers 
(n=22) 
Type of session N of attendees (% of the stakeholder group) 
Group session 20 (71%) 9 (64%) 10 (45%) 
Individual session 2 (7%) 1 (7%) 1 (5%) 
Remotely (answer 
sheets submitted by 
post) 
6 (21%) 4 (29%) 11 (50%) 
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Table 12 shows the average numbers of clusters participants generated when 
performing the clustering task. The stakeholder groups did not differ. 
 
Table 12: Average number of clusters generated by participants in each 
stakeholder group 
Total 
(n=64) 
People with 
depression (n=28) 
Family and friends 
(n=14) 
Healthcare 
workers (n=22) 
P value 
Number of clusters (Mean, SD) 
7.5 (2.6) 7.5 (2.2) 6.4 (2.5) 5.1 (3) NS1 
1 Not significant 
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6.6.3.1 Missing data 
Table 13 shows the number of missing entries which occurred in each stakeholder 
group for each of the two tasks. Some participants omitted more than one 
statement.  
 
Table 13: Numbers of missing entries in each stakeholder group 
Missing entries of 
statements 
Whole sample  
(n=64) 
People with 
depression (n=28) 
Family and 
friends (n=14) 
Healthcare 
workers (n=22) 
 N (%) 
Prioritising 23 (0.6%) 7 (0.4%) 3 (0.4%) 13 (1%) 
Clustering 22 (0.6%) 5 (0.3%) 3 (0.4%) 14 (1.1%) 
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 Chapter 7 Clustering 
 
7.1 Final set of statements 
The original statements were reviewed and we generated a final set of 59 items, 
which were used in the prioritising and clustering tasks (study phase 2). The whole 
set of items is listed in Table 14.  
 
Table 14: The final set of statements 
Number Statement 
1 Financial costs related to the particular treatment option 
2 Practical issues related to starting treatment 
3 Being given a choice of treatments 
4 Recognizing I have a problem I need help with 
5 Playing an active role in getting better 
6 Desperation to try anything that could help 
7 Information about depression and its treatment 
8 Having my view about what is the best treatment confirmed 
9 Inability to make a choice because of my depression 
10 Beliefs of family and friends about depression 
11 Weighing up the risks and benefits of treatments 
12 Wanting a treatment that works quickly 
13 My past experiences of treatment 
14 Feeling it's my fault for having depression 
15 Worries about the side effects of medication 
16 My knowledge and understanding of the effects of treatment 
17 Wanting to share my experiences with depression with others 
18 Healthcare professionals' beliefs about depression and its treatment 
19 Healthcare professionals' knowledge and understanding about depression and its 
treatment 
20 My relationship with the healthcare professional 
21 My personal characteristics (age, being male or female, ethnicity - being black, 
white or other) 
22 Culture (my background as well as my current culture) 
23 My religion 
24 Continuity of care (seeing the same healthcare professional) 
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Table 14 (continued) 
25 Personal characteristics of the healthcare professional (age, being male or female, 
ethnicity - being black, white or other) 
26 My understanding of the side effects of treatment 
27 My experiences with healthcare professionals 
28 My expectations from healthcare professionals 
29 Wanting to escape from the situation 
30 My past experience with depression (knowing whether I can feel better or not) 
31 How I feel right now 
32 Fear of dealing with problems 
33 Desire to get to the root (the bottom) of depression 
34 Not wanting to have depression listed in health records 
35 A desire to get better for people I care about 
36 Isolation, and not having the support network close 
37 My belief that depression is a chemical imbalance 
38 Understanding it is normal to have depression and I am not alone 
39 Thinking that nothing can help me 
40 Having an introverted or extroverted personality 
41 Wanting to please the doctor (to be a good patient) 
42 Realizing all people's experiences with depression are different 
43 Being ready to accept treatment 
44 Being ready to engage with treatment 
45 Healthcare professionals being ready to discuss depression and its treatment with 
family and friends 
46 Worries about becoming dependent on medication 
47 Realizing there is no quick fix 
48 Views about depression in society 
49 Not wanting to be a burden on others 
50 Wanting the easiest treatment 
51 My upbringing 
52 The healthcare professionals' personality 
53 Healthcare professionals discussing depression and its treatment openly 
54 Wanting a 'natural' treatment 
55 Other people's experiences with depression and its treatment 
56 Being given a clear diagnosis 
57 Communication between different healthcare professionals 
58 Wanting what doctors say is the most effective treatment 
59 Wanting a treatment that is provided with no time limitations 
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7.2 Principal component analysis 
Results of the Principal component analysis (PCA) were the statements’ scores on 
five dimensions and their eigenvalues, all listed in Appendix 38.  
 
7.3 Statements on concept maps and the 5 dimensions 
7.3.1 Dimensions 1 and 2 
Figure 5 shows a concept map where the x-axis is dimension 1 identified in the PCA, 
and the y-axis is dimension 2. The map is divided into four parts by the two axes in 
the approximate centre. Values on dimension 1 range from -0.3 to 0.2, and the 
range of statements’ scores on dimension 2 is from -0.3 to 0.3.  
 
7.3.1.1 Dimension 1 
At the left end of dimension 1 several statements are placed close to each other. 
There are 13 items in this part of the map, and all are related to healthcare 
professionals as a factor affecting treatment decisions. They include, for example, 
trust and relationship with the professional, healthcare professionals’ beliefs, 
attitudes and experiences.  
 
Statements on the right hand side of axis 1 are spread across a wider area. Focusing 
on those located at the most distant areas from the zero point, a common theme is 
a patient’s personal approach to depression and treatment. Immediately below the 
zero line, there are items related to patients’ emotions and feeling that one does 
not have control over the situation, for example, how I feel right now, wanting to 
escape from the situation, feeling it’s my fault for depression. Above the zero line 
(which also represents dimension 2), statements relate to a patient’s own insight 
into their situation. Examples are, recognising I have a problem I need help with, 
wanting to play an active role in treatment, realising there is no quick fix.  
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Statements at the left and right ends of axis 1 convey different themes, i.e. the 
impact of health professionals (left) and the effects of a patient’s personal view on 
depression treatment. The dimension could therefore be viewed as a continuum 
between the effect and reliance on the professionals, and a person’s own approach 
to depression, and the impacts of their cognition and emotion. Consequently, the 
left end is labelled ‘professionals’ and right end is ‘a patient’. 
 
7.3.1.2 Dimension 2 
Dimension 2 is the vertical axis on the map shown in Figure 5. Statements placed at 
the top end of this axis all refer to making a rational decision by understanding and 
evaluating the available information about depression and treatment. This includes: 
weighing up the risks and benefits of treatment, being given a choice, information 
about depression treatment, one’s knowledge and understanding of the effects of 
treatment. A common theme these items share is an emphasis on an individual’s 
control over treatment choice, and one’s personal involvement in decision-making.  
 
The items at the opposite side of dimension 2, at the bottom of the map, are mostly 
related to the influence of other people and their opinions. This is demonstrated by 
statements such as upbringing, beliefs of family and friends about depression, one’s 
culture and the views about depression in society. These statements refer to the 
external factors and emphasise the effects of one’s cultural background and social 
environment on their depression treatment decisions.  
 
Dimension 2 could therefore be considered as a continuum between one’s 
perception of having control over treatment decisions (internal) and viewing other 
people and their views as highly influential (external).  
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Figure 5: A concept map with dimensions 1 and 2 
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7.3.2 Dimensions 3, 4 and 5 
Figure 6 shows a concept map with statements placed on dimensions 3 (axis x) and 
4 (axis y). Statement coordinates on dimension 3 range between -0.3 and 0.3, and 
they are between -0.4 and 0.2 on dimension 4. Unlike in the first concept map, 
statements on this graph are relatively evenly spread across the whole graph. Figure 
7 shows a concept map with dimension 4 as axis x and dimension 5 as axis y. 
Dimension 5 is shown in a range between -0.4 and 0.2, but only two statements 
have a dimension value lower than -0.2. 
  
7.3.2.1 Dimension 3 
Statements which are located at greater distances from the zero point of axis x 
define dimension 3. Those placed around the left end of the map emphasise the 
effects of a patient’s cultural and social background on their depression treatment 
decisions, for example, culture, upbringing, religion, a person’s age, gender and 
ethnicity (i.e. demographic characteristics). These items relate to the external social 
and cultural influences relating to where a person might search for an explanation 
of their depression. 
 
Statements located at the right end of the dimension 3 are linked to a patient’s 
emotions, mostly negative depressive thoughts about own ability to deal with 
depression. These include how I feel right now, fear of problems, desperation to try 
anything that could help, wanting to escape from the situation, feeling that nothing 
can help and inability to make a decision due to depression.  
 
The common theme of statements on the left is the influence of the cultural, i.e. 
external influences, while the items on the right emphasise a person’s emotional, 
i.e. internal approach to the problem. The dimension 3 is therefore an individual’s 
perceived source of support – own cultural identity versus focus on own emotional 
response to depression and a need for treatment.  
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7.3.2.2 Dimension 4 
Items in the upper end of the map characterise the top part of dimension 4. These 
items are related to a person’s perception of barriers and limitations when deciding 
about treatment, for example, wanting a quick treatment, wanting an easy 
treatment, not wanting to have depression listed in health records, wanting 
treatment with no time limitations.  
 
Items located in the bottom part of the map all relate to appreciating and benefiting 
from own and others’ experiences with depression and its treatment. These 
statements include: realising all people's experiences with depression are different, 
understanding it is normal to have depression and I am not alone, wanting to share 
my experience with others, past experience with treatment.  
 
Considering the two areas of the map, dimension 4 could be interpreted as a 
continuum between making a treatment choice based on a sense of caution and 
fear of the unknown, and ability to benefit from experiences with depression and 
treatment.  
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Figure 6: A concept map with dimensions 3 and 4 
Experiences 
Sense of caution 
External - cultural 
identity 
Internal – emotional 
response 
Dimension 3 
Di
m
en
sio
n 
4 
Page 154 of 386 
7.3.2.3 Dimension 5 
The concept map in Figure 7 shows that the majority of statements are located in 
the central part of the graph. The statements placed at the top and bottom ends of 
the horizontal axis exhibit the most extreme values on dimension 5, and therefore 
define it. The items located in the top part of the map relate to a person’s internal 
awareness and insight into their depression and a need for treatment, for example 
readiness to engage with treatment, readiness to accept treatment, personality, 
wanting to play an active role in treatment, religion.  
 
Statements in the bottom part of the graph refer to a patient’s communication with 
people in similar situations, and sharing experiences with depression, such as 
wanting to share my experiences of depression with others, and other people’s 
experiences with depression. Contrasting the statements’ themes in the top and 
bottom parts of the graph, the dimension 5 could be described as a continuum 
between an individual focusing on their own awareness of depression, and an 
individual’s focus on what they can learn from sharing experiences with others. The 
dimension is therefore labelled as ‘internal – personal awareness’ (top part) and 
‘external – sharing experiences (bottom part).  
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  Figure 7: A concept map with dimensions 4 and 5 
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7.3.3 The 5 dimensions from another perspective 
The five dimensions have been described and labelled, and several of them share a 
contrast between the internal and external factors affecting patients’ treatment 
decisions. In the first dimension, it is a patient’s emotionally based approach to 
treatment decisions versus a focus on the health professional as a source of advice. 
In the second dimension, the internal aspect of treatment decision-making is 
characterised by a person’s focus on information and making an informed choice, as 
opposed to an external approach, i.e. an emphasis on the cultural influences and 
other people’s views.  
 
The third, fourth and fifth dimensions also represent the internal versus external 
approaches. They also demonstrate that concepts which are close and similar to 
each other on the first two dimensions are relatively distinct and at considerably 
greater distances when inspected from a different point of view, i.e. adding another 
dimension to the picture.  
 
Similarly to the dimension 2, the third dimension represents the external aspect as 
a person’s social and cultural context, i.e. a person’s background which is out of 
one’s control. The internal aspect is an individual’s emotional response and attempt 
to avoid a problem, i.e. a person’s individual emotional response. The fourth 
dimension, unlike the others, does not involve the internal and external aspects of 
decision-making. Instead, it shows a distinction between a person’s concerns about 
treatment and their comprehension of depression, which is based on experience 
and awareness of the problem. The fifth dimension adds another perspective on a 
concept which defines one end of the dimension 4, i.e. experience and awareness 
of depression as a problem. Dimension 5 is then a continuum between an external 
aspect of depression awareness, i.e. sharing experiences with others in similar 
situations, and an internal recognition of a need for help with depression.  
 
Page 157 of 386 
7.4 Cluster analysis 
The scores for all five dimensions were used as input in the k-means cluster 
analysis. I ran the cluster analysis 15 times, in order to obtain information for 
solutions with 2 to 16 clusters. Results of each time the analysis was run consisted 
of the information about cluster membership for each statement, and the 
statements’ distances from their cluster centres. From the distances, I calculated 
the Sums of squared distances (entropy values) for each cluster solution. Table 15 
shows the entropy values and Figure 8 shows an elbow plot depicting the entropies.  
 
Table 15: Sums of square distances for 15 cluster solutions 
N of clusters Sum of square 
distances 
Difference between the Sum of 
squared distances 
2 4.10  
3 3.33 0.77 
4 2.59 0.74 
5 1.78 0.81 
6 0.94 0.84 
7 0.80 0.14 
8 0.61 0.19 
9 0.55 0.06 
10 0.49 0.06 
11 0.43 0.05 
12 0.38 0.06 
13 0.36 0.01 
14 0.31 0.05 
15 0.25 0.06 
16 0.25 -0.01 
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Figure 8: An elbow graph of sums of squared distances plotted for each cluster 
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7.4.1 The number of clusters 
Based on the entropy values for each cluster arrangement, I identified an ‘end of a 
jump’ on the graph’s line of best fit at the number of clusters 6, which should be the 
best number of clusters for this dataset. The next acceptable solutions are at 8 and 
at 12 clusters. With the research team we evaluated each arrangement’s clusters 
and their abilities to represent the themes conveyed by their statements. We 
selected the 12 cluster solution as the most appropriate, and this decision is 
justified in the section describing the final cluster arrangement. The three sets of 
clusters are described and contrasted in the following sections. 
 
7.4.2 Six cluster solution 
Table 16 shows a solution with 6 clusters in the set of 59 final statements. The 
clusters are graphically depicted on a concept map with the first two dimensions in 
Figure 9. 
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Table 16: Statements in 6 clusters 
   
Cluster 
number 
Statement 
number 
Statement 
1 1 Financial costs related to the particular treatment option 
1 2 Practical issues related to starting treatment 
1 3 Being given a choice of treatments 
1 7 Information about depression and its treatment 
1 8 Having my view about what is the best treatment confirmed 
1 11 Weighing up the risks and benefits of treatments 
1 12 Wanting a treatment that works quickly 
1 15 Worries about the side effects of medication 
1 16 My knowledge and understanding of the effects of treatment 
1 26 My understanding of the side effects of treatment 
1 37 My belief that depression is a chemical imbalance 
1 46 Worries about becoming dependent on medication 
1 50 Wanting the easiest treatment 
1 54 Wanting a 'natural' treatment 
1 59 Wanting a treatment that is provided with no time limitations 
2 10 Beliefs of family and friends about depression 
2 13 My past experiences of treatment 
2 17 Wanting to share my experiences with depression with others 
2 30 My past experience with depression (knowing whether I can feel 
better or not) 
2 42 Realizing all people's experiences with depression are different 
2 48 Views about depression in society 
2 55 Other people's experiences with depression and its treatment 
3 18 Healthcare professionals' beliefs about depression and its 
treatment 
3 19 Healthcare professionals' knowledge and understanding about 
depression and its treatment 
3 20 My relationship with the healthcare professional 
3 24 Continuity of care (seeing the same healthcare professional) 
3 25 Personal characteristics of the healthcare professional (age, being 
male or female, ethnicity - being black, white or other) 
3 27 My experiences with healthcare professionals 
3 28 My expectations from healthcare professionals 
3 41 Wanting to please the doctor (to be a good patient) 
3 45 Healthcare professionals being ready to discuss depression and its 
treatment with family and friends 
3 52 The healthcare professionals' personality 
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Table 16 (continued) 
3 53 Healthcare professionals discussing depression and its treatment 
openly 
3 56 Being given a clear diagnosis 
3 57 Communication between different healthcare professionals 
3 58 Wanting what doctors say is the most effective treatment 
4 4 Recognizing I have a problem I need help with 
4 5 Playing an active role in getting better 
4 33 Desire to get to the root (the bottom) of depression 
4 38 Understanding it is normal to have depression and I am not alone 
4 43 Being ready to accept treatment 
4 44 Being ready to engage with treatment 
4 47 Realizing there is no quick fix 
5 21 My personal characteristics (age, being male or female, ethnicity - 
being black, white or other) 
5 22 Culture (my background as well as my current culture) 
5 23 My religion 
5 40 Having an introverted or extroverted personality 
5 51 My upbringing 
6 6 Desperation to try anything that could help 
6 9 Inability to make a choice because of my depression 
6 14 Feeling it's my fault for having depression 
6 29 Wanting to escape from the situation 
6 31 How I feel right now 
6 32 Fear of dealing with problems 
6 34 Not wanting to have depression listed in health records 
6 35 A desire to get better for people I care about 
6 36 Isolation, and not having the support network close 
6 39 Thinking that nothing can help me 
6 49 Not wanting to be a burden on others 
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 Figure 9: A concept map with 6 clusters 
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7.4.2.1 Description of the 6 cluster solution 
Cluster 1 contains 15 statements and is the largest in this set. It is located in the 
upper part of a concept map showing dimensions 1 and 2, relevant to the internal 
aspect of dimension 2. Statements in this group are broadly related to a person’s 
thoughts about treatment and their expectations of it. Further inspection of this 
cluster’s items reveals that most are related to two main themes. One theme, 
making an informed and considered decision about depression treatment, describes 
a part of dimension 2. The other theme, wanting to avoid the problem and have an 
easy solution, is relevant for dimension 4. Both themes describe internal factors, 
but they differ in the perspectives they emphasise, information driven approach, 
versus an attitude based on avoiding the situation and wanting a quick fix. 
 
Cluster 2 contains seven statements and is located in the central area of a graph 
with dimensions 1 and 2. Because it stretches across the central and bottom part of 
dimension 2, it contains statements related to personal and internal aspects of 
depression treatment decision-making (relating to the individual’s own 
experiences), as well as more external issues, including other people’s experiences, 
others’ beliefs about depression and views about depression in society.  
 
Cluster 3 groups 14 statements located at the left hand side of the concept map. 
The majority of these items are located at small distances to each other and the 
whole cluster is visibly separate from all other statements on a graph with 
dimensions 1 and 2. The statements characterise the external aspect of the 
dimension 1, and they refer to a range of issues associated with doctors and health 
professionals, such as professionals’ personal characteristics, their knowledge and 
beliefs, relationship and ability to discuss depression with the patient and their 
family in an open manner. 
 
Cluster 4 contains seven statements located at the right hand side part of the 
concept map, which is characterised by the internal aspect of patient treatment 
decision-making. It is located adjacent to some of the items in cluster 1, which are 
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related to concerns and worries about treatment. The cluster 4 also emphasises a 
patient’s focus on their internal factors. Specifically, it groups the items linked to a 
person recognising they have a problem, and feeling ready to seek help for their 
problem. These statements refer to an insightful approach to own depression, and 
were highlighted on dimension 5. 
 
Cluster 5 groups 5 statements positioned at small distances to each other at the 
bottom end of dimension 2, which represents external aspects of the dimension 2 
(and the dimension 3), including cultural background. The statements are related to 
a person’s social and cultural context, such as the social environment in which they 
were brought up and which influenced their current attitudes.  
 
Cluster 6 is positioned in the central part of the dimensions 1 and 2, extending to 
the right end of dimension 1, the internal aspect which was labelled ‘a patient’. It 
contains 11 statements associated with a patient’s emotions and emotional 
response to depression. These statements refer to a patient’s own and highly 
individual understanding of their situation and their acceptance of having 
depression and a need for treatment. The items are mostly related to emotions 
specific for depressive symptoms: how I feel right now, fear of dealing with the 
situation, feelings of guilt for depression, low self-confidence, feeling unable to 
make a decision due to depression.   
 
Some clusters in this solution contain statements, which are related to rather 
different themes. For example, some items in cluster 1 are associated with making 
an informed decision, but others are related to perceived barriers and wanting an 
easy treatment, rather than the most appropriate and effective option. Cluster 2 
contains statements related to stigma, as well as personal encounters with 
depression, and experiences of other people. I believe this cluster solution does not 
allow the best possible representation of the concepts that participants had raised. I 
therefore searched for an arrangement that would provide a more detailed 
distinction between the themes. 
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7.4.3 Eight cluster solution 
Table 17 shows a solution with statements being grouped into 8 clusters. Figure 10 
shows a spatial configuration of the 8 clusters on a concept map. The graph shows 
the statements as points labelled as individual numbers. 
 
Table 17: Statements in 8 clusters 
Cluster 
number 
Statement 
number 
Statement 
1 1 Financial costs related to the particular treatment option 
1 2 Practical issues related to starting treatment 
1 12 Wanting a treatment that works quickly 
1 34 Not wanting to have depression listed in health records 
1 50 Wanting the easiest treatment 
1 54 Wanting a 'natural' treatment 
1 59 Wanting a treatment that is provided with no time limitations 
2 3 Being given a choice of treatments 
2 7 Information about depression and its treatment 
2 8 Having my view about what is the best treatment confirmed 
2 11 Weighing up the risks and benefits of treatments 
2 15 Worries about the side effects of medication 
2 16 My knowledge and understanding of the effects of treatment 
2 26 My understanding of the side effects of treatment 
2 37 My belief that depression is a chemical imbalance 
2 46 Worries about becoming dependent on medication 
3 21 My personal characteristics (age, being male or female, ethnicity - being 
black, white or other) 
3 22 Culture (my background as well as my current culture) 
3 23 My religion 
3 40 Having an introverted or extroverted personality 
3 51 My upbringing 
4 4 Recognizing I have a problem I need help with 
4 5 Playing an active role in getting better 
4 33 Desire to get to the root (the bottom) of depression 
4 43 Being ready to accept treatment 
4 44 Being ready to engage with treatment 
4 47 Realizing there is no quick fix 
5 10 Beliefs of family and friends about depression 
5 48 Views about depression in society 
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Table 17 (continued) 
5 55 Other people's experiences with depression and its treatment 
6 6 Desperation to try anything that could help 
6 9 Inability to make a choice because of my depression 
6 14 Feeling it's my fault for having depression 
6 29 Wanting to escape from the situation 
6 31 How I feel right now 
6 32 Fear of dealing with problems 
6 35 A desire to get better for people I care about 
6 36 Isolation, and not having the support network close 
6 39 Thinking that nothing can help me 
6 49 Not wanting to be a burden on others 
7 13 My past experiences of treatment 
7 17 Wanting to share my experiences with depression with others 
7 30 My past experience with depression (knowing whether I can feel better or 
not) 
7 38 Understanding it is normal to have depression and I am not alone 
7 42 Realizing all people's experiences with depression are different 
8 18 Healthcare professionals' beliefs about depression and its treatment 
8 19 Healthcare professionals' knowledge and understanding about depression 
and its treatment 
8 20 My relationship with the healthcare professional 
8 24 Continuity of care (seeing the same healthcare professional) 
8 25 Personal characteristics of the healthcare professional (age, being male or 
female, ethnicity - being black, white or other) 
8 27 My experiences with healthcare professionals 
8 28 My expectations from healthcare professionals 
8 41 Wanting to please the doctor (to be a good patient) 
8 45 Healthcare professionals being ready to discuss depression and its 
treatment with family and friends 
8 52 The healthcare professionals' personality 
8 53 Healthcare professionals discussing depression and its treatment openly 
8 56 Being given a clear diagnosis 
8 57 Communication between different healthcare professionals 
8 58 Wanting what doctors say is the most effective treatment 
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Figure 10: A concept map with 8 clusters 
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7.4.3.1 Description of the 8 cluster solution 
Some of the 8 clusters in this arrangement are identical with those identified in the 
6-cluster arrangement. For example, cluster 8 is related to health professionals and 
their influence on a patient’s depression treatment decisions, and contains the 
same statements as cluster 3 in the previous solution. The new cluster 3, which 
refers to a person’s cultural and social context, is also identical with the relevant 
group, the former cluster 5 in the previous solution. 
 
Other clusters in the new arrangement are similar to their preceding versions, and 
most of the differences between the versions of clusters were caused by minor 
changes to the allocation of some statements to groups. Two larger clusters in the 
previous arrangement have been divided into two separate groups, and in several 
instances one or two statements have been removed from their original cluster, in 
order to form a new group.  
 
For example, statements in the former cluster 1 are grouped into two separate 
clusters (1 and 2) in the current cluster solution. The new group 1 contains 7 
statements, one of which (no.34) has been removed from its original clusters and 
placed in this group. The new cluster 2 contains 9 statements related to making an 
informed choice based on understanding of treatment options. All of these were 
part of the original cluster. 
 
The former cluster 2 has also been divided into smaller groups, the new clusters 5 
and 7. Cluster 5 contains three statements related to the external factors that 
emphasise the influence of other people’s views, and is located at the bottom part 
of the dimension 2, i.e. its external aspect described as society. 
 
Cluster 7 contains 5 statements located in the central part of the dimensions 1 and 
2. Statements in this cluster are related to a person’s appreciation of their own 
experiences with depression. Four out of the 5 statements in this cluster were 
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already grouped together in the previous cluster solution, except for item 38 which 
was originally placed in another group. Thematically, statement 38 relates to the 
items in this cluster as it refers to an understanding that depression also affects 
other people. 
 
The new cluster 4 refers to a patient’s insight into their situation, and realising they 
need treatment to deal with depression. It contains the same statements as its first 
version in the previous solution, except for statement 38 (i.e. understanding it is 
normal to have depression and I am not alone), which has been moved to the new 
cluster 7.   
 
Cluster 6 refers to a patient’s emotions and depressive thoughts as factors 
influencing their treatment choices and decision-making, and is located at the right 
hand side of dimension 1. It contains all but one statement which formed this 
cluster in the previous solution. The removed statement is number 34, not wanting 
to have depression listed in health records, which is now part of cluster 1. 
 
The eight cluster solution provides a better categorisation of the statements into 
groups, compared to the six cluster solution. This is shown by separating the 
clusters 1 and 2. Some of the groups still appear to contain items that are related to 
different themes. For example, the statements in clusters 5 and 7 have been re-
grouped but the themes they contain could be further divided for an improved 
reflection of the concepts. This arrangement of statements in clusters has therefore 
been rejected.   
 
7.4.4 Twelve cluster solution 
Table 18 shows how the statements were grouped into 12 clusters. Figure 11 shows 
a concept map with the 12 clusters portrayed in the space of the first two 
dimensions. The final 12 clusters are placed at approximate locations of the map, 
emphasising the concepts represented and the relationships between them. 
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Table 18: Statements in 12 clusters 
Cluster 
number 
Statement 
number 
Statement 
1 4 Recognizing I have a problem I need help with 
1 5 Playing an active role in getting better 
1 33 Desire to get to the root (the bottom) of depression 
1 43 Being ready to accept treatment 
1 44 Being ready to engage with treatment 
1 47 Realizing there is no quick fix 
2 31 How I feel right now 
2 35 A desire to get better for people I care about 
3 13 My past experiences of treatment 
3 30 My past experience with depression (knowing whether I can feel better 
or not) 
3 38 Understanding it is normal to have depression and I am not alone 
3 42 Realizing all people's experiences with depression are different 
4 3 Being given a choice of treatments 
4 7 Information about depression and its treatment 
4 8 Having my view about what is the best treatment confirmed 
4 11 Weighing up the risks and benefits of treatments 
4 15 Worries about the side effects of medication 
4 16 My knowledge and understanding of the effects of treatment 
4 26 My understanding of the side effects of treatment 
4 37 My belief that depression is a chemical imbalance 
4 46 Worries about becoming dependent on medication 
5 6 Desperation to try anything that could help 
5 9 Inability to make a choice because of my depression 
5 14 Feeling it's my fault for having depression 
5 29 Wanting to escape from the situation 
5 32 Fear of dealing with problems 
5 36 Isolation, and not having the support network close 
5 39 Thinking that nothing can help me 
5 49 Not wanting to be a burden on others 
6 56 Being given a clear diagnosis 
6 58 Wanting what doctors say is the most effective treatment 
7 18 Healthcare professionals' beliefs about depression and its treatment 
7 19 Healthcare professionals' knowledge and understanding about 
depression and its treatment 
7 20 My relationship with the healthcare professional 
7 24 Continuity of care (seeing the same healthcare professional) 
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Table 18 (continued) 
7 25 Personal characteristics of the healthcare professional (age, being male 
or female, ethnicity - being black, white or other) 
7 27 My experiences with healthcare professionals 
7 28 My expectations from healthcare professionals 
7 41 Wanting to please the doctor (to be a good patient) 
7 45 Healthcare professionals being ready to discuss depression and its 
treatment with family and friends 
7 52 The healthcare professionals' personality 
7 53 Healthcare professionals discussing depression and its treatment openly 
7 57 Communication between different healthcare professionals 
8 1 Financial costs related to the particular treatment option 
8 2 Practical issues related to starting treatment 
8 12 Wanting a treatment that works quickly 
8 50 Wanting the easiest treatment 
8 54 Wanting a 'natural' treatment 
8 59 Wanting a treatment that is provided with no time limitations 
9 17 Wanting to share my experiences with depression with others 
9 55 Other people's experiences with depression and its treatment 
10 10 Beliefs of family and friends about depression 
10 48 Views about depression in society 
11 21 My personal characteristics (age, being male or female, ethnicity - being 
black, white or other) 
11 22 Culture (my background as well as my current culture) 
11 23 My religion 
11 40 Having an introverted or extroverted personality 
11 51 My upbringing 
12 34 Not wanting to have depression listed in health records 
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Figure 11: A concept map with 12 clusters 
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Figure 12: Final concept map 
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7.4.4.1 Description of the 12 cluster solution 
In this arrangement the statements are divided into 12 groups. Most statements 
have been grouped together with the same statements as in the previous solution 
with 8 clusters. Several minor modifications in the ways the statements are grouped 
in this arrangement have allowed conceptualising the issues independently from 
the larger groups of other items. As a result, this cluster solution has been selected 
as final. 
 
Of the 12 clusters, 3 are identical with their previous versions (new clusters 1, 4 and 
11). Three pairs of clusters were created by dividing three of the clusters’ former 
versions into two: group 8 from the previous solution has been divided into new 
clusters 6 and 7; the previous cluster 1 is now separated into clusters 8 and 12; and 
clusters 2 and 5 have been created by dividing group number 6 from the previous 
solution. Statements in the three remaining clusters of this solution (clusters 3, 9 
and 10) were previously grouped as two clusters. In their current formation two 
statements, located at the neighbouring ends of their original groups (nos. 17 and 
55), have been put together into a new cluster.  
 
The 12 clusters are factors that affect people’s treatment decision-making, and 
statements are their components. The statements provide particular details of the 
factors, and define their nature. In the following sections I describe the clusters 
based on the statements’ themes, positions on the map and relationships with their 
neighbours. 
 
7.4.4.2  Cluster 4: Making an informed choice 
This cluster is located at the top of the concept map, and characterises the internal 
aspect of dimension 2. It contains nine statements, which are related to a person’s 
evaluation of the depression treatment options from different perspectives, i.e. an 
attempt to make a considered and informed decision. Six statements located in the 
top area of the cluster (numbers 3, 7, 8, 11, 16 and 26) refer to being given a choice 
of treatments and information and understanding about different options and their 
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effects, as well as side effects. The six items emphasise an information-focused 
approach to decision-making, which is based on understanding the effects and side 
effects of options, and weighing up the positive and negative aspects of different 
options.  
 
One statement, number 37, is thematically different from the other items, referring 
to a person’s belief about the origin of depression (i.e. chemical imbalance in brain), 
rather than their approach to information about treatment. This is the only 
statement in the set, that refers to a person’s conceptualisation of the cause of 
depression, and based on the participants’ views about the statements’ 
relationships it is related to other items in this cluster. 
 
Two statements at the bottom right hand side of the cluster, numbers 15 and 46, 
relate to a patients’ worries and concerns about treatment. One is related to 
treatment in general, i.e. worries about the side effects of treatment, while the 
other is specific to medication, such as worries about becoming dependent on 
medication. Considering these items in relation to the other statements in the 
cluster, its information-focused atmosphere could be viewed from the perspective 
of a person who wants to be given a choice of treatment options due to being 
worried about the possible side effects. They want to evaluate the different options 
and the relevant information, in order to find the best treatment for their own 
needs. Based on this relationship I labelled this cluster as ‘Making an informed 
choice’.  
 
7.4.4.3 Cluster 8: Seeking effortless treatment 
Cluster 8 contains 6 statements related to a person’s thoughts about treatment. Its 
main subject and location on the concept map indicate a thematic relationship with 
its close neighbour, cluster 4.  
 
Items 12, 50, 54 and 59 reflect patients’ specific desires from their treatment, for 
example wanting a treatment that works quickly, wanting the easiest treatment, 
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natural treatment, or wanting a treatment that is provided with no time limitations. 
Statements 1 and 2, concerning financial and practical issues, relate to a person’s 
wish to avoid or overcome practical difficulties and barriers, such as physical and 
geographical access to a therapist or a place where the treatment is provided. A 
theme that links the statements in this cluster is a wish to avoid problems with 
treatment provision, and wanting to avoid any effort necessary to face their 
negative thinking patterns and depressive cognitions. As a result, rather than 
emphasising the information-seeking approach which is characteristic for cluster 4, 
cluster 8 focuses on wanting a treatment with little or no barriers, and minimal 
effort needed. Based on this observation, I labelled it ‘seeking effortless treatment’. 
 
7.4.4.4 Cluster 1: Personal insight  
This cluster is bordering with clusters 8 and 3, and is located at the right hand side 
of the concept map with dimensions 1 and 2. It groups 6 statements about a 
person’s insight into their depression and gaining a personal awareness of having a 
problem that needs to be dealt with. For example, statement 4 refers to a person 
realising their depressive feelings are symptoms of an illness and that they might 
need help to deal with it. Statements 5 and 33 share a theme of an individual being 
pro-active in improving their symptoms. In particular, these statements reflect a 
person’s desire to take control over the situation, and to find out the cause of their 
current state in order to enable them to deal with it effectively. Statement 47 
contributes with an idea that depression cannot be treated quickly and without a 
patient’s active involvement in the process. The remaining items 43 and 44 refer to 
a person’s readiness to accept treatment and engage with it.  
 
The theme in this cluster relates to a person internally acknowledging having a 
problem (depression), which warrants treatment, and the individual statements 
each add a specific feature to this concept. For instance, a patient’s feeling of 
readiness for a change, recognition of a need for help, feeling determined to face 
the problem, rather than avoid it. Based on these themes the cluster is labelled as 
patient’s ‘personal insight’. 
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The six items in this cluster had also been put into a single group in previous cluster 
solutions, and the only modification occurred between 6 and 8 cluster 
arrangements, when statement 38 was moved away from this cluster. This suggests 
that the six statements form a stable group. The six statements, together with 
statements about personality, demographic characteristics and religion, also 
characterised the internal aspect of dimension 4, one’s personal attentiveness to, 
and recognition of their depression. 
 
7.4.4.5 Cluster 3: Experiences with depression 
Cluster 3 contains four statements and is located in the top right quadrant of the 
concept map, between its adjacent clusters 8 and 1. Two of the items in this group, 
numbers 13 and 30, are related to a person’s own past experiences with a 
depressive illness. Two other statements reflect a person’s recognition of 
depression as a common illness which affects people differently (numbers 38 and 
42). Together they emphasise a person learning from their own experience, that 
depression is an illness affecting various people in various ways, rather than a 
personal weakness. Although not specifically mentioning people’s own 
experience(s) with depression, these items refer to personal familiarity with 
depression, and conceptualisation of the condition from a viewpoint of a person 
with knowledge or experience with it. I labelled the cluster ‘experiences with 
depression’ to reflect its character oriented to practice and learning from personal 
encounters of the illness. 
 
7.4.4.6 Cluster2: Emotional state 
Cluster 2 is located next to cluster 5, and both are at the right hand side of the 
concept map, together characterising the internal aspect of dimension 1. This 
cluster contains two statements related to patients’ personal issues as factors 
influencing depression treatment choices, for example number 31: how I feel right 
now, and 35: a desire to get better for people I care about. These two items relate 
to a patient’s emotions, an issue which is reflected in general terms by one of the 
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statements. The other statement relates to a person’s sense of responsibility 
towards important people in their life, and a wish to get treatment for depression. 
These are highly subjective issues, and may be largely dependent on a person’s 
mood in a given situation. The two statements emphasise one’s mood and 
emotions in general terms, rather than focusing on specific, either negative or 
positive valence of the feeling. To articulate the theme of this cluster I labelled it 
‘emotional states’.  
 
7.4.4.7 Cluster 5: Depressive symptoms 
Cluster 5 contains eight statements located next to cluster 2 but distinct from other 
groups. Statements in cluster 5 relate to several aspects of treatment decision-
making. For example, items 36 (isolation, and not having the support network 
nearby) and 49 (not wanting to be a burden on others) focus on a patient’s 
consideration of other people in relation to own depression. Items 9, 14, 32 and 39 
convey a negative attitude and a concept of being prevented from facing the 
problem and effectively dealing with it by own depressive emotions. These 
statements share a pessimistic, apprehensive and avoidance-oriented approach to 
the reality of having depression, including feeling unable to make a choice due to 
depressive symptoms, feeling guilty for depression, thinking that nothing can help 
and a wish to escape from the situation. From this perspective, item 6 (desperation 
to try anything that could help) is different from the others in this cluster, since it 
demonstrates an approach based on hope and one’s openness to search for new 
treatment possibilities.   
 
From another point of view, the 8 statements in this cluster are very similar. They 
all reflect some of the characteristic features of a depressive illness and its effect on 
a patient, that is symptoms of depression. The cluster is, therefore, labelled 
‘depressive symptoms’. It emphasises how depression as an illness can directly 
influence people’s decision-making, specifically related in this instance to the 
selection of treatment for depression.  
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7.4.4.8 Cluster 9: Sharing experiences of depression with others 
Cluster 9 is located near the central part of the concept map with dimensions 1 and 
2, not directly characterising either of the dimensions. It contains two statements, 
number 17 – ‘wanting to share my experiences with depression with others’ and 
number 55 – ‘other people’s experiences with depression and its treatment’. The 
themes represented by the two items are related to experiences with depression, 
specifically focusing on a person’s own experience in relation to the experience of 
other people. Wanting to share one’s own, and to know about others’ encounters 
with depression are two aspects of a communication channel, of giving and 
receiving information about personal experiences with the illness, and strategies for 
dealing with it. Based on the subject of this cluster, I labelled it ‘sharing experiences 
of depression with others’. 
 
7.4.4.9 Cluster 10: External views about depression 
Cluster 10 is located in the bottom area of the concept map, and together with 
cluster 11 it characterises an external aspect of dimension 2, society. The cluster 
contains two statements which reflect beliefs about depression held by a patient’s 
family and friends and their wider social environment. The statements are 
formulated in a neutral way, and in relation to patients’ treatment choices they 
could include others’ negative and stigmatising attitudes to depression and 
treatment, as well as positive and supporting views. I labelled the cluster ‘external 
views about depression’, to reflect its core concept that patients with depression 
might modify their treatment decisions according to the supporting or stigmatising 
views held by other people.  
 
7.4.4.10 Cluster 11: My social context 
The five statements in cluster 11 are located at the bottom of the concept map and 
on the concept map they are around the statements in cluster 10. These items can 
be described as the features and attributes of a person with depression, that place 
them in their current social environment – demographic characteristics (age, 
gender, and ethnicity), personality, upbringing, religion and cultural background. 
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Unlike cluster 10 which emphasises the effects of others’ views on one’s treatment 
choices, the focus of cluster 11 is on a patient’s social and cultural identity. Whilst 
this is partly influenced by other people (in terms of such aspects as upbringing, 
religion and culture), in this cluster an individual’s perception of external views is 
secondary. Instead, the emphasis is on an interaction of different aspects of a 
person’s social identity. Acknowledging the cluster’s focus on a patient’s personal 
characteristics and their social environment, I labelled it ‘my social context’. 
 
7.4.4.11 Cluster 12: Depression in health records 
Cluster 12 is the only cluster containing a single statement. It is located in the 
central part of the concept map, neighbouring with cluster 9 (sharing experiences of 
depression with others). This statement (not wanting to have depression listed in 
health records) represents a person’s fear of disclosing the diagnosis to others, for 
example potential future employers. It could also be described as a fear of being 
discriminated against and stigmatised based on the illness.  
 
The statement in this cluster was the only item belonging to different clusters in 
each of the three solutions. It was first put together with statements regarding 
depressive symptoms’ influence on decisions (in the 6-cluster solution), and then 
with the statements about effortless treatment in the 8-cluster solution. In the final 
arrangement it is a cluster on its own, suggesting that the participants did not think 
that keeping the diagnosis of depression a secret was closely related to other 
statements in the set. 
 
7.4.4.12 Cluster 7: Healthcare professionals 
Clusters 7 and 6 are the only two clusters located on the left hand side of the 
concept map. Together, they characterise the external aspect of dimension 1, i.e. 
health professionals as a factor influencing patients’ treatment decision-making. In 
the previous solutions these two groups formed one large cluster and in this final 
arrangement they are considered as two separate factors.  
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Cluster 7 is the largest in this set, and it contains 12 statements related to health 
professionals, viewing them from several perspectives. These include, for example, 
a patient’s subjective perceptions of the professional (such as patients’ experiences, 
expectations and relationships with the professional), professionals’ personal 
characteristics (including demographic and personality factors) and provision of 
healthcare (for example continuity of care). Several statements, in addition, reflect 
the healthcare workers’ communication skills (such as professionals openly 
discussing depression and its treatment with the patient and their family and 
friends) and the doctors’ personal views about depression (including their beliefs, 
knowledge and understanding about this mental illness).  
 
All of the 12 statements are located at small distances from each other, reflecting 
the participants’ perception of the similar themes they represent, a person’s 
reliance on their health professional as a major pillar when selecting depression 
treatment. Based on this observation, I labelled the cluster ‘health professionals’. 
 
7.4.4.13 Cluster 6: needing the doctor’s advice 
Cluster 6 is the only close neighbour to cluster 7, but its two statements are placed 
approximately halfway between clusters 7 and 4 (making an informed choice). 
Based on these items’ position on the map and their subject, they can be viewed as 
a connecting link between clusters 7 and 4. They refer to a patient relying on the 
doctor’s advice and needing the professional’s confirming their treatment choices 
(for instance a need for a clear diagnosis and wanting treatment recommended by 
the doctor). Whilst this theme is related to health professionals, the cluster also 
places an emphasis on the patient’s desire to be involved in treatment choice and 
using the expert advice of a doctor to inform their decision. This cluster was 
therefore labelled ‘needing the doctor’s advice’.  
 
7.4.5 Meta-clusters  
Based on descriptions and positions of the 12 individual clusters, it is apparent that 
some are related to each other more than others. These groups of related clusters 
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can be considered as meta-clusters for the purposes of interpreting their shared 
focus on decision-making about treatment. 
 
7.4.5.1 An informed and perceptive approach 
Clusters 4 (an informed choice), 8 (seeking effortless treatment), 1 (personal insight) 
and 3 (experiences) are closely adjacent to each other on the concept map. All are 
related to a decision that is based on information and understanding of a variety of 
issues, including the effects of depression as an illness on a person’s life, and the 
effects and side effects of different treatment options. Whilst some statements can 
be viewed as having an emotional character (for example worries about becoming 
dependent on medication), in general they emphasise problem solving and can be 
viewed as concerns related to a lack of information. From this perspective, the four 
clusters all refer to factors based on an informed and perceptive approach to 
decision-making, demonstrating themselves as a person’s internal locus of control 
over improving the depressive symptoms. 
 
7.4.5.2 Depressive emotions 
The three clusters related to relatively subjective and sentiment-driven factors are 
clusters 2 (emotions), 5 (depressive symptoms) and 12 (depression in health 
records). In the 6-cluster solution they formed a single cluster, and most of them 
describe patients’ negative feelings about themselves from various perspectives. 
When regarded as a factor influencing patients’ treatment decisions, the effect of 
emotional states in particular situations is closely related to a persons’ depressive 
symptoms, including feeling guilt about depression, fear of facing their problem, or 
wanting to avoid the situation. The clusters’ close positions on the map suggest that 
participants viewed them as related, and together they form a meta-cluster 
‘depressive emotions’. 
 
7.4.5.3 External factors 
Three clusters are related to the external factors, such as views of other people 
about depression (cluster 10), a person’s social and cultural context (cluster 11) and 
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sharing experiences with depression with other people (cluster 9). The shared 
theme here is a person emphasising the influence of factors which are not directly 
related to their subjective living with depression. Instead, the focus is on the factors 
related to a person’s environment, and the opinions and advice of other people, 
such as a need for an input from other people. 
 
7.4.5.4 Health professionals 
Two clusters (numbers 6 and 7) in this set are directly related to health 
professionals as an influence on patients’ decision-making. Their location on the 
map (close to each other but distinct from other clusters), and their common focus 
on healthcare practitioners indicate that they can be regarded as one meta-group, 
health professionals. The theme of this meta-cluster is a person’s attention and 
hope being projected onto the doctor as an expert with an authority, rather than a 
person’s sense of confidence in their own judgement. 
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 Chapter 8  Prioritising 
 
8.1 Relative importance of clusters 
Table 19 (key to table on separate page) shows the relative importance rankings of 
the final 12 clusters for the whole sample and for each stakeholder group 
separately. The group as a whole ranked patients’ personal insight, emotional states 
and needing the doctor’s opinion (expert advice) as the three most important 
factors affecting patients’ treatment choices. The factors viewed as the least 
important were sharing experiences of depression with others, patient’s social 
context and not wanting to have depression listed in health records. The three 
stakeholder groups differed significantly in their perceptions of the relative 
importance of 5 clusters, marked by asterisks in the table. 
 
8.1.1 People with depression 
Table 19 shows that people with depression emphasised the importance of the 
internal factors. They ranked personal insight into depression, their current 
emotional states and their own experiences with depression as the most influential 
factors on their decision-making about treatment. This group pointed to health 
professionals and expert advice as moderately important, and reported that 
external factors, such as external views about depression, social context, and 
depression in health records were the least influential factors. 
 
8.1.2 Family and friends 
Family and friends thought that people with depression are most influenced by the 
doctors’ expert advice. They also felt that patients’ personal insight and their desire 
to make informed choices were important for their treatment decisions. The group 
reported external factors, such as depression in health records, patient’s social 
context, and their desire to share experiences of depression with other people, as 
the least influential. 
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8.1.3 Healthcare workers 
The group of healthcare workers thought that people with depression make their 
treatment decisions mostly influenced by external views about depression (the 
opinions and beliefs of their family and friends or generally within society). The 
patients’ need for doctors’ expert advice about depression and treatment, and 
patients’ own insight into their condition and symptoms were also thought to be 
important. Similarly to the two other groups, healthcare workers felt that the least 
important factors were patients’ social contexts, sharing experiences with other 
people, and a desire to avoid having depression listed in health records. 
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Table 19: Clusters' importance rankings by stakeholder groups 
Cluster Whole group 
(N = 63) 
People with depression 
(N = 28) 
Family and friends 
(N = 14) 
Healthcare workers 
(N = 21) 
Post-hoc test 
Label   Rank Mean (SD; 95% CI) Rank  Mean (SD; 95% CI) Rank Mean (SD; 95% CI) Rank Mean (SD; 95% CI)  
(1) Personal insight 1 3.7 (.7; 3.5-3.9) 1 4.0 (.6; 3.8-4.3) 2 3.5 (.8; 3.0-3.9) 3 3.4 (.7; 3.1-3.7) PWDÆHCW** 
PWDÆFF* 
(2) Emotional states 2 3.6 (1.0; 3.3-3.8) 2 4.0 (.8; 3.7-4.3) 5 3.2 (1.1; 2.6-3.8) 4 3.3 (1.0; 2.8-3.7) PWDÆHCW* 
PWDÆFF* 
(3) Experiences with 
depression 
4 3.3 (.8; 3.2-3.5) 3 3.5 (.8; 3.2-3.8) 4 3.3 (.6; 3.0-3.7) 5 3.2 (.7; 2.8-3.5)  
(4) Making an informed 
choice 
5 3.2 (.7; 3.0-3.4) 4 3.2 (.6; 2.9-3.4) 3 3.4 (.7; 3.1-3.8) 6 3.1 (.9; 2.7-3.5)  
(5) Depressive symptoms 6 3.1 (.7; 2.9-3.2) 5 3.2 (.7; 2.9-3.4) 6 3.1 (.6; 2.8-3.4) 8 2.9 (.7; 2.6-3.2)  
(6) Needing the doctor’s 
opinion 
3 3.4 (1.0; 3.2-3.6) 6 3.1 (1.0; 2.7-3.5) 1 4.0 (.8; 3.5-4.4) 2 3.4 (.9; 3.0-3.8) FFÆPWD* 
(7) Healthcare professionals 8 2.8 (.6; 2.7-3.0) 7 2.8 (.7; 2.5-3.1) 7 2.9 (.5; 2.6-3.2) 9 2.8 (.5; 2.6-3.1)  
(8) Seeking effortless 
treatment 
9 2.8 (.7; 2.6-3.0) 8 2.7 (.7; 2.5-3.0) 8 2.6 (.6; 2.3-3.0) 7 3.0 (.8; 2.6-3.3)  
(9) Sharing experiences of 
depression with others 
10 2.5 (.9; 2.3-2.7) 9 2.6 (1.0; 2.2-3.0) 12 2.1 (.9; 1.6-2.7) 12 2.6 (.8; 2.2-2.9)  
(10) External views about 
depression 
7 2.9 (1.0; 2.6-3.1) 10 2.5 (.8; 2.2-2.8) 9 2.6 (1.1; 2.0-3.2) 1 3.5 (.8; 3.1-3.9) HCWÆPWD** 
HCWÆFF** 
(11) My social context 11 2.3 (.9; 2.1-2.6) 11 2.0 (.6; 1.8-2.2) 11 2.3 (1.3; 1.6-3.1) 10 2.8 (.9; 2.4-3.2) HCWÆPWD*** 
(12) Depression in health 
records 
12 2.2 (1.3; 1.9-2.5) 12 1.8 (1.1; 1.4-2.3) 10 2.4 (1.5; 1.5-3.2) 11 2.7 (1.3; 2.1-3.3)  
Page 187 of 386 
* p<.05 using Tukey’s post-hoc test 
** p<.01 using Tukey’s post-hoc test 
*** p<.01 using Welch’s test and Tamhane’s T2 post-hoc test, as the Levene’s test was significant, which violated assumption of Anova and indicated need for alternative test. 
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8.2 Relative importance of the individual statements 
Table 20 shows the perceived relative importance rankings of all statements for 
each stakeholder group and for the participants as a whole. The groups significantly 
differed in their rankings of 12 statements, which are marked by an asterisk. 
 
8.2.1 Whole group perspectives 
According to the group as a whole, the top ten most important issues affecting 
patients’ choices included several statements related to a person’s insight, including 
patients’ ability to recognise their illness, readiness to accept treatment and engage 
with it, and wanting to get to the root of their depressive illness. Participants also 
valued patient’s current emotional state (how I feel right now), and their past 
experience with depression and treatment. Other highly ranked items included 
patients’ information about depression and treatment, professionals’ knowledge 
about depression, and people’s feeling of desperation to try any treatment option 
that could help them.  
 
The 10 least important statements all belonged to clusters rated as less influential 
by people with depression, i.e. clusters 7-12. These statements relate to a person 
wishing to have a ‘quick fix’ treatment and avoid a more in-depth dealing with 
depression (for instance wanting the easiest treatment), patient’s social contexts 
(including personality, religion, personal characteristics) and external factors (such 
as sharing experiences with others) and depressive emotions, (i.e. not wanting to 
have depression listed in health records). Several of the least important statements 
related to health professionals (such as professionals’ readiness to discuss 
depression with the family and friends, communication between different health 
professionals, and patients wishing to please their doctor). 
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8.2.2 People with depression 
The top ten most important statements for this group include mostly internally 
focused items, such as recognising that they have a problem they need help with, 
and feeling ready to accept treatment. People with depression thought that their 
treatment decision-making is greatly affected by their past experience, including 
knowing whether one can feel better, and the current emotional states. Overall, the 
group also emphasised the importance of being actively involved in treatment and 
getting to the root of their depressive illness when selecting treatment for 
depression. Whilst several of the top ten most influential statements are related to 
people’s insightful approach and making informed decisions, patients also felt that 
their treatment choices are shaped by their depressive emotions, such as wanting 
to avoid dealing with the situation and feeling desperate to try anything that might 
help.  
 
The ten statements ranked as the least influential on patients’ own treatment 
choices were mostly external factors, such as religion, culture, beliefs of family and 
friends about depression. Patients did not consider that they made decisions in an 
attempt to please their doctor, or that they wanted to avoid having depression 
listed in health records. A wish to have a ‘natural’ treatment was not regarded as 
highly influential. Additionally, patients did not think that their own or their health 
professional’s personality or demographic characteristics had a significant influence 
on their decisions.  
 
8.2.3 Family and friends 
Family and friends emphasised the need for patients to see the same health 
professionals during the course of their illness, and the need to be given a clear 
diagnosis, in order to make informed decisions. They also considered that people’s 
depressive illness significantly affected their ability to make treatment decisions, 
but that it was important for patients to recognise their problem and that they are 
not alone with the illness. Other important items, according to the family and 
friends, are patients’ information and understanding about depression and their 
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readiness to engage with treatment. The group thought that patients want to feel in 
control by being given a choice of treatment, but want to have treatment which is 
recommended by their health professional. 
 
This group thought that the least influential factors related to the age, gender and 
ethnicity of health professional, the patient’s social context (including religion, 
culture), and wanting to please the doctor. Family and friends did not think that 
sharing experiences with others was important for people with depression, or that 
it was relevant for them to realise that depression affects people differently. 
Similarly to people with depression, this group did not find a wish for a ‘natural’ 
treatment to be highly significant for patients’ decisions. 
 
8.2.4 Healthcare workers 
Healthcare workers, similarly to people with depression, thought that patients’ 
recognition of their illness was the most important statement of all. They also 
suggested that patients’ past experiences were highly influential, together with 
their personal readiness to accept treatment. The group attributed significance to 
people’s need for information about depression and its treatment, and thought that 
patients want treatment that works quickly. This is supported by the group’s low 
relative ranking of the importance of patients’ realisation that there is no quick fix 
for depression. Other highly rated items include patients’ reliance on the doctor’s 
recommendation, and their experience with the professional. 
 
Statements that were not considered to be as important include the patients’ 
realisation that people’s experiences with depression are different and feeling guilty 
about depression. Healthcare workers agreed with the other stakeholder groups’ 
low rankings of the professionals’ personal characteristics, and the patients’ wish 
for a ‘natural’ treatment and to please the doctor. 
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Table 20: The relative importance of statements 
Statement Whole sample 
(n=64) 
People with 
depression (n=28) 
Family and friends 
(n=14) 
Healthcare workers 
(n=22) 
cluster  ID   rank Mean (SD) rank Mean (SD) rank Mean (SD) rank Mean (SD) 
1 4 Recognizing I have a problem I need help with 1 4.3 (1.1) 1 4.5 (0.9) 4 3.9 (1.2) 1 4.2 (1.2) 
1 43 Being ready to accept treatment 2 4.1 (1.1) 2 4.4 (0.8) 13 3.6 (1.2) 4 4 (1.2) 
3 30 My past experience with depression (knowing whether I can 
feel better or not) 
3 3.9 (1.2) 3 4.1 (1.3) 14 3.6 (1.1) 3 4 (1.2) 
2 31 How I feel right now 8 3.6 (1.3) 4 4.1 (1)** 31 3 (1.4) 16 3.4 (1.3) 
1 33 Desire to get to the root (the bottom) of depression 9 3.6 (1.3) 5 4 (1.2) 20 3.4 (1.4) 22 3.3 (1.3) 
1 5 Playing an active role in getting better 15 3.4 (1.4) 6 4 (1.1)* 33 2.9 (1.6) 39 2.9 (1.2) 
5 29 Wanting to escape from the situation 11 3.5 (1.5) 7 3.9 (1.5) 23 3.4 (1.3) 36 2.9 (1.4) 
5 6 Desperation to try anything that could help 10 3.6 (1.5) 8 3.9 (1.4) 21 3.4 (1.3) 19 3.3 (1.6) 
4 16 My knowledge and understanding of the effects of treatment 12 3.5 (1.4) 9 3.9 (1.2)* 10 3.6 (1.5) 35 2.9 (1.6) 
2 35 A desire to get better for people I care about 14 3.5 (1.3) 10 3.9 (1.2) 17 3.4 (1.6) 24 3.2 (1.3) 
1 44 Being ready to engage with treatment 4 3.8 (1.2) 11 3.9 (1) 7 3.8 (1.2) 10 3.7 (1.3) 
7 19 Healthcare professionals' knowledge and understanding 
about depression and its treatment 
7 3.7 (1.1) 12 3.7 (1.2) 11 3.6 (1.5) 7 3.8 (0.9) 
3 13 My past experiences of treatment 5 3.7 (1.3) 13 3.6 (1.3) 16 3.5 (1.2) 2 4 (1.2) 
7 24 Continuity of care (seeing the same healthcare professional) 13 3.5 (1.3) 14 3.6 (1.3) 1 4.1 (1.1)* 31 3 (1.3) 
5 49 Not wanting to be a burden on others 23 3.3 (1.3) 15 3.6 (1.2) 18 3.4 (1.6) 44 2.7 (1.2) 
8 59 Wanting a treatment that is provided with no time limitations 30 3 (1.5) 16 3.4 (1.5)* 19 3.4 (1.6) 53 2.2 (1.3) 
4 7 Information about depression and its treatment 6 3.7 (1.2) 17 3.4 (1.3) 6 3.9 (0.8) 5 3.9 (1.2) 
Page 192 of 386 
Table 20 (continued) 
6 56 Being given a clear diagnosis 16 3.4 (1.4) 18 3.3 (1.4) 2 4 (1.2) 28 3.1 (1.4) 
7 27 My experiences with healthcare professionals 19 3.4 (1) 19 3.3 (1.2) 26 3.4 (0.8) 6 3.8 (1) 
1 47 Realizing there is no quick fix 35 2.9 (1.3) 20 3.3 (1.2)** 27 3.3 (1.3)** 56 2 (1.1) 
8 12 Wanting a treatment that works quickly 20 3.3 (1.4) 21 3.2 (1.3) 34 2.9 (1.5) 8 3.7 (1.5) 
7 20 My relationship with the healthcare professional 21 3.3 (1.3) 22 3.2 (1.3) 22 3.4 (1.3) 21 3.3 (1.3) 
3 42 Realizing all people's experiences with depression are different 47 2.5 (1.2) 23 3.2 (1)*** 50 2.4 (1) 58 1.7 (0.8) 
4 15 Worries about the side effects of medication 18 3.4 (1.3) 24 3.1 (1.4) 12 3.6 (1.2) 11 3.6 (1.2) 
3 38 Understanding it is normal to have depression and I am not 
alone 
26 3.2 (1.3) 25 3.1 (1.4) 5 3.9 (1.2) 33 3 (1.3) 
5 36 Isolation, and not having the support network close 28 3.1 (1.3) 26 3.1 (1.3) 25 3.4 (1) 37 2.9 (1.4) 
4 11 Weighing up the risks and benefits of treatments 42 2.8 (1.2) 27 3.1 (1) 32 3 (1) 46 2.4 (1.4) 
4 3 Being given a choice of treatments 25 3.2 (1.4) 28 3 (1.5) 9 3.7 (1.3) 26 3.1 (1.5) 
7 53 Healthcare professionals discussing depression and its 
treatment openly 
29 3 (1.5) 29 3 (1.4) 37 2.8 (1.4) 30 3 (1.6) 
4 26 My understanding of the side effects of treatment 27 3.1 (1.3) 30 3 (1.3) 24 3.4 (1.1) 38 2.9 (1.3) 
4 46 Worries about becoming dependent on medication 22 3.3 (1.3) 31 3 (1.3) 15 3.5 (1.3) 18 3.4 (1.1) 
7 28 My expectations from healthcare professionals 40 2.8 (1.3) 32 3 (1.2) 45 2.5 (0.9) 40 2.8 (1.5) 
4 37 My belief that depression is a chemical imbalance 31 3 (1.3) 33 3 (1.2) 28 3.2 (1.6) 32 3 (1.3) 
5 9 Inability to make a choice because of my depression 24 3.2 (1.5) 34 2.9 (1.6) 3 3.9 (1.3) 25 3.1 (1.6) 
6 58 Wanting what doctors say is the most effective treatment 17 3.4 (1.4) 35 2.9 (1.4) 8 3.8 (1.1) 9 3.7 (1.4) 
7 52 The healthcare professionals' personality 39 2.8 (1.4) 36 2.9 (1.3) 35 2.9 (1.5) 43 2.7 (1.5) 
5 32 Fear of dealing with problems 44 2.7 (1.4) 37 2.8 (1.4) 44 2.5 (1) 41 2.8 (1.5) 
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Table 20 (continued) 
4 8 Having my view about what is the best treatment confirmed 32 3 (1.1) 38 2.8 (0.9) 29 3.1 (1.3) 23 3.2 (1.3) 
5 14 Feeling it's my fault for having depression 46 2.5 (1.4) 39 2.7 (1.4) 49 2.4 (1.2) 50 2.3 (1.5) 
8 1 Financial costs related to the particular treatment option 33 2.9 (1.5) 40 2.6 (1.5) 40 2.6 (1.7) 15 3.4 (1.4) 
11 51 My upbringing 34 2.9 (1.5) 41 2.6 (1.4) 39 2.6 (1.8) 13 3.5 (1.3) 
8 2 Practical issues related to starting treatment 38 2.8 (1.4) 42 2.6 (1.3) 48 2.4 (1.3) 20 3.3 (1.5) 
9 17 Wanting to share my experiences with depression with others 54 2.2 (1.8) 43 2.6 (1.3)** 54 2.2 (1.1) 59 1.6 (0.8) 
9 55 Other people's experiences with depression and its treatment 43 2.8 (1.2) 44 2.6 (1.2) 56 2.1 (1.1) 14 3.5 (1)**** 
7 18 Healthcare professionals' beliefs about depression and its 
treatment 
37 2.9 (1.1) 45 2.6 (0.9) 30 3.1 (1) 29 3.1 (1.2) 
10 48 Views about depression in society 41 2.8 (1.3) 46 2.5 (1.2) 47 2.4 (1.5) 17 3.4 (1.3) 
7 45 Healthcare professionals being ready to discuss depression and 
its treatment with family and friends 
52 2.3 (1.4) 47 2.4 (1.5) 42 2.5 (1.6) 57 1.9 (0.8) 
5 39 Thinking that nothing can help me 45 2.6 (1.3) 48 2.4 (1.3) 43 2.5 (1.4) 34 3 (1) 
11 40 Having an introverted or extroverted personality 51 2.4 (1.3) 49 2.4 (1.2) 41 2.6 (1.5) 47 2.4 (1.4) 
10 10 Beliefs of family and friends about depression 36 2.9 (1.2) 50 2.4 (1.1) 36 2.8 (1.4) 12 3.6 (0.9)** 
8 54 Wanting a 'natural' treatment 53 2.3 (1.3) 51 2.3 (1.4) 52 2.3 (1.1) 51 2.3 (1.3) 
7 57 Communication between different healthcare professionals 50 2.4 (1.4) 52 2.3 (1.4) 38 2.8 (1.3) 52 2.2 (1.4) 
8 50 Wanting the easiest treatment 49 2.4 (1.4) 53 2.2 (1.3) 55 2.1 (1.3) 42 2.8 (1.5) 
11 21 My personal characteristics (age, being male or female, 
ethnicity - being black, white or other) 
55 2.2 (1.3) 54 1.9 (1.3) 53 2.2 (1.7) 49 2.4 (1.1) 
11 22 Culture (my background as well as my current culture) 
 
48 2.4 (1.4) 55 1.9 (1.1) 51 2.3 (1.5) 27 3.1 (1.4)** 
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Table 20 (continued) 
7 25 Personal characteristics of the healthcare professional (age, 
being male or female, ethnicity - being black, white or other) 
58 1.8 (1.2) 56 1.8 (1.2) 59 1.6 (1.2) 54 2 (1.3) 
12 34 Not wanting to have depression listed in health records 56 2.2 (1.3) 57 1.8 (1.1) 46 2.4 (1.5) 45 2.6 (1.3) 
7 41 Wanting to please the doctor (to be a good patient) 59 1.8 (1.2) 58 1.6 (1.1) 58 1.9 (1.1) 55 2 (1.2) 
11 23 My religion 57 1.8 (1.2) 59 1.1 (0.4) 57 2 (1.4)* 48 2.4 (1.3)** 
*p<.05 
**p<.01 
***people with depression ranked the statement as significantly more important than family and friends at p<.05, and more important than healthcare workers at p<.01 
****healthcare workers ranked the statement as significantly more important than people with depression at p<.05, and more important than family and friends at p<.01
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8.3 Conclusion 
The three stakeholder groups differed significantly in their views about how people 
with depression make treatment choices. Whilst people with depression 
emphasised the importance of understanding their own situation, feeling ready to 
seek help and deal with emotions, the other two groups thought that the factors 
external to the person were more influential than their insight or emotions. 
Healthcare workers ranked the insight and emotions factors as significantly less 
important than people with depression did, and focused on the role of views about 
depression held by people’s family and within their social circles. Family and friends, 
on the other hand, appeared to be mostly concerned about a need to tell people 
what is wrong (to give a diagnosis), and to provide suggestions how to treat the 
illness. The two latter groups focused on the influence of stigma and expert advice 
on people’s treatment decisions. Patients’ inner understanding of their depression, 
and their emotions, are recognised as important by themselves, but not by the 
family or professionals. This observation was made, despite the professionals and 
patients assigning high importance rankings to two insight-related statements, 
namely recognising I have a problem I need help with, and being ready to accept 
treatment. Overall, the two groups’ views about the role of several factors differed 
significantly.  
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 Chapter 9 Types of stakeholder groups 
 
9.1 Clustering of participants  
The dimension scores for each stakeholder group separately were used in k-means 
cluster analysis to compute several cluster solutions. 
 
9.2 People with depression 
9.2.1 Types of people with depression 
Table 21 shows the sums of squared distances for 10 different cluster solutions for 
people with depression. These values are plotted on an elbow graph in Figure 13. 
The most appropriate cluster solution is marked by a point located at the bottom of 
a steady ‘jump’ of the line of best fit. Such point is typically followed by another 
point at a very similar value, i.e. shown as a flat line and indicating a non-significant 
improvement in the values. Such point on the elbow graph in Figure 13 represents a 
solution with 5 clusters, i.e. 5 types of patients.  
 
Table 21: Sums of squared distances for clusters of people with depression 
N of clusters Sum of square 
distances 
Difference between the Sum of 
squared distances 
2 3.46  
3 2.67 0.79 
4 2.08 0.60 
5 1.74 0.34 
6 1.65 0.09 
7 1.18 0.47 
8 1.07 0.11 
9 0.94 0.12 
10 0.79 0.15 
11 0.72 0.07 
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Figure 13: An elbow plot of sums of squared distances for different numbers of 
clusters of people with depression 
 
 
9.2.2 Types of patients described 
9.2.2.1 Demographic characteristics 
Table 22 shows the demographic characteristics of the 5 types of people with 
depression. Two of the types contain 7 participants, one has 2 patients, one 
includes 4 people and one has 8 participants. The five types did not differ in most of 
the demographic characteristics, except for gender. Three out of four people in 
Type 5 were males, whilst two other types only included between 0-43% of males. 
Average age among the types ranged between 36-59, all people described 
themselves being of the White ethnic group and approximately half of the patients 
were married or co-habiting. Just over a half of the patients in most types said they 
had a University degree or higher education. Approximately half of the people were 
employed and one in five was retired.  
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Table 22: Demographic characteristics of the 5 patient types 
 Type 1 
(n=7) 
Type 2 
(n=4) 
Type 3 
(n=2) 
Type 4 
(n=7) 
Type 5  
(n=8) 
PWD total 
(n=28) 
 N (%), unless *, then Mean (SD) 
Female 6 (86) 4 (100) 2 (100) 4 (57) 2 (25) 18 (64) 
Age in years* 46.3 (18.4) 35.8 (18.2) 59 (24) 44.3 (13) 48.8 (15.9) 46 (16; 18-79) 
White British or White Irish 7 (100) 3 (75) 2 (100) 7 (100) 8 (100) 27 (96) 
Highest achieved qualification       
Secondary education 3 (43) 2 (50) 1 (50) 3 (43) 3 (38) 12 (43) 
University Degree or higher 4 (57) 2 (50) 1 (50) 4 (57) 5 (63) 16 (57) 
Marital status       
Single 2 (29) 2 (50) 1 (50) 3 (43) 3 (38) 11 (39) 
Married/co-habiting 4 (57) 1 (25) 1 (50) 4 (57) 4 (50) 14 (50) 
Divorced/separated 1 (14) 1 (25) 0 0 1 (13) 3 (11) 
Employment status       
Employed  2 (29) 2 (50) 1 (50) 6 (86) 4 (50) 15 (54) 
Unemployed 1 (14) 0 0 1 (14) 1 (13) 3 (11) 
Student 1 (14) 2 (50) 0 0 1 (14) 4 (14) 
Retired 3 (43) 0 1 (50) 0 2 (25) 6 (21) 
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9.2.2.2 Clinical characteristics 
Participants in the 5 types reported having experienced an average of 3-9 
depressive episodes, and had suffered from their symptoms for 13-35 years on 
average.  
 
Table 23 shows treatment patients said they had been prescribed or recommended. 
Based on self-reports, the most commonly prescribed treatment was a combination 
of antidepressant medication and psychological therapy (50-57% of types 1, 2 and 
4). Patients in type 3 (n=2) did not report that they had been prescribed any 
treatment, since they either did not seek medical help or were recommended other 
therapies (such as mindfulness). Seventy-five percent of type 5 patients said they 
had only been prescribed medication (compared to 30-50% of other types), and 
25% were given a combination of antidepressants and psychological therapy.  
 
Table 23: Clinical characteristics of the 5 patient types: treatment prescribed 
 Type 1 
(n=7) 
Type 2 
(n=4) 
Type 3 
(n=2) 
Type 4 
(n=7) 
Type 5 
(n=8) 
PWD total  
(n=28) 
 N (%) 
Antidepressant 
medication alone 
2 (29) 2 (50) 0 2 (29) 6 (75) 12 (43) 
Psychological 
therapy alone 
1 (14) 0 0 1 (14) 0 2 (7) 
Combination of 
medication and 
psychological 
treatment 
4 (57) 2 (50) 0 4 (57) 2 (25) 12 (43) 
Other 0 0 2 (100)1 0 0 2 (7)1 
Total 7 (100) 4 (100) 2 (100) 7 (100) 8 (100) 28 (100) 
1 One person did not seek medical help and was therefore not prescribed any treatment, and one 
person was recommended mindfulness-based therapy   
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Table 24 shows that 25-50% of patients in most types reported taking the treatment 
they had been prescribed. Between 25-38% of patients in most types decided to 
take only a proportion of their prescribed treatment options, or no treatment at all. 
This was true for almost 3 out of 4 people in the type 4. Approximately half of the 
patients in types 1 and 2 initiated a therapy to complement or replace one of their 
prescribed treatment options (for example, signed up for private counselling in 
addition to taking medication). No participants in types 3 or 4, and 1 person in type 
5 reported taking anything other than prescribed treatment.  
 
Table 24: Clinical characteristics of the 5 subgroups of patients: reported 
adherence to prescribed treatment options 
 Type of 
treatment 
reported to 
have taken: 
Type 1 
(n=7) 
Type 2 
(n=4) 
Type 3 
(n=2) 
Type 4 
(n=7) 
Type 5 
(n=8) 
PWD total 
(n=28) 
  N (%)   
 As prescribed  2 (29) 1 (25) 1 (50) 2 (29) 4 (50) 10 (36) 
 Discontinued 
one or more of 
the prescribed 
treatment 
options  
2 (29) 1 (25) 0 5 (71) 3 (38) 11 (39) 
 One or more 
self-initiated 
treatment 
options were 
taken in 
addition, or 
instead of a 
prescribed 
treatment 
option1 
3 (43) 2 (50) 0 0 1 (13) 4 (21) 
 Total 7 (100) 4 (100) 2 (100)3 7 (100) 8 (100) 28 (100)3 
1 Self-initiated treatment options participants reported to have been taking included privately 
accessed psychological therapy, as well as self-help books, emotional regulation therapy, 
mindfulness-based therapy, and alternative treatments, such as reflexology, blu-light box, for 
example, when prescribed medication and CBT course, but reported taking medication and having 
private counselling, or when prescribed medication but reported having reflexology instead. 
3 Data for one person was not provided 
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9.2.3 Patient types: importance rankings of 12 factors 
Table 25 (key to table on a separate page) shows the importance rankings of the 12 
factors for each of the five patient types. Their average scores were compared using 
a one-way ANOVA and Welch’s test where appropriate, followed by a Tukey’s and 
Tamhane’s Post Hoc tests (respectively). I identified significant differences in the 
subgroups’ views about the following 5 factors, i.e. Making an informed choice, 
Depressive symptoms, Health professionals, Wanting to share experiences and My 
social context. The views about the remaining 7 factors were similar across the five 
patient types.  
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Table 25: Patient subgroups' importance rankings of the 12 factors that affect treatment choices 
 Type 1: Needing experts 
(n=7) 
Type 2: Irrational emotional 
(n=4) 
Type 3: Stigma driven 
(n=2) 
Type 4: Not trusting experts 
(n=7) 
Type 5: Externally driven 
(n=8) 
Cluster   Rank   Mean (SD; 95% CI) Rank   Mean (SD; 95% CI) Rank     Mean (SD; 95% CI) Rank   Mean (SD; 95% CI) Rank    Mean (SD; 95% CI) 
(1) Personal insight 2 3.6 (0.8; 2.9-4.4) 3 3.7 (0.7; 2.5-4.8) 2 4.2 (0.5; -0.1-8.4) 2 4.3 (0.2; 4.1-4.5) 1 4.2 (0.6; 3.8-4.7) 
(2) Emotional states 1 3.9 (1.0; 2.9-4.8) 2 3.9 (0.8; 2.7-5.1) 4 3.8 (1.8; -12.1-19.6) 1 4.3 (0.5; 3.8-4.7) 2 4.0 (0.9; 3.3-4.7) 
(3) Experiences with 
depression 
7 2.9 (1.1; 1.9-3.8) 6 3.2 (0.7; 2.1-4.3) 3 3.9 (0.2; 2.3-5.5) 3 3.7 (0.7; 3.0-4.3) 3 4.0 (0.4; 3.7-4.4) 
(4) Making an 
informed choice 
6 3.1 (1.1; 2.6-3.5) 8 2.8 (0.7; 2-3.6) 5 3.7 (0.2; 1.2-6.2) 4 3.7 (0.7; 3.2-4.1)15 6 2.8 (0.4; 2.4-3.2)14 
(5) Depressive 
symptoms 
4 3.4 (0.3; 3.2-3.6)45 1 4.2 (0.3; 3.7-4.7)34,5 11 1.8 (0.9; -6.2-9.7) 6 3.3 (0.5; 2.9-3.7)32 7 2.7 (0.3; 2.4-2.9)41,2 
(6) Needing the 
doctor’s opinion 
3 3.4 (1.3; 2.2-4.5) 4 3.6 (1.2; 1.7-5.5) 6 3.5 (0.7; -2.9-9.9) 8 2.5 (0.8; 1.8-3.2) 5 3.0 (1.0; 2.2-3.8) 
(7) Healthcare 
professionals 
5 3.3 (0.3; 3-3.6)22,4 9 2.4 (0.6; 1.5-3.2)21,5 10 2.4 (0.7; -3.4-8.2) 10 2.1 (0.3; 1.9-2.4)21,5 4 3.3 (0.5; 2.9-3.6)22,4 
(8) Seeking effortless 
treatment 
9 2.7 (0.6; 2.2-3.2) 5 3.4 (0.7; 2.3-4.6) 9 2.8 (0.2; 0.7-5.0) 7 2.6 (0.6; 2.1-3.1) 9 2.4 (0.7; 1.8-3.0) 
(9) Sharing 
experiences of 
depression 
10 2.0 (0.7; 1.4-2.6)14 10 2.1 (0.9; 0.8-3.5) 8 2.8 (0.4; -0.4-5.9) 5 3.6 (1.1; 2.7-4.6)11 8 2.5 (0.9; 1.7-3.3) 
(10) External views  8 2.8 (0.8; 2.1-3.5) 7 2.8 (1.3; 0.6-4.9)  3.0* 9 2.4 (0.7; 1.7-3.0) 11 2.1 (0.6; 1.6-2.7) 
(11) My social 
context 
11 1.7 (0.5; 1.2-2.1)13,5 11 1.9 (0.4; 1.2-2.5)13 7 3.1 (0.4; -0.7-6.9)11,2,4 12 1.7 (0.4; 1.4-2.0)13,5 10 2.4 (0.4; 2.0-2.7)11,4 
(12) Depression in 
health records 
12 1.4 (0.5; 0.9-1.9) 12 1.0 (0; 1-1) 1 4.5 (0.7; -1.9-10.9) 11 1.7 (0.8; 1-2.4.0) 12 2.0 (1.2; 1.0-3.0) 
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*Based on response of one participant due to missing data for the other participant.  
1p<.05, based on Tukey’s Post Hoc test 
2p<.01, based on Tukey’s Post Hoc test 
3p<.05, based on Tamhane’s Post Hoc test 
4p<.01, based on Tamhane’s Post Hoc test 
Note: number(s) after superscripted number in the table indicate the patient type(s) which had ranked the particular cluster as significantly different. 
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9.2.4 Types of patients compared 
9.2.4.1 Type 1: Depressed and relying on experts 
Type 1 patients ranked four factors differently to some of the other types. Together 
with type 5, they found health professionals as significantly more influential than 
types 2 and 4 did. Type 1 patients thought their depressive symptoms affected their 
choices more than type 5 people did, and found sharing experiences with other 
people to be less important than type 4. Patients in type 1 ranked the impact of 
their social environment as smaller than types 3 and 5.   
 
Based on the differences in the perceived importance of the factors, type 1 patients 
are described as influenced by depressive symptoms and an increased need for the 
input of health professionals. They are not affected by their social context, and do 
not find exchanging knowledge and experiences with others to be highly influential 
of their decisions. The type was therefore described as Depressed and relying on 
experts.  
 
9.2.4.2 Type 2: Emotion driven 
Type 2 patients emphasised the role of the depressive symptoms and emotions on 
their treatment decisions, and ranked the factor significantly more influential than 
types 4 and 5. Unlike type 1, type 2 patients did not consider health professionals to 
have a large impact on their choices, and found them as significantly less important 
than types 1 and 5. They also differed from type 3 by ranking their social context as 
less influential. 
 
Type 2 patients are distinctive in their focus on the effect of depressive symptoms 
and emotions over the external factors, such as health professionals or their social 
environment and background. They are therefore described as Emotion driven. 
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9.2.4.3 Type 3: Fearing stigma 
Type 3 patients found their social context to be significantly more influential than 
types 1, 2 and 4 did. In addition, this type of participants was the only type who 
viewed any of the external factors as more influential than the internal factors, i.e. 
not wanting to have depression listed in health records was the most important of 
all factors for this type. The views of the type 3 patients also emphasised the 
importance of having personal insight and benefiting from their personal 
experiences over the role of depressive emotions and worries. Based on their 
distinctive focus on social and cultural background, and a wish to avoid having an 
‘official’ or formal diagnosis of depression, the type is labelled as Fearing stigma. 
 
9.2.4.4 Type 4: Independent from experts 
Type 4 patients ranked their depressive symptoms as moderately important, but 
significantly less influential than type 2. Type 4 found it significantly more important 
to make informed decisions than type 5 did, and significantly more important to 
share experiences than type 1 did. Similar to type 1, type 4 patients did not find 
their social context to have a high impact on their choices, and ranked it less 
important than types 3 and 5.  
 
Overall, type 4 can be characterised as wanting to make informed decisions based 
on the effects of their depressive symptoms and the anecdotal evidence coming 
from people with similar experiences. Based on their cluster rankings, type 4 
patients did not find the health professionals to be very influential. Consequently, I 
labelled the type as ‘Independent from experts’ in order to reflect their reliance on 
themselves in treatment decision-making.   
 
9.2.4.5 Type 5: Externally driven 
Type 5 patients ranked their depressive symptoms as significantly less influential 
than types 1 and 2, and found it less important in order to make informed 
treatment decisions than type 4. These patients reported that health professionals 
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influenced their choices significantly more than types 2 and 4. They also attributed 
more importance to their social context and background than types 1 and 4 did.   
 
In contrast to other types of patients, type 5 emphasised the role of professionals 
and their own social and cultural backgrounds. Although the most important factors 
for this type were personal insight and emotional states (ranked similarly to other 
types), these patients did not find their symptoms to be highly influential and did 
not find it highly important to make informed decisions. Reflecting their relative 
emphasis of professionals and the cultural aspects and lower rankings of making 
informed choices, I labelled this type of patients as Externally driven.  
 
9.3 Types of patients based on self-report of treatment taken 
In order to explore the differences between depressed people further, I performed 
a second subgroup analysis based on patients’ self-reported adherence to their 
prescribed treatment. Specifically, I aimed to compare people who reported taking 
treatment as prescribed, those saying that they had discontinued one or more of 
prescribed treatment options and those who took one or more other options in 
addition to their prescribed treatment.  
 
9.3.1 Three types of patients described 
Table 26 shows the demographic characteristics of the three types of depressed 
people. Type 1 patients (n=10) reported taking treatment as prescribed, type 2 
patients (n=11) said that they had discontinued one or more of prescribed 
treatment options, and type 3 patients (n=6) said that they had taken one or more 
other options in addition to their prescribed treatment. The three types were 
similar in most of the characteristics. The mean age of all groups was between 42 
and 48 years and the majority of all types described themselves being of the White 
ethnic group. The groups differed in the highest achieved education. While most 
patients in type 1 and 2 had a University degree, 83% of type 3 patients reported 
having secondary education as the highest.  
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Table 26: Demographic characteristics of the three patient types 
 Type 1 (as 
prescribed) 
(n=10) 
Type 2 
(discontinue
d one or 
more) 
(n=11) 
Type 3 (added 
one or more) 
(n=6) 
PWD total 
(n=28) 
 N (%), unless *, then Mean (SD) 
Female 5 (50) 7 (64) 5 (84) 18 (64) 
Age in years* 48 (17.5) 42 (13.4) 44 (17.2) 46 (16; 18-79) 
White British or White 
Irish 
10 (100) 10 (91) 6 (100) 27 (96) 
Highest achieved 
qualification 
    
Secondary education 2 (20) 4 (36) 5 (83) 12 (43) 
University Degree or 
higher 
8 (80) 7 (64) 1 (17) 16 (57) 
Marital status     
Single 3 (30) 4 (36) 3 (50) 11 (39) 
Married/co-habiting 5 (50) 7 (64) 2 (33) 14 (50) 
Divorced/separated 2 (20) 0 (0) 1 (17) 3 (11) 
Employment status     
Employed  6 (60) 6 (55) 3 (50) 15 (54) 
Unemployed 0 (0) 3 (27) 0 (0) 3 (11) 
Student 1 (10) 2 (18) 1 (17) 4 (14) 
Retired 3 (30) 0 (0) 2 (33) 6 (21) 
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9.3.2 Three types of patients: comparison of the cluster 
importance rankings 
Table 27 shows the results of a one-way ANOVA and a Tukey’s post-hoc (Tamhane’s 
in cluster 10) test comparing the three types of patients in how they ranked the 
importance of the 12 clusters. There were no significant differences between the 
three groups’ rankings. 
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Table 27: Importance rankings of 12 clusters for patients based on reported adherence 
Cluster Type 1: As prescribed (n=10) 
Type 2: Discontinued one or more of 
the prescribed treatment options 
(n=11) 
Type 3: One or more self-initiated 
treatment taken in addition or 
instead of prescribed treatment1 
(n=6)  
Post-hoc 
test3 
Label   Rank Mean (SD; 95% CI) Rank  Mean (SD; 95% CI) Rank Mean (SD; 95% CI) P value 
(1) Personal insight 1 4.1 (0.6; 3.7-4.5) 1 4.1 (0.7; 3.6-4.6) 2 3.7 (0.7; 3.0-4.4) NS2 
(2) Emotional states 2 3.9 (0.9; 3.2-4.5) 2 4.1 (0.8; 3.6-4.6) 1 3.9 (0.9; 3.0-4.9) NS 
(3) Experiences with depression 3 3.5 (0.7; 3.0-4.1) 3 3.7 (1.0; 3.0-4.3) 6 3.1 (0.8; 2.2-4.0) NS 
(4) Making an informed choice 4 3.2 (0.5; 2.8-3.5) 5 3.2 (0.8; 2.7-3.7) 7 3.0 (0.3; 2.6-3.3) NS 
(5) Depressive symptoms 6 3.0 (0.7; 2.5-3.5) 4 3.3 (0.4; 3.0-3.6) 3 3.5 (0.6; 2.8-4.2) NS 
(6) Needing the doctor’s opinion 5 3.2 (1.2; 2.1-3.9) 6/7 2.9 (1.0; 2.3-3.6) 4 3.4 (1.0; 2.4-4.4) NS 
(7) Healthcare professionals 8 2.8 (0.7; 2.3-3.3) 8 2.6 (0.5; 2.2-2.9) 5 3.2 (0.9; 2.3-4.1) NS 
(8) Seeking effortless treatment 7 2.9 (0.6; 2.4-3.3) 9 2.6 (0.7; 2.2-3.1) 10 2.5 (0.7; 1.7-3.3) NS 
(9) Sharing experiences of 
depression with others 
10 2.3 (1.3; 1.3-3.3) 6/7 2.9 (1.0; 2.3-3.6) 9 2.6 (0.5; 2.1-3.1) NS 
(10) External views about 
depression 
9 2.6 (0.4; 2.3-2.9) 10 2.3 (0.8; 1.8-2.8) 8 2.8 (1.2; 1.5-4.0) NS4 
(11) My social context 11 2.1 (0.5; 1.7-2.5) 11 1.9 (0.6; 1.5-2.3) 11 1.7 (0.4; 1.3-2.1) NS 
(12) Depression in health records 12 1.8 (1.2; 0.9-2.7) 12 1.8 (1.1; 1.1-2.5) 12 1.5 (0.8; 0.6-2.4) NS 
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1 Self-initiated treatment options participants reported to have been taking included privately accessed psychological therapy, as well as self-help books, emotional regulation 
therapy, mindfulness-based therapy, and alternative treatments, such as reflexology, blu-light box, for example, when prescribed medication and CBT course, but reported taking 
medication and having private counselling, or when prescribed medication but reported having reflexology instead. 
2 Not significant 
3 Tukey’s post-hoc test unless 4 
4 Tamhane’s post-hoc test 
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9.4 Family and friends 
Table 28 shows the Sums of squared distances for 10 cluster solutions for family and 
friends. These values are plotted on an elbow graph in Figure 14. A point, after 
which the following point does not provide a significant improvement in the 
entropy value, represents an arrangement with 5 types of participants, i.e. types of 
family and friends. Two of these types include one participant each, two contain 
two participants each, and one types includes 8 members of the family and friend 
stakeholder group. Due to the small numbers of participants and a relatively large 
number of types in this stakeholder group, it is not possible to compare all groups’ 
characteristics and importance rankings of the 12 factors.   
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Table 28: Sums of squared distances for clusters of family and friends 
N of clusters Sum of square 
distances 
Difference between the Sum of 
squared distances 
2 1.61   
3 1.29 0.32 
4 1.03 0.26 
5 0.70 0.33 
6 0.60 0.10 
7 0.41 0.18 
8 0.32 0.10 
9 0.24 0.08 
10 0.16 0.09 
11 0.08 0.08 
 
 
Figure 14: An elbow plot of sums of squared distances for different clustering 
options for family and friends 
 
 
 
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
0 2 4 6 8 10 12
Su
m
 o
f s
qu
ar
ed
 d
is
ta
nc
es
 
Number of clusters 
Page 213 of 386 
9.4.1 Description of the largest type of family and friends 
9.4.1.1 Demographic characteristics 
Table 29 shows the demographic characteristics of the largest out of the 5 types of 
family and friends, which included 8 participants. The mean age of this sub-group 
was 62.4 years, ranging between 46 and 76 years. Most of these participants were 
women and all of them reported being of White British or White Irish ethnic group. 
Half of these participants reported that they had achieved a University Degree or 
higher level of education, 50% were married and 50% were employed. The table 
shows that this sub-group of family and friends was similar to the whole group of 
family and friends in terms of their demographic characteristics. 
 
 
Table 29: Largest type of family and friends: demographic characteristics 
 Type 1  
(n=8) 
Whole group  
(n=14) 
 N (%) unless *, then mean (SD; min-max) 
Female 5 (63%) 10 (71%) 
Age in years* 62.4 (11.4; 46-76) 60 (13; 41-80) 
White British or White Irish 8 (100%) 14 (100%) 
Highest achieved qualification   
Secondary education 4 (50%) 6 (42%) 
University Degree or higher 4 (50%) 7 (50%) 
Marital status   
Single 1 (13%) 2 (14%) 
Married/co-habiting 4 (50%) 9 (64%) 
Widowed 3 (38%) 3 (21%) 
Employment status   
Employed  4 (50%) 8 (57%) 
Retired 4 (50%) 6 (43%) 
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9.4.1.2 Perceived importance of the 12 clusters 
Table 30 shows the perceived importance rankings of the 12 factors, as assigned by 
the 8 members of the largest type of family and friends. This sub-group of 
participants found the experts’ advice to be the most important factor, followed by 
the patients’ need to make informed treatment choices, and their depressive 
symptoms. The least influential were thought to be the factors related to external 
views about depression, people’s social context and their wish to share experiences 
with depression with other people. The relative importance rankings of the sub-
group were similar to those of the whole group, but the individual ranks differed in 
several factors. For example, the sub-group thought the depressive symptoms were 
the third most important, whilst the whole group of family and friends put it to a 
sixth place. Conversely, the sub-group ranked personal insight as the 5th most 
important factor, whilst the group as a whole thought it was the second most 
influential factor.  
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Table 30: Largest type of family and friends: relative importance of the 12 factors 
 Type 1 (n=8) Whole group (n=14) 
 Rank    Mean (SD; 95% CI) Rank Mean (SD; 95% CI) 
(6) Needing the doctor’s 
opinion 
1 4.1 (.7; 3.5-4.7) 1 4.0 (0.8; 3.5-4.4) 
(4) Making an informed 
choice 
2 3.7 (.4; 3.4-3.9) 3 3.4 (0.7; 3.1-3.8) 
(5) Depressive symptoms 3 3.4 (.2; 3.2-3.6) 6 3.1 (0.6; 2.8-3.4) 
(3) Experiences with 
depression 
4 3.3 (.5; 2.9-3.7) 4 3.3 (0.6; 3.0-3.7) 
(1) Personal insight 5 3.1 (.6; 2.6-3.6)  2 3.5 (0.8; 3.0-3.9) 
(7) Healthcare professionals 6 3.0 (.4; 2.7-3.6) 7 2.9 (0.5; 2.6-3.2) 
(2) Emotional states 7 3.0 (.9; 2.3-3.7) 5 3.2 (1.1; 2.6-3.8) 
(8) Seeking effortless 
treatment 
8 2.6 (.5; 2.2-3.0) 8 2.6 (0.6; 2.3-3.0) 
(12) Depression in health 
records 
9 2.6 (1.5; 1.4-3.9) 10 2.4 (1.5; 1.5-3.2) 
(10) External views about 
depression 
10 2.3 (.8; 1.6-3.0) 9 2.6 (1.1; 2.0-3.2) 
(11) My social context 11 1.8 (.9; 1.0-2.5) 11 2.3 (1.3; 1.6-3.1) 
(9) Sharing experiences of 
depression with others 
12 1.7 (.6; 1.2-2.2) 12 2.1 (0.9; 1.6-2.7) 
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9.5 Healthcare workers 
Table 31 shows Sums of squared distances for 10 clustering solutions of healthcare 
workers. In Figure 15 the values are plotted on an elbow graph. Based on the 
differences in these values, the most appropriate number of types of healthcare 
workers is 8, since the corresponding point on the map is followed by a 
considerably worse cluster solution (i.e. the value for 9 clusters is larger than that 
for 8 clusters).  
 
Out of the eight types of healthcare workers, three contain 2 participants, four have 
three participants each, and one has 4 people. Comparison of professional types 
with too few participants does not yield meaningful and generalisable results. I 
therefore decided to abandon further analyses of the 8 types of healthcare workers.  
 
Table 31: Sums of squared distances for clusters of healthcare workers 
N of clusters Sum of square 
distances 
Difference between the Sum of 
squared distances 
2 3.01   
3 2.49 0.52 
4 1.97 0.52 
5 1.66 0.31 
6 1.42 0.25 
7 1.19 0.23 
8 1.02 0.17 
9 1.09 -0.07 
10 0.74 0.35 
11 0.69 0.05 
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Figure 15: An elbow plot of sums of squared distances for different clustering 
options for healthcare workers 
  
9.6 Conclusion 
In this chapter, I presented a typology of stakeholder groups, attempting to explore 
the possibility of describing patients, family and friends and healthcare workers 
according to their views about treatment decision-making. The results suggested a 
potential for typology especially in the group of people with depression but the 
sample size in all three groups are not sufficient for meaningful conclusions. 
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 Chapter 10 Discussion 
 
10.1 Summary of aims and findings 
In this study, I aimed to understand how people with depression make treatment 
choices. To explore this issue, I conducted a concept mapping study. Firstly, I asked 
participants to brainstorm about the factors they thought influence depressed 
patients’ decisions. Participants were then asked to rank the relative importance of 
each factor and to put the factors that seemed to be related together. From this 
data I generated a final list of 12 factors and calculated their relative importance 
based on the individual items’ rankings. I found that participants across categories 
thought that decisions made by people with depression are largely influenced by 
doctors’ recommendations, but mostly based on their internal understanding and 
emotional states. The different stakeholder groups did not agree about the 
perceived relative importance of stigma, personal insight, emotional states and 
advice from doctors.   
 
10.2 Views of the entire group  
Overall, the most important factors were thought to be insight, emotional states 
and doctors’ advice, whilst the least influential was stigma. This observation is 
consistent with public and patient surveys demonstrating that peoples’ recognition 
of their mental illness is related to a positive attitude to seeking medical help 
(Meltzer et al., 2003, Verhaak et al., 2009). The group’s views are not consistent 
with research suggesting that patients consider healthcare professionals and 
relationships with them among the most important aspects of healthcare for 
depression (Cooper et al., 2000, Deledda et al., 2013). Moreover, the limited 
perceived influence of stigma and side effects on patients’ choices contradict 
commonly held views about the role of these factors (Thornicroft, 2006). 
Participants’ emphasis on the role of insight and emotions suggests that they 
viewed patients as in need of developing a personal interpretation of depression in 
order to make treatment decisions. On the other hand, the high importance 
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attributed to doctors’ advice appears to contradict their perception about the role 
of insight. This in turn suggests that participants viewed patients as in need of 
seeking health professionals’ recommendations, as opposed to seeking active 
engagement in treatment choice. Alternatively, it could suggest that patients are 
thought to be in an urgent need of physician’s direct instructions and 
recommendations about diagnosis and treatment and that their personal insight is 
viewed mainly as a first step to help-seeking.  
 
Participants’ high rankings of doctors’ advice contrast with research showing that 
patients prefer an active engagement in treatment choices (Patel and Bakken, 
2010). In addition, Stacey et al (2008) suggested that fewer than one in ten patients 
wanted to allow the professional to make the treatment decisions. A wish for active 
involvement in treatment choices does not automatically imply a lack of 
appreciation of professionals’ recommendations. On the contrary, this advice can 
be helpful for patients’ involvement in shared decision-making. After gaining insight 
about their own depressive symptoms, patients might wish to receive confirmation 
that their symptoms are treatable. In addition, due to the emotional burden of 
depression, patients might also want to hand over the weight of treatment 
decision-making to the doctor and follow their advice. I suggest that participants 
across groups viewed patients as trusting the professionals’ recommendations, 
which has been shown as important for people with mental illness (Verhaak et al., 
2009). 
 
10.3 Differences between the stakeholder groups 
The observed disparity between the views of the three stakeholder groups suggests 
that patients’ decision-making about treatment for depression is not clearly 
understood by their health professionals and close family and friends. 
Consequently, people who are emotionally vulnerable might not be adequately 
supported in the decisions they make to improve their condition. Their different 
perspectives also retrospectively support our decision to involve all three 
stakeholder groups in the study. By recognising their misunderstanding, health 
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professionals might be better able to develop understanding of patients’ decision-
making needs and facilitate a person-centred approach. 
 
Identification of group differences is consistent with evidence that patients and 
professionals disagree about various aspects of health care, including adherence in 
schizophrenia, selection of antidepressant medication and general preferences for 
treatment of physical illnesses (Kikkert et al., 2006, Gardner et al., 2007). The views 
about the factors affecting patients’ treatment choices in depression have not yet 
been studied from the perspectives of patients, professionals and close family and 
friends, although the latter is often considered as an important part of patients’ 
support system. My findings therefore provide a novel characterisation of decisions 
about treatment for depression. 
 
10.3.1 Stigma 
External views about depression were considered to be the most important factor 
by healthcare workers, but not by the other groups. Together with patients’ social 
context, external views were ranked as significantly more influential by the 
healthcare workers than by people with depression. I categorised these factors as 
stigma because some of the main concepts they contain correspond with the 
dimensions described in stigma.  
 
Stigma has been described as negative attitudes, emotions or behaviours towards 
people who belong to a certain subgroup, for example, having a specific illness or 
displaying certain behaviour, based on that characteristic (Link and Phelan, 2001). 
Corrigan and Watson (2002) described two main ways in which stigma affects 
people. The commonly recognised concept is public stigma, i.e. attitudes and 
behaviours of other people. Internalised negative attitudes by the stigmatised 
person were referred to as self-stigma, or personal stigma, and the two types 
influence people in different ways (Corrigan et al., 2005).  
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The four factors that were conceptually related to stigma referred to its effect on 
the public level, including the views about depression held in society and beliefs of 
family and friends about depression among others. Participants did not explore the 
concept of personal stigma, although some of the self-stigmatising attitudes and 
beliefs resemble the factor insight. For example, thinking that no-one can help and 
that people should be able to deal with the problems alone (Coppens et al., 2013), 
relates to the more positively-charged attitudes such as recognition of the need for 
help and readiness to accept treatment, that is to say insight. Participants in this 
study, however, viewed insight and stigma as conceptually unrelated factors, which 
were positioned in different parts of the concept map. 
 
10.3.1.1 Stigma: external views about depression 
Healthcare workers’ views about the importance of stigma in patients’ treatment 
choices reflect commonly held perceptions about the strong impact of stigma on 
patients’ help-seeking and other decisions (Jorm and Reavley, 2013, Thornicroft, 
2006). Stigma towards and discrimination of people with mental illnesses is very 
common in society across different countries (Lasalvia et al., 2013) and negatively 
impacts on people’s self-esteem (Link and Phelan, 2001). There is, nevertheless, 
mixed evidence of the effect of perceived or anticipated public stigma on people’s 
treatment decisions.  
 
Professionals’ views are consistent with reports that readiness to seek treatment is 
negatively influenced by anticipated discrimination, although it was as important as 
patients’ attitudes and knowledge (Schomerus and Angermeyer, 2008). The effect 
of perceived stigma was shown to be mainly as a consequence of increasing 
patients’ personal stigma, which in turn impacted upon help-seeking (Vogel et al., 
2007). One study also suggested that stigma negatively influenced adherence (Sirey 
et al., 2001), which supports professionals’ views but contradicts those of patients. 
Personal stigma has been found to predict patients’ preference for dealing with 
depression alone (Griffiths et al., 2011) and to perceptions that professional 
treatment was unhelpful (Coppens et al., 2013). This does not correspond with the 
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views of healthcare workers observed in this study, which underscore the role of 
external views, i.e. perceived stigma.  
 
There isconflicting evidence about the impact of stigma. Health professionals’ views 
suggest that any stigma is highly influential, but their opinion is not consistent with 
the findings of previous studies. For example, Roeloffs et al. (2003) showed that 
perceiving stigma among close family had a negative impact on help-seeking and 
adherence, but patients’ anticipated stigma had little effect on the behaviour. 
Anticipated stigma and discrimination were also found to have limited effect on 
patients’ help-seeking intentions (Schomerus et al., 2009b). These studies, on the 
other hand, support the views of people with depression in this study. Patients’ low 
ranking of stigma is also consistent with the findings of a systematic review 
suggesting that treatment barriers related to stigma and embarrassment were less 
important than practical barriers (Prins et al., 2008). My observation suggests that 
people with depression do not consider the views and beliefs held by people in their 
social environment to be very influential of the treatment decisions they make.  
 
10.3.1.2 Stigma: Social context 
The views of professionals and patients also differed regarding the role of social 
context. Whilst both groups thought it was one of the least important factors, 
professionals ranked it significantly higher than patients ranked it. This observation 
is difficult to compare with previous research, since participants’ perspectives about 
their views about the role of their age, gender or culture have seldom been 
explored. Instead, researchers have used socio-demographic factors to detect 
differences between particular subgroups of the population. For example, gender 
and age appear to be related to different treatment preferences (Winter and 
Barber, 2013) and members of ethnic and cultural minorities are less likely to seek 
medical help (Prins et al., 2008). In addition, studies show that attitudes towards 
help-seeking for mental illnesses are related to gender, age and level of education 
(Coppens et al., 2013, Griffiths et al., 2011). Some characteristics, for example, 
younger age, were also found to predict adherence to treatment for mood 
disorders (Pompili et al., 2013). My findings regarding professionals’ views about 
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social context are therefore consistent with previous research about the effects of 
personal characteristics. Whilst all groups attributed relatively little importance to 
social context, healthcare workers appeared to think that some of patients’ 
decisions are due to this factor. Based on their exposure to patients from various 
backgrounds, I suggest that professionals might have greater awareness of the 
effects of different individual characteristics than patients or close family. 
Alternatively, their views might be an additional sign of healthcare workers’ over-
emphasis on the impact of stigma and external views. 
 
10.3.1.3 Stigma: overall 
Patients’ lower ranking of stigma despite evidence that it is common suggests that it 
might not affect people’s treatment choices directly and that other factors are more 
influential than stigma. Consequently, strategies intended to support involvement 
in decision-making by addressing stigma might not be effective. Currently, there is 
limited evidence about the impact of such interventions on patients’ attitudes or 
help-seeking behaviour (Gulliver et al., 2012). 
 
Understanding patients is an important part of professionals’ practice and is seen as 
underpinning professional practice (Joseph-Williams et al., 2013, Gray, 2014). 
Whilst healthcare workers often think that they understand patients, my findings 
challenge this view. By overestimating the importance of stigma professionals 
demonstrate reliance on assumptions about patients’ decision-making, rather than 
on their clinical observations. This supports previous research about professionals’ 
willingness to involve patients in shared decision-making as a result of a belief that 
many would not appreciate being actively engaged in their treatment choices 
(Legare et al., 2008). Based on my observation, I suggest that health professionals 
and researchers should regard patients as individuals, rather than focus on stigma 
which is currently viewed as a priority (Jorm and Reavley, 2013, Thornicroft, 2006). 
Instead, I suggest that professionals should develop a better understanding of the 
patients’ views and explore what stigma means to individual patients. 
 
Page 224 of 386 
10.3.2 Insight 
People with depression considered their personal insight about experiencing 
symptoms to be the most important factor affecting their treatment decisions. 
Although healthcare workers and family and friends ranked the factor as the third 
and second most important respectively, there were significant differences 
between the views of patients and the other two groups. To my knowledge, the role 
of insight in patients’ treatment decisions has not been explored from the 
perspectives of patients, family and friends and healthcare workers before. Insight 
has mostly been studied in relation to severe mental illness and there has been 
limited focus on the impact of insight on treatment choices made by people with 
depression.  
 
Insight is a complex concept that describes the patients’ ability to reflect on their 
own experiences and to recognise some of these as symptoms of an illness. It has 
been described as a continuous construct consisting of several overlapping 
dimensions: awareness of having a mental illness, ability to recognise own 
symptoms, and recognition of a need for treatment (David, 1990). Two more 
aspects, awareness of social consequences of the illness and attribution of 
symptoms to the illness were added to the concept (Amador and David, 1998 ).  
 
I describe insight into depression based on ideas extracted from what participants 
said influences patients’ treatment decisions. The factor that was labelled as insight 
is consistent with the main dimensions of a person’s awareness of symptoms and a 
need for treatment, as described originally (David, 1990). In addition to these, the 
concept of insight used in this study also includes an ability to be pro-active in the 
treatment and a wish to understand the root of depression. Contrary to our 
observation, these aspects have not been considered as part of patients’ insight into 
illness, although research shows that people often try to explain their illness and 
have theories about what caused their depression (Fu and Parahoo, 2009, Hansson 
et al., 2010) and that these beliefs might influence treatment decisions and help-
seeking behaviour (Prins et al., 2008). My findings suggest that awareness of the 
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causes of low mood or depressive episodes might be an important aspect of 
patients’ insight into their mental illness. 
 
Lack of insight has typically been investigated in relation to schizophrenia-spectrum 
and bipolar disorders and has been shown to affect between 50 and 80% of patients 
(Crumlish et al., 2005, Varga et al., 2006). Improved insight into these disorders has 
been associated with better adherence and treatment outcomes (Kampman et al., 
2002, Depp et al., 2014), but also with an increase in depressive symptoms 
(Crumlish et al., 2005). Approximately 40% of people with unipolar depression have 
been shown to have impaired insight (Yen et al., 2005). 
 
Overall, there is a paucity of literature about the role of insight on the treatment 
decisions made by people with depression. Research shows that patients and 
professionals differ in how they perceive the severity of patients’ symptoms (Enns 
et al., 2000, Rane et al., 2010), although the effects on decision-making are unclear. 
Other authors have suggested that depressed people commonly experience 
avoidance and somatisation of symptoms, failure to determine a need for help and 
defensiveness (Farmer et al., 2012, Goldman et al., 1999, Meltzer et al., 2003). 
Failure to recognise the symptoms as sign of a depressive illness has been 
associated with delayed help-seeking (Farmer et al., 2012, Thompson et al., 2008). 
This evidence supports my findings that patients’ insight may strongly impact on 
their treatment choices. 
 
My observation disagrees with research suggesting that lack of insight is not an 
important issue for people with non-psychotic depression (Dell'Osso et al., 2002, 
Peralta and Cuesta, 1998). In addition, Lee et al (2010) found that insight did not 
predict adherence, although people with more severe depression had greater 
insight. This evidence indicates that the role of insight has not yet been fully 
understood and that its influence might be different in people with depression 
compared to schizophrenia. The differences in effect might be explained by 
variations in understanding of the concept between different illnesses. Whilst in 
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psychotic disorders lack of insight is viewed as a cognitive syndrome and symptom 
of the illness (Chakraborty and Basu, 2010), in affective disorders insight appears to 
be more related to psychological denial or avoidance of an unpleasant situation, i.e. 
illness. This interpretation is consistent with evidence that patients with depression 
feel a need for help with knowing, naming and explaining their symptoms (Epstein 
et al., 2010).  
 
Depressed people’s focus on the role of insight suggests that in order to engage in 
treatment decision-making, they first expect to be aware of the problem and feel 
ready to engage actively with their treatment. This finding supports the results of 
several surveys of the opinions of the public and people with mental illness, which 
all concluded that people’s recognition of their mental illness is crucial for having a 
positive attitude towards seeking medical help (Lauber et al., 2005, Meltzer et al., 
2003, Verhaak et al., 2009).  
 
Some authors recommend that psycho-education and improving public’s mental 
health literacy is required in order to address the general lack of recognition of 
mental problems (Riedel-Heller et al., 2005). My findings, on the other hand, 
demonstrate that patients’ insight into their depression and need for help are 
conceptually a separate factor from their knowledge about depression and 
treatment options. Having information was viewed as part of ‘making informed 
decisions’ and was considered only moderately important. This suggests that rather 
than general information, participants valued patients’ ability to recognise and 
accept their depressive symptoms and a need for treatment. The patients’ views are 
consistent with reports that in addition to receiving a diagnosis, people felt a need 
to link their own experiences with what their doctor described as depression 
(Wittink et al., 2008). I suggest that patients’ personal insight into depression is 
recognised as a central part of treatment decision-making. Helping patients to 
improve insight might therefore be empowering, and might facilitate their 
engagement in better informed treatment choices. 
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In contrast, depressed people’s views were not shared with the other two 
stakeholder groups, who appear to under-estimate the role of insight in affecting 
patients’ treatment choices. Whilst patients’ and professionals’ perceptions about 
insight in depression have not been directly compared, my observation is consistent 
with evidence that the two groups disagree about various aspects of health care 
(Kikkert et al., 2006, Lester et al., 2005). Alternatively, professionals might be aware 
of patients’ need for insight, but not necessarily believe it is important, especially if 
it directly challenges their own understanding of patients’ decision and treatment 
needs. Over-reliance on their training might then prevent them from having an 
empathetic understanding of people with depression. This is consistent with 
evidence that, despite training and improved skills in facilitating shared decision-
making, physicians still subjectively decide which patients might be suitable for the 
approach (Elwyn et al., 2012, Edwards et al., 2005). Consequently, training clinicians 
to understand their patients and facilitate gaining insight might not be effective.  
 
An alternative strategy to help patients develop recognition and insight is contact 
with peer support workers, i.e. people with experience with mental illness who do 
not have extensive professional training and could be more able to empathise with 
patients and understand their perspectives (Lloyd-Evans et al., 2014). Peer support 
workers can help reduce hospital admissions and engagement with the service 
(Repper and Carter, 2011) and positively impact on patients’ sense of hope, control, 
ability to make changes and self-awareness (Proudfoot et al., 2012, Jones et al., 
2013). Peer support workers might help people with depression improve insight to 
facilitate engagement in making informed treatment decisions. 
 
My observation suggests that the person and the internal resources are more 
important than external views when dealing with depression. I propose that 
professionals should not focus on stigma, but address people’s subjective views and 
understanding about their depression. My findings show that it is imperative that 
they should view patients as equal partners in the decision-making process, and 
take their views seriously, rather than wanting to change them. 
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10.3.3 Emotions and depressive symptoms  
Unlike insight, patients’ emotional states have rarely been studied in relation to 
their treatment decision-making. Cognitive research, on the other hand, shows that 
emotional states play a considerable role in judgement and decision-making 
(Blanchette and Richards, 2010). Whilst often viewed as a source of irrational 
decisions, emotions can positively influence decision-making due to their increase in 
reliance on heuristics and cognitive shortcuts in reaching judgements (Reyna, 2008). 
My observation supports this evidence, although the extent of the data does not 
allow the determination of the effect of specific emotions on decision-making. 
Differences I found between the stakeholder groups regarding the perceived 
importance of emotions suggest that patients might be relying on how they feel in a 
given situation to inform their healthcare choices, but professionals undermine the 
impact of emotions.  
 
10.3.3.1 Depressive symptoms 
Relative positions of emotions and depressive symptoms on the concept map 
suggest that the factors are distinct yet closely related. This is consistent with the 
definition of depression and its effect on mood (WHO, 2010, APA, 2013). By 
emphasising the role of emotions whilst ranking depressive symptoms as only 
moderately important, participants highlighted the effect of patients’ current mood 
over generally negative thinking styles associated with depression. I suggest that 
these concepts might have separate effects on patients’ treatment decisions. 
 
The groups’ perceptions about the role of patients’ depressive symptoms support 
previous research suggesting that the nature and severity of mental illness affect 
patients’ selection of professional (Mojtabai et al., 2002). My results are also in line 
with the suggestion that people with depression perceive more barriers to 
psychotherapy than healthy people (Mohr et al., 2006). Severity of symptoms has 
also been related to a perceived need for treatment (Beljouw et al., 2010, Farmer et 
al., 2012) and more perceived barriers to visiting a doctor (Bell et al., 2011). 
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10.3.3.2 Emotions 
Emotions have been described in terms of valence (type of emotions ranging from 
positive to negative) and arousal, i.e. intensity (Winkielman et al., 2007). Research 
shows that emotions influence people’s decisions and judgement and that the 
effects differ between emotions with the same valence. For example, sad mood but 
not anxiety has been linked to high-risk/high-reward behaviour (Raghunathan and 
Pham, 1999). Sad mood can also increase the systematic information processing 
and a more elaborate evaluation of the situation than positive mood (Blanchette 
and Richards, 2010). Patients’ views about the role of emotions are in line with the 
evidence that affective states impact on judgement and decision-making. My 
findings are consistent with the evidence that people with depression rely on 
emotional processing more than healthy people (Harle et al., 2010). This suggests 
that patients’ mood might have a stronger effect on their treatment decisions than 
previously thought. 
 
The results of this study are not consistent with previous research about patients’ 
self-reported decision-making needs in which patients did not mention addressing 
their emotional states (Stacey et al., 2008, Cooper-Patrick et al., 1997b). Emotions 
might therefore be a factor that is identified only in response to certain research 
questions, since it is not easy to address and might not be an issue patients typically 
consider in relation to treatment choices. This reflects evidence that the influence 
of emotions is considered to be subconscious and that people are either generally 
unaware of how they make decisions, or they might rationalise past decisions to 
justify their behaviour (Andrade and Ariely, 2009). 
 
Unlike patients, healthcare workers viewed emotions as only moderately important, 
suggesting that they view patients’ decisions as more rational. It is surprising that 
mental health professionals did not consider emotions to have a strong impact on 
decisions made by people with mood disorders. This observation suggests that 
professionals might not realise that patients’ emotional states are a fundamental 
part of their internal states (Paulus and Yu, 2012) and that emotions are tightly 
linked to their judgements and reasoning about behaviour (Blanchette and 
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Richards, 2010). As a consequence, they might undermine patients’ emotions and 
fail to effectively meet their decision-making needs. 
 
On the other hand, by ranking the factor as the fourth most important, 
professionals demonstrated some awareness about the relevance of patients’ 
emotions on treatment decisions. My observation might suggest that professionals 
do not feel able to influence patients’ emotions during consultations, and therefore 
fail to resolve this problem. Ignoring a factor that patients consider to be highly 
important might, however, have negative impact on the professional-patient 
communication and relationship.  
 
10.3.3.3 Emotions as information 
Participants’ views support the theory of mood acting as information for decision-
making (Schwartz, 1990, Schwartz, 2012), proposing that experienced emotions 
might be an indicator of the situation and possible problems. As a result, sad mood 
might cause people to process information in a more detail-oriented manner and 
with reduced creativity and playfulness (Schwartz, 2012). The mechanism in people 
with depression might be more complex than in healthy people, since their 
performance in cognitive tasks involving judgements has been found to be different 
(Cella et al., 2010, van Randenborgh et al., 2010). I wonder if the different emotions 
in people with depression might cause them to use different decision-making 
mechanisms in relation to their treatment. Consequently, in addition to 
understanding of their problem, patients’ emotional states might also directly 
influence their treatment choices. 
 
My findings suggest that emotions play a significant role in patients’ decision-
making about treatment for depression. Patients’ awareness of the importance of 
their emotions, highlights the need for professionals to acknowledge and explore 
the issue in practice. I suggest that paying more attention to patients’ emotional 
states might be empowering for depressed people. Addressing patients’ emotions 
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directly during consultations could therefore help them engage in making more 
considered treatment choices. 
 
10.3.4 Doctors’ advice and healthcare professionals 
Doctors’ advice is another factor that was perceived differently by the stakeholder 
groups. Patients considered it as only moderately influential, but family and friends 
and healthcare workers ranked it among the two most important factors. Difference 
in views was significant between patients and family and friends. ‘Doctors’ advice’ 
was viewed as conceptually distinct from the factor ‘healthcare professionals’ 
relating to doctor-patient relationship and communication, among other aspects 
and was considered as moderately important by all groups. There is a dearth of 
literature about the perceived influence of healthcare professionals on patients’ 
decisions in relation to other factors affecting their choices. This study provides 
novel evidence about the influence of doctors’ advice on patients’ treatment 
choices as perceived by the three groups. 
 
Participants’ moderate ranking of health professionals as care providers is 
consistent with the findings of a large European survey suggesting that a third of the 
public does not think that mental health professionals would be helpful for serious 
mental conditions (ten Have et al., 2010). My findings contrast with previous 
evidence that the therapeutic relationship is an important predictor of adherence 
(Pompili et al., 2013) and that helping alliance and relationship with clinicians are 
the most important aspects of psychiatric care (Johansson and Eklund, 2003). My 
findings suggest that, within the context of all factors affecting patients’ choices, 
professionals’ personal characteristics and relationships with patients might not 
play as important a role as previously thought. Alternatively, professionals might 
have a strong influence on patients’ treatment choices depending on the patients’ 
perception of their relationship. For example, negative experiences and lack of trust 
in physicians might discourage patients from contacting them, and instead motivate 
them to seek other means of help.  
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10.3.4.1 Views of people with depression 
Patients’ views suggest that they do not strongly rely on expert advice. My findings 
are consistent with the results of a recent systematic review (Deledda et al., 2013), 
which showed that, although patients want to openly discuss the illness and 
treatment with physicians, they do not generally expect to be given a prescription 
or direct advice (Little et al., 2001). Other studies have also shown that the most 
common barrier to help-seeking was a fear of having unwanted medication 
prescribed (Bell et al., 2011). I suggest that patients’ views might be a reflection of 
their previous dissatisfaction or disappointment with professionals, possibly 
resulting from being given less than helpful advice in the past. This interpretation 
corresponds with evidence that professionals sometimes do not meet patients’ 
decision-making needs (Kravitz et al., 2011). Alternatively, people with depression 
might not want to defer the treatment decisions to physicians. Instead, they might 
view professionals as a reference or a supporting factor in the process of making 
decisions.  
 
10.3.4.2 Views of healthcare workers and family and friends 
The two groups prioritised the role of expert advice over patients’ engagement in 
informed choices and this view is further supported by their lower rankings of 
factors related to patients’ informed choice, understanding and the doctor-patient 
relationship. Their perspectives correspond to a common view that the doctor 
knows best and their advice is most important for patients. Professionals have been 
found to consider their opinions as dominant to the patients’ (Elwyn et al., 2012), 
be reticent to involve patients in treatment choices (Young et al., 2008) and to 
overestimate patients’ expectation to receive advice (Lado et al., 2008). This 
corresponds with evidence that the NHS maintains the paternalistic approach 
(Doherty and Doherty, 2005), despite patients’ preferences and clinical guidelines 
that recommend patients’ active involvement (Annunziato et al., 2009). The two 
groups’ views might therefore be reflecting their knowledge about the 
opportunities patients really have to actively engage in the treatment decision-
making process during consultations with their doctors. Alternatively, the two 
groups might be overrating the need for giving advice and instructions and might 
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think that paternalistic approach is preferable. Such view disagrees with the 
evidence that patients’ active engagement in decisions helps improve adherence 
and treatment outcomes (Hack et al., 2006, Loh et al., 2007a). 
 
Family and friends’ emphasis on the role of doctors’ advice might suggest that they 
care about the patient, and that they wish to ensure that they are receiving the 
needed treatment. Due to being in a close relationship with the patient, they might 
be negatively affected by the depressive and decision-making problems the person 
faces, and even struggle to recognise their signs and symptoms (Highet et al., 2005). 
Family and friends’ focus on advice and diagnosis might therefore reflect their own 
wish for the person to receive recommendations from their doctor. Alternatively, 
this finding might also suggest that family and friends, like professionals, endorse a 
more directive approach to patients.  
 
Disagreement and conflict between a patient and their close family can put strain 
on interpersonal relationships and act as a source of additional stress for patients, 
possibly negatively impacting on their wellbeing. Feelings of being criticised and 
blamed by family members have been shown to worsen symptoms and treatment 
outcomes in people with bipolar disorder (Barrowclough and Hooley, 2003, Scott et 
al., 2012) and adherence in depression (Pompili et al., 2013). Interpersonal conflicts 
have not yet been demonstrated to directly influence treatment decisions made by 
people with depression, but the effect might be similar to that in serious mental 
illness and have detrimental effects on their symptoms and wellbeing.  
 
Based on all these findings, I suggest that mental health professionals should adopt 
an approach that helps patients address or deal with the interpersonal problems 
with their family and friends. Rather than automatically assuming that all patients 
struggle with interpersonal conflicts, professionals should be vigilant to patients’ 
personal views and needs in relation to decision-making support.  
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How professionals perceive the views and needs of their patients can have a large 
impact on their consultation style (Legare et al., 2008) and treatment 
recommendations. For example, Cockburn and Pit (1997) found that professionals’ 
understanding of what patients expect from them influenced medication 
prescription more than patients’ actual preferences or expectations. Our 
observation about professionals overestimating the influence of doctors’ advice on 
patients’ treatment choices is therefore very important. Since providing information 
and advice is what professionals tend to do most of the time (Loh et al., 2006), 
thinking that patients want and need advice might be natural for professionals and 
further encourage such approach. This is in contrast with evidence, which shows 
that more than receive advice, patients want to be understood and treated as 
equal. For example, Schout et al (2010) found that people who previously avoided 
care mostly appreciated professionals’ qualities such as compassion, loyalty, 
patience and diplomacy, i.e. empathy (Schout et al., 2010).  
 
Health professionals often talk about patient-centred care and shared decision-
making, but thinking that the second most influential factor for patients’ choices is 
receiving an advice does not correspond with principles of these approaches. I 
suggest that professionals should be more attentive to the patients’ individual 
expectations from the consultations, and to their personal decision-making needs. 
Rather than assuming that giving patients an advice has the most impact on their 
decisions, they should initiate and engage in more discussions about patients’ 
individual perspectives and expectations of the consultation. 
 
10.4 Other factors 
Stakeholder groups did not differ significantly in their views about the role of past 
experiences, wanting to make informed choices and a wish for effortless treatment, 
but they considered these factors as moderately important. The groups’ views are 
consistent with research about the impact of past experiences on help-seeking and 
adherence (Pompili et al., 2013), and the evidence that involvement in treatment 
choices can improve adherence (Loh et al., 2007a). Barriers to treatment were 
thought to be less influential than most other factors, contradicting the findings of a 
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systematic review about the factors related to a perceived need for care (Prins et 
al., 2008). This suggests that participants might have emphasised the importance of 
the enabling, rather than inhibiting factors. 
 
The fact that these factors were located adjacent to each other on the concept map 
suggests that they were perceived as closely interrelated and affecting each other. 
This might suggest, for example, that based on experiences with depressive 
symptoms people are better able to recognise their need for help and adjust their 
approach to treatment decision-making and perceived barriers. This interpretation 
is consistent with the evidence that experiences influence treatment preferences, 
although it is unclear whether people are more likely to prefer treatment they had 
taken before (Churchill et al., 2000) or a different option (Dwight-Johnson et al., 
2000). My observation about the factors’ relationships suggests that helping people 
recognise and address one of the aspects might facilitate their awareness about the 
others, and eventually support better informed treatment choices. 
 
10.5 Types of people with depression 
Another interesting finding in this study is identification of five different types of 
people with depression. The individual subgroups mostly differed in their 
perspectives about the importance of healthcare professionals, depression 
symptoms and stigma. This finding suggests that the same factors might influence 
different patients in different ways and emphasises the importance of 
professionals’ individual approach to patients. 
 
Only one identified previous study classified patients into groups based on their 
views about depression treatment decisions. Thacher et al (2005) used a latent-
class analysis to identify subgroups of people with depression using a sample of 104 
participants. The authors found that a three-group model best explained their data, 
and that the three subgroups of people with depression vary in their sensitivity to 
side effects, the cost of treatment and to treatment effectiveness, mostly based on 
their age and gender. Unlike Thacher et al (2005), I found no relationships between 
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patients’ views and their socio-demographic factors. My observation also contrasts 
with research suggesting that gender, age and ethnicity influence patients’ 
preferences for treatment and level of engagement in decisions (Say et al., 2006).  
 
The findings of this study indicate that patients might vary in what decision factors 
they value the most when making treatment choices. The observation supports the 
findings of a scoping review of literature that emphasised the differences between 
patients in how they make decisions and that they should not be considered as a 
homogenous group making decisions in the same ways (Victoor et al., 2012). Health 
professionals should therefore consider the benefit of recognising patients’ 
individual needs and preferences, in order to tailor their approach accordingly. 
However, the sample sizes of all stakeholder groups in this study were insufficient 
and further research is required to determine any typology of depressed people, 
family and friends or healthcare workers. 
 
10.6 Strengths and limitations of the study 
This study has important strengths and limitation that influence the interpretation 
and generalisability of the findings.  
 
10.6.1 Concept mapping method 
The use of concept mapping is a significant strength of this study. This method 
ensured data were collected and analysed in a highly structured way, whilst 
enabling the detailed exploration for a wide range of relevant concepts. 
Consequently, each of the ideas generated during the brainstorming phase could be 
evaluated and included in the analysis. In addition, the two-stage data collection 
and analysis allowed participants to focus fully on one task at a time and generate 
detailed information about the relative importance of factors and the perceived 
relationships between them.  
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10.6.1.1 Brainstorming sessions 
Use of brainstorming sessions as a means of generating statements about factors 
affecting patients’ treatment decisions had its strengths as well as limitations. An 
important strength of the data collection method was the flexibility offered to 
participants. Group brainstorming sessions were preferred mainly due to providing 
an opportunity for participants to interact with others and explore the details of 
treatment decision-making they might not have realised during individual 
discussions. Participants were also able to take part individually. Whilst this flexible 
approach caused more time-consuming data collection and more repetition in 
factors generated, it also allowed the inclusion of the people who did not feel 
comfortable to talk within a group setting. The quality of the sessions and the ideas 
generated was enhanced by involving a number of experienced facilitators. 
 
The first limitation relating to the use of brainstorming sessions involves 
participants’ potential recall bias due to relying on people’s retrospective self-
reports of factors they viewed as affecting their treatment decision-making, for 
example, inaccuracies in remembering how the decisions had been made, omitting 
of factors or providing more elaborate justifications for decisions. Consequently, the 
factors reported in this study might not be exhaustive and they are limited to 
concepts relevant to the focus question used in the study. Since the primary aim of 
this study was to understand the perceptions of the three stakeholder groups about 
patients’ treatment decision-making, use of retrospective self-report was 
considered as an appropriate method for eliciting the participants’ views. 
 
10.6.1.2 Participatory approach 
In combination with the participatory approach I adopted in the study, concept 
mapping proved to be an effective and useful tool in identifying a large number of 
factors and subsequently synthesising them to a relatively concise but an inclusive 
list of concepts. The study, therefore demonstrates that concept mapping can be 
used effectively to understand and relate perspectives of different groups about 
patients’ decision-making. 
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The extent to which a study is participatory can vary. Whilst this study involved 
seeking stakeholders’ advice and opinions about a number of study aspects, other 
research has shown that participants can be involved to a greater extent, for 
example to act as interviewers (Dodd et al., 2014) or take the lead in data analysis 
(van Bon-Martens et al., 2012). In the present project, I did not involve participants 
extensively due to time constraints and practical complications. In addition, the 
number of final clusters was decided based on complex data analysis and 
participants’ involvement in this stage was not thought to be sufficiently productive 
in the process.  
 
10.6.1.3 Data analysis: number of dimensions and clustering method 
The specific data analysis used as part of the concept mapping method is another 
important strength of this study. The combination of multidimensional scaling 
techniques (for example, Principal Component Analysis) and a cluster analysis 
allowed me to analyse data from a unique perspective, using the perceived 
relationships between statements to identify underlying concepts. In addition, this 
is the first concept mapping study using data from five instead of two dimensions 
produced in the Principal Component Analysis. This allowed to utilise 76% of the 
variance rather than the 50% that is typically used in other concept mapping studies 
(Kikkert et al., 2006, Rosas and Kane, 2012). The present study is also the first to 
apply the K-means clustering, as opposed to one of the hierarchical methods, such 
as Ward’s or Centroid methods. It has been argued that two dimensions sufficiently 
reflect the main relationships within the dataset, and that hierarchical clustering 
methods group the items together according to their relative closeness, i.e. 
similarity (Trochim, 1989). The findings of this study, on the other hand, suggest 
that the five dimensions can reflect sensitively even more subtle relationships 
between statements. Consequently, in order to identify the final set of clusters, I 
maximised the use of information about the data available. I suggest that this 
resulted in the generation of coherent final clusters that represented the original 
dataset more accurately than if the typical concept mapping analyses had been 
used.  
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Since the way the data were analysed largely depended on the number of 
dimensions, the clustering method and the number of clusters in the final set, the 
data could potentially have been interpreted differently. For example, another type 
of the clustering analysis could have been used, for example a hierarchical method 
instead of the K-means.  Despite this, I suggest that the clusters strongly resemble 
the factors described in previous research, which supports their validity. 
 
10.6.2 Study focus question 
The focus questions used in the brainstorming stage in this study prompted 
participants to think about any type of treatment decisions for depression they had 
most recently been involved in. This study is the first to explore people’s treatment 
decision-making while not focusing on a pre-defined type of decisions, such as help-
seeking or adherence. An advantage of this approach is allowing participants to 
think about the most recent and relevant treatment decision they had been 
involved in. The decision is therefore most likely to be well-remembered and 
influenced by current factors. 
 
 A limitation of exploring all types of decisions altogether is a potential lack of focus 
and detail about any of them. Consequently, participants’ responses might not be 
generalisable to other people’s treatment decisions, since different patients might 
have discussed different types of choices. This limitation results in a need for 
further research to determine whether the different types of decisions can be 
studied together as one topic.  
 
 
10.6.3 Multiple comparisons 
Performing multiple comparisons as opposed to testing specific hypotheses is an 
important limitation of this study that increased the risk of Type one error (i.e. 
reporting a false-positive difference). This was necessary in order to explore the 
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differences between the views of three stakeholder groups. Since the final set of 
factors, the importance which participants would rank had not been known when 
the study was being planned, explicit hypotheses about group differences could not 
have been articulated before data collection was completed. In order to compare 
and contrast the groups’ views about the factors I performed a total of 36 individual 
comparisons (12 factors times 3 groups). At a criterion alpha of p<0.05, two of the 
comparisons could have been found significant by chance alone. To address the 
elevated risk of Type one error, I first determined the significance of an F-test 
(ANOVA) for rankings of each cluster, and then computed Tukey’s HSD (Honestly 
Significant Difference) post-hoc test to identify the particular group differences. This 
is a standard procedure for reducing the risk of error, and Tukey’s post-hoc test is 
one of the most commonly used tests (Pallant, 2001). 
 
The risk of bias due to multiple comparisons was also elevated when comparing the 
stakeholder groups’ importance rankings attributed to the individual statements, 
and when comparing cluster rankings of the group subtypes, that is to say patient 
types. The risk was addressed by using the same method of an F-test, followed by a 
Tukey’s post-hoc test. The results should, however, be interpreted with caution. 
Identifying a relatively few significant differences (n=12) between the groups’ 
rankings of the individual statements might suggest that some or all of them were 
due to chance rather than a real difference in opinions. At p<0.05, the expected 
number of differences ‘significant’ by chance is 5% of 177 (i.e. 59 statements times 
3 stakeholder groups), which equals 9. Since all reported differences between the 
groups were confirmed by an F-test and an appropriate post-hoc test, the risk of the 
Type one error was minimised. 
 
The interpretation of the different views of five types of people with depression 
also carries risk of bias. The risk of Type one error was elevated, but addressed as 
described above. In addition, comparing five groups of unequal size carried an 
increased risk of Type two error due to violating one of the assumptions of ANOVA. 
Consequently, with larger and more equal groups, the non-significant differences 
could eventually be found significant. 
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The sizes of stakeholder groups limited the opportunity for performing effective 
subtype analyses. As a result, the identification of the five types of people with 
depression should be viewed as an indicator of potential differences among 
patients with the same illness, rather than as a confident description of patient 
types. The identification of the distinct types of patients highlights the need to 
consider them as individuals with various decision-making needs and preferences. 
To determine the predictive validity of the patient types a larger and more 
representative sample of people with depression would be required. 
 
10.6.4 Number of participants 
Considering the method used in the study, I recruited a good number of 
participants. A total of 98 people took part in the process of generating statements 
about how people with depression make treatment choices, and 64 took part in the 
ranking and clustering of the statements to final clusters. The numbers are similar 
to a study conducted in seven countries (Kikkert et al., 2006) and to other studies 
using concept mapping where average numbers of participants vary between 62 
and 122 (Rosas and Kane, 2012). The authors also reported that number of 
participants is generally lower in the second stage of data collection, i.e. prioritising 
and clustering tasks and recommend having at least 20-30 participants. In my study, 
a total of 64 participants completed the second stage of data collection, which 
contributes to better quality of the study (Rosas and Kane, 2012), although I was 
unable to calculate the reliability of the analyses due to the type of concept 
mapping software chosen. Involving a relatively large number of participants 
allowed me to compare the stakeholder groups’ views about the importance of the 
clusters and test for statistically significant differences between groups. 
 
Whilst the overall number of participants was sufficient and added power and 
quality to the study considering the methodology used, it might enhance the 
generalisability of findings to involve more family and friends in future work. The 
number of family and friends taking part was less than optimal, which was the case 
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especially when comparing importance rankings of the three stakeholder groups. In 
several instances the groups’ variances were unequal and a non-parametric 
alternative to Friedman’s ANOVA was used. This addressed the possibility of bias in 
the comparisons, but involving a larger sample of family and friends would have 
been preferable. In addition, the number of family and friends recruited was 
considerably smaller compared to numbers in other stakeholder groups, limiting the 
validity of comparisons with the other groups, and elevated risk of Type two error. 
Their number also suggests specific problems with recruitment. One reason could 
be limited access to this stakeholder group via contact with people with depression, 
who often reported lack of close family and friends able to discuss their treatment 
decision-making. Inviting family and friends via published adverts was therefore the 
main recruitment strategy for this group and which was also limited by difficulties 
with the efficient wording of the adverts.  
 
Recruitment of family and friends or carers has also been reported as problematic 
in other studies. Some authors, for example, suggested that this group of people 
might not want to engage in extensive discussions about the illness that caused 
them distress and difficulties, such as dementia (McCabe and Adams, 2013). 
Consequently, it is possible that only a few family and friends expressed an interest 
in taking part in the study as a result of their low motivation to spend time and 
effort discussing an illness that had already negatively affected their daily lives. 
 
10.6.5 Selection bias 
The selection bias might also have resulted from the dearth of the depressed 
people who had not sought help for depression or those who perceive their 
opinions as undesirable. Those people might have perceived additional barriers to 
taking part, despite my attempt to make the research appealing to all people with 
depression. Research shows that up to half of people with depression do not seek 
help for the condition and only half of them receive treatment (Kessler et al., 2003), 
whilst all but one person with depression in this study reported having sought help 
from a mental health professional or worker. This suggests that people who avoid 
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help-seeking and disclosing of depression were under-represented in the study and 
that the findings might not be generalisable to such groups of people.  
 
The demographic characteristics of the sample also suggest that women, older 
people and those with higher educational achievement were over-represented in 
the study compared to the general population, both of Norfolk and of England as a 
whole (ONS, 2012). An important limitation of this study is also a limited number of 
participants from ethnic minorities, whose views could not be explored. Although 
people from other than White ethnic group were under-represented, the 
percentage of White British or Irish participants in the study was similar to that of 
the general population of Norfolk (ONS, 2012). The groups of people that were 
under-represented in this study are frequently found as most difficult to recruit 
(Patel et al., 2003), emphasising a need for their better involvement in research 
about depression treatment decisions.  
 
The lack of objective information about the participants’ depressive illness, such as 
diagnosis and severity, is another limitation of the study. These factors have been 
found to influence patients’ treatment decisions (Bebbington et al., 2000, Farmer et 
al., 2012) although it is unclear whether the process of making treatment decisions 
is also different among people with various severity and duration of the depression. 
On the other hand, not requiring participants to undergo re-diagnosis of depression 
for purposes of this exploratory study, was expected to help maintain a comfortable 
and trusting atmosphere during data collection. As a result, participants might have 
been more honest and open in describing the factors affecting their treatment 
decision-making. 
 
10.6.6 Recruitment strategies 
Another limitation of this study is a possible sampling bias. A disadvantage of the 
recruitment strategies used in this study, was the reliance on the potential 
participants’ self-selection to take part in the study. Whilst the use of a variety of 
methods was expected to inform as many people as possible about the study and to 
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minimise the overall selection bias, each of the methods had its limitations and 
carried a potential of bias. For example, no participants were recruited via the 
contact with their mental health practitioners, although this is one of the most 
common methods of recruitment in other studies. This might have been the result 
of the practitioners’ lack of time during consultations, their possible doubts about 
the importance of the study, or another reason. Alternatively, it could have resulted 
from the lack of systematic identification of eligible patients from the health 
professionals’ case lists.  
 
Another strategy that yielded a small number of participants was the engagement 
of the local mental health charities, although charities are often supportive of 
research. Despite the willingness and support offered by the charity representatives 
(including the MIND and the Age UK), people with depression in these organisations 
expressed little interest in joining in this study. This could have been due to the 
charities focusing on people with other long term mental health conditions, such as 
bipolar disorder and dementia, and therefore involving a limited number of people 
meeting the inclusion criteria for this study. The charity organisations that provide 
support specifically to people with depression were not involved in this research.  
 
The most successful recruitment strategies were publishing of information about 
the study on the University’s website and in the local media, and the snowballing 
method. Using the website and the local newspapers to invite the potential 
participants corresponds with the recommendations to publicise the research 
widely in the target population (Brown et al., 1998). Similarly, the flyers distributed 
in the GP practices could be considered as widely publicising the study in the 
population, but unlike the newspaper articles, the flyers did not help me recruit any 
participants. The lack of effectiveness of the flyers is not surprising, since they were 
placed in the waiting rooms by the surgery staff with potentially no interest in the 
study. Such posters may be easy to miss if placed amidst a large number of other 
adverts and notices (Namageyo-Funa et al., 2014).  
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The success of the articles on the University’s website and in the newspapers was, 
however, a surprise, although engaging the public is generally advised (Brown et al., 
1998). People were unlikely to spot the newspaper articles immediately, as they 
were printed on either page 7, 17 or 25 in the individual newspapers. Despite this, 
the readers could have noticed them possibly due to reading the papers in their 
own time, as opposed to the time when waiting for a doctor’s appointment. In 
addition, unlike the newspaper articles, the flyers could also be associated with 
feelings of embarrassment, since some people might not feel comfortable to pick 
up a leaflet about depression if others in the waiting room can see this. Combined 
with the article about the study, published on the University’s website, the 
newspaper articles helped me to recruit participants with a variety of demographic 
characteristics, although the sample was not fully representative of the general 
population. 
 
The snowballing method was also considered to be successful, although in some 
cases it was difficult to determine whether a person had read about the study or 
whether they had heard about it from their family members. Whilst snowballing is a 
recognised strategy (Sadler et al., 2010), it can also increase the risk of selection 
bias (Groger et al., 1999), since the process of spreading the information about the 
study is not random but specific to the individuals. For example, people might not 
share the information about the study if they do not find it appealing even if their 
friend might be interested. Moreover, people might be more willing to say 
interesting information to others who share their views and values, which further 
increases the bias. Despite its drawbacks, this strategy was crucial for the 
recruitment of family and friends of depressed people, since accessing this group 
would have proved to be considerably more difficult.  
 
10.7 Conclusion 
Despite the under-representation of some patient groups relative to the general 
population, my findings provide a detailed list of factors affecting patients’ 
treatment decisions. Consequently, health professionals could use these factors to 
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explore and develop a better understanding of how different patients make their 
depression treatment decisions.  
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 Chapter 11 Conclusion 
 
11.1 Summary of thesis 
In this thesis, I described and discussed an explorative study about the factors 
influencing treatment decisions made by people with depression, as perceived by 
members of three stakeholder groups: people with depression, their family and 
friends and healthcare workers. Using concept mapping, a mixed method designed 
for gathering and processing a large amount of information, I identified 59 
statements representing factors affecting the patients’ choices and grouped them 
into 12 distinct clusters of closely related items.  
 
The findings of this study demonstrate that people with depression make their 
treatment decisions based on a number of different factors. These include internal 
factors related to their personal insight and understanding, emotional aspects that 
might be related to the illness. The treatment decisions are also influenced by the 
external factors, mostly associated with health professionals, family and friends and 
the person’s wider social environment. The perspectives of depressed patients, 
their family and friends and healthcare workers about the relative importance of 
the individual factors suggest that these groups do not share the views about how 
patients make their treatment decisions patients. 
 
11.2 Treatment decision-making  
When experiencing low mood and other changes in emotional state, individuals 
might first think that the problems could be resolved by a simple and quick 
treatment that would provide an easy solution. Based on the results of the 
multidimensional scaling analysis, I suggest that such views could be informed and 
altered by the person’s growing experience with living with depressive symptoms. 
There is evidence that people become less likely to seek professional help with the 
passing time of their illness (Thompson et al., 2008). Based on my observation, I 
suggest that this might be a result of the diminishing direct impact of insight on 
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help-seeking. Additionally, this may be due to another factor becoming more 
influential over time, such as people’s current emotional states, which are closely 
related to the depressive symptoms people have. In line with the recent 
psychological theories of decision-making, this suggests that emotions have a large 
influence on how people decide in the critical situations. In relation to help-seeking, 
this effect might demonstrate as a sudden change in the person’s decision to 
consult a professional based on a change in their emotional state. The other factors, 
then appear to play less prominent roles. For example, doctor’s advice might be less 
influential on decisions made by a person who has not yet visited the physician to 
seek help. Although the anticipated views of the doctor might encourage or inhibit 
an individual’s intention to consult the professional, their advice might still be most 
relevant once a person develops insight into their symptoms. On the other hand, 
perceived stigma and the beliefs of family and friends were previously found 
important in this stage of treatment decision-making. For example, research shows 
that some people might consider the members of their close social environment as 
a source of advice (Farmer et al., 2012). The family and friends’ views could 
therefore be an important factor in a person’s decision-making about treatment. 
The findings of this study, however, suggest that the external views about 
depression have a relatively small effect on patients’ choices, when considered in 
the context of the people’s internal representations of depression. 
 
11.3 The findings in relation to particular treatment decisions 
When conducting this study, a decision was made not to ask participants to 
differentiate between individual treatment decisions when discussing the factors 
affecting them. This was based on an assumption that people’s treatment choices 
are influenced by the same set of factors, which reflects previous research 
demonstrating a number of similar factors found to predict the different types of 
decisions. Consequently, in this last section of the thesis, I attempt to relate the 
findings of this study to the individual types of decisions.  
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11.3.1 Help-seeking 
My findings are consistent with the theoretical models suggesting that when people 
make the decision to consult a professional about depression, they had already 
developed some understanding of their symptoms. In relation to care-seeking, 
researchers have previously mentioned insight and some of its dimensions such as 
recognition of symptoms and ability to relate them to an illness. For example, 
Epstein et al (2010) specified that people go through a process of knowing, naming 
and explaining their experiences and symptoms, before they consult a GP. Farmer 
et al (2012) suggested that within the process of developing insight and awareness, 
people might become intimidated by their symptoms. Consequently, they may first 
need to come to terms with the thought that they are a depressed person. My 
findings provide additional detail into how depressed people might come to terms 
with the symptoms of their condition and develop insight.  
 
11.3.2 Treatment selection  
Research is scarce about how depressed people develop their treatment 
preferences and there is a paucity of theoretical models that could be used to 
explain this process. Based on the findings of this study I suggest that patients 
develop their preferences based on their insight into how depression affects their 
life, leading them to better understanding the treatment outcomes they require. 
This understanding is a product of having knowledge and more personal experience 
with depression. At the same time, patients’ emotional states are seen influential, 
suggesting that development of treatment preferences is affected by the irrational 
factors. The impact of professionals appears to be more indirect. For example, they 
might help patients by providing relevant information and helping them make best 
use of their own experience to select treatment options. 
 
11.3.3 Adherence  
My findings can be related to the necessity-concerns framework that has been used 
to explain and address adherence to medication (Aikens et al., 2008). According to 
the framework, a patient is more likely to adhere to treatment better if they hold 
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beliefs that support the overall perception of necessity of treatment. Poorer 
adherence is therefore associated with an increased perception of the concerns 
about treatment. This was identified as a part of the factor related to making 
informed decisions. My findings suggest that patients’ beliefs about the necessity 
and their concerns about treatment are closely related to their past experiences 
and a personal insight into their depression. Addressing these factors together with 
the patients’ emotional states might therefore help improve their adherence.  
 
11.3.4 Shared decision-making  
Although a shared decision-making (SDM) is a generally accepted as the most 
appropriate approach to patients, including mental health patients, theoretical 
models that would effectively explain the SDM process are lacking (Gray, 2014). 
Adoption of the SDM principles in practice can have a positive impact on patients’ 
involvement in decisions, acceptance of treatment and adherence (Loh et al., 
2007a). The findings of this study suggest that insight and emotional states are the 
key aspects of treatment decision-making, which are further influenced by the 
patients’ knowledge, understanding, experience and depressive symptoms. By 
understanding the underlying processes of these factors’ interaction, health 
professionals could become better equipped to help patients make sense of the 
available information and benefit from their experience.  
 
11.4 Practice implications 
The findings of this study demonstrate that depressed people take treatment 
decision-making seriously and that they strongly rely on the internal 
representations and an understanding of their situations. Based on the findings, I 
suggest that health and mental health professionals should be wary not to rely on 
their personal assumptions about particular patients. Instead, they should adopt a 
more open-minded approach and help patients to address the issues that they find 
troubling. Based on their roles of the treatment gatekeepers, they should be vigilant 
to the patients’ individual perspectives, in order to provide most appropriate 
treatment and facilitate shared decision-making. Similar suggestions have been 
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made in relation to other conditions, for example, schizophrenia (Gray et al., 2010). 
My findings show that in order to provide a more tailored care for depressed 
patients, professionals might need to adopt a more open-minded approach to the 
way the people with depression make their treatment choices. 
 
11.5 Suggestions for future research and work in this area 
The findings of this study show that a number of different factors influence 
treatment decisions depressed patients make and that family and healthcare 
professionals do not share the perspectives of patients about the most important 
aspects of the process. In order to help patients make more effective treatment 
choices, I suggest that future research should explore the following questions. 
x I identified twelve distinct, but related factors that influence patients’ 
treatment decisions and I explored their relative importance as perceived by 
the stakeholder groups involved in the study. Future research should be 
done to investigate the predictive validity of these factors on the patients’ 
treatment choices, and the applicability of the findings in more diverse 
populations. For example, it should be determined whether depressed 
people could improve their insight as a result of gaining information tailored 
to their personal needs and reflecting on their personal experiences with 
depression. 
x This study shows that there are a number of points about which patients 
and professionals disagree. Since these issues are directly related to the 
ways patients decide about the issues that are the subject of consultations 
with the professionals, these misunderstandings should be addressed. One 
way of supporting health professionals in facilitating shared decision-
making, would be to develop an educational programme that would 
improve the professionals’ understanding of how depressed patients make 
their treatment choices. The main purpose of such training would be to 
encourage the professionals’ empathy and improve their abilities to address 
patients’ needs specific to the decision-making about depression treatment. 
The effectiveness of such educational programme could be a subject of 
further research. 
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x Future research should also aim to test the feasibility of the interventions 
that involve peer support workers helping depressed patients to make their 
treatment decisions.  Because GPs have limited time available for patient 
consultations, they might not be able to understand fully the factors that 
patients find most troubling. Involving a person with a prior relevant 
experience, such as a peer support worker in the decision-making process, 
might provide an additional time and a more empathetic approach to 
patients.  
 
11.6 Conclusion to thesis 
In this thesis, I described and discussed an exploratory study about how depressed 
people make treatment decisions, and how their perspectives compare to those 
held by family and friends and health professionals. Demonstrating that patients 
and professionals differ considerably in their views about the decision-making 
process, I suggest that health professionals should adopt a more individual 
approach to patients. By helping patients address their specific, rather than 
assumed problems, professionals could provide the support the patients need when 
dealing with depression. Consequently, patients could engage in shared decision-
making about their treatment in more straightforward ways. 
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Project summary 
Depression is a common mental illness that is typically treated with antidepressant medication or 
talking therapies. Treatment choices made by people with depression have a large impact on their 
behaviour, including selection of a practitioner and adherence to therapy. People should make 
informed decisions about treatment but that can be hard to facilitate if healthcare workers do not 
comprehend what factors influence patients’ decisions. We therefore aim to provide a better 
understanding of how people with depression make treatment choices.  
We will use concept mapping, an established methodology to compare and collate views of three 
stakeholder groups: 30 people with depression, 30 family and friends, and 30 healthcare workers. 
In the first part of the study, participants join in focus groups to produce as many statements as 
possible, about how people with depression make treatment decisions. In the second part, the same 
volunteers are invited to perform two individual tasks: (1) rank the importance of each statement 
(prioritizing), and (2) put the statements that seem to go together, into groups (clustering). This data 
will be analysed using a specialised software package called Ariadne, and a concept map will be 
produced depicting importance and relations of the statements, as viewed by participants. The 
results of this analysis will provide a better understanding about the factors that influence patients’ 
treatment choices.  
The findings of this study can help healthcare workers better understand the patients’ perception of 
different treatment options, and support patients in their informed decision-making. It could be used 
to inform future policy making about depression treatment, and help service managers to tailor the 
services to better meet patients’ needs.  
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1.1 Abbreviations: 
AM – Alternative Medicine 
CBT – Cognitive Behavioural Therapy 
GP – General practitioner 
IAPT – ‘Improving Access to Psychological Therapies’ government program launched in 2007 to 
provide psychological treatment to patients who need them 
NHS – National Health Service 
NICE – the National Institute for Health and Clinical Excellence  
NHS Norfolk – Norwich and Norfolk Primary Care NHS Trust 
NSFT – Norfolk and Suffolk NHS Foundation Trust 
UK – United Kingdom 
WHO – World Health Organization 
 
Page 292 of 386 
 2 Background information 
2.1 Depression  
Depression is a common treatable mental illness. It affects approximately 3% of general population 
at any one time (Singleton et al. 2001) and at least one third of GP time is spent to treat people with 
this mood disorder (Unit 2004). In primary care patients, depression is most common in women aged 
30-39 years (20%) and in men aged 40-49 years (almost 10%) (Martín-Merino 2010). Symptoms 
include feelings of sadness, worthlessness, disturbed sleep and problems concentrating and making 
decisions (WHO 1992). Left untreated, depression is a potentially fatal illness with more than two 
thirds of acutely depressed people experiencing thoughts of suicide (Moller 2003). It causes a 
significant burden to the patient, their family as well as the society (WHO, 2008). In England, the 
total estimated cost of depression in adults is £9 billion (Thomas and Morris 2003). 
 
2.2 Treatment for depression  
The majority of people with depression are seen in primary care where optimised treatment should 
achieve remission in about 50-67% of patients (Dawson et al. 2004). Antidepressants, such as SSRIs 
(e.g. fluoxetine) are prescribed to about 90% of primary care patients with depression (Martín-
Merino 2010) and should be administered for at least 6 months following improvement of 
symptoms. Used alone or combined with medication, psychological therapies such as cognitive 
behaviour therapy (CBT), interpersonal therapy (IPT) and counselling are also effective for 
depression if patients receive 16 to 20 sessions of therapy (NICE 2009). As a therapy for depression, 
physical exercise may be recommended for patients in addition to their usual care. A recent 
Cochrane systematic review showed that exercise can be as effective as cognitive therapy in 
alleviating symptoms of depression, but more research is needed to determine the most suitable 
type (e.g. aerobic, anaerobic) and the exact therapeutic effect (Mead et al. 2009). Other publicly 
available therapies for depression include the Alternative medicines (AMs) such as St John’s Wort, 
nutritional supplements, Acupuncture or Neuro-linguistic Programming. The results from the Health 
Survey for England showed that despite the lack of scientific evidence of most of the AMs’ 
effectiveness, 35% of respondents with depression and/or anxiety symptoms had used some AM, 
compared to 25% of those who had good mental health (Hunt et al. 2010).  
2.3 Adherence to treatment 
Psychological and pharmacological therapies have been found equally effective for depression, but 
patients’ adherence to them is poor, regardless of the type received. Up to one third of patients 
discontinue in the first month (Fairman et al. 1998) and as few as one third of patients complete only 
3 months of their prescribed treatment (Olfson et al. 2006). In attempt to understand this 
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phenomenon, researchers found that patients generally express the need for a better understanding 
of their illness and side effects of treatment (Prins et al. 2009). Interventions designed to improve 
adherence, that focus solely on patient education, are not effective (Haynes et al. 2002) as they do 
not address the real reasons why patients do not compete their therapy course (Donovan 1995). 
Other researchers suggest a link between adherence and patients’ treatment choices as an 
explanation. 
 
2.4 Treatment preferences held by people with depression 
Preferences held by people with depression appear to have a strong influence on their actions, such 
as help-seeking behaviour, choice of therapy or practitioner, and adherence (Prins et al. 2009). 
Studies show that around 51-66% of people with depression would prefer talking therapies over 
medication if given the choice (van Schaik et al. 2004). Despite of its effectiveness, exercise is rarely 
offered as a therapy of choice in studies on patients’ treatment preferences for depression (Prins et 
al. 2008). Compared to antidepressants and talking therapies, limited information is available about 
patients’ preferences for exercise or alternative medicines. 
Receiving the preferred choice of therapy, regardless of its type, appears to be related to better 
concordance and higher patient satisfaction (Hunot et al. 2007). Many patients feel uncomfortable if 
a treatment they do not want is given to them (Nolan and Badger 2005). Other researchers suggest it 
is not the preference itself but rather their strength that has an effect on the extent to which 
patients follow their health advice (Raue et al. 2009). The importance of including patients in 
decision-making and prescribing has also been recognized by the NICE. Health professionals are 
recommended to use the person-centred care approach (NICE 2009) and encourage patients to play 
an active role in treatment decisions.  
 
2.5 What factors influence treatment choices made by people 
with depression? 
Treatment preferences held by people with depression influence their help-seeking behaviour and a 
number of researchers have attempted to understand the individual differences related to particular 
treatment choices, but conflicting results are often shown. Women seem to be more likely to opt for 
talking therapies (Prins et al. 2008) but in a study with mostly male patients, almost one quarter of 
them preferred psychotherapy and more than 60% combination of antidepressants and 
psychological treatment (Lin et al. 2005). Beliefs and opinions are also important. People who 
believe that antidepressants are addictive seem to prefer counselling (Churchill et al. 2000) and if 
individuals believe a particular treatment can help them, they are more likely to use it (Jorm et al. 
2000). A review of studies about treatment preferences has shown that a large number of beliefs, 
e.g. perceived consequences of  the illness, and beliefs about importance of treatment and its side 
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effects, have an effect on patients’ preference for therapy (Prins et al. 2008). The direct effect of 
these beliefs has not yet been shown and a limited number of studies investigating what factors 
influence patients’ treatment choices have been published. In this study, we aim to combine the 
ideas and perspectives of three different stakeholder groups about how people with depression 
make their treatment decisions. Members of the three groups will first generate a variety of ideas on 
the topic, and then they will structure the ideas in terms of their importance and meaning. Concept 
mapping methodology will be used for this task. 
 
2.6 Concept Mapping 
Concept mapping is an established, mixed design methodology that combines qualitative and 
quantitative aspects. It is a systematic process of developing and evaluating ideas of different 
stakeholder groups. For its nature it is ideal for bringing a number of groups with different 
viewpoints together, and analysing their perspectives to aid decision-making and policy development 
(Kane 2007). Researchers have applied concept mapping to explore and analyse perspectives of 
patients with schizophrenia, their carers and health professionals (Kikkert et al. 2005). In this study it 
will be used to understand the differences and similarities of opinions held by people with 
depression, their family and friends, and healthcare workers about how people with depression 
make their treatment choices.  
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 3 Rationale 
People are actively involved in decision-making about their health care in everyday life, and not 
exclusively during consultations with their health care worker. Preferences for particular type of 
therapy are often formed outside of the practitioner’s office, and may be based on 
misunderstanding or anecdotal information from friends or media. These choices and beliefs about 
therapies have a strong influence on people’s behaviour (Prins et al. 2008) but it is not yet clear what 
factors influence these choices. Exploring this issue further is eminent as only a third of people with 
depression seek medical help (NICE 2009), what means the majority of those affected do not get 
professional help and continue suffering. In addition, meeting patients’ expectations in general 
practice is challenging, and not helped by a common misunderstanding between patients and 
healthcare workers (Britten et al. 2000). Understanding how people with depression make treatment 
choices would be informative and could help us tailor the healthcare to better meet patients’ needs. 
It can also inform healthcare workers about how to help people make informed choices about their 
depression therapy, and help them seek treatment when needed. 
In this study we will collect information about how people make depression treatment choices, from 
three stakeholder groups: people with depression, their family and friends, and their healthcare 
workers. This will help us understand the most important issues that people with depression 
consider when choosing a therapy and using the concept mapping methodology will enable us study 
the differences between the three groups.  
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 4 Aims and objectives 
4.1 Aim 
The aim of this study is to develop a conceptual framework portraying the factors that influence 
treatment decisions made by people with depression. Using concept mapping methodology, we will 
demonstrate the differences and similarities between the views of health workers, people with 
depression and their family and friends (i.e. close friends or family members). Our study will provide 
an in-depth analysis of the aspects people with depression consider when selecting a treatment for 
depression. A better understanding about the factors that influence patients’ treatment choices will 
be presented, not shown to this extent elsewhere. To achieve this aim we will work with people with 
depression; partners, family members or close friends helping these patients (family and friends) and 
healthcare workers currently or recently involved in treatment of people with depression.  
4.2 Objectives 
The primary objective is to identify differences and similarities between the perspectives of three 
stakeholder groups on what factors influence treatment choices made by people with depression, 
using concept mapping methodology. We aim to develop a conceptual framework which can be used 
to inform healthcare workers about helping patients make informed decisions about their 
treatment, and help improve the health care offered to people with depression. 
 
The secondary objective is to analyze the data in terms of sub-groups’ differences of the stakeholder 
groups. We will seek to view differences in perspectives of people with depression according to their 
gender, age groups, number of depression episodes, treatment received and possibly other baseline 
characteristics listed in section 6.1.1.4. For healthcare workers, we will analyse differences according 
to their profession. Understanding the effect of participants’ individual differences in relation to 
treatment decisions will provide further information about how people make treatment decisions. 
We also aim to develop visual ‘maps’ of the factors that influence treatment choices made by people 
with depression. The ‘maps’ will depict the importance of individual statements, and their relations 
to each other from perspectives of the three stakeholder groups. They will serve as a basis for 
development of the conceptual framework of the factors important for all groups of participants.  
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 5 Study design  
This study is a mixed methods participatory research involving members of the public in the design 
and management of the research, analysis of results and dissemination of findings. 
 
5.1 Steering group and the research team 
5.1.1 Steering Group  
A steering group will be established and will include: an adult person with depression; a healthcare 
worker with experience of treating people with depression (Nesta Reeve); and the academic 
supervisory team (Professor Richard Gray, Dr Bridget Penhale and the researcher (Ada Mackovova).  
5.1.2 Research Team  
The research team includes Ada Mackovova, Professor Richard Gray and Dr Bridget Penhale. 
Research assistants will also be involved and will assist with data collection, and will be trained in 
appropriate consent procedures and how to assist in the concept mapping process. They will be Dr 
Katherine Deane (Senior Lecturer in Research Related to Nursing) and postgraduate research 
students in the School of Nursing Sciences: Helen Flaherty, Katrina Emerson, Kelda Hargreaves and 
Stephen Smith. All members of the research team and research assistants have been trained in Good 
Clinical Practice (GCP). 
 
5.2 Concept mapping method 
This study is designed to produce a graphical illustration of the factors that influence treatment 
decisions made by people with depression, using concept mapping methodology.  
Concept mapping is an established, mixed methodology design where participants take part in two 
activity sessions. Focus groups form the qualitative part of the study. The second part of the study 
involves participants prioritizing and clustering statements about how people with depression make 
treatment choices (structuring sessions). The data from this part will be analysed using a specialized 
software package called Ariadne, and it is the quantitative aspect of the study. Using this method 
allows researchers to collect and analyse new and unique ideas from different stakeholder groups, 
and compare the individual groups to understand the differences in their views. The results can be 
used to develop a theoretical model to help explain the process of decision-making about treatment 
options that patients undertake. 
Concept mapping is a phased methodology and will be conducted in the following steps:  
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5.2.1 Step 1: Preparation 
5.2.1.1 Development of the focus 
The focus is a sentence used as the starting point in focus groups. In order to complete it, 
participants will be asked to articulate as many relevant statements as possible. Focus for people 
with depression will differ from that of health care workers and the family and friends, and will be as 
follows: 
People with depression: ‘My most recent choice of treatment for depression was influenced by..’ 
Healthcare workers and the family and friends: ‘Treatment choices made by people with depression 
are influenced by ...’ 
5.2.1.2 Participants’ selection 
Three groups of stakeholders will take part in the study: 30 people with depression, 30 family and 
friends (e.g. partner, family member, a close friend) and 30 healthcare workers experienced in 
treating people with depression. 
5.2.1.3 Setting a schedule 
Times and dates of the focus groups and the structuring sessions will be set, considering the 
participants’ preferences. A meeting room will be booked for each of the three groups (people with 
depression, family and friends and healthcare workers) separately.  
 
5.2.2 Step 2: Generation of statements 
5.2.2.1 Focus groups 
In the focus groups about 5-10 participants will work together to generate as many statements as 
possible in order to complete the focus sentence. An example of a statement is: ‘My most recent 
choice of treatment for depression was influenced by...  my belief that only antidepressants would 
be helpful for me’.  
5.2.2.2 Statements review and reduction 
After all focus groups have taken place, the research team will review wording of statements, discard 
any duplicates and ensure their final number does not exceed 80. Several sets of statements will be 
printed, each statements on a separate card. 
5.2.3 Step 3: Structuring of statements 
A second session will be held for small groups of participants to prioritize and cluster the statements 
according to their views. These tasks are performed individually. The structuring session will take 
place within approximately 5 months after the initial focus groups. 
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5.2.3.1 Prioritizing 
In the prioritizing task participants organize the statements into five equal piles according to their 
opinion of statements’ importance.  
5.2.3.2 Clustering 
In the clustering task participants decide which statements are thematically related and group them 
together. Each participant should name their clusters.  
 
5.2.4 Step 4: Concept mapping analysis 
Data from the clustering and prioritizing tasks will be analysed using a software package called 
Ariadne. A ‘map’ of the statements (concepts) will be produced for each stakeholder group, as well 
as all participants together.  
 
5.2.5 Step 5: Interpretation of the maps 
The concept map is a graphical illustration of the relations among statements: the more often 
statements were grouped together by participants, the closer they are shown on the ‘map’. The 
similarities and differences between the three stakeholder groups are demonstrated and from these 
results a conceptual framework is developed. 
The Ariadne software also allows analysis of differences between any sub-groups, e.g. age groups, 
gender, number of depression episodes, treatment received, or profession of healthcare workers. 
5.2.6  Step 6: Application of the results 
At this stage, the application and future usage of the ‘maps’ is determined.  
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 6 Method of investigation 
6.1 Study population 
Three stakeholder groups will take part in the study, 1) people with depression, 2) family and friends 
(e.g. partner, spouse, a close family member of the patients, and 3) healthcare workers experienced 
in treating people with depression. The total number of participants will be approximately 90, with 
30 volunteers in each group:  
6.1.1 People with depression 
6.1.1.1 Inclusion criteria 
The criteria all people with depression must meet in order to take part in the study are shown in 
Table 1. 
Table 1: People with depressions’ inclusion criteria 
Have been recommended or receiving treatment for unipolar depression currently or within past 12 
months.  
Age over 18 years, for participants to be adults with the capacity to consent. Ten people aged over 
65 will be included to ensure the elderly population is represented in the study. There is no upper 
age limit.  
Speak English. This is to enable discussion about wording of statements. 
Provide written informed consent 
6.1.1.2 Recruitment  
We will recruit 30 people with depression using the following strategies: 
a) Contact via the healthcare workers: as agreed with their team leaders, the healthcare 
workers from any locality or team of the NSFT, the NHS Norfolk and the NHS Great 
Yarmouth and Waveney may be asked to give the information sheets for people with 
depression to their clients meeting the inclusion criteria in this study.  
b) Press release in the local newspaper: A press release will be published in the local 
newspaper (Eastern Daily Press). It will provide brief information about the study and the 
researcher’s contact details for queries or interest in participation. 
c) Advertising in GP surgeries: Posters briefly informing about our study and inviting patients 
to participate will be distributed in GP practices in Norwich. 
d) Contact via the Age UK charity: We will attend the charity’s support group meetings and 
invite older people with depression to take part in the study.  
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e) Article in charity newsletters and/or magazines: We will publish an article briefly describing 
the study and inviting people with depression and their family and friends to take part in 
this research, as approved by the individual charities operating in the Norwich area.  
f) Snowball sampling: We will invite people who have already agreed to participate in the 
study to tell their family, friends and colleagues about the project. They will be encouraged 
to give them the researcher’s contact details should anyone be interested in having more 
information or in taking part in the study.  
6.1.1.3 Obtaining consent  
The researcher’s work address, email and phone number will be provided in the press release and all 
posters distributed. People who express their interest by post, email or telephone call will be posted 
an information pack with a reply slip and a pre-paid return envelope. All potential participants will be 
advised to take time (at least 24 hours) to read through the information sheet and discuss it with 
their friends or people close to them. They will be asked if they would like to nominate a member of 
their family or a friend (i.e. partner, spouse, close family member) and hand them the information 
pack for family and friends. People with depression can take part in the study regardless of whether 
they nominate a member of family or friend, or not. The potential participants will be asked to post 
the filled reply slip to the researcher who will contact the respondents by telephone and inform 
them whether they are invited to take part in the study. This will be decided based on the number of 
participants already recruited in the study and the inclusion criteria. Personal meetings will be 
arranged with those invited to participate to discuss the study in more detail, fill in the baseline 
information questionnaire, obtain their written informed consent and answer any outstanding 
questions. These meetings will take place at agreed public places or alternatively in the potential 
participants’ homes.  
All participants will be asked to note their preference for time and day of the focus group, in order to 
meet people’s individual needs and increase the response rates.  
6.1.1.4 Information collected from people with depression 
People with depression will be asked to provide the information listed in Table 2. This information 
will be collected for statistical purposes. 
Table 2: People with depression: information to be collected 
Name Treatment prescribed and received/receiving for depression 
Address Year of first period of depression 
Email and phone number Number of depression periods 
Age Level of education and employment status 
Gender Marital status 
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Ethnicity Relationship with the family and friend (if nominated) 
 
6.1.2 Family and friends 
6.1.2.1 Inclusion criteria 
Family and friends of people with depression will be recruited based on the criteria shown in Table 3: 
Table 3: Family and friends: inclusion criteria 
Be close to a person with unipolar depression as their family member or a friend  
Age 18 or above, to ensure participants are adults with the capacity to consent. 
Speak English  
Provide written informed consent 
6.1.2.2 Recruitment 
We will approach the family and friends using the following strategies: 
a) Via people with depression: In the information sheet we will ask the people with depression 
to nominate their ‘family and friend’ for this study if they wish to, and give them the 
information pack for family and friends that will be attached. 
b) Via adverts and posters: It is anticipated that some people with depression might not wish 
anyone close to them to participate in the study. To make sure we include a sufficient 
number of ‘family and friends’, the posters in GP practices and the press release will also be 
used to recruit people who know a person with depression who is close to them.  
c) A press release (Spring 2012): A press release will be publicised in local media outlets 
specifically inviting people who are close to someone with depression (i.e. their family and 
friends) to take part in the study. This decision is based on a good response rate that was a 
result of the first press release targeting people with depression.  
d) An article in charity newsletters and/or magazines: We will publish an article briefly 
describing the study and inviting people with depression and their family and friends to take 
part in this research, as approved by the individual charities operating in the Norwich area.  
e) Posters: Posters (version 3 F&F: 21/02/2012) will be displayed at public places such as 
churches in order to be seen by as wide a population as possible. This will be done as 
approved by the relevant authorities governing the particular public places.  
f) Snowball sampling: We will invite people who have already agreed to participate in the 
study to tell their family, friends and colleagues about the project. They will be encouraged 
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to give them the researcher’s contact details should anyone be interested in having more 
information or in taking part in the study. 
6.1.2.3 Obtaining consent 
Those who contact the researcher expressing their interest to take part in the study will be sent the 
information pack for family and friends and asked to return the reply slip in the prepaid envelope 
provided if they wish to. Informed consent will be obtained at a personal meeting with the 
researcher, taking place at a community location or in people’s homes if necessary. Individuals who 
are close to a person with depression (i.e. family and friends) can take part in the study regardless of 
whether the other joins in the research, or not.  
 
6.1.2.4  Information collected from the family and friends 
The family and friends will be asked to provide the information as shown in Table 4. This information 
will be collected for statistical purposes. 
Table 4: Family and friends: information to be collected 
Name Level of education 
Address, email and phone number Marital status 
Age Relationship to the person with depression who 
is close to them 
Gender Having received treatment for depression 
Ethnicity Details of most recent treatment received (if 
any) 
Employment status Participation of the person with depression who 
is close to them 
 
 
6.1.3 Healthcare workers:  
6.1.3.1 Inclusion criteria 
All healthcare workers taking part in the study will meet the criteria shown in Table 5: 
Table 5: Healthcare workers: inclusion criteria 
Currently/ within past 12 months treating/ having treated people with unipolar depression. This is to 
ensure healthcare workers have a recent experience of helping people with depression.  
Provide written informed consent 
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Alternative medicine (AM) practitioners will be recruited on the basis of meeting the inclusion 
criteria listed in Table 6 (below), in addition to those in Table 5. 
Table 6: AM practitioners: Additional inclusion criteria 
There is anecdotal evidence for effectiveness of the therapy they offer for depression 
Practice in Norwich 
6.1.3.2 Recruitment 
Approximately 30 healthcare workers will take part in the study, including GPs, nurses, mental health 
nurses, IAPT and Wellbeing Service workers, link workers, AM practitioners and other healthcare 
workers meeting the inclusion criteria. 
6.1.3.2.1  IAPT and Wellbeing Service workers  
The IAPT and Wellbeing Service workers will be recruited from the Norfolk and Suffolk NHS 
Foundation Trust as a whole. They will include link workers, counsellors, high and low intensity IAPT 
and Wellbeing Service workers in order to provide a wider variety of views. The Service leads in each 
cluster location will be invited to send workers the information packs with information sheets, 
consent forms, reply slips and prepaid return envelopes. A researcher will also present the study to 
the individual teams and give the information packs to those interested in the study. 
6.1.3.2.2 GPs and nurse practitioners 
The GPs and nurse practitioners treating people with depression will be invited to take part in the 
study by the Wellbeing Service team leads who will approach GPs with interest in mental health and 
send or give them the invitation sheets and/or the information packs for healthcare workers. In 
addition a researcher will contact the practice managers or staff members dealing with research in 
medical practices in the Norfolk area to invite GPs and nurse practitioners to take part in the study. 
They might be invited by a researcher briefly explaining the project at their practice meetings or 
other means as agreed with the designated staff members in individual surgeries. 
6.1.3.2.3 All healthcare workers 
If we do not receive sufficient responses through the above processes, we will recruit additional 
participants by sending reminder letters to individuals we have previously contacted, invitation 
letters to individuals not previously contacted and by delivering presentations via the IAPT and the 
Wellbeing Service. Other mental health teams within the NSFT will be invited to join in the study, as 
agreed with their team leaders in advance.  
 
We will also use a snowballing method and invite healthcare workers who know about this study 
(who might or might not have already agreed to join in the study) to tell their colleagues about the 
project. They will be encouraged to give those interested in having more information the 
researcher’s contact details and/or the invitation letter for healthcare workers. Using the 
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snowballing method we aim to invite healthcare workers treating people with depression and 
working in any team within the NHS Trusts collaborating with us on this study: the Norfolk and 
Suffolk NHS Foundation Trust (NSFT), the NHS Norfolk Primary Care Trust and the NHS Great 
Yarmouth and Waveney Primary Care Trust.  
6.1.3.2.4 AM practitioners 
Purposive sampling will be used to recruit two to three AM practitioners in order to provide their 
views for this research. Low interest of this group is anticipated but we believe it is an important 
population to access because there is a public perception that these treatments, although not 
evidence based, may be effective against depression. We therefore intend to include this 
perspective.  
In order to identify the AM practitioners for this study, we will first list the alternative therapies for 
which there is anecdotal evidence for effectiveness against depression. The Yellow Pages and Google 
will be searched with the aim to create a directory of practitioners offering these therapies in 
Norwich. We will purposively select ten practitioners from this directory in order to include as many 
different therapies as possible, and send them an invitation letter via email or post. The first three 
therapists interested in taking part in the study and meeting the inclusion criteria will be invited to 
the focus group session. Any other not invited practitioners will be sent a letter informing they were 
not selected to join in the study. If there is insufficient uptake of participants from this population we 
will approach another ten practitioners from the directory and repeat this procedure until we have 
recruited two or three AM therapists. 
6.1.3.3 Obtaining consent 
We do not intend to meet healthcare workers face-to-face to gain informed consent. They will 
complete the consent form and return it to us by post. All healthcare workers who meet the 
inclusion criteria, and send the reply slip and consent form to the researcher, will be contacted by 
the researcher and informed whether they are invited to take part in the study. This will be decided 
based on the number of participants already joining in, and the inclusion criteria. The focus groups 
will be scheduled in accordance with participants’ preferences for time and location.  
6.1.3.4 Information collected from the healthcare workers 
Healthcare workers will be asked to provide the information listed in Table 6. This information will be 
collected for statistical purposes. 
 
Table 7: Healthcare workers: information collected 
Name Email 
Age and gender Phone number 
Work address Profession 
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The information about the participants from reply slips and consent forms will be analysed and used 
as descriptive information of the groups.  
 
6.2 The concept mapping process 
Concept mapping methodology consists of two phases. In the first part participants join in focus 
groups to generate statements about what factors influence treatment choices made by people with 
depression. In the second part the same participants are invited to perform two individual tasks: 
prioritizing and clustering of the statements. Data will then be analysed.  
For each part, participants will be asked to attend a group meeting which should last no more than 2 
hours each. Separate activity sessions will be organized for members of each stakeholder group to 
prevent interaction between people with depression and the family and friends. These meetings may 
take place at the same time (in separate rooms) in order to ease travel and time organisation of 
participants. The groups should include approximately 5-10 people, but sessions will also be held for 
fewer individuals if needed, to reduce their waiting times. Activity sessions on a one to one basis 
might be organized on some occasions to meet participants’ individual needs. Healthcare workers 
will have an opportunity to take part via telephone, a short personal meeting with the researcher or 
in writing, if they cannot attend any of the offered group sessions. This is to maximize their 
representation in the study.  
All participants will be sent a time, date and place reminder two days prior the session via post, 
email or telephone call. 
The sessions will take place in a suitable venue at the University of East Anglia, provided by the NHS 
Trusts included in the study (e.g. at the Hellesdon Hospital), or in other location as appropriate and 
agreed with participants. The group meetings will be facilitated by the researcher (or another 
facilitator) and an assistant, and will last for a maximum of two hours. Attendees will be informed of 
the health and safety issues, and the ground rules of the meeting (respect of others, no judgement 
of ideas expressed). The aim of the study and particular tasks will be explained in detail before 
beginning of each session.  
 
6.2.1 Focus groups 
Focus groups are held in the first phase of the concept mapping procedure and will take place within 
approximately 6 weeks of participants expressing their interest to join in, at a time (and location if 
applicable) scheduled according to their preferences. During these sessions participants are required 
to generate as many statements as possible, in response to the given focus. A poster with the focus 
sentence printed will be put up clearly for all to see throughout the session and to help the cognitive 
processes. People with depression will be asked to generate as many statements as possible, in 
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order to complete the following sentence: ‘My most recent choice of treatment for depression was 
influenced by...’ Health care workers and family and friends will be asked to complete the following 
sentence: ‘Treatment choices made by people with depression are influenced by...’  
All statements used in the latter steps are produced in this phase, and will be recorded on a flip chart 
and a voice recorder. The quality of the sessions and statements produced depend on the 
participants’ free association and interaction with other group members. Discussion at the meeting 
will be supported by the facilitator and assistant and they will make sure participants do not feel 
inhibited to express their ideas. 
The focus groups will be audio-recorded to make sure no statements or ideas are missed during the 
data analysis. The recordings will be transcribed after the sessions and securely stored for 3 years 
following publication of research reports. After this time the necessity of data storage will be 
reviewed. 
6.2.1.1 Characteristics of statements 
The facilitator and the assistant are responsible for ‘quality’ of the focus groups and the statements 
produced. Statements must meet the following criteria to justify and enable their use in the 
prioritizing and clustering phases: 
a) Clear: Statements must be sufficiently clear to enable their possible applicability to other 
participants in that group and their use within a concept map. They need to be concrete but 
not too specific.  For example, the statement ‘Dr House told me that Prozac is the best 
medicine for me’ is too specific. Reference to the participant’s own GP or to a particular 
medicine might not apply to other participants. A less specific and more generally useful 
statement might be: ‘My health professional’s advice is important for me’. While being too 
specific is to be avoided, so is being too general. ‘We need a therapy’ is an example of a too 
general statement.  
b) Singular: A statement should only refer to one topic to enable its use in prioritizing and 
clustering phases. The statement: ‘I try to obey my GP and my wife’ contains two different 
aspects other participants may not find equally important and therefore is not singular.  
c) Understandable: Statements must be understandable and unambiguous for all participants 
and should not contain medical or technical words. An example of an ambiguous statement is: ‘I 
should be prescribed more medication...’  ‘More’ in this case might mean a larger dose of a particular 
medicine, but could equally mean other drugs in addition to drugs already prescribed. Long and 
complicated statements should be avoided as should any words that may be the jargon commonly 
used within one of the groups and not in the others, e.g. ‘euthymia’ and ‘remission’. If in doubt, 
group members may discuss if the sentence is likely to be understood, bearing in mind that health 
professionals might understand words or phrases that other participants do not, or vice versa.  
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After all focus groups have taken place, the research team will review the statements. Any duplicates 
will be removed and the total number of statements will be kept below 80. Sets of cards will be 
printed one statement on one card and these cards will be used in the next phase of the study. 
Below is an example of a card: 
 
 
 
 
Treatment choices made by people with depression 
are influenced by: 
 
Understanding the side effects of medication.  
 
12 
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Structuring sessions: Prioritizing and clustering tasks 
After the ‘statements review’ phase, all participants who had joined in the focus groups will be 
invited to take part in the second, structuring session. This will take approximately two hours, 
including a short break with refreshments provided. At the second session each participant will 
receive one set of cards with statements and will be asked to perform two individual tasks, 
prioritizing and clustering of the statements. Structuring sessions will take place within 
approximately 5 months of the focus group meetings. 
6.2.1.2 Prioritizing  
In the first task participants are asked to sort the cards into five equal piles according to their view of 
statements’ importance, using the following ratings: 
Pile 1 = relatively unimportant 
Pile 2 = somewhat important 
Pile 3 = moderately important 
Pile 4 = very important 
Pile 5 = extremely important 
 
6.2.1.3 Clustering 
Clustering the cards into categories or piles is the second task of the second session. Participants are 
asked to group together the statements that they think are thematically related. All statements have 
to be used, and each can only be used once. Participants may not put all statements into a single 
category, and piles must contain more than one statement. At the end of this task participants 
should label the categories according to their own views. 
 
6.2.2 Data analysis 
The qualitative data (statements) will be noted for each stakeholder group separately and a thematic 
analysis will be performed to understand differences in topics covered by individual groups.  
 
All statements will then be pooled, reviewed, and if necessary reworded, by the research team. They 
will be used in the second, quantitative part of the study where participants rank each statement’s 
importance and group the similar ones together. This data will be analysed using a specialised 
software package called Ariadne:   
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1) First, a graphical representation of all participants’ perspectives will be presented in a 
two-dimensional graph called ‘concept map’. An example of a concept map is shown in 
Figure 1. Each statement is shown as a single point, and their positions on the ‘map’ and 
distances to other points will have been determined by participants’ responses during the 
clustering task. The closer the statements are displayed on the map, the more participants 
had perceived them to be related.  
2) In the cluster analysis Ariadne will group the points on the ‘map’ that are located close to 
each other, into approximately 6-9 clusters. The number of clusters will depend on the 
meaning of sentences. A ‘box’ will be drawn around each cluster (by Ariadne) to make 
clear distinctions between them (see Figure 1).  
3) Based on the data from prioritizing task, the average rankings of importance will be 
calculated for each statement individually, and for the clusters. The average importance of 
each cluster can be viewed on the concept map, and is reflected by the ‘height’ or 
thickness of the clusters. 
4) The average importance rankings of statements and clusters, as viewed by each 
stakeholder group and their subgroups, will also be calculated. 
In step 5, Interpretation of results, the clusters on the concept map will be given a label which best 
describes the content or theme of the cluster. This task will be performed as a group discussion 
within the steering group. An example of a concept map produced by Ariadne software is shown in 
Figure 1. 
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Figure 1: A concept map produced by Ariadne software package. Image adapted from (van Bon-
Martens et al. 2011) 
 
 
Stage 6 involves the translation of the concept map and agreement on how the results can be used 
in practice as agreed by the steering group. The concept map sheds light on the views and priorities 
of the group as a whole and this information can be used as the basis for improving health 
professionals’ and public awareness of the factors that influence choices in depression treatment.  
 
 7 Duration of the project 
This project will be carried out as a three year PhD study and should be completed by the end of 
September 2013. 
 
 8 Dissemination of the findings  
Findings of the study will be disseminated to professionals through the academic journals and 
conferences. We will work closely with the NHS and charities concerned about mental health to 
distribute the research findings to health care workers as well as the general public. In addition, all 
participants will be sent a short final report after the study completion.   
The study findings can be used to inform health care providers of the factors affecting patients’ 
treatment choices. This can then help improve doctor patient communication and patients’ active 
participation in treatment decisions.  
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 9 Problems anticipated 
9.1 Researcher bias 
Some authors suggest that people who are rather communicative and cooperative, and have more 
socially desirable opinions might be more likely to participate in research studies (Lauber 2005). This 
may be true especially for focus groups as when discussing ideas within a group, some individuals 
can feel inhibited to express their views in case the group was to disagree with them. To help 
participants feel comfortable and to achieve good quality of focus groups, ground rules will be set at 
every session. These will include no judgement posed on people or opinions expressed, and 
respecting those who speak. The facilitator and assistant will make sure the rules are followed. In 
order to limit potential researcher bias facilitators and assistants will support the participants and 
ask questions on occasion but will not add any ideas or opinions to the group.  
 
9.2 Sampling bias 
9.2.1 People with depression 
There is a potential for sampling bias when using some recruitment strategies and different methods 
will be applied to address this issue. Charity clients are likely to be more active in the community 
than non-clients. A press release or an advert in local newspaper (EDP) can be accessed by a wide 
scope of the population, but is limited to those buying the particular paper and those who read the 
relevant pages. To reduce the risk of bias we will also invite volunteers to participate via adverts in 
GP practices and via contact with healthcare workers. Information about level of education and 
other demographic data will be collected from participants, to allow us to assess and report these 
issues in more detail.  
 
9.2.2 Family and friends 
Family and friends will be recruited primarily via people with depression, but it is anticipated that 
some people might not want anyone close to them to take part. In the GP practice poster and the 
press release we will mention the need to include family and friends in the study, to ensure we 
recruit a sufficient number of participants in this stakeholder group. 
 
9.2.3 Healthcare workers  
We will recruit healthcare workers using convenience sampling, as opposed to random selection. 
GPs with special interest in mental health will be approached by the service leads of the IAPT and 
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Wellbeing Service in Norfolk. The researcher will also contact the medical practices in Norwich that 
are already involved in the study displaying the posters to invite people with depression to take part. 
This is to maximise recruitment rates of the interested GPs and nurse practitioners.  
The decision to include the whole NSFT Trust in inviting the healthcare workers to take part in this 
study has been made to increase the possibility of recruiting a sufficient number of participants in 
this stakeholder group. This method will also minimise the unnecessary strain placed on the Service 
and the participants, and will enable us to include a wider variety of perspectives about the focus 
question of the study.  
 
9.3 Assessment of depression 
People with depression will be recruited to take part in the study if they were recommended to, or 
they had received treatment for unipolar depression within the past 12 months. They will be asked 
to provide brief information about their depression treatment in the Baseline questionnaire during a 
personal meeting with the researcher. This strategy has been decided upon to allow the inclusion of 
people with depression who have not been clinically diagnosed by their GP and treatment received 
might include therapies not provided by the NHS. 
9.4 Geographical area 
9.4.1 People with depression and family and friends 
This study is based in Norwich and people from ethnic minorities, those not speaking English and 
living in rural areas are more likely to be underrepresented in the study. This is likely to negatively 
affect generalisation of results to other parts of UK with more diverse population and differences in 
health services provided by other NHS Trusts.  
9.4.2 Healthcare workers 
Healthcare workers may be recruited from any locality of the NSFT, the NHS Norfolk and the NHS 
Great Yarmouth and Waveney, as agreed with the relevant team leaders. This method has been 
chosen to maximise recruitment rates for this stakeholder group, as including all workers from one 
cluster location would cause significant strain on the Service and workers.  
Alternative medicine (AM) therapists practicing in Norwich will be identified via the Yellow Pages and 
Google. It is likely that AM practitioners who do not have a website or are not listed in the Yellow 
Pages directory will not be represented in the study. 
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 10Study administration and ethical issues 
10.1 Informed consent  
All people who are sent the information sheet will be asked to read it carefully and take at least 24 
hours to think about their wish to participate, before they return the reply slip.  
Personal meetings with the researcher will be scheduled for people with depression and the family 
and friends to make sure they understand what the participation involves, to obtain their informed 
consent and fill in the baseline information questionnaire. These meetings will take place at agreed 
public places or if necessary, at people’s homes. The researcher will strictly adhere to the University 
Lone worker policy at all times.  
Healthcare workers will be asked to post the signed consent form with the reply slip if interested in 
participation, we do not intend to meet them individually for consenting purposes. Should any 
suitable participants arrive at any of the meetings without having been consented, consent will be 
taken face-to-face before the session commences. 
Participants will be fully explained what the focus groups and structuring sessions will involve before 
the beginning of each session. Process consent will be obtained throughout the study to make sure 
everyone is fully aware of their right to withdraw from the study at any time without giving any 
reason. 
  
10.2 Safety 
10.2.1 Lone worker policy 
Visiting participants in their homes or meeting tem in public places in order to obtain their informed 
consent and discuss the study involves an element of risk for the researcher. The University’s Lone 
Worker Policy will be followed in these situations. In practice this means that prior to every visit, the 
academic supervisor (or designated member of the research team) will be informed of the address 
and time of the meeting. The researcher will always carry a fully charged mobile phone with her, and 
will contact the supervisor (or a designated member of the research team) immediately before and 
after every meeting, and in case of any problem arising. Should the researcher feel unsafe during a 
meeting with a participant, she will leave the property immediately and telephone the academic 
supervisor (and the appropriate emergency services if necessary). 
10.2.2 Health and safety at group sessions 
Health and safety precautions and insurance for the meeting room will be covered by the venue 
owners. 
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10.3 Risks for participants 
10.3.1 Unprofessional practice and maltreatment 
For health care workers joining in the study, there is a risk the facilitator could be made aware 
through discussion of unprofessional practice, e.g. prescribing inadequate treatment. For people 
with depression and their family and friends there is a potential risk that during discussions the 
researcher could be made aware of maltreatment or abuse. Any practice that is potentially 
detrimental to a vulnerable person may have to be reported to an appropriate authority. All 
participants will be advised of this risk in the information sheet provided to them. 
 
10.3.2 Distress and withdrawal of participants 
This project is low risk in that all participants are competent, able to give full consent and are being 
asked questions that are not overly sensitive or personal. Taking part in focus groups and the 
structuring sessions is anticipated to pose minimal direct risk to participants but some people might 
experience distress when talking about the factors that influenced their choice of treatment for 
depression. To deal with such situations the facilitator will inform all participants they can take a 
break and have tea/coffee provided, at any time. In addition, during the sessions there will be a 
person available to talk to participants, should anyone become upset. Participants will be free to 
withdraw from the study at any time without providing a reason and their health care will not be 
affected in any way. They will also be aware of a confidential method of disclosing information to the 
researcher or assistant if they prefer a certain issue not to be discussed in a group setting.  
If a participant shows signs of stress during the research activities, the researcher will advise them to 
seek professional help regarding the issue (e.g. from their GP or healthcare worker of usual contact).  
There is a potential for additional distress in some people who might make the effort to read the 
information sheets and return the reply slips and might not be invited to take part in order not to 
exceed the planned number of participants. This possibility will be emphasized in the information 
sheet to prevent any unrealistic expectations.  
Contact details of the NHS Direct, a mental health charity and the Samaritans will be provided in case 
people would like to discuss their concerns with an anonymous listening service. 
 
10.4 Benefits for participants 
No immediate benefits are anticipated for the participants, but this research has a potential to 
improve the quality of care offered to future patients with depression. Through discussing the 
factors that influenced people with depression choose a particular treatment, participants may 
benefit from better awareness of options available, and meeting other people in similar situations. 
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Participation in the study will be voluntary and except for travel expenses, no financial or material 
incentives will be offered. For their effort chief investigator will offer to send the participants a short 
summary of the results and a reference to the paper once it is published. Free refreshments will be 
provided during the sessions. 
 
10.5 Participants with disabilities 
In order to meet the inclusion criteria of this study, participants must be able to understand and 
speak English well. This is due to the nature of group and individual exercises performed in this 
study, i.e. agreeing on wording of statements. 
If a participant indicates they are illiterate or have visual impairments, the researcher/facilitator 
and/or the assistant will make sure the person has fully understood the written information 
provided, and is able to provide the informed consent. The researcher will take time to read the 
documents out in full and give simplified explanations if necessary. 
 
10.6 Loss of capacity to consent 
A loss of capacity to consent in a participant who had given informed consent is an unlikely situation 
not anticipated to occur in this study. In the unlikely event of a loss of capacity, the research team 
would retain the statements generated by that person, and their personal information, such as age, 
gender, prescribed/recommended treatment for depression. The audio-recordings of the focus 
groups meetings will be destroyed after transcription. No personally identifiable information of 
participants will be published and all quotes will be anonymised. 
 
10.7 Anonymity and confidentiality 
10.7.1 Access to participant information  
In any of the recruitment methods used in this study the researcher is not required and able to 
access any personal or medical information about any potential participants unless they directly 
contact the researcher and provide this information. In order for any individual to take part in this 
research they will be required to first phone or write to the researcher. The relevant contact 
information is listed in all documents and advertising material. Having expressed their interest in 
joining in the study they will be contacted by the researcher and the recruitment process will 
continue as appropriate to the particular method.   
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10.7.2 Anonymity and confidentiality of collected data 
Paper documents that contain personal data of participants, or information that could be used to 
identify participants, will be kept in a locked cabinet in a locked room at the University of East Anglia. 
These documents will only be accessible to the researcher and her Primary Academic Supervisor. 
Potential participants will be made aware of the security and storage arrangements of all data, and 
their informed consent will be sought prior to any data collection. All documents relating to each 
participant (i.e. consent form, reply slip, questionnaire, data answer sheet) will be allocated a 
random reference code. The use of the anonymised code will ensure that individuals cannot be 
identified directly but the researchers can trace back the participants at a later stage if necessary. All 
data will be anonymised within 12 months of the end of this study. Names and contact information 
will only be kept for contact purposes. 
 
10.8 Transfer and storage of research data 
10.8.1 Transfer of data 
All data collected during the personal meetings (to obtain consent), focus groups and structuring 
sessions will be taken to the University of East Anglia by the researcher/facilitator in person as soon 
as possible after each meeting, and stored appropriately. During transfer from the research site to 
the UEA the documents containing confidential information will be carried in a lockable briefcase. 
Depending on location of the research site the researcher will travel to the UEA by various means, 
including public and private transport. She will attend to the briefcase at all times and will bring the 
documents to the UEA as soon as possible after the research session, at which point they will be 
transferred to a locked cabinet in a locked room. 
10.8.2 Storage of data 
All data will be collected and processed according to the Data Protection Act 1998.  
10.8.2.1 Personal data 
Any electronic documents that contain personal information about participants will be securely 
stored on the UEA central network server within UEA firewall and will be saved as a password 
protected document. They will not at any time be transferred by mobile devices. Electronic 
documents related to this study will be anonymised within 12 months after the end of this study.  
All paper documents that contain personal information about participants and (e.g. reply slips, 
consent forms) will be kept in a locked cabinet in a locked room at the University of East Anglia. The 
information will be transcribed to digital format and anonymised within 12 months after the end of 
the study. Paper documents containing personal data will be securely destroyed within 12 months of 
the end of the study. 
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10.8.2.2 Research data 
Focus groups discussions with participants will be recorded on an audio device and transcribed into 
digital format after each session by the researcher. All raw data, including focus group recordings, 
will be securely stored for a minimum of 3 years following publication of research reports. After this 
time the necessity of data storage will be reviewed. 
Reports and publications may contain respondents' direct quotes. These will have been anonymised 
and will contain no information that could be used to identify any individuals 
After the end of the study the Primary Academic Supervisor will take responsibility for all data 
generated during this research. The data in paper form will be stored in a locked cabinet within a 
locked room at the University of East Anglia. Electronic files related to the study will be stored in line 
with the University's guidelines. After 5 years of the end of the study the storage of data and its 
necessity will be reviewed. 
 
10.9 Resource requirements 
Below is a list of requirements for conducting this study: 
 A research assistant joining the researcher for group sessions 
 Additional facilitator and assistant to run group sessions for family and friends. These 
sessions are expected to be run in parallel with sessions for people with depression. 
 Concept mapping software (Ariadne) for data analysis 
 A suitable meeting room for group sessions 
 Stationary (pens, paper, flip chart), cards for statements printing, audio recording device 
 Paper for printing the information packs, invitation and thank you letters 
 Postage costs and envelopes for sending the invitations and information packs 
 Refreshments for all group meetings 
 Travel expenses for participants, facilitators and assistants 
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Appendix 8: Amendment 1, Notice of 
changes 
 
 
 
 
 
Dear Sir or Madam, 
 
RE: The Choice study: What factors influence treatment choices made by people with depression? 
A concept mapping study about views of people with depression, family and friends and 
healthcare workers.  
 
Reference number: 11/EE/0321 
I am writing to submit proposed amendments to the protocol for the above research project to be 
reviewed by the Research Ethics Committee. Please find enclosed the Notice of substantial 
amendment, the original and new versions of amended documents, and the new documents 
proposed to be used in the study. All proposed changes are listed in the table below and explained in 
detail in the revised version of the protocol (enclosed). 
 
Table 1: The proposed changes in the study documentation and participant recruitment methods 
Proposed changes in the study documentation and methods 
Document  Change proposed Justification of the 
change 
NRES Committee East of England – Essex 
East of England Rec Office 1 
Victoria House 
Capital Park 
Fulbourn, Cambridge 
CB21 5XB 
 
Ada Mackovova 
The Choice study 
Edith Cavell Building 
University of East Anglia 
Norwich, NR4 7TJ 
  
Email: a.mackovova@uea.ac.uk 
Mobile: 07898 287 055 
 05/03/2012 
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All participant 
documentation 
and the research 
protocol 
The phrase “Norfolk and Waveney Mental Health NHS 
Foundation Trust” (NWMHFT) to be changed to “Norfolk 
and Suffolk NHS Foundation Trust” (NSFT). Where 
abbreviations are used, “NWMHFT” will be changed to 
“NSFT”.  
The version number and date of the amended 
documents will be updated. 
Change of the NHS 
Trust name. 
All consent 
forms 
Reference to the relevant information sheet for 
participants has been changed in each consent form. 
This is to reflect the 
version number and 
date changes. 
Research 
protocol  
Recruitment methods to be added for people with 
depression: 
x An article published in charity newsletters/ 
magazines briefly explaining the study and inviting 
people with depression and their family and friends to 
take part in this research, as approved by the individual 
charities operating in the Norwich area. 
x Snowball sampling: we will invite people who have 
already agreed to take part in the study to tell their 
family, friends and colleagues about the project. They 
will be encouraged to give them the researcher’s contact 
details should anyone be interested in having more 
information or in taking part in the study. 
The additional 
recruitment 
methods have been 
selected to increase 
the number of 
participants in the 
study. 
Recruitment methods to be added for family and 
friends: 
x A press release to be publicised via local media 
outlets specifically inviting people who are close to 
someone with depression (i.e. their family and friends) 
to take part in the study.  
x An article to be published in charity newsletters/ 
magazines briefly explaining the study and inviting 
people with depression and their family and friends to 
take part in this research, as approved by the individual 
charities operating in the Norwich area. 
x A poster to be displayed at community places, e.g. 
churches, supermarkets, etc. in order for it to be seen by 
as wide a population as possible. This will be done as 
approved by the relevant authorities governing the 
particular public places. 
x Snowball sampling: we will invite people who have 
already agreed to take part in the study to tell their 
family, friends and colleagues about the project. They 
will be encouraged to give them the researcher’s contact 
details should anyone be interested in having more 
information or in taking part in the study. 
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Recruitment methods to be added for healthcare 
workers: 
x The IAPT (Improving Access to Psychological 
Therapies) and Wellbeing Service workers to be 
recruited from the Norfolk and Suffolk NHS Foundation 
Trust as a whole by the team leads sending workers the 
information packs and/or the researcher presenting the 
study to the individual teams. 
x The GPs and nurse practitioners to be invited to take 
part in the study by the researcher directly contacting 
medical practices. The researcher will send the invitation 
letters, attend the practice meetings or use other similar 
methods of recruitment as agreed with the practice 
managers or other staff members specifically dealing 
with research.  
x Snowball sampling: we will invite healthcare workers 
who are aware of the study or who have already agreed 
to take part to tell their colleagues about the project. 
They will be encouraged to give those interested in 
having more information the researcher’s contact details 
and/or the invitation letter for healthcare workers. 
 
Research 
protocol 
I have amended the following sections in the protocol: 
9.2.3 Sampling bias: healthcare workers, and 9.4.2 
Geographical area: healthcare workers 
This was done to 
reflect the changes 
of recruitment 
methods used in the 
study and to ensure 
the information 
provided in the 
protocol is 
consistent. 
Thank you for your review of the proposed amendments in advance. 
Please do contact me if you require additional information or have any comments. 
 
Kind regards 
Ada Mackovova, Chief Investigator 
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Appendix 9: Amendment 1, Ethics approval 
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Appendix 10: Amendment 1, Norfolk and 
Suffolk NHS Foundation Trust approval 
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Appendix 11: Amendment 2, notice of 
changes  
 
 
 
 
Dear Sir or Madam, 
 
RE: The Choice study: What factors influence treatment choices made by people with depression? 
A concept mapping study about views of people with depression, family and friends and 
healthcare workers.  
 
Reference number: 11/EE/0321 
 
I am hereby submitting a notice of protocol amendment for the above research project to be 
reviewed by the Research Ethics Committee. Through supervision it has become evident that there is 
an undesired degree of ambiguity about the inclusion criteria and the recruitment of participants. In 
order to make the information in the protocol clearer we propose the sections below to be added 
to/ changed in the study protocol. Please find enclosed the current and revised versions of the 
protocol and the IRAS amendment notice form. 
 
Section in 
the 
Protocol/ 
IRAS form 
Proposed change Reason for the change 
Protocol Recruitment of people with depression [change in This is to ensure sufficient 
NRES Committee East of England – Essex 
East of England Rec Office 1 
Victoria House 
Capital Park 
Fulbourn, Cambridge 
CB21 5XB 
 
Ada Mackovova 
The Choice study 
Edith Cavell Building 
University of East Anglia 
Norwich, NR4 7TJ 
  
Email: a.mackovova@uea.ac.uk 
Mobile: 07898 287 055 
 08/05/2012 
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section 
6.1.1.2 (a) 
wording]: Contact via the healthcare workers: as 
agreed with their team leaders, the healthcare 
workers from any locality or team of the NSFT, the 
NHS Norfolk and the NHS Great Yarmouth and 
Waveney may be asked to give the information sheets 
for people with depression to their clients meeting 
the inclusion criteria in this study.  
numbers of participants are 
recruited in the study. 
Protocol 
section 
6.1.3.2 
Recruitment of healthcare workers [change in 
wording]: Approximately 30 healthcare workers will 
take part in the study, including GPs, nurses, mental 
health nurses, IAPT and Wellbeing Service workers, 
link workers, AM practitioners and other healthcare 
workers meeting the inclusion criteria.  
 
This is to ensure that any 
relevant healthcare workers 
can be included in the study 
to provide their views about 
the research topic. 
Protocol 
section 
6.1.3.2.3 
Recruitment of healthcare workers: Other mental 
health teams within the NSFT will be invited to join in 
the study, as agreed with their team leaders in 
advance. 
This is to ensure that any 
relevant healthcare workers 
meeting the inclusion criteria 
can be included in this study. 
We will also use a snowballing method and invite 
healthcare workers who know about this study (who 
might or might not have already agreed to join in the 
study) to tell their colleagues about the project. 
Wording changed for clearer 
meaning 
Using the snowballing method we aim to invite 
healthcare workers treating people with depression 
and working in any team within the NHS Trusts 
collaborating with us on this study: the Norfolk and 
Suffolk NHS Foundation Trust (NSFT), the NHS Norfolk 
Primary Care Trust and the NHS Great Yarmouth and 
Waveney Primary Care Trust. 
This statement has been 
added to make clear how the 
snowballing method is used. 
Protocol 
section 
6.2; IRAS 
form 
section 
A18 
The sessions will take place in a suitable venue at the 
University of East Anglia, provided by the NHS Trusts 
included in the study (e.g. at the Hellesdon Hospital), 
or at other location as appropriate and agreed with 
participants. 
This is to ensure that the 
participants who might be 
unable to attend the group 
sessions can take part in the 
study. On such occasions the 
location of sessions will be 
agreed with the participants. 
Protocol 
section 
9.2.1 
To reduce the risk of bias we will also invite 
volunteers [people with depression] to participate via 
adverts in GP practices and via contact with 
healthcare workers. 
This is to reflect the above 
changes in recruitment of 
people with depression. 
Protocol 
section 
9.4.2 
Healthcare workers may be recruited from any locality 
of the NSFT, the NHS Norfolk and the NHS Great 
Yarmouth and Waveney, as agreed with the relevant 
team leaders. This method has been chosen to 
maximise recruitment rates for this stakeholder 
group, as including all workers from one cluster 
location would cause significant strain on the Service 
Wording of this section has 
been amended to reflect the 
above changes in recruitment 
of healthcare workers. 
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and workers.  
 
Please do contact me if you require additional information or have any comments regarding the 
proposed changes to the protocol. 
Thank you in advance for your review of the above amendments. 
 
Kind regards 
 
Ada Mackovova 
Chief Investigator 
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Appendix 12: Amendment 2, Ethics 
approval 
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Appendix 13: Amendment 2, Norfolk and 
Suffolk NHS Foundation Trust approval 
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Appendix 14: Amendment 1 and 2, NHS 
Norfolk and Waveney approval 
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Appendix 15: Recruitment press release 1 
Press release for the Eastern Daily Press, Version 2: 31/08/2011 
 
Researchers at the University of East Anglia are looking for people who have depression* to help 
them understand more about how people make treatment choices. 
Patients’ preferences for treatment have a strong influence on their adherence to treatment but we 
do not know what those are based on. ‘The Choice Study’ aims to find out what factors patients 
consider when selecting a therapy for depression. 
As well as surveying people with depression themselves, the researchers also want to interview their 
family and friends.  
Professor Richard Gray, who is leading the research in the University’s School of Nursing Sciences, 
said: “Our aim is to understand how people with depression make decisions about their treatment.”  
“We want to find out what people take into account when choosing a treatment. Do patients really 
know what they are opting for when selecting antidepressants or talking therapy for their 
depression, or not taking any treatment at all?”  
The researchers are looking for 60 people to volunteer to take part – 30 who have been 
recommended or have received treatment for depression* by a health care worker using 
antidepressants, psychological therapy, or alternative therapies, and 30 family members and friends.  
“We are interested to talk to volunteers about the treatment choices that were offered to them, 
what treatment they chose, and how they made that decision,” said Professor Gray. 
“Their views are really important for us and will be used to help patients make informed decisions 
about treatment for depression” he added.  
Volunteers must be over 18, and have been recommended or treated for depression* within the last 
12 months, or be a close family member or friend to such person. Participants will be invited to join 
in two small group sessions (with about 6 other volunteers) at the University of East Anglia, taking 
about 2 hours each. 
 
* We are inviting people with depression to take part. The study is not seeking to recruit people with 
bipolar disorder or other mental illness. 
To find out more about the research or to volunteer, please contact the researcher Ada Mackovova 
by emailing a.mackovova@uea.ac.uk or call 07707 298 277. 
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Appendix 16: Recruitment press release 2 
Press Release for recruitment of family and friends, version 1: 
29/02/2012 
FOR IMMEDIATE RELEASE 
 
Family and friends of people with depression are needed for research at UEA 
 
Researchers at the University of East Anglia are looking for close friends and family of 
people suffering from depression for a study investigating how people with the illness make 
treatment choices. 
 
Patients’ preferences for treatment have a strong influence on their adherence to treatment 
but it is not yet known what those are based on. The ‘Choice Study’ aims to find out what 
factors patients consider when selecting a therapy for depression. 
 
Prof Richard Gray, the lead researcher in the University’s School of Nursing Sciences, said: 
“Our aim is to understand how people with depression make choices about their treatment. 
Do people really know what they are opting for when taking medication, talking therapies or 
no treatment at all?” 
 
“The views of family and friends are really important for us, and will be used to help patients 
make informed decisions about treatment for depression in the future.” 
 
Volunteers must be over 18, and be a close family member or friend to a person who has 
received or been recommended to receive treatment for depression within the past year. The 
study is not seeking to recruit family or friends of people with bipolar disorder or other 
mental illness other than depression. 
 
Participants will be invited to join in two small group sessions (with about four other 
volunteers) at the University of East Anglia, taking about two hours each. 
 
To find out more about the research or to volunteer, please contact Ada Mackovova by 
emailing a.mackovova@uea.ac.uk or calling 07707 298 277. 
 
ENDS 
 
EDITOR’S NOTES 
  
1/ For more information or to set up an interview, please contact Fiona Billings in the UEA 
Press Office on 01603 592226 or email f.billings@uea.ac.uk.  
 
2/ The University’s School of Nursing Sciences is ranked third in the UK for Nursing and 
Paramedical Studies (Guardian University Tables, 2012) and seventh in the UK for Nursing 
(The Complete University Guide, 2012). www.uea.ac.uk/nsc.  
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Appendix 17: Recruitment article published 
in the Eastern Daily Press 
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Appendix 18: Recruitment article published 
in the Norwich Evening news 
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Appendix 19: Recruitment article published 
in the Ipswich Star 
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Appendix 20: Recruitment article published 
in the MIND magazine  
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Appendix 21: Recruitment poster 1 
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Appendix 22: Recruitment poster 2 
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Appendix 23: Invitation letter to healthcare 
workers 
 
 
 
 
Ada Mackovova, The Choice Study 
Edith Cavell Building, University of East Anglia 
Norwich Research Park 
Norwich, NR4 7TJ 
Email: a.mackovova@uea.ac.uk, Tel: 07707 298 277 
Dear Sir or Madam 
Re: Invitation to participate in The Choice Study: What factors influence treatment choices made 
by people with depression? 
We would like to invite you to take part in a research study about how people with depression make 
treatment decisions. People’s preferences have a strong influence on adherence to therapy, but we 
do not know what they are based on. The purpose of this study is to provide a better understanding 
of what factors influence treatment choices made by people with depression. We are interested in 
your opinion about how people with depression make treatment choices. 
You are invited to take part if you have worked with a person with depression within the past 12 
months. Participation is voluntary and you can withdraw from the study at any time without giving a 
reason. The project is conducted in two parts:  
 
1) Focus group sessions to produce as many statements as possible, completing the sentence: 
“Treatment choices made by people with depression are influenced by...” The location, time, 
and form of these sessions will be of your preference, e.g. a short (15 minutes) phone 
conversation or a personal meeting. Responses from all participants will be reviewed and 
individually printed on cards as statements.  
2) Structuring session will take place within 5 months of the focus group meeting. You will be 
invited to (1) rank the importance of the individual statements about how people with 
depression make treatment choices, and to (2) put statements that seem to go together into 
groups. Duration of this part will depend on the number of statements but should take no 
longer than 1-2 hours. 
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The results of this study will be published in academic journals and we will also send you a summary 
of findings once the study is completed.  
If you have any questions or would like to take part in this study, please do contact me. Thank you 
very much for your time and effort, and for reading this letter. 
 
Yours Sincerely, 
Ada Mackovova, researcher 
  
 
 
 
 
 
 
 
 
  
This study is conducted by a PhD student Ada Mackovova, supervised by 
Professor Richard Gray, School of Nursing Sciences, University of East Anglia. 
This research is funded by the University of East Anglia and has been approved by 
the NHS Research Ethics Committee in Essex.  
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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Appendix 24: Participant Information sheet 
for people with depression 
 
 
Information sheet – People with depression (Version 4: 
29/02/2012) 
The Choice Study: What factors influence treatment choices 
made by people with depression? 
Dear Sir or Madam, 
 
We would like to invite you, a person with depression, to take part in a research study looking at the 
factors that influenced your choice of treatment. Your opinion is very important to us. After talking 
to you we will collate the information gathered and use it to enable healthcare workers to have a 
better understanding of people’s needs in this matter.  
 
We are also interested in views of a person who is close to you, i.e. your family and friend. This can 
be your partner, spouse, or someone close to you. If you would like to nominate such a person for 
this study, please hand them the sheet titled “Information sheet for family and friends”. You can join 
in the study even if you do not nominate a family and friend. 
 
The following pages contain information about our project. Yours and your family and friend’s 
participation is entirely optional and if you change your mind and do not want to take part anymore 
you are free to withdraw from the study at any time. You do not have to give us any reason. Before 
you decide whether or not you would like to take part it is important that you understand why this 
study is being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. 
 
If you would like to take part please complete the enclosed reply slip and return it to us in the pre-
paid envelope provided. Ada, the researcher will contact you within one week of receiving your reply 
slip to arrange a personal meeting to discuss the study with you, answer your questions and ask you 
to sign a consent form. You will also be asked to fill in a short questionnaire that should take no 
more than 10 minutes to complete. This meeting will take place at a community location agreed with 
you. If that would be difficult for you please discuss alternatives with the researcher. If you have any 
comments or questions about this study, please contact the researcher Ada Mackovova. 
Thank you for your time, Yours faithfully, Ada Mackovova, researcher 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation     
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
 
Page 352 of 386 
What is the purpose of this research? 
Healthcare workers and patients often have different perceptions about treatment for depression. 
Patients’ preferences play an important role in their acceptance and adherence to therapy, and even 
ultimate treatment outcomes, but we still do not know what they are based on. In this study, we aim 
to gain a better understanding of how people with depression make their treatment choices, and 
what is important to them.  
 
To do this we will gather the opinions of 30 people with depression, 30 family members and friends 
of these people and 30 healthcare workers. We will compare these groups to see how similar or 
different their views are about people’s treatment choices.  
 
The findings of this study can help healthcare workers better understand the patients’ perception of 
different treatments and support patients in their informed decision-making.  
 
This study is being undertaken for educational purposes, as part of Ada Mackovova’s PhD. 
 
Are there any inclusion criteria? 
We invite people with depression who have been recommended or prescribed treatment by a 
healthcare worker or alternative medicine therapists. This includes your GP, nurse practitioner, 
psychologist, herbalist or other practitioners.  
 
We are inviting people with depression to join in this research, including people with pre-natal and 
post-natal depression. The study is not seeking to recruit people with bi-polar disorder or other 
mental illness.  
 
All participants need to be adults aged over 18 and speak English. 
 
Do I have to take part? 
It is completely up to you whether you take part. It is important that you read this information sheet 
so that you can make an informed decision. If you change your mind, you can withdraw from the 
study at any time. You do not have to give us any reason and your health care will not be affected in 
any way.  
 
Who is the ‘family and friend’ and why should they participate? 
The ‘family and friend’ is an English speaking adult who is close to you, for instance your partner, 
spouse, parent, sibling, or a close friend or family member. Their views are very important and will 
help us understand better how people make their treatment choices. If you would like to nominate a 
person for this study, please write their name in the reply slip, and give them the Information sheet 
for family and friends, that is enclosed. You can take part even if you do not nominate a family and 
friend for this study.    
 
What will happen to me if I take part? 
After receiving your reply slip, Ada, the researcher will contact you within one week to arrange a 
personal meeting with you and your family and friend (if participating). This will be a short, up to 30-
60 minute discussion and will normally take place at a community location as agreed with you. Ada 
will talk to you about the study, and answer your queries. If you wish to take part you will be asked 
to sign the consent form and fill in a short questionnaire that takes no more than 10 minutes.  
 
Within another 4-6 weeks you will be invited to an informal group discussion with about 6 other 
people at the University of East Anglia in Norwich, at a time and day you prefer. You are welcome to 
arrive together with your family and friend as there will be two separate sessions taking place at the 
same time. The task for the group will be to think of as many ideas as possible, to complete the 
sentence: “My most recent treatment choice for depression was influenced by...” You can say as 
many or as few things as you feel comfortable with. We will note the group’s ideas on a flip chart, 
and record the session on a tape to make sure we do not miss any important issues discussed. We 
will not note details about who said any particular statement.  
 
The second session will take place within 5 months of the initial session and you will work on two 
individual tasks. We will give you a set of cards with statements about how people make depression 
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treatment choices. First, you will be invited to say which are more or less important in informing 
people’s treatment choices. In the second part you will be asked to put the statements that seem to 
go together into groups. 
 
All meetings will be led by a trained and friendly facilitator (this will be the researcher, Ada 
Mackovova or her colleague/supervisor) and at least one assistant. Each session will take maximum 
of 2 hours including a break. We will provide the refreshments and reimburse you for travel 
expenses. 
 
Have a problem with group sessions? 
If you are interested in taking part but for any reason feel uncomfortable with any aspect of this 
study, please contact us and we can discuss other options with you. 
 
If I want to take part what do I need to do? 
If you would like to take part, please: 
1. Give the pack titled “Information sheet for the family and friends” to a person you nominated. 
You can still take part if you do not nominate anyone. 
2. Fill in the reply slip and send it to us in the pre-paid envelope provided. 
3. Take part in a focus group at time and day that is convenient for you. 
4. Take part in the second session within about 5 months later. We will arrange it at your 
convenience.   
 
Expenses and payments 
We will pay your travel expenses for our study and provide free refreshments, but unfortunately we 
do not have funds to compensate you for your time.  
 
What are the possible disadvantages and risks of taking part? 
The risk of harm as a result of participation in this study is very low. On some occasions thinking 
about, and discussing your depression treatment decisions might make you feel upset. You are 
welcome to take a break or stop your participation if you wish to, without giving us any reason. If 
your feelings of distress persist, we recommend that you visit your GP or other healthcare worker of 
usual contact. 
 
A disadvantage arising from your participation is that you spend approximately four hours of your 
time, which will not be paid for. We will reimburse you for travel expenses and provide free 
refreshments during both activity sessions. 
 
What are the possible benefits of taking part?  
There might be no immediate or direct benefits to you. We will try to make the sessions enjoyable 
and interesting for you, and you will have the opportunity to meet new people – other participants. 
This research will help us understand how people make their treatment choices and we hope that 
health care workers will use our findings when treating future patients. 
 
Will my taking part in this study be kept confidential? 
All of the information that you provide us for this study will be kept strictly confidential. Your 
personal details, such as your name and contact details, will be recorded and stored according to the 
Data Protection Act (1998). To protect your privacy the following measures will be taken to ensure 
that no-one, apart from the researcher (Ada Mackovova) and her primary supervisor (Professor 
Richard Gray) has access to your personal information: 
x Your name and other indentifying details (e.g. your address) will not appear on any report or 
publication which arises from this research. 
x We will only use your name and contact details to invite you to take part in the forthcoming 
sessions. 
x You will be allocated a code number which might be used when the study results are produced. 
Only you, the researcher and her supervisor will know your name and code number. The 
documents showing a link between your name and other information will be securely destroyed 
within 12 months after the end of the study.  
x All electronically stored personal information will be securely stored on the UEA central network 
server within UEA’s firewall, and saved as a password protected documents. 
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x All data will be anonymised, and our records of your personal information will be securely 
destroyed within 12 months after the end of the study. 
x Raw data including focus group recordings will be securely stored in a locked cabinet at the UEA 
for 3 years following publication of research reports. After this time the necessity of data 
storage will be reviewed. 
x Should you withdraw from this research, or in the unlikely event of a participant losing their 
capacity to consent during the study any data already collected with consent would be retained 
and used in the analysis.  
 
Important:   
If there is any information disclosed during the sessions that concerns the researcher (e.g. 
information that a crime is about to be committed or somebody is at risk of significant harm) then 
confidentiality may have to be broken.  
 
What will happen to the results of the research study? 
We will send you a summary of our findings after completion of the study. We hope you will find this 
report interesting and it will help you understand other people’s views about depression treatment 
decisions. We will also produce reports and publications based on the study results. No names or 
contact details of participants will be included in any publications and no individuals will be 
identifiable. 
 
Who is organising and funding the research? 
This research is being undertaken as part of a PhD study of Ada Mackovova. She is supervised by 
Professor Richard Gray and Dr Bridget Penhale from the School of Nursing Sciences, University of 
East Anglia, Norwich. Our study is funded by the University of East Anglia. 
 
Who has reviewed the study? 
The study’s protocol has been reviewed and approved by the NHS Research Ethics Committee East of 
England – Essex and the Research and Development Teams in the Norfolk and Suffolk NHS 
Foundation Trust, NHS Norfolk and NHS Great Yarmouth and Waveney.  
 
Can I talk to anyone about this study? 
Feel free to discuss this study with anyone you wish to. You can ask your GP for opinion and talk to 
your family and friends. 
 
Who can I contact for further information? 
Further information about the study is available from Ada Mackovova: 
 
The Choice Study 
Edith Cavell Building 
University of East Anglia 
Norwich Research Park 
Norwich, NR4 7TJ 
Tel number: 07707 298 277 
Email: a.mackovova@uea.ac.uk 
 
 
For general information about taking part in research studies, please contact the Research and 
Development department, Hellesdon Hospital, Drayton High Road, Norwich, NR6 5BE. 
 
What if there is a problem or I have a complaint? 
If you have a concern about any aspect of this study, you should ask to speak to the researcher Ada 
Mackovova, who will do her best to answer your questions. If you remain unhappy and wish to 
complain formally, you can do this by writing to [Professor Richard Gray, Edith Cavell Building, 
University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ].  
 
Alternatively, you can complain in writing to Professor Valerie Lattimer, Head of School of Nursing 
Sciences, Edith Cavell Building, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ. 
Please note that you may have to pay for postage of complaint letters. 
Thank you for your time and effort!  
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Appendix 25: Participant Information Sheet 
for family and friends 
 
 
 
Information sheet – Family and friends (Version 4: 
29/02/2012) 
The Choice Study: What factors influence treatment choices 
made by people with depression? 
 
Dear Sir or Madam, 
 
We would like to invite you, a person close to someone with depression (i.e. the family and friend) to 
take part in a research study looking at the factors that influence a person’s choice of depression 
treatment. Your opinion is very important to us. After talking to you we will collate the information 
gathered and use it to enable healthcare workers to have a better understanding of people’s needs 
in this matter.  
 
The following pages contain information about our project. Your participation is entirely optional 
and if you change your mind and do not want to take part anymore you are free to withdraw from 
the study at any time. You do not have to give us any reason. Before you decide whether or not you 
would like to take part it is important that you understand why this study is being done and what it 
will involve. Please take time to read the following information carefully and discuss it with others if 
you wish. 
 
If you would like to take part please complete the enclosed reply slip and return it to us in the pre-
paid envelope provided. Ada, the researcher will contact you within one week of receiving your reply 
slip to arrange a personal meeting to discuss the study with you, answer your questions and ask you 
to sign a consent form. You will also be asked to fill in a short questionnaire that should take no 
more than 10 minutes to complete. This meeting will take place at a community location agreed with 
you. If that would be difficult for you please discuss alternatives with the researcher. 
 
If you have any comments or questions about this study, please contact the researcher Ada 
Mackovova, contact details on page 5. Thank you for your time,  
Yours faithfully, Miss Ada Mackovova, Researcher 
 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
 
Page 356 of 386 
What is the purpose of this research? 
Healthcare workers and patients often have different perceptions about treatment for depression. 
Patients’ preferences play an important role in their acceptance and adherence to therapy, and even 
ultimate treatment outcomes, but we still do not know what they are based on. In this study, we aim 
to gain a better understanding of how people with depression make their treatment choices, and 
what is important to them.  
 
To do this we will gather the opinions of 30 people with depression, 30 family members and friends 
of these people and 30 healthcare workers. We will compare these groups to see how similar or 
different their views are about people’s treatment choices.  
 
The findings of this study can help healthcare workers better understand the patients’ perception of 
different treatments and support patients in their informed decision-making.  
 
This study is being undertaken for educational purposes, as part of Ada Mackovova’s PhD. 
 
Who is the ‘family and friend’ and are there any inclusion criteria? 
In this study the ‘family and friend’ is a person close to someone with depression. You could be their 
family member or a friend. We are inviting people with depression and those close to them to join in 
this research. The study is not seeking to recruit people with bi-polar disorder or other mental 
illness.  
  
All participants need to be adults aged over 18 and speak English. 
 
Do I have to take part? 
It is completely up to you whether you take part. It is important that you read this information sheet 
so that you can make an informed decision. If you change your mind, you can withdraw from the 
study at any time. You do not have to give us any reason and your health care will not be affected in 
any way.  
 
What will happen to me if I take part? 
After receiving your reply slip, Ada, the researcher will contact you within one week to arrange a 
personal meeting with you and the person with depression who is close to you (if participating). This 
will be a short, about 30-60 minute discussion and will normally take place at a community location 
as agreed with you. Ada will talk to you about the study, and answer your queries. If you wish to take 
part you will be asked to sign the consent form and fill in a short questionnaire that takes no more 
than 10 minutes.  
 
Within another 4-6 weeks you will be invited to an informal group discussion with about 6 other 
people at the University of East Anglia in Norwich, at a time and day you prefer. You are welcome to 
arrive together with your person with depression as there will be two separate sessions taking place 
at the same time. The task for the group will be to think of as many ideas as possible, about: 
“Treatment choices made by people with depression are influenced by...” You can say as many or 
as few things as you feel comfortable with. We will note the group’s ideas on a flip chart, and record 
the session on a tape to make sure we do not miss any important issues discussed. We will not note 
details about who mentioned any particular issue.  
 
The second session will take place within 5 months of the initial session and you will work on two 
individual tasks. We will give you a set of cards with statements about how people make depression 
treatment choices. First, you will be invited to say which are more or less important in informing 
people’s treatment choices. In the second part you will be asked to put the statements that seem to 
go together into groups. 
 
All meetings will be led by a trained and friendly facilitator (this will be the researcher, Ada 
Mackovova or her colleague/supervisor) and at least one assistant. Each session will take maximum 
of 2 hours including a break. We will provide the refreshments and reimburse you for travel 
expenses. 
 
Have a problem with group sessions? 
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If you are interested in taking part but for any reason feel uncomfortable with any aspect of this 
study, please contact us and we can discuss this with you. 
 
If I want to take part what do I need to do? 
If you would like to take part, please: 
1. Fill in the reply slip and send it to us in the prepaid envelope provided. 
2. Take part in a focus group at time and day that is convenient for you. 
3. Take part in the second session within about 5 months later. We will arrange it at your 
convenience.   
 
Expenses and payments 
We will pay your travel expenses for our study and provide free refreshments, but unfortunately we 
do not have funds to compensate you for your time.  
 
What are the possible disadvantages and risks of taking part? 
The risk of harm as a result of participation in this study is very low. On some occasions thinking 
about, and discussing depression treatment decisions made by a person close to you might make 
you feel upset. You are welcome to take a break or stop your participation if you wish to, without 
giving us any reason. If your feelings of distress persist after the end of study, we recommend that 
you visit your GP or other healthcare worker of usual contact. 
 
A disadvantage arising from your participation is that you spend approximately four hours of your 
time, which will not be paid for. We will reimburse you for travel expenses and provide free 
refreshments during both activity sessions. 
 
What are the possible benefits of taking part?  
There might be no immediate or direct benefits to you. We will try to make the sessions enjoyable 
and interesting for you, and you will have the opportunity to meet new people – other participants. 
This research will help us understand how people make their treatment choices and we hope that 
health care workers will use our findings when treating future patients. 
 
Will my taking part in this study be kept confidential? 
All of the information that you provide us for this study will be kept strictly confidential. Your 
personal details, such as your name and contact details, will be recorded and stored according to the 
Data Protection Act (1998). To protect your privacy the following measures will be taken to ensure 
that no-one, apart from the researcher (Ada Mackovova) and her primary supervisor (Professor 
Richard Gray) has access to your personal information: 
x Your name and other indentifying details (e.g. your address) will not appear on any report or 
publication which arises from this research. 
x We will only use your name and contact details to invite you to take part in the forthcoming 
sessions. 
x You will be allocated a code number which might be used when the study results are produced. 
Only you, the researcher and her supervisor will know your name and code number. The 
documents showing a link between your name and other information will be securely destroyed 
within 12 months after the end of the study.  
x All electronically stored personal information will be securely stored on the UEA central network 
server within UEA’s firewall, and saved as a password protected documents. 
x All data will be anonymised, and our records of your personal information will be securely 
destroyed within 12 months after the end of the study.  
x Raw data including focus group recordings will be securely stored in a locked cabinet at the UEA 
for 3 years following publication of research reports. After this time the necessity of data 
storage will be reviewed.  
x Should you withdraw from this research, or in the unlikely event of a participant losing their 
capacity to consent during the study any data already collected with consent would be retained 
and used in the analysis.  
 
Important: 
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If there is any information disclosed during the sessions that concerns the researcher (e.g. 
information that a crime is about to be committed or somebody is at risk of significant harm) then 
confidentiality may have to be broken. 
 
What will happen to the results of the research study? 
We will send you a summary of our findings after completion of the study. We hope you will find this 
report interesting and it will help you understand other people’s views about depression treatment 
decisions. We will also produce reports and publications based on the study results. No names or 
contact details of participants will be included in any publications and no individuals will be 
identifiable. 
 
Who is organising and funding the research? 
This research is being undertaken as part of a PhD study of Ada Mackovova. She is being supervised 
by Professor Richard Gray and Dr Bridget Penhale from the School of Nursing Sciences, University of 
East Anglia, Norwich. Our study is funded by the University of East Anglia. 
 
Who has reviewed the study? 
The study’s protocol has been reviewed and approved by the NHS Research Ethics Committee East of 
England - Essex and the Research and Development Teams in the Norfolk and Suffolk NHS 
Foundation Trust, NHS Norfolk and NHS Great Yarmouth and Waveney.  
 
Can I talk to anyone about this study? 
Feel free to discuss this study with anyone you wish to. You can ask your GP for opinion and talk to 
your family and friends. 
 
Who can I contact for further information? 
Further information about the study is available from Ada Mackovova: 
 
The Choice Study 
Edith Cavell Building 
University of East Anglia 
Norwich Research Park 
Norwich, NR4 7TJ 
 
Tel number: 07707 298 277 
Email: a.mackovova@uea.ac.uk 
 
 
For general information about taking part in research studies, please contact the Research and 
Development department, Hellesdon Hospital, Drayton High Road, Norwich, NR6 5BE. 
 
What if there is a problem or I have a complaint? 
If you have a concern about any aspect of this study, you should ask to speak to the researcher Ada 
Mackovova, who will do her best to answer your questions. If you remain unhappy and wish to 
complain formally, you can do this by writing to [Professor Richard Gray, Edith Cavell Building, 
University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ].  
 
Alternatively, you can complain in writing to Professor Valerie Lattimer, Head of School of Nursing 
Sciences, Edith Cavell Building, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ. 
 
Please not that you may have to pay for postage of complaint letters. 
 
 
Thank you for your time and effort! 
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Appendix 26: Participant Information Sheet 
for healthcare workers 
 
 
 
 
 
Information sheet – Healthcare workers (Version 3: 
29/02/2012) 
The Choice Study: What factors influence treatment choices 
made by people with depression? 
 
Dear Sir or Madam, 
Thank you for your interest in our research study about how people with depression make treatment 
choices. Your opinion is very important to us. After talking to you we will collate the information 
gathered and use it to enable healthcare workers to have a better understanding of peoples’ needs 
in this matter.  
 
The following pages contain information about our project. Your participation is entirely optional 
and you can withdraw from the study at any time, without giving us any reason. Before you decide 
whether or not you would like to take part it is important that you understand why this study is 
being done and what it will involve. Please take time to read the following information carefully and 
discuss it with others if you wish to. 
 
If you would like to take part please complete the enclosed reply slip, sign the consent form, and 
return them to us in the envelope provided. Alternatively, you can contact the researcher, Ada 
Mackovova, by phone, email or post and discuss the possibilities of taking part. 
 
If you have any queries or would like more information, please contact Ada Mackovova, contact 
details on page 4. 
 Thank you for your time, 
 
Yours sincerely, Ada Mackovova, Researcher 
 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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What is the purpose of this research? 
Healthcare workers and patients often have different perceptions about treatment for depression. 
Patients’ preferences play an important role in their acceptance and adherence to therapy, and even 
ultimate treatment outcomes, but we still do not know what they are based on. In this study, we aim 
to gain a better understanding of how people with depression make their treatment decisions, and 
what is important to them.  
 
To do this we will collect the opinions of 30 people with depression, 30 family members and friends 
of these people and 30 healthcare workers. We will compare these groups to see how similar or 
different their views are about people’s treatment choices.  
 
The findings of this study can help healthcare workers better understand the patients’ perception of 
different treatments and support patients in their informed decision-making.  
 
This study is being undertaken for educational purposes, as part of Ada Mackovova’s PhD. 
 
Are there any inclusion criteria? 
We invite healthcare workers and professionals with a recent (within the past 12 months) experience 
of treating a patient with unipolar depression. 
 
What will my participation in the study involve? 
The study is in two phases. 
After signing the consent form you will be invited to a focus group session. Its aim is to produce as 
many statements as possible, to complete the sentence: “Treatment choices made by people with 
depression are influenced by...”  
 
The second part will take place within 5 months after the focus group and will involve two individual 
tasks. We will give you a set of cards with statements about how people make depression treatment 
choices. First, you will be invited to say which are more or less important in informing patients’ 
treatment choices. In the second task you will be asked to put the statements that seem to go 
together into groups.  
 
What commitment is needed from me? 
The focus group meeting might take form of a group session with other healthcare workers, a 
personal meeting with the researcher or a short phone call lasting 15 minutes. Duration will depend 
on participants’ preferences but sessions will last for a maximum of two hours.  
 
You can perform the second part of the project in your own time. Duration of this part depends on 
the number of statements but it should take no longer than an hour. 
 
If I want to take part what do I need to do? 
1. Fill in the reply slip and send it to us in the prepaid envelope provided, OR 
Contact us and we will discuss the options with you 
2. Take part in the focus group session at location, time and form of your preference. 
3. Take part in the second session within about 5 months, in your own time.  
 
Do I have to take part? 
It is entirely up to you to decide whether or not you participate. If you change your mind and do not 
wish to participate, you can withdraw from the study at any time and you do not have to give us any 
reason.  
 
Expenses and payments 
We will pay for your travel expenses for our study and provide free refreshments, but unfortunately 
we do not have funding to compensate you for your time.  
 
What are the possible disadvantages and risks of taking part? 
There is a minimal risk of harm as a result of participation in this study. We consider the greatest 
disadvantage for you to be the time you invest in our study. As a thank you we will send you a 
summary of the results after completion of this study. 
Page 361 of 386 
 
What are the possible benefits of taking part?  
There might be no immediate or direct benefits to you. This research will help us understand how 
people make depression treatment choices and we hope that health care workers will be informed 
by our findings when treating future patients. 
 
Will my taking part in this study be kept confidential? 
All of the information that you provide us for this study will be kept strictly confidential. Your 
personal details, such as your name and contact details, will be recorded and stored according to the 
Data Protection Act (1998). To protect your privacy the following measures will be taken to ensure 
that no-one, apart from the researcher (Ada Mackovova) and her primary supervisor (Professor 
Richard Gray) has access to your personal information: 
x Your name and other identifying details (e.g. your address) will not appear on any report or 
publication which arises from this research. 
x We will only use your name and contact details to invite you to take part in the forthcoming 
sessions. 
x You will be allocated a code number which might be used when the study results are produced. 
Only you, the researcher and her supervisor will know your name and code number. The 
documents showing a link between your name and other information will be securely destroyed 
within 12 months after the end of the study.  
x All electronically stored personal information will be securely stored on the UEA central network 
server within UEA’s firewall, and saved as a password protected documents. 
x All data will be anonymised, and our records of your personal information will be securely 
destroyed within 12 months after the end of the study. 
x Raw data including focus group recordings will be securely stored in a locked cabinet at the UEA 
for 3 years following publication of research reports. After this time the necessity of data 
storage will be reviewed. 
x Should you withdraw from this research, or in the unlikely event of a participant losing their 
capacity to consent during the study any data already collected with consent would be retained 
and used in the analysis.  
 
Important: 
If there is any information disclosed during the sessions, about practice potentially harmful to 
vulnerable people (e.g. information about mistreatment, abuse or a crime) then confidentiality may 
have to be broken.  
 
What will happen to the results of the research study? 
We will send you a summary of our findings after completion of the study. We hope you will find this 
report interesting and that it will help you understand better how patients make depression 
treatment decisions. We will also produce reports and publications based on the study results for 
academic journals. No names or contact details of participants will be included in publications and no 
individuals will be identifiable. 
 
Who is organising and funding the research? 
The research is being undertaken as part of a PhD study of Ada Mackovova. Ada is supervised by 
Professor Richard Gray and Dr Bridget Penhale from the School of Nursing Sciences, University of 
East Anglia, Norwich. Our study is funded by the University of East Anglia. 
 
Who has reviewed the study? 
The study’s protocol has been reviewed and approved by the NHS Research Ethics Committee East of 
England - Essex and the Research and Development Teams in the Norfolk and Suffolk NHS 
Foundation Trust, NHS Norfolk and NHS Great Yarmouth and Waveney.  
 
Can I talk to anyone about this study? 
Please feel free to talk to anyone about this study. 
 
Who can I contact for further information? 
Further information about the study is available from Ada Mackovova: 
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The Choice Study 
Edith Cavell Building 
University of East Anglia 
Norwich Research Park 
Norwich, NR4 7TJ 
 
Tel number: 07707 298 277 
Email: a.mackovova@uea.ac.uk 
 
For general information about taking part in research studies, please contact the Research and 
Development department, Hellesdon Hospital, Drayton High Road, Norwich, NR6 5BE. 
 
What if there is a problem or I have a complaint? 
If you have a concern about any aspect of this study, you should ask to speak to the researcher Ada 
Mackovova, who will do her best to answer your questions. If you remain unhappy and wish to 
complain formally, you can do this by writing to [Professor Richard Gray, Edith Cavell Building, 
University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ].  
 
Alternatively, you can complain in writing to Professor Valerie Lattimer, Head of School of Nursing 
Sciences, Edith Cavell Building, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ. 
 
Please note that you may have to pay for postage of complaint letters. 
 
Thank you for your time and effort! 
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Appendix 27: Participant Reply slip for 
people with depression 
 
 
 
             
 
 
  REPLY SLIP: People with depression (Version 3: 29/02/2012) 
The Choice Study: What factors influence treatment choices 
made by people with depression?  
Please complete this reply slip and return it to us in the envelope provided, if you have been 
recommended or have received treatment for depression within the past 12 months, you are aged 
over 18 and you would like to take part in the above study. All information you provide will be kept 
strictly confidential. We will not give your details to anybody outside of our research team here at 
the University of East Anglia. 
 
Name:   Title:   ..... First name/s:  ........ Surname:  …....... 
 
Address:   House number/name:.........................................................................   
  
Street:  ........................................................................... 
Town/City:  .................................................  Postcode:  ................... 
 
Please provide your phone number or email for us to talk to you about dates and times of 
meetings: 
 
Phone: ............................................................................................................................ 
 
E-mail:  ..................................................................................................................................... 
 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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Personal meeting with the researcher 
Upon receiving your reply slip we will schedule a personal meeting with you and your family and 
friend if you wish to nominate someone. Please answer the following questions or circle the 
appropriate: 
 
a) I would like to identify my ‘family and friend’ for this study (please confirm this with your 
friend/ relative before providing their name!).        Yes    /    No 
b) My family and friend’s name is: ..................................................................................... 
c) My relationship with this person is: ............................................................................... 
(Please hand them the pack titled: “Information pack for the family and friends”).  
You can take part even if you do not nominate anyone to join in. 
 
1) Focus group sessions 
If you are returning this reply slip to us, you should be willing to attend two two-hour meetings at 
the University of East Anglia in Norwich.  
 
Which of the following session times would suit you best for the first session that will take place 
within the next 6 weeks?: 
 
 Tues Wed Thurs 
Morning (9am-12pm)    
Afternoon (12pm-4pm)    
Evening (6pm-9pm)    
 
If you are interested in taking part but for any reason feel uncomfortable with any aspect of this 
study, please contact us and we can discuss this with you. 
 
The second session will take place within the next 5 months and we will contact you in due course to 
inform you about the time and day of the session. 
 
2) In this study all participants must be over 18 years old.  
 
Please confirm your age: .................... 
Signature:  ...................................................................  Date:  ................................................. 
 
Thank you for completing this form. Please return it to us in the envelope provided by:  
We will be in touch with you within one week of receiving this form.  
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Appendix 28: Participant Reply slip for 
family and friends 
 
 
 
 
 
              REPLY SLIP: Family and friends (Version 3: 29/02/2012) 
The Choice Study: What factors influence treatment choices made by 
people with depression? 
 
Please complete this reply slip and return it to us in the pre-paid envelope provided, if you are a 
family or friend of a person with depression, you are aged over 18 and would like to take part in the 
above study. All information you provide will be kept strictly confidential. We will not give your 
details to anybody outside of our research team here at the University of East Anglia. 
 
Name:   Title:   ............ First name/s:  .................. Surname:  ................................ 
 
Address:   House number/name:................................................   
  
Street:  ............................................................. 
  
Town/City:  ..............................  Postcode:  .................................... 
 
Please provide your phone number or email for us to talk to you about dates and times of 
meetings: 
 
Phone: ............................................................................................................................ 
 
E-mail:  ................................................................................................................................... 
 
 
 
 
 
 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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3) Focus group sessions 
If you are returning this reply slip to us, you should be willing to attend two two-hour meetings at 
the University of East Anglia in Norwich.  
 
Which of the following session times would suit you best for the first session that will take place 
within the next 6 weeks?: 
 
 Tues Wed Thurs 
Morning (9am-12pm)    
Afternoon (12pm-4pm)    
Evening (6pm-9pm)    
 
If you are interested in taking part but for any reason feel uncomfortable with any aspect of this 
study, please contact us and we can discuss this with you. 
 
The second session will take place within the next 5 months and we will contact you in due course to 
inform you about the time and day of the session. 
 
 
4) In this study all participants must be over 18 years old.  
 
Please confirm your age: .................... 
 
 
Signature:  ...................................................................  Date:  ................................................. 
 
Thank you for completing this form. Please return it to us in the envelope provided  
by:  
 We will be in touch with you within one week of receiving this form.  
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Appendix 29: Participant Consent form for 
people with depression 
               
 
 
 
 
Consent form: People with depression (Version 4: 29/02/2012) 
The Choice Study: What factors influence treatment choices made by people with depression? 
 Researcher: Ada Mackovova 
 
 
Participant Identification Number for this study:   Please initial box  
1. I confirm that I have read and understand the information sheet for the research 
project “The Choice Study: What factors influence treatment choices made by 
people with depression?”, dated 29/02/2012 (version 4). 
 
 
2. I have had a chance to think about taking part in the study and ask any questions. 
I confirm that my questions have been answered to my satisfaction.  
 
 
3. I know that I do not have to take part and it is my own choice. If I start joining in 
this research study, I know that I can stop at any time if I want to. I do not have to 
give any reason for opting out if I decide to.  
 
4. I agree to have the group meeting audio-recorded. I understand that the audio-
recordings will be listened to by the research team at the University of East Anglia, 
they will be transcribed and securely stored for a minimum of 3 years. 
5. I understand that if I disclose information about any person being at risk of harm 
or of any unprofessional practice (e.g. prescription of an inappropriate treatment) 
confidentiality may have to be broken.  
6. I agree to take part in The Choice Study.  
 
Name of Participant (please print):  ............................................................ 
Signature:  ...................................... Date:  .................................. 
Name of Person taking consent (please print):  .................................................... 
Signature:  ........................................................ Date:  .................................. 
When completed: 1 copy for participant; 1 copy (original) for researcher site file. 
 
  
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation     
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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Appendix 30: Participant Consent form for 
family and friends 
 
 
 
 
 
 
Consent form: Family and friends (Version 4: 29/02/2012) 
The Choice Study: What factors influence treatment choices made by people with depression? 
 
 
 Researcher: Ada Mackovova 
Participant Identification Number for this study: 
Please initial box  
1. I confirm that I have read and understand the information sheet for the research 
project “The Choice Study: What factors influence treatment choices made by 
people with depression?”, dated 29/02/2012 (version 4) 
 
 
2. I have had a chance to think about taking part in the study and ask any questions. 
I confirm that my questions have been answered to my satisfaction.  
 
 
3. I know that I do not have to take part and it is my own choice. If I start joining in 
this research study, I know that I can stop at any time if I want to. I do not have to 
give any reason for opting out if I decide to.  
 
4. I agree to have the group meeting audio-recorded. I understand that the audio-
recordings will be listened to by the research team at the University of East Anglia, 
they will be transcribed and securely stored for a minimum of 3 years. 
 
5. I understand that if I disclose information about any person being at risk of harm 
or of any unprofessional practice (e.g. prescription of an inappropriate treatment) 
confidentiality may have to be broken. 
6. I agree to take part in The Choice Study.  
Name of Participant (please print):  ................................................ 
Signature:  .................................... Date:  .................................. 
Name of Person taking consent (please print):  .................................................... 
Signature:  ........................................................ Date:  .................................. 
When completed: 1 copy for participant; 1 copy (original) for researcher site file. 
 
 
  
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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Appendix 31: Participant Consent form for 
healthcare workers 
 
 
 
 
 
Consent form: Healthcare workers (Version 3: 29/02/2012) 
The Choice Study: What factors influence treatment choices made by people with depression? 
 Researcher: Ada Mackovova 
Participant Identification Number for this study: 
Please initial box  
1. I confirm that I have read and understand the information sheet for the research 
project “The Choice Study: What factors influence treatment choices made by 
people with depression?”, dated 29/02/2012 (version 3) 
 
 
2. I have had a chance to think about taking part in the study and ask any questions. 
I confirm that my questions have been answered to my satisfaction.  
 
 
3. I know that I do not have to take part and it is my own choice. If I start joining in 
this research study, I know that I can stop at any time if I want to. I do not have to 
give any reason for opting out if I decide to.  
 
4. I agree to have the group meeting audio-recorded. I understand that the audio-
recordings will be listened to by the research team at the University of East Anglia, 
they will be transcribed and securely stored for a minimum of 3 years. 
 
5. I understand that if I disclose information about any person being at risk of harm 
or of any unprofessional practice (e.g. prescription of an inappropriate treatment) 
confidentiality may have to be broken. 
 
6. I agree to take part in The Choice Study.  
Name of Participant (please print):  ........................................................ 
Signature:  .................................... Date:  .................................. 
Name of Person taking consent (please print):  .......................................... 
Signature:  ........................................................ Date:  .................................. 
When completed: 1 copy for participant; 1 copy (original) for researcher site file. 
  
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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Appendix 32: Participant Questionnaire for 
people with depression 
 
 
 
 
Questionnaire: People with depression (Version 3: 
29/02/2012) 
Researcher: Ada Mackovova 
Participant Identification Number for this study: 
The Choice Study: What factors influence treatment choices made by people with depression? 
Please complete this questionnaire if you have been recommended or have received treatment for 
depression within the past 12 months, you are aged over 18 years and you would like to take part in 
the above study. 
 
1) Are you: (tick the appropriate):  
 
 
2) What is your age? 
 
 
3) What is your ethnicity (tick the appropriate): 
White:  □  British □  Irish □  Other White background  
Mixed: □  White and Asian  □  White and Black African  
 □  White and Black Caribbean □  Other mixed background  
Asian or Asian 
British: 
□  Indian 
 
□  Pakistani 
□  Bangladeshi 
 
□  Other Asian background 
 
Black or Black 
British: 
 
□  African 
 
□  Caribbean 
 
□  Other Black background 
Other Ethnic 
Groups: 
□  Chinese □  Other ethnic group (please state): 
□  Not stated 
 
 
□  Male □  Female 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation     
 NHS Trust, NHS Norfolk, NHS Great Yarmouth and Waveney and Age UK.                                                       
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4) What is your marital status? 
 
5) What is your highest level of education? 
□  No formal qualification   
□  GCSE/O Level or equivalent  
□  A’ Level or equivalent 
□  University Degree or equivalent  
□  Postgraduate Degree/Diploma or equivalent 
 
 
6) What is your employment status? 
□  student   □  unemployed  □  employed part-time 
□  employed full time □  self-employed  □  retired 
 
7) What treatment(s) for depression were you prescribed or recommended most 
recently? 
 
 
 
8) What treatment for depression are you currently receiving? 
 
 
 
9) What year did you have your first period of depression in? 
 
 
 
10) How many periods of depression have you had? 
 
 
 
 
Thank you for completing this questionnaire! 
  
□  single 
 
□  divorced or separated 
 
□  married or co-habiting 
 
□  widowed 
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Appendix 33: Participant Questionnaire for 
family and friends 
 
 
 
Questionnaire: Family and friends (Version 3: 29/02/2012) 
Researcher: Ada Mackovova 
Participant Identification Number for this study: 
The Choice Study: What factors influence treatment choices made by people with depression? 
 
Please complete this questionnaire if you are close to a person with depression, you are aged over 
18 years and you would like to take part in the above study. 
 
1) Are you: (tick the appropriate): 
 
 
2) What is your age? 
 
3) What is your ethnicity (tick the appropriate): 
 
White:  □  British □  Irish □  Other White background  
Mixed: □  White and Asian  □  White and Black African  
 □  White and Black Caribbean □  Other mixed background  
Asian or Asian 
British: 
□  Indian 
 
□  Pakistani 
□  Bangladeshi 
 
□  Other Asian background 
 
Black or Black 
British: 
 
□  African 
 
□  Caribbean 
 
□  Other Black background 
Other Ethnic 
Groups: 
□  Chinese □  Other ethnic group (please state): 
 
□  Not stated 
 
 
 
 
 
 
□  Male □  Female 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
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4) What is your marital status? 
 
5) What is your highest level of education? 
□  No formal qualification   
□  GCSE/O Level or equivalent  
□  A’ Level or equivalent 
□  University Degree or equivalent  
□  Postgraduate Degree/Diploma or equivalent 
 
 
6) What is your employment status? 
□  student   □  unemployed  □  employed part-time 
□  employed full time □  self-employed  □  retired 
 
7) Are you (or have you recently been) receiving treatment for depression? 
 
 
 
8) If applicable, what treatment for depression did you receive most recently? 
 
 
 
9) What is your relationship to the person with depression who is close to you? 
 
 
 
10) Is the person with depression who is close to you, taking part in this study? 
 
 
 
 
Thank you for completing this questionnaire! 
 
  
□  single 
 
□  divorced or separated 
 
□  married or co-habiting 
 
□  widowed 
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Appendix 34: Useful Information Sheet 
Useful Information Sheet (Version 3: 29/02/2012) 
 
Thank you for taking part in our study and for sharing your opinion with us. If you would like any 
additional information about this study contact Ada Mackovova (07707 298277 or 
a.mackovova@uea.ac.uk), address:  
 
The Choice Study, School of Nursing Sciences, Edith Cavell Building, University of East Anglia, 
Norwich Research Park, Norwich NR4 7TJ. 
 
Helpful telephone numbers and websites 
Below is a list of several charity organisations that provide support to people who are in distress or 
emotional crisis. Please remember that you should contact your GP if your problems persist. 
  
NHS Direct 
Telephone: 0845 46 47 
Lines are open 24-hours every day.  
 
Samaritans: www.samaritans.org.uk 
Samaritans provide 24-hour confidential emotional support to anyone experiencing feelings of 
distress.  
 
Telephone: 0845 7909 090 
Telephone from most mobile providers and some landlines: 116 123 
 
Age UK Norwich: http://www.ageuk.org.uk/norwich/   
The Age UK Group works to improve later life for everyone by providing life-enhancing services and 
vital support. 
 
Local Service, telephone: 01603 496333 
Lines are open 5 days a week Monday to Friday 10.00 am to 4.00 pm each day, except Wednesday 
when they close at 2.00 pm for staff training. 
 
Sane: http://www.sane.org.uk/what_we_do/support/helpline/  
SANE runs a national, out-of-hours helpline offering specialist emotional support and information to 
anyone affected by mental illness, including family, friends and carers.  
Telephone: 0845 767 8000 
Lines are open every day of the year from 6pm to 11pm. 
 
Please note that rates for the above numbers vary. For details please check with your 
mobile/landline phone provider. 
 
 
 
 
 
 
  
 
This study is run in collaboration with Norfolk and Suffolk Foundation    
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Appendix 35: Refusal letter to prevent over-
recruitment (Version 3: 29/02/2012) 
 
Ada Mackovova 
The Choice Study 
Edith Cavell Building 
University of East Anglia 
Norwich Research Park 
 
Norwich, NR4 7TJ 
Email: a.mackovova@uea.ac.uk, Tel: 07707 298 277 
 
Date: 
 
 
Dear Sir or Madam, 
 
 
We would like to thank you for your interest in our study. Unfortunately, we are unable to invite you 
to take part in this study because we have already recruited the necessary number of participants. 
We really appreciate your offer of help. 
 
 
Kind regards, 
 
 
Ada Mackovova 
Researcher  
 
 
 
 
 
 
 
 
 
 
This study is run in collaboration with Norfolk and Suffolk Foundation      
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Appendix 36: Brainstorming session plan 
and list of prompts 
The Choice study: What factors influence treatment choices made by people with depression? 
Tasks before the sessions: 
x Prepare the room set up 
x Put post-it notes and pens on tables 
x Water on each desk 
x Start the voice recorders 
x Refreshments 
x Name badges, travel expenses forms, parking permits 
Introduction to the session: all participants together (Ada) 
x Thank everybody for coming and their time and effort 
x Introduce myself and the helpers – briefly; let helpers say something about themselves 
x Roles   
o mine and facilitators’ – give everybody a chance to talk and make their point. 
Sometimes people talk a little or a lot and my role is to give everyone option to 
speak. 
o people with depression – to freely say what factors influenced your choice of 
treatment for depression 
o Family and friends – your views of the factors that influenced treatment choices 
made by the person with depression 
x Ground rules  
o  time limits –break at... finish at... 
o Speaking one at a time 
o No judgement of ideas/people 
o right to withdraw 
o Post-it notes and pens – feel free to use them 
x Agenda  
o We are interested in understanding how people with depression make their 
decisions about what treatment for depression they take. What factors influence 
their preferences/choices of therapies they used/didn’t use 
o  today’s task – to generate as many statements as possible to finish the focus 
sentence: 
o ‘My most recent choice of treatment for depression was influenced by:’ 
o ‘Treatment choices made by people with depression are influenced by:’ 
Focus group suggested areas of discussion (prompts) 
x What first comes to your mind when you see the focus sentence? 
o How did you make the choice of treatment you are taking? 
x Treatment options  
o Different antidepressants  
o Talking therapies  
o Alternative therapies  
o What made you think of the particular therapy?  
o if people mention wanting a ‘healthy’ or ‘non-drug’ treatments: How would your 
view about treatments be different if you had e.g. a back pain? 
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x Decision to seek help 
o How did you realize you needed help? 
o How difficult/easy was this decision? 
o What made you visit the particular practitioner? 
x Beating it on your own – many people mention this as an option, what do you think about 
it and how did it affect your decisions? 
x GP/ other health practitioners 
o Relationship, expertise, behaviour, etc. 
x Family, friends, co-workers, other people 
o What effect do people around you have on your decisions? 
o How do other people influence your preferences? 
x Attitudes towards depression and different treatments in society (your family, etc.) 
x Information sources 
o Where do you find information about depression/treatments? 
o How do you know you can trust them? 
Topic areas - prompts 
Medication or technology Is there anything else you want to say about medication 
or any technology  or equipment that has influenced 
decisions? 
Attitudes Is there anything about other people’s 
attitudes?  Professionals or colleagues, family, or any 
other people? 
Environment Anything about the home environment, or work 
environment, or the area/ town/ village the person with 
depression lives in? 
Support and relationships Is there anything about family relationships that makes a 
difference to decision-making? 
What about services that are provided, or the health 
system? 
Physical health/condition Anything about the person with depression’s physical 
health/ condition? 
Involvement in activities Anything about being able or unable to take part in 
things the person with depression would like to be 
involved in? 
End of session (Ada) 
x Thank everybody for coming and their contribution 
x What will happen next –  
o we will run more focus groups with other participants 
o I will contact you within the next 5 months or so – to invite you to the next 
session 
o Next session – you will rank the statements and group them together 
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Appendix 37: Instructions and helping 
sheets used in prioritising and clustering 
  
Ada Mackovova 
The Choice study 
Edith Cavell Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Mobile: 07898 287 055 
Email: a.mackovova@uea.ac.uk 
 
7th September 2012 
 
  
Dear (name), 
 
RE: The Choice study: How do people with depression make treatment choices? 
 
Thank you very much for taking part in a brainstorming session which was the first part of the above 
research study. I am now inviting you to complete two tasks which form the last phase of this 
project: 1) Prioritizing, and 2) Clustering. Each task should take approximately 30-60 minutes and all 
you will need is this sheet and a set of cards with statements about how people with depression 
make treatment choices (enclosed).  
There are no right or wrong answers as we are interested in your own opinions on this issue. 
Therefore, I would be very grateful if you could complete these tasks on your own, without 
discussing them with other people.  
Once you have completed the tasks, please post the sheets with your answers to me in the enclosed 
stamped envelope. 
 
Thank you very much for your help with this research study. If you have any questions or would like 
to discuss this project further, please contact me. 
 
Kind regards, 
 
Ada Mackovova 
Researcher  
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The Prioritising task: 
Please sort the cards into five piles, according to how important you think the statements written on 
them are. Make sure there are no more than 12, and no less than 11 cards in each pile. Please use all 
cards, but remember that each card can only be used once: 
Pile 1 = the least important statements  
Pile 2 = somewhat important statements 
Pile 3 = moderately important statements 
Pile 4 = very important statements  
Pile 5 = the most important statements 
Once you have finished this task, please write the card numbers in the appropriate columns in the 
table below: 
No. 
of 
Cards   
Pile 1: the 
LEAST 
important  
Pile 2: 
SOMEWHAT 
important 
Pile 3: 
MODERATELY 
important 
Pile 4:  
VERY 
important 
Pile 5: the 
MOST 
important 
1      
2      
3      
4      
5      
6      
7      
8      
9      
10      
11      
12      
 
The Clustering task 
This is completely separate from the first task. To complete the clustering task, please put into 
groups (clusters) the statements that you think go together. I would be very grateful if you could 
follow the rules below: 
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Please use all cards, but remember each card can only be used once. 
You can create a minimum of 2 and a maximum of 12 groups, and: 
Do not put all statements into one group. 
Each group must contain more than one card. 
Please note down the number of each card in each of your ‘groups’ in the table overleaf. 
Please put a name/label to each group (cluster), as they make most sense to you. 
 
Table 2: The Clustering task: Please note down the number of each card as you put them into groups 
(clusters). There is an additional table on the following page, should you have more clusters. 
 Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7 
Group 
label: 
       
Card 
numbers: 
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 Group 8 Group 9 Group 10     
Group 
label: 
       
Card 
numbers: 
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Appendix 38: Results of PCA: 
statements’ scores on five dimensions 
 
Statement Scores Dimension: 
  1 2 3 4 5 
1 Financial costs related to the particular 
treatment option 
.05 .03 -.18 .18 .06 
2 Practical issues related to starting 
treatment 
.07 .12 -.14 .19 .02 
3 Being given a choice of treatments .01 .24 -.08 .04 .04 
4 Recognizing I have a problem I need 
help with 
.15 .05 .16 -.19 .2 
5 Playing an active role in getting better .15 .06 .14 -.15 .22 
6 Desperation to try anything that could 
help 
.15 -.05 .2 .15 -.02 
7 Information about depression and its 
treatment 
-.02 .23 -.09 -.02 -.04 
8 Having my view about what is the best 
treatment confirmed 
-.01 .23 -.07 -.02 .04 
9 Inability to make a choice because of 
my depression 
.14 -.08 .2 .14 -.05 
10 Beliefs of family and friends about 
depression 
0 -.2 -.14 -.05 -.13 
11 Weighing up the risks and benefits of 
treatments 
.07 .24 -.12 0 0 
12 Wanting a treatment that works 
quickly 
.12 .11 0 .23 .02 
13 My past experiences of treatment .09 .11 -.03 -.22 -.15 
14 Feeling it's my fault for having 
depression 
.14 -.11 .16 .12 -.13 
15 Worries about the side effects of 
medication 
.08 .17 -.1 .16 -.15 
16 My knowledge and understanding of 
the effects of treatment 
.06 .23 -.11 -.02 -.05 
17 Wanting to share my experiences with 
depression with others 
.07 -.03 -.05 -.26 -.24 
18 Healthcare professionals' beliefs about 
depression and its treatment 
-.22 .04 .1 0 .01 
19 Healthcare professionals' knowledge 
and understanding about depression 
and its treatment 
-.21 .05 .1 -.01 .02 
20 My relationship with the healthcare 
professional 
-.22 .04 .1 -.01 .03 
21 My personal characteristics (age, being 
male or female, ethnicity - being black, 
white or other) 
-.02 -.19 -.21 -.02 0.23 
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22 Culture (my background as well as my 
current culture) 
0 -.2 -.23 -.01 .17 
23 My religion 0 -.2 -.22 .01 .21 
24 Continuity of care (seeing the same 
healthcare professional) 
-.22 .04 .11 0 .02 
25 Personal characteristics of the 
healthcare professional (age, being 
male or female, ethnicity - being black, 
white or other) 
-.21 -.04 .01 0 .12 
26 My understanding of the side effects 
of treatment 
.05 .23 -.14 .06 -.1 
27 My experiences with healthcare 
professionals 
-.21 .04 .1 -.04 -.02 
28 My expectations from healthcare 
professionals 
-.21 .04 .11 -.01 0 
29 Wanting to escape from the situation .14 -.08 .21 .15 0 
30 My past experience with depression 
(knowing whether I can feel better or 
not) 
.09 .04 -.02 -.26 -.11 
31 How I feel right now .16 -.05 .2 .02 .08 
32 Fear of dealing with problems .14 -.09 .2 .13 -.05 
33 Desire to get to the root (the bottom) 
of depression 
.15 .07 .1 -.16 .19 
34 Not wanting to have depression listed 
in health records 
.02 -.08 -.05 .22 -.11 
35 A desire to get better for people I care 
about 
.12 -.08 .14 -.1 -.02 
36 Isolation, and not having the support 
network close 
.09 -.13 .08 .13 -.14 
37 My belief that depression is a chemical 
imbalance 
.09 .12 -.09 -.06 -.07 
38 Understanding it is normal to have 
depression and I am not alone 
.13 .08 .06 -.25 0 
39 Thinking that nothing can help me .14 -.08 .21 .15 -.07 
40 Having an introverted or extroverted 
personality 
.02 -.19 -.17 -.02 .27 
41 Wanting to please the doctor (to be a 
good patient) 
-.15 -.01 .09 .06 -.05 
42 Realizing all people's experiences with 
depression are different 
.09 .01 -.01 -.33 -.16 
43 Being ready to accept treatment .13 .12 .11 -.12 .27 
44 Being ready to engage with treatment .14 .13 .09 -.09 .28 
45 Healthcare professionals being ready 
to discuss depression and its 
treatment with family and friends 
-.21 .03 .11 0 0 
46 Worries about becoming dependent 
on medication 
.08 .18 -.09 .13 -.14 
47 Realizing there is no quick fix .15 .09 .09 -.17 .16 
48 Views about depression in society .01 -.17 -.17 -.06 -.17 
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49 Not wanting to be a burden on others .12 -.11 .16 .03 -.12 
50 Wanting the easiest treatment .12 .11 .02 .2 .07 
51 My upbringing .01 -.21 -.21 -.02 .18 
52 The healthcare professionals' 
personality 
-.22 .02 .09 -.01 .06 
53 Healthcare professionals discussing 
depression and its treatment openly 
-.21 .05 .1 -.01 .02 
54 Wanting a 'natural' treatment .09 .14 -.17 .14 .05 
55 Other people's experiences with 
depression and its treatment 
.03 -.09 -.11 -.22 -.35 
56 Being given a clear diagnosis -.12 .17 .05 -.04 .02 
57 Communication between different 
healthcare professionals 
-.22 .03 .11 0 .02 
58 Wanting what doctors say is the most 
effective treatment 
-.15 .16 .05 .04 .01 
59 Wanting a treatment that is provided 
with no time limitations 
.09 .16 -.1 .15 .08 
 
 
 
